{
  "graph": {
    "directed": false,
    "type": "BEL-V1.0",
    "label": "Response to DNA Damage-2.0-Hs",
    "metadata": {
      "description": "The Response to DNA Damage network depicts the causal mechanisms that are involved in multiple DNA damage response pathways. This includes those components that regulate TP53, TP63, and TP73 activities, the impact of G1/S and G2/M transitions of the cell cycle downstream of DNA damage, and DNA repair processes following single-strand and double-strand DNA damage. The network describes inhibition of DNA repair by various exogenous compounds, as well as components that function in nucleotide excision repair such as the XP proteins.\\u003c/p\\u003e\\n\\u003ch2\\u003eJamboree Review Focus\\u003c/h2\\u003e\\n\\u003cp\\u003eInterplay of components medaiting the processes of non-homologous end-joining (NHEJ) and homologous recombination (HR). Reviewed during Jamboree2014",
      "species_common_name": "Human",
      "version": "2.0",
      "boundary_conditions": "The human model sets represent healthy processes and were not enhanced with COPD data or literature due to the lack of relevant COPD literature for these processes at the time of construction. If COPD literature is identified, it is acceptable to add to these networks. We prioritized data collected from studies of lung-relevant cell types. We excluded cancer, idiopathic pulmonary fibrosis, cystic fibrosis, all virus infections, all bacterial infections, septic pneumonitis, acute respiratory distress syndrome (ARDS), allergic responses/asthma, pneumoconiosis, and COPD exacerbations. We also excluded animal inhalation studies with solid particles (titanium dioxide, quartz, asbestos, carbon black, diesel exhaust etc). For the in vitro-specific exclusion criteria we excluded tumor-derived cell lines, immortalized cell lines, neuronal cells, and cell types that cannot be found in the respiratory/vascular system. There were some exceptions where we included immortalized cell lines and non-lung cell types for canonical mechanisms where there was evidence that the relationship was not tissue-specific but could also take place in the lung. Human-specific connections were preferred, but rat and mouse were also included where human data was not available."
    },
    "nodes": [
      {
        "id": "kin(p(HGNC:CHEK2))",
        "label": "kin(p(HGNC:CHEK2))",
        "metadata": {
          "coordinate": [
            0.334646228088851,
            0.441682389237276
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe081e"
        }
      },
      {
        "id": "bp(GOBP:\"nucleotide-excision repair\")",
        "label": "bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "coordinate": [
            0.300581931729473,
            0.769359192247617
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe081f"
        }
      },
      {
        "id": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "label": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "coordinate": [
            0.85306223830814,
            0.338286726120984
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0820"
        }
      },
      {
        "id": "bp(GOBP:\"DNA repair\")",
        "label": "bp(GOBP:\"DNA repair\")",
        "metadata": {
          "coordinate": [
            0.0905831302937973,
            0.437229671719125
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "alvarrben",
          "nodeId": "55775d252f9e24174cfe0917"
        }
      },
      {
        "id": "p(HGNC:TP73,pmod(P,S,47))",
        "label": "p(HGNC:TP73,pmod(P,S,47))",
        "metadata": {
          "coordinate": [
            0.568838265559577,
            0.546364068063971
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0822"
        }
      },
      {
        "id": "phos(p(HGNC:CDC25A))",
        "label": "phos(p(HGNC:CDC25A))",
        "metadata": {
          "coordinate": [
            0.570612447661628,
            0.606549603310768
          ],
          "bel_function_type": "phosphataseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0823"
        }
      },
      {
        "id": "p(HGNC:FANCD2)",
        "label": "p(HGNC:FANCD2)",
        "metadata": {
          "coordinate": [
            0.515257966077638,
            0.453513733772972
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0824"
        }
      },
      {
        "id": "p(HGNC:WRN)",
        "label": "p(HGNC:WRN)",
        "metadata": {
          "coordinate": [
            0.445710027677241,
            0.267813065190973
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0825"
        }
      },
      {
        "id": "p(HGNC:XPC)",
        "label": "p(HGNC:XPC)",
        "metadata": {
          "coordinate": [
            0.101385263709219,
            0.848200950667438
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0826"
        }
      },
      {
        "id": "kin(p(HGNC:CHEK1))",
        "label": "kin(p(HGNC:CHEK1))",
        "metadata": {
          "coordinate": [
            0.467709885742673,
            0.518071722435134
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0827"
        }
      },
      {
        "id": "p(HGNC:POLB)",
        "label": "p(HGNC:POLB)",
        "metadata": {
          "coordinate": [
            0.208679298843233,
            0.722548220388997
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0828"
        }
      },
      {
        "id": "p(HGNC:CHEK1,pmod(P,S,317))",
        "label": "p(HGNC:CHEK1,pmod(P,S,317))",
        "metadata": {
          "coordinate": [
            0.42548435171386,
            0.454799749483373
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0829"
        }
      },
      {
        "id": "p(HGNC:RAD23B)",
        "label": "p(HGNC:RAD23B)",
        "metadata": {
          "coordinate": [
            0.136577555820214,
            0.881987876815575
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe082a"
        }
      },
      {
        "id": "tscript(p(HGNC:YY1))",
        "label": "tscript(p(HGNC:YY1))",
        "metadata": {
          "coordinate": [
            0.302710950251934,
            0.518328925577215
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe082b"
        }
      },
      {
        "id": "p(EGID:5424,pmod(P,Y,15))",
        "label": "p(EGID:5424,pmod(P,Y,15))",
        "metadata": {
          "coordinate": [
            0.684160102192889,
            0.677023264240778
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe082c"
        }
      },
      {
        "id": "p(HGNC:RASSF1)",
        "label": "p(HGNC:RASSF1)",
        "metadata": {
          "coordinate": [
            0.641934568164076,
            0.447083655220963
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe082d"
        }
      },
      {
        "id": "p(HGNC:LIG1)",
        "label": "p(HGNC:LIG1)",
        "metadata": {
          "coordinate": [
            0.391065218934071,
            0.837775228040985
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe082e"
        }
      },
      {
        "id": "p(HGNC:CDKN2A)",
        "label": "p(HGNC:CDKN2A)",
        "metadata": {
          "coordinate": [
            0.514113829315893,
            0.557197545802913
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe082f"
        }
      },
      {
        "id": "complex(SCOMP:\"TFIIH Complex\")",
        "label": "complex(SCOMP:\"TFIIH Complex\")",
        "metadata": {
          "coordinate": [
            0.251259669292456,
            0.892045091019934
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0830"
        }
      },
      {
        "id": "p(HGNC:APEX1)",
        "label": "p(HGNC:APEX1)",
        "metadata": {
          "coordinate": [
            0.113937974593712,
            0.677023264240778
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0831"
        }
      },
      {
        "id": "p(HGNC:NBN,pmod(A))",
        "label": "p(HGNC:NBN,pmod(A))",
        "metadata": {
          "coordinate": [
            0.294827697143066,
            0.0454545454545455
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0832"
        }
      },
      {
        "id": "p(HGNC:ATF2,pmod(P,S,490))",
        "label": "p(HGNC:ATF2,pmod(P,S,490))",
        "metadata": {
          "coordinate": [
            0.515967638918458,
            0.352947305219562
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0833"
        }
      },
      {
        "id": "p(HGNC:APTX)",
        "label": "p(HGNC:APTX)",
        "metadata": {
          "coordinate": [
            0.173851779332606,
            0.6657375993576
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0834"
        }
      },
      {
        "id": "p(HGNC:PRKDC)",
        "label": "p(HGNC:PRKDC)",
        "metadata": {
          "coordinate": [
            0.325775317578596,
            0.245950798114145
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0835"
        }
      },
      {
        "id": "p(HGNC:PRKDC,pmod(P,S,2056))",
        "label": "p(HGNC:PRKDC,pmod(P,S,2056))",
        "metadata": {
          "coordinate": [
            0.319743098431623,
            0.275271956311303
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0836"
        }
      },
      {
        "id": "p(HGNC:RAD51,pmod(P,Y,54))",
        "label": "p(HGNC:RAD51,pmod(P,Y,54))",
        "metadata": {
          "coordinate": [
            0.636966858278334,
            0.278101190874186
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0837"
        }
      },
      {
        "id": "p(HGNC:PNKP)",
        "label": "p(HGNC:PNKP)",
        "metadata": {
          "coordinate": [
            0.236711376055638,
            0.72486304866772
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0838"
        }
      },
      {
        "id": "p(HGNC:TP53,pmod(P,S,37))",
        "label": "p(HGNC:TP53,pmod(P,S,37))",
        "metadata": {
          "coordinate": [
            0.346000993541977,
            0.401558699072745
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0839"
        }
      },
      {
        "id": "p(HGNC:HUS1)",
        "label": "p(HGNC:HUS1)",
        "metadata": {
          "coordinate": [
            0.346293262097428,
            0.657651201289814
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe083a"
        }
      },
      {
        "id": "cat(p(HGNC:ERCC8))",
        "label": "cat(p(HGNC:ERCC8))",
        "metadata": {
          "coordinate": [
            0.312646370023419,
            0.836489212330583
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe083b"
        }
      },
      {
        "id": "cat(p(HGNC:POLE))",
        "label": "cat(p(HGNC:POLE))",
        "metadata": {
          "coordinate": [
            0.2771627279824,
            0.737723205771736
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe083c"
        }
      },
      {
        "id": "p(HGNC:FANCD2,pmod(P,S,1257))",
        "label": "p(HGNC:FANCD2,pmod(P,S,1257))",
        "metadata": {
          "coordinate": [
            0.504967709885743,
            0.403101917925227
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe083d"
        }
      },
      {
        "id": "kin(p(HGNC:PRKDC))",
        "label": "kin(p(HGNC:PRKDC))",
        "metadata": {
          "coordinate": [
            0.376162089276843,
            0.311280396202549
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe083e"
        }
      },
      {
        "id": "p(HGNC:TP53)",
        "label": "p(HGNC:TP53)",
        "metadata": {
          "coordinate": [
            0.525548222269534,
            0.487978954811736
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe083f"
        }
      },
      {
        "id": "p(HGNC:ATM)",
        "label": "p(HGNC:ATM)",
        "metadata": {
          "coordinate": [
            0.396032928819814,
            0.415704871887163
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0840"
        }
      },
      {
        "id": "p(HGNC:XRCC1)",
        "label": "p(HGNC:XRCC1)",
        "metadata": {
          "coordinate": [
            0.140905542544887,
            0.630726698666319
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0841"
        }
      },
      {
        "id": "p(HGNC:FEN1)",
        "label": "p(HGNC:FEN1)",
        "metadata": {
          "coordinate": [
            0.465935703640622,
            0.815655757822076
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0842"
        }
      },
      {
        "id": "p(HGNC:SFN)",
        "label": "p(HGNC:SFN)",
        "metadata": {
          "coordinate": [
            0.526257895110354,
            0.524244597845062
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0843"
        }
      },
      {
        "id": "kin(p(HGNC:ABL1))",
        "label": "kin(p(HGNC:ABL1))",
        "metadata": {
          "coordinate": [
            0.601483216237315,
            0.255210111229037
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0844"
        }
      },
      {
        "id": "kin(p(HGNC:RPS6KB1))",
        "label": "kin(p(HGNC:RPS6KB1))",
        "metadata": {
          "coordinate": [
            0.269001490312966,
            0.237463094425494
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0845"
        }
      },
      {
        "id": "p(HGNC:WWOX)",
        "label": "p(HGNC:WWOX)",
        "metadata": {
          "coordinate": [
            0.735256546731956,
            0.569769553993281
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0846"
        }
      },
      {
        "id": "p(HGNC:BRCA1,pmod(P,S,1457))",
        "label": "p(HGNC:BRCA1,pmod(P,S,1457))",
        "metadata": {
          "coordinate": [
            0.392484564615712,
            0.437309935821911
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0847"
        }
      },
      {
        "id": "kin(p(HGNC:CDK2))",
        "label": "kin(p(HGNC:CDK2))",
        "metadata": {
          "coordinate": [
            0.250549996451636,
            0.246465204398306
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0848"
        }
      },
      {
        "id": "p(HGNC:TP73,pmod(P,T,27))",
        "label": "p(HGNC:TP73,pmod(P,T,27))",
        "metadata": {
          "coordinate": [
            0.747675821446313,
            0.60063393104292
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0849"
        }
      },
      {
        "id": "a(SCHEM:\"double-stranded DNA break\")",
        "label": "a(SCHEM:\"double-stranded DNA break\")",
        "metadata": {
          "coordinate": [
            0.48154850613867,
            0.35063247694084
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe084a"
        }
      },
      {
        "id": "p(HGNC:FANCI)",
        "label": "p(HGNC:FANCI)",
        "metadata": {
          "coordinate": [
            0.355260740154011,
            0.494617100894634
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe084b"
        }
      },
      {
        "id": "p(HGNC:ABL1,pmod(P,S,446))",
        "label": "p(HGNC:ABL1,pmod(P,S,446))",
        "metadata": {
          "coordinate": [
            0.507806401249024,
            0.320282506175361
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe084c"
        }
      },
      {
        "id": "a(SCHEM:Nickel)",
        "label": "a(SCHEM:Nickel)",
        "metadata": {
          "coordinate": [
            0.23990490383933,
            0.784534177630356
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe084d"
        }
      },
      {
        "id": "p(HGNC:ATM,pmod(P,S,1981))",
        "label": "p(HGNC:ATM,pmod(P,S,1981))",
        "metadata": {
          "coordinate": [
            0.393194237456533,
            0.368379493744382
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe084e"
        }
      },
      {
        "id": "cat(p(HGNC:ERCC5))",
        "label": "cat(p(HGNC:ERCC5))",
        "metadata": {
          "coordinate": [
            0.222872755659641,
            0.90464804498187
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe084f"
        }
      },
      {
        "id": "deg(p(HGNC:CDKN1A))",
        "label": "deg(p(HGNC:CDKN1A))",
        "metadata": {
          "coordinate": [
            0.563870555673834,
            0.649502528038183
          ],
          "bel_function_type": "degradation",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0850"
        }
      },
      {
        "id": "p(HGNC:CDC25A)",
        "label": "p(HGNC:CDC25A)",
        "metadata": {
          "coordinate": [
            0.5,
            0.64718769975946
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0851"
        }
      },
      {
        "id": "p(HGNC:FANCD2,pmod(P,S,222))",
        "label": "p(HGNC:FANCD2,pmod(P,S,222))",
        "metadata": {
          "coordinate": [
            0.490419416648925,
            0.406445558772271
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0852"
        }
      },
      {
        "id": "p(HGNC:RAD52)",
        "label": "p(HGNC:RAD52)",
        "metadata": {
          "coordinate": [
            0.55535448158399,
            0.242607157267101
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0853"
        }
      },
      {
        "id": "kin(p(HGNC:POLD1))",
        "label": "kin(p(HGNC:POLD1))",
        "metadata": {
          "coordinate": [
            0.600063870555674,
            0.620695776125186
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0854"
        }
      },
      {
        "id": "p(HGNC:RHOA)",
        "label": "p(HGNC:RHOA)",
        "metadata": {
          "coordinate": [
            0.954545454545454,
            0.281702034863311
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0855"
        }
      },
      {
        "id": "kin(p(HGNC:PLK1))",
        "label": "kin(p(HGNC:PLK1))",
        "metadata": {
          "coordinate": [
            0.814739904903839,
            0.626097042108873
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0856"
        }
      },
      {
        "id": "p(HGNC:CHEK2,pmod(P,S,33))",
        "label": "p(HGNC:CHEK2,pmod(P,S,33))",
        "metadata": {
          "coordinate": [
            0.378291107799304,
            0.395128620520737
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0857"
        }
      },
      {
        "id": "p(HGNC:RNF8)",
        "label": "p(HGNC:RNF8)",
        "metadata": {
          "coordinate": [
            0.49578687571059,
            0.446512164012028
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0858"
        }
      },
      {
        "id": "kin(p(SFAM:\"AKT Family\"))",
        "label": "kin(p(SFAM:\"AKT Family\"))",
        "metadata": {
          "coordinate": [
            0.63022496629054,
            0.7094308601429
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0859"
        }
      },
      {
        "id": "cat(p(HGNC:XRCC1))",
        "label": "cat(p(HGNC:XRCC1))",
        "metadata": {
          "coordinate": [
            0.206195443900362,
            0.634327542655444
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe085a"
        }
      },
      {
        "id": "p(SFAM:\"PPP1R Family\")",
        "label": "p(SFAM:\"PPP1R Family\")",
        "metadata": {
          "coordinate": [
            0.190937477822724,
            0.369151103170623
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe085b"
        }
      },
      {
        "id": "tscript(p(HGNC:E2F1))",
        "label": "tscript(p(HGNC:E2F1))",
        "metadata": {
          "coordinate": [
            0.325420481158186,
            0.387155323116246
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe085c"
        }
      },
      {
        "id": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "metadata": {
          "coordinate": [
            0.5278546590022,
            0.538519372230521
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe085d"
        }
      },
      {
        "id": "kin(p(HGNC:SRC))",
        "label": "kin(p(HGNC:SRC))",
        "metadata": {
          "coordinate": [
            0.849513874104038,
            0.602177149895402
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe085e"
        }
      },
      {
        "id": "p(HGNC:SMC1A)",
        "label": "p(HGNC:SMC1A)",
        "metadata": {
          "coordinate": [
            0.602065358969708,
            0.336265217257472
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe085f"
        }
      },
      {
        "id": "p(HGNC:CDKN1A,pmod(P,T,145))",
        "label": "p(HGNC:CDKN1A,pmod(P,T,145))",
        "metadata": {
          "coordinate": [
            0.584805904478036,
            0.666477935415485
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0860"
        }
      },
      {
        "id": "a(SCHEM:Arsenic)",
        "label": "a(SCHEM:Arsenic)",
        "metadata": {
          "coordinate": [
            0.247356468667944,
            0.799194756728935
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0861"
        }
      },
      {
        "id": "cat(p(HGNC:SIRT1))",
        "label": "cat(p(HGNC:SIRT1))",
        "metadata": {
          "coordinate": [
            0.72212759917678,
            0.593946649348832
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0862"
        }
      },
      {
        "id": "cat(p(HGNC:POLE2))",
        "label": "cat(p(HGNC:POLE2))",
        "metadata": {
          "coordinate": [
            0.347065502803208,
            0.870440027085186
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0863"
        }
      },
      {
        "id": "p(HGNC:GADD45A)",
        "label": "p(HGNC:GADD45A)",
        "metadata": {
          "coordinate": [
            0.515257966077638,
            0.582629711097297
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0864"
        }
      },
      {
        "id": "p(HGNC:ERCC4)",
        "label": "p(HGNC:ERCC4)",
        "metadata": {
          "coordinate": [
            0.142158565901857,
            0.836491676212702
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0865"
        }
      },
      {
        "id": "p(HGNC:ATRIP)",
        "label": "p(HGNC:ATRIP)",
        "metadata": {
          "coordinate": [
            0.389645873252431,
            0.585458945660181
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0866"
        }
      },
      {
        "id": "p(HGNC:FANCD2,pmod(P,T,691))",
        "label": "p(HGNC:FANCD2,pmod(P,T,691))",
        "metadata": {
          "coordinate": [
            0.461677666595699,
            0.481806079401808
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0867"
        }
      },
      {
        "id": "p(HGNC:RHOB)",
        "label": "p(HGNC:RHOB)",
        "metadata": {
          "coordinate": [
            0.738804910936058,
            0.3668362748919
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0868"
        }
      },
      {
        "id": "p(HGNC:WRN,pmod(P,S,1292))",
        "label": "p(HGNC:WRN,pmod(P,S,1292))",
        "metadata": {
          "coordinate": [
            0.434000425803704,
            0.318739287322879
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0869"
        }
      },
      {
        "id": "p(HGNC:BRCA1,pmod(P,S,1466))",
        "label": "p(HGNC:BRCA1,pmod(P,S,1466))",
        "metadata": {
          "coordinate": [
            0.434710098644525,
            0.427279013280778
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe086a"
        }
      },
      {
        "id": "p(HGNC:POLD1)",
        "label": "p(HGNC:POLD1)",
        "metadata": {
          "coordinate": [
            0.653644170037613,
            0.656189809732272
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe086b"
        }
      },
      {
        "id": "phos(p(SFAM:\"PPP1R Family\"))",
        "label": "phos(p(SFAM:\"PPP1R Family\"))",
        "metadata": {
          "coordinate": [
            0.263678944006813,
            0.387155323116246
          ],
          "bel_function_type": "phosphataseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe086c"
        }
      },
      {
        "id": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "label": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "metadata": {
          "coordinate": [
            0.609289617486339,
            0.546364068063971
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe086d"
        }
      },
      {
        "id": "p(HGNC:RIF1)",
        "label": "p(HGNC:RIF1)",
        "metadata": {
          "coordinate": [
            0.490419416648925,
            0.421877747297091
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe086e"
        }
      },
      {
        "id": "p(HGNC:CHEK1,pmod(P,S,345))",
        "label": "p(HGNC:CHEK1,pmod(P,S,345))",
        "metadata": {
          "coordinate": [
            0.443226172734369,
            0.455828562051694
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe086f"
        }
      },
      {
        "id": "kin(p(HGNC:ATR))",
        "label": "kin(p(HGNC:ATR))",
        "metadata": {
          "coordinate": [
            0.351146121637925,
            0.536847551806998
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0870"
        }
      },
      {
        "id": "p(HGNC:TP53,pmod(P,T,18))",
        "label": "p(HGNC:TP53,pmod(P,T,18))",
        "metadata": {
          "coordinate": [
            0.335710737350082,
            0.484635313964692
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0871"
        }
      },
      {
        "id": "bp(GOBP:\"base-excision repair\")",
        "label": "bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "coordinate": [
            0.365871833084948,
            0.713546110416185
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0872"
        }
      },
      {
        "id": "p(HGNC:UNG)",
        "label": "p(HGNC:UNG)",
        "metadata": {
          "coordinate": [
            0.123518557944787,
            0.699914343885928
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0873"
        }
      },
      {
        "id": "cat(p(HGNC:FEN1))",
        "label": "cat(p(HGNC:FEN1))",
        "metadata": {
          "coordinate": [
            0.420161805407707,
            0.769873598531778
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0874"
        }
      },
      {
        "id": "cat(p(HGNC:TRIM28))",
        "label": "cat(p(HGNC:TRIM28))",
        "metadata": {
          "coordinate": [
            0.511354765453126,
            0.259325361502322
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0875"
        }
      },
      {
        "id": "p(HGNC:ERCC1)",
        "label": "p(HGNC:ERCC1)",
        "metadata": {
          "coordinate": [
            0.121317794396363,
            0.79694337922636
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0876"
        }
      },
      {
        "id": "p(HGNC:CDKN1A)",
        "label": "p(HGNC:CDKN1A)",
        "metadata": {
          "coordinate": [
            0.523419203747073,
            0.605777993884527
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0877"
        }
      },
      {
        "id": "tscript(p(SFAM:\"GTF2H Family\"))",
        "label": "tscript(p(SFAM:\"GTF2H Family\"))",
        "metadata": {
          "coordinate": [
            0.271485345255837,
            0.840604462603868
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0878"
        }
      },
      {
        "id": "p(HGNC:SMC3)",
        "label": "p(HGNC:SMC3)",
        "metadata": {
          "coordinate": [
            0.631990692683438,
            0.372621183807707
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0879"
        }
      },
      {
        "id": "p(HGNC:TOP2A)",
        "label": "p(HGNC:TOP2A)",
        "metadata": {
          "coordinate": [
            0.407658508293028,
            0.53517801789419
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe087a"
        }
      },
      {
        "id": "p(HGNC:RPRM)",
        "label": "p(HGNC:RPRM)",
        "metadata": {
          "coordinate": [
            0.521290185224612,
            0.57722844511361
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe087b"
        }
      },
      {
        "id": "a(CHEBI:cisplatin)",
        "label": "a(CHEBI:cisplatin)",
        "metadata": {
          "coordinate": [
            0.520935348804201,
            0.416733684455484
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe087c"
        }
      },
      {
        "id": "bp(MESHPP:Apoptosis)",
        "label": "bp(MESHPP:Apoptosis)",
        "metadata": {
          "coordinate": [
            0.167873110496061,
            0.255467314371117
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe087d"
        }
      },
      {
        "id": "bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "label": "bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "metadata": {
          "coordinate": [
            0.532644950677738,
            0.391013370247451
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe087e"
        }
      },
      {
        "id": "bp(GOBP:\"single strand break repair\")",
        "label": "bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "coordinate": [
            0.281775601447733,
            0.658504638010995
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe087f"
        }
      },
      {
        "id": "p(HGNC:WWP1)",
        "label": "p(HGNC:WWP1)",
        "metadata": {
          "coordinate": [
            0.1657440919736,
            0.21071396764914
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0880"
        }
      },
      {
        "id": "cat(p(HGNC:APEX1))",
        "label": "cat(p(HGNC:APEX1))",
        "metadata": {
          "coordinate": [
            0.189518132141083,
            0.669564373120449
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0881"
        }
      },
      {
        "id": "p(HGNC:TP53BP2)",
        "label": "p(HGNC:TP53BP2)",
        "metadata": {
          "coordinate": [
            0.712547015825704,
            0.606549603310768
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0882"
        }
      },
      {
        "id": "p(HGNC:CHEK2,pmod(P,T,68))",
        "label": "p(HGNC:CHEK2,pmod(P,T,68))",
        "metadata": {
          "coordinate": [
            0.364452487403307,
            0.386126510547925
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0883"
        }
      },
      {
        "id": "p(HGNC:GADD45B)",
        "label": "p(HGNC:GADD45B)",
        "metadata": {
          "coordinate": [
            0.527322404371585,
            0.572084382272004
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0884"
        }
      },
      {
        "id": "a(CHEBI:\"nitric oxide\")",
        "label": "a(CHEBI:\"nitric oxide\")",
        "metadata": {
          "coordinate": [
            0.269711163153786,
            0.805624835280944
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0885"
        }
      },
      {
        "id": "complex(p(HGNC:XRCC1),p(HGNC:APTX))",
        "label": "complex(p(HGNC:XRCC1),p(HGNC:APTX))",
        "metadata": {
          "coordinate": [
            0.181889149102264,
            0.645387277764898
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0886"
        }
      },
      {
        "id": "p(HGNC:FANCD2,pmod(P,S,717))",
        "label": "p(HGNC:FANCD2,pmod(P,S,717))",
        "metadata": {
          "coordinate": [
            0.468064722163083,
            0.492351408227101
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0887"
        }
      },
      {
        "id": "p(HGNC:TOPBP1)",
        "label": "p(HGNC:TOPBP1)",
        "metadata": {
          "coordinate": [
            0.226421119863743,
            0.535304332954516
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0888"
        }
      },
      {
        "id": "cat(p(HGNC:POLD1))",
        "label": "cat(p(HGNC:POLD1))",
        "metadata": {
          "coordinate": [
            0.386452345468739,
            0.787877818477401
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0889"
        }
      },
      {
        "id": "p(HGNC:RASSF1,pmod(P,S,131))",
        "label": "p(HGNC:RASSF1,pmod(P,S,131))",
        "metadata": {
          "coordinate": [
            0.562096373571783,
            0.431137060411983
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe088a"
        }
      },
      {
        "id": "bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\")",
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\")",
        "metadata": {
          "coordinate": [
            0.263324107586403,
            0.821828633232004
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe088b"
        }
      },
      {
        "id": "p(HGNC:ERCC8)",
        "label": "p(HGNC:ERCC8)",
        "metadata": {
          "coordinate": [
            0.319743098431623,
            0.892045091019934
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe088c"
        }
      },
      {
        "id": "cat(p(HGNC:LIG3))",
        "label": "cat(p(HGNC:LIG3))",
        "metadata": {
          "coordinate": [
            0.403129657228018,
            0.772702833094661
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe088d"
        }
      },
      {
        "id": "kin(p(HGNC:WEE1))",
        "label": "kin(p(HGNC:WEE1))",
        "metadata": {
          "coordinate": [
            0.732063018948265,
            0.718690173257792
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe088e"
        }
      },
      {
        "id": "p(HGNC:TRIM28)",
        "label": "p(HGNC:TRIM28)",
        "metadata": {
          "coordinate": [
            0.438551368087318,
            0.302817140827607
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe088f"
        }
      },
      {
        "id": "p(HGNC:H2AFX,pmod(P,S,140))",
        "label": "p(HGNC:H2AFX,pmod(P,S,140))",
        "metadata": {
          "coordinate": [
            0.419629550777092,
            0.300477864235175
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0890"
        }
      },
      {
        "id": "p(HGNC:YY1)",
        "label": "p(HGNC:YY1)",
        "metadata": {
          "coordinate": [
            0.226421119863743,
            0.51447087844601
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0891"
        }
      },
      {
        "id": "p(HGNC:RAD9A)",
        "label": "p(HGNC:RAD9A)",
        "metadata": {
          "coordinate": [
            0.341861622796577,
            0.621005456241073
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0892"
        }
      },
      {
        "id": "p(HGNC:RAD50)",
        "label": "p(HGNC:RAD50)",
        "metadata": {
          "coordinate": [
            0.478354978354978,
            0.224345734179397
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0893"
        }
      },
      {
        "id": "p(HGNC:BRCA1,pmod(P,S,1330))",
        "label": "p(HGNC:BRCA1,pmod(P,S,1330))",
        "metadata": {
          "coordinate": [
            0.460258320914059,
            0.429336638417421
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0894"
        }
      },
      {
        "id": "tscript(p(HGNC:TP53))",
        "label": "tscript(p(HGNC:TP53))",
        "metadata": {
          "coordinate": [
            0.419274714356682,
            0.515756894156412
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0895"
        }
      },
      {
        "id": "p(HGNC:ATF2)",
        "label": "p(HGNC:ATF2)",
        "metadata": {
          "coordinate": [
            0.57451564828614,
            0.373780759728069
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0896"
        }
      },
      {
        "id": "p(HGNC:ERCC5)",
        "label": "p(HGNC:ERCC5)",
        "metadata": {
          "coordinate": [
            0.201227734014619,
            0.954545454545454
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0897"
        }
      },
      {
        "id": "p(HGNC:CHEK2)",
        "label": "p(HGNC:CHEK2)",
        "metadata": {
          "coordinate": [
            0.25764672485984,
            0.431394263554063
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0898"
        }
      },
      {
        "id": "a(CHEBI:\"3-aminobenzoic acid\")",
        "label": "a(CHEBI:\"3-aminobenzoic acid\")",
        "metadata": {
          "coordinate": [
            0.48154850613867,
            0.715346532410748
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0899"
        }
      },
      {
        "id": "cat(p(HGNC:RAD50))",
        "label": "cat(p(HGNC:RAD50))",
        "metadata": {
          "coordinate": [
            0.514903129657228,
            0.240292328988378
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe089a"
        }
      },
      {
        "id": "bp(GOBP:\"double-strand break repair\")",
        "label": "bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "coordinate": [
            0.506387055567383,
            0.300992270519336
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe089b"
        }
      },
      {
        "id": "bp(GOBP:\"response to oxidative stress\")",
        "label": "bp(GOBP:\"response to oxidative stress\")",
        "metadata": {
          "coordinate": [
            0.458129302391598,
            0.730521517793487
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe089c"
        }
      },
      {
        "id": "p(HGNC:CCND1)",
        "label": "p(HGNC:CCND1)",
        "metadata": {
          "coordinate": [
            0.658611879923355,
            0.458914999756658
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe089d"
        }
      },
      {
        "id": "tscript(p(HGNC:TP73))",
        "label": "tscript(p(HGNC:TP73))",
        "metadata": {
          "coordinate": [
            0.661095734866227,
            0.56874074142496
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe089e"
        }
      },
      {
        "id": "p(HGNC:MYC)",
        "label": "p(HGNC:MYC)",
        "metadata": {
          "coordinate": [
            0.448193882620112,
            0.313852427623352
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe089f"
        }
      },
      {
        "id": "p(HGNC:BRCA1,pmod(P,S,1387))",
        "label": "p(HGNC:BRCA1,pmod(P,S,1387))",
        "metadata": {
          "coordinate": [
            0.447484209779292,
            0.42882223213326
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a0"
        }
      },
      {
        "id": "p(HGNC:PRKDC,pmod(P,S,2612))",
        "label": "p(HGNC:PRKDC,pmod(P,S,2612))",
        "metadata": {
          "coordinate": [
            0.345291320701157,
            0.26498383062809
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a1"
        }
      },
      {
        "id": "p(HGNC:CHEK2,pmod(P,S,35))",
        "label": "p(HGNC:CHEK2,pmod(P,S,35))",
        "metadata": {
          "coordinate": [
            0.366936342346178,
            0.393585401668255
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a2"
        }
      },
      {
        "id": "p(HGNC:SIRT1)",
        "label": "p(HGNC:SIRT1)",
        "metadata": {
          "coordinate": [
            0.298858032802602,
            0.0664198032380836
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a3"
        }
      },
      {
        "id": "p(HGNC:POLA1)",
        "label": "p(HGNC:POLA1)",
        "metadata": {
          "coordinate": [
            0.11038961038961,
            0.653617778311468
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a4"
        }
      },
      {
        "id": "p(HGNC:YAP1)",
        "label": "p(HGNC:YAP1)",
        "metadata": {
          "coordinate": [
            0.730998509687034,
            0.582115304813136
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a5"
        }
      },
      {
        "id": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 3'-to lesion\")",
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 3'-to lesion\")",
        "metadata": {
          "coordinate": [
            0.255162869916968,
            0.841118868888029
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a6"
        }
      },
      {
        "id": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "metadata": {
          "coordinate": [
            0.326484990419417,
            0.80305280386014
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a7"
        }
      },
      {
        "id": "p(HGNC:TP53,pmod(P,S,46))",
        "label": "p(HGNC:TP53,pmod(P,S,46))",
        "metadata": {
          "coordinate": [
            0.284614292811014,
            0.504182752762797
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a8"
        }
      },
      {
        "id": "p(HGNC:ATR)",
        "label": "p(HGNC:ATR)",
        "metadata": {
          "coordinate": [
            0.399226456603506,
            0.575428023119048
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08a9"
        }
      },
      {
        "id": "p(HGNC:POLE2)",
        "label": "p(HGNC:POLE2)",
        "metadata": {
          "coordinate": [
            0.363033141721666,
            0.924195483779976
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08aa"
        }
      },
      {
        "id": "p(HGNC:RAD51)",
        "label": "p(HGNC:RAD51)",
        "metadata": {
          "coordinate": [
            0.608934781065929,
            0.331599444426895
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ab"
        }
      },
      {
        "id": "p(HGNC:TOP2B)",
        "label": "p(HGNC:TOP2B)",
        "metadata": {
          "coordinate": [
            0.431124290831039,
            0.496409987394551
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ac"
        }
      },
      {
        "id": "p(HGNC:ABL1,pmod(P,S,465))",
        "label": "p(HGNC:ABL1,pmod(P,S,465))",
        "metadata": {
          "coordinate": [
            0.532290114257327,
            0.308965567923826
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ad"
        }
      },
      {
        "id": "cat(p(HGNC:POLB))",
        "label": "cat(p(HGNC:POLB))",
        "metadata": {
          "coordinate": [
            0.2771627279824,
            0.707373235006257
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ae"
        }
      },
      {
        "id": "bp(GOBP:\"response to ionizing radiation\")",
        "label": "bp(GOBP:\"response to ionizing radiation\")",
        "metadata": {
          "coordinate": [
            0.584451068057626,
            0.359377383771571
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08af"
        }
      },
      {
        "id": "p(HGNC:TP53,pmod(P,S,15))",
        "label": "p(HGNC:TP53,pmod(P,S,15))",
        "metadata": {
          "coordinate": [
            0.353452558370591,
            0.406959965056432
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b0"
        }
      },
      {
        "id": "phos(p(HGNC:PNKP))",
        "label": "phos(p(HGNC:PNKP))",
        "metadata": {
          "coordinate": [
            0.294194876162089,
            0.705315609869615
          ],
          "bel_function_type": "phosphataseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b1"
        }
      },
      {
        "id": "kin(p(HGNC:HCK))",
        "label": "kin(p(HGNC:HCK))",
        "metadata": {
          "coordinate": [
            0.85377191114896,
            0.587002164512663
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b2"
        }
      },
      {
        "id": "p(HGNC:TP73,pmod(P,Y,28))",
        "label": "p(HGNC:TP73,pmod(P,Y,28))",
        "metadata": {
          "coordinate": [
            0.77819175360159,
            0.583401320523538
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b3"
        }
      },
      {
        "id": "p(HGNC:RAD1)",
        "label": "p(HGNC:RAD1)",
        "metadata": {
          "coordinate": [
            0.300587033962865,
            0.642091644416482
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b4"
        }
      },
      {
        "id": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 5'-to lesion\")",
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 5'-to lesion\")",
        "metadata": {
          "coordinate": [
            0.214711517990207,
            0.793793490745248
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b5"
        }
      },
      {
        "id": "p(HGNC:EP300)",
        "label": "p(HGNC:EP300)",
        "metadata": {
          "coordinate": [
            0.355936413313463,
            0.575428023119048
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b6"
        }
      },
      {
        "id": "cat(p(HGNC:EP300))",
        "label": "cat(p(HGNC:EP300))",
        "metadata": {
          "coordinate": [
            0.416258604783195,
            0.548936099484774
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b7"
        }
      },
      {
        "id": "p(HGNC:PRKDC,pmod(P,T,2609))",
        "label": "p(HGNC:PRKDC,pmod(P,T,2609))",
        "metadata": {
          "coordinate": [
            0.366936342346178,
            0.254438501802796
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b8"
        }
      },
      {
        "id": "cat(p(HGNC:ERCC6))",
        "label": "cat(p(HGNC:ERCC6))",
        "metadata": {
          "coordinate": [
            0.349549357746079,
            0.773731645662982
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08b9"
        }
      },
      {
        "id": "kin(p(HGNC:HIPK2))",
        "label": "kin(p(HGNC:HIPK2))",
        "metadata": {
          "coordinate": [
            0.190227804981903,
            0.493380220795423
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ba"
        }
      },
      {
        "id": "p(HGNC:TP53,pmod(P,S,20))",
        "label": "p(HGNC:TP53,pmod(P,S,20))",
        "metadata": {
          "coordinate": [
            0.381484635582996,
            0.492608611369182
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08bb"
        }
      },
      {
        "id": "p(HGNC:NET1)",
        "label": "p(HGNC:NET1)",
        "metadata": {
          "coordinate": [
            0.860868639557164,
            0.266527049480572
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08bc"
        }
      },
      {
        "id": "bp(GOBP:\"response to hypoxia\")",
        "label": "bp(GOBP:\"response to hypoxia\")",
        "metadata": {
          "coordinate": [
            0.475871123412107,
            0.727435080088523
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08bd"
        }
      },
      {
        "id": "p(HGNC:MDC1)",
        "label": "p(HGNC:MDC1)",
        "metadata": {
          "coordinate": [
            0.520411848481302,
            0.408123745782621
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08be"
        }
      },
      {
        "id": "p(HGNC:CDK2)",
        "label": "p(HGNC:CDK2)",
        "metadata": {
          "coordinate": [
            0.207259953161592,
            0.201454654534248
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08bf"
        }
      },
      {
        "id": "p(HGNC:HIPK2)",
        "label": "p(HGNC:HIPK2)",
        "metadata": {
          "coordinate": [
            0.115712156695763,
            0.484378110822611
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c0"
        }
      },
      {
        "id": "kin(p(HGNC:PKMYT1))",
        "label": "kin(p(HGNC:PKMYT1))",
        "metadata": {
          "coordinate": [
            0.746256475764672,
            0.707373235006257
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c1"
        }
      },
      {
        "id": "p(HGNC:CHEK1)",
        "label": "p(HGNC:CHEK1)",
        "metadata": {
          "coordinate": [
            0.46238733943652,
            0.555366178036782
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c2"
        }
      },
      {
        "id": "p(HGNC:UBE2N)",
        "label": "p(HGNC:UBE2N)",
        "metadata": {
          "coordinate": [
            0.605741253282237,
            0.376609994290953
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c3"
        }
      },
      {
        "id": "p(HGNC:EP300,pmod(P,S,106))",
        "label": "p(HGNC:EP300,pmod(P,S,106))",
        "metadata": {
          "coordinate": [
            0.459903484493648,
            0.315138443333754
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c4"
        }
      },
      {
        "id": "kin(p(HGNC:ATM))",
        "label": "kin(p(HGNC:ATM))",
        "metadata": {
          "coordinate": [
            0.447129373358882,
            0.380725244564238
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c5"
        }
      },
      {
        "id": "p(HGNC:ERCC6)",
        "label": "p(HGNC:ERCC6)",
        "metadata": {
          "coordinate": [
            0.363387978142076,
            0.825172274079048
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c6"
        }
      },
      {
        "id": "p(HGNC:RPS6KB1)",
        "label": "p(HGNC:RPS6KB1)",
        "metadata": {
          "coordinate": [
            0.24025974025974,
            0.186279669151509
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c7"
        }
      },
      {
        "id": "p(HGNC:XPA)",
        "label": "p(HGNC:XPA)",
        "metadata": {
          "coordinate": [
            0.085551060960897,
            0.915964983233405
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c8"
        }
      },
      {
        "id": "cat(p(HGNC:UNG))",
        "label": "cat(p(HGNC:UNG))",
        "metadata": {
          "coordinate": [
            0.195905187708466,
            0.682938936508626
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08c9"
        }
      },
      {
        "id": "p(HGNC:TP73)",
        "label": "p(HGNC:TP73)",
        "metadata": {
          "coordinate": [
            0.627741111347669,
            0.496466658500387
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ca"
        }
      },
      {
        "id": "cat(p(HGNC:DDB1))",
        "label": "cat(p(HGNC:DDB1))",
        "metadata": {
          "coordinate": [
            0.107550919026329,
            0.852950213423724
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08cb"
        }
      },
      {
        "id": "bp(GOBP:\"response to UV\")",
        "label": "bp(GOBP:\"response to UV\")",
        "metadata": {
          "coordinate": [
            0.548612589596196,
            0.371465931449346
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08cc"
        }
      },
      {
        "id": "p(HGNC:TRIM28,pmod(P,S,824))",
        "label": "p(HGNC:TRIM28,pmod(P,S,824))",
        "metadata": {
          "coordinate": [
            0.465758285430417,
            0.310508786776308
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08cd"
        }
      },
      {
        "id": "cat(p(HGNC:NET1))",
        "label": "cat(p(HGNC:NET1))",
        "metadata": {
          "coordinate": [
            0.804804485132354,
            0.29661981710397
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ce"
        }
      },
      {
        "id": "p(HGNC:FHIT)",
        "label": "p(HGNC:FHIT)",
        "metadata": {
          "coordinate": [
            0.357710595415514,
            0.46765990658739
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08cf"
        }
      },
      {
        "id": "p(HGNC:MRE11A)",
        "label": "p(HGNC:MRE11A)",
        "metadata": {
          "coordinate": [
            0.435239592978981,
            0.30780005131769
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d0"
        }
      },
      {
        "id": "tscript(p(HGNC:ATF2))",
        "label": "tscript(p(HGNC:ATF2))",
        "metadata": {
          "coordinate": [
            0.696224540486836,
            0.384326088553363
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d1"
        }
      },
      {
        "id": "cat(p(HGNC:WWP1))",
        "label": "cat(p(HGNC:WWP1))",
        "metadata": {
          "coordinate": [
            0.22074373713718,
            0.250323251529511
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d2"
        }
      },
      {
        "id": "p(HGNC:RPA1)",
        "label": "p(HGNC:RPA1)",
        "metadata": {
          "coordinate": [
            0.381484635582996,
            0.557423803173425
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d3"
        }
      },
      {
        "id": "p(HGNC:BRCA1)",
        "label": "p(HGNC:BRCA1)",
        "metadata": {
          "coordinate": [
            0.446774536938471,
            0.482834891970129
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d4"
        }
      },
      {
        "id": "p(HGNC:PRKDC,pmod(P,T,2638))",
        "label": "p(HGNC:PRKDC,pmod(P,T,2638))",
        "metadata": {
          "coordinate": [
            0.329678518203108,
            0.266784252622652
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d5"
        }
      },
      {
        "id": "p(HGNC:NBN)",
        "label": "p(HGNC:NBN)",
        "metadata": {
          "coordinate": [
            0.473387268469236,
            0.263183408633527
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d6"
        }
      },
      {
        "id": "p(HGNC:PCNA)",
        "label": "p(HGNC:PCNA)",
        "metadata": {
          "coordinate": [
            0.35203321268895,
            0.656447012874352
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d7"
        }
      },
      {
        "id": "p(HGNC:CHEK2,pmod(P,S,19))",
        "label": "p(HGNC:CHEK2,pmod(P,S,19))",
        "metadata": {
          "coordinate": [
            0.378645944219715,
            0.404130730493548
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d8"
        }
      },
      {
        "id": "cat(p(HGNC:XPA))",
        "label": "cat(p(HGNC:XPA))",
        "metadata": {
          "coordinate": [
            0.133453977716273,
            0.877641715063436
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08d9"
        }
      },
      {
        "id": "p(HGNC:CCNA2)",
        "label": "p(HGNC:CCNA2)",
        "metadata": {
          "coordinate": [
            0.224292101341282,
            0.668792763694208
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08da"
        }
      },
      {
        "id": "p(HGNC:DDB1)",
        "label": "p(HGNC:DDB1)",
        "metadata": {
          "coordinate": [
            0.0454545454545455,
            0.877127308779275
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08db"
        }
      },
      {
        "id": "p(HGNC:RAD52,pmod(P,Y,104))",
        "label": "p(HGNC:RAD52,pmod(P,Y,104))",
        "metadata": {
          "coordinate": [
            0.603257398339366,
            0.209170748796658
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08dc"
        }
      },
      {
        "id": "cat(p(HGNC:TOP1))",
        "label": "cat(p(HGNC:TOP1))",
        "metadata": {
          "coordinate": [
            0.424065006032219,
            0.73309354921429
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08dd"
        }
      },
      {
        "id": "p(HGNC:ABL1)",
        "label": "p(HGNC:ABL1)",
        "metadata": {
          "coordinate": [
            0.562451209992194,
            0.269870690327616
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08de"
        }
      },
      {
        "id": "a(CHEBI:camptothecin)",
        "label": "a(CHEBI:camptothecin)",
        "metadata": {
          "coordinate": [
            0.390000709672841,
            0.758299457138163
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08df"
        }
      },
      {
        "id": "p(HGNC:SP1,pmod(P,S,101))",
        "label": "p(HGNC:SP1,pmod(P,S,101))",
        "metadata": {
          "coordinate": [
            0.466290540061032,
            0.329799022432333
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e0"
        }
      },
      {
        "id": "p(HGNC:POLE)",
        "label": "p(HGNC:POLE)",
        "metadata": {
          "coordinate": [
            0.212227663047335,
            0.757013441427761
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e1"
        }
      },
      {
        "id": "p(HGNC:FANCI,pmod(P))",
        "label": "p(HGNC:FANCI,pmod(P))",
        "metadata": {
          "coordinate": [
            0.353203430895968,
            0.515732326350816
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e2"
        }
      },
      {
        "id": "phos(p(HGNC:PPP1R13B))",
        "label": "phos(p(HGNC:PPP1R13B))",
        "metadata": {
          "coordinate": [
            0.732772691789085,
            0.557423803173425
          ],
          "bel_function_type": "phosphataseActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e3"
        }
      },
      {
        "id": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "metadata": {
          "coordinate": [
            0.190227804981903,
            0.82620108664737
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e4"
        }
      },
      {
        "id": "deg(p(HGNC:CDC25A))",
        "label": "deg(p(HGNC:CDC25A))",
        "metadata": {
          "coordinate": [
            0.484032361081541,
            0.587002164512663
          ],
          "bel_function_type": "degradation",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e5"
        }
      },
      {
        "id": "p(HGNC:NET1,pmod(P,S,152))",
        "label": "p(HGNC:NET1,pmod(P,S,152))",
        "metadata": {
          "coordinate": [
            0.698708395429707,
            0.324140553306566
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e6"
        }
      },
      {
        "id": "cat(p(HGNC:POLA1))",
        "label": "cat(p(HGNC:POLA1))",
        "metadata": {
          "coordinate": [
            0.187034277198212,
            0.655932606590191
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e7"
        }
      },
      {
        "id": "p(HGNC:ATF2,pmod(P,T,71))",
        "label": "p(HGNC:ATF2,pmod(P,T,71))",
        "metadata": {
          "coordinate": [
            0.783159463487332,
            0.357062555492848
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e8"
        }
      },
      {
        "id": "deg(p(HGNC:TP53))",
        "label": "deg(p(HGNC:TP53))",
        "metadata": {
          "coordinate": [
            0.596870342771982,
            0.494923439647905
          ],
          "bel_function_type": "degradation",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08e9"
        }
      },
      {
        "id": "gtp(p(HGNC:RHOB))",
        "label": "gtp(p(HGNC:RHOB))",
        "metadata": {
          "coordinate": [
            0.66783762685402,
            0.382782869700881
          ],
          "bel_function_type": "gtpBoundActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ea"
        }
      },
      {
        "id": "cat(p(HGNC:LIG1))",
        "label": "cat(p(HGNC:LIG1))",
        "metadata": {
          "coordinate": [
            0.368710524448229,
            0.784791380772437
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08eb"
        }
      },
      {
        "id": "p(HGNC:ATF2,pmod(P,T,69))",
        "label": "p(HGNC:ATF2,pmod(P,T,69))",
        "metadata": {
          "coordinate": [
            0.787417500532255,
            0.365550259181499
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ec"
        }
      },
      {
        "id": "a(SCHEM:Cadmium)",
        "label": "a(SCHEM:Cadmium)",
        "metadata": {
          "coordinate": [
            0.29596905826414,
            0.814626945253755
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ed"
        }
      },
      {
        "id": "p(HGNC:GADD45G)",
        "label": "p(HGNC:GADD45G)",
        "metadata": {
          "coordinate": [
            0.634128166915052,
            0.583144117381458
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ee"
        }
      },
      {
        "id": "p(HGNC:TP53BP1)",
        "label": "p(HGNC:TP53BP1)",
        "metadata": {
          "coordinate": [
            0.526257895110354,
            0.360920602624053
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ef"
        }
      },
      {
        "id": "p(HGNC:RAD51,pmod(P,Y,315))",
        "label": "p(HGNC:RAD51,pmod(P,Y,315))",
        "metadata": {
          "coordinate": [
            0.6497409694131,
            0.281959238005391
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f0"
        }
      },
      {
        "id": "gtp(p(HGNC:RHOA))",
        "label": "gtp(p(HGNC:RHOA))",
        "metadata": {
          "coordinate": [
            0.89032006245121,
            0.297648629672292
          ],
          "bel_function_type": "gtpBoundActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f1"
        }
      },
      {
        "id": "p(HGNC:MDM4)",
        "label": "p(HGNC:MDM4)",
        "metadata": {
          "coordinate": [
            0.33180753672557,
            0.529131457544589
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f2"
        }
      },
      {
        "id": "p(HGNC:TP53BP1,pmod(P))",
        "label": "p(HGNC:TP53BP1,pmod(P))",
        "metadata": {
          "coordinate": [
            0.487935561706054,
            0.341373163825948
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f3"
        }
      },
      {
        "id": "p(HGNC:WRN,pmod(P,S,1141))",
        "label": "p(HGNC:WRN,pmod(P,S,1141))",
        "metadata": {
          "coordinate": [
            0.421581151089348,
            0.318739287322879
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f4"
        }
      },
      {
        "id": "p(HGNC:BRCA1,pmod(P,S,1423))",
        "label": "p(HGNC:BRCA1,pmod(P,S,1423))",
        "metadata": {
          "coordinate": [
            0.413419913419913,
            0.437567138963991
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f5"
        }
      },
      {
        "id": "p(HGNC:LIG3)",
        "label": "p(HGNC:LIG3)",
        "metadata": {
          "coordinate": [
            0.439322972109857,
            0.820285414379522
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f6"
        }
      },
      {
        "id": "p(HGNC:DNMT3A)",
        "label": "p(HGNC:DNMT3A)",
        "metadata": {
          "coordinate": [
            0.343162302178696,
            0.54559245863773
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f7"
        }
      },
      {
        "id": "p(HGNC:H2AFX)",
        "label": "p(HGNC:H2AFX)",
        "metadata": {
          "coordinate": [
            0.446517825187959,
            0.292218451980929
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f8"
        }
      },
      {
        "id": "p(HGNC:PRKDC,pmod(P,T,2647))",
        "label": "p(HGNC:PRKDC,pmod(P,T,2647))",
        "metadata": {
          "coordinate": [
            0.352742885529771,
            0.255981720655278
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08f9"
        }
      },
      {
        "id": "complex(p(HGNC:XPC),p(HGNC:RAD23B))",
        "label": "complex(p(HGNC:XPC),p(HGNC:RAD23B))",
        "metadata": {
          "coordinate": [
            0.11908310268966,
            0.8650387611015
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08fa"
        }
      },
      {
        "id": "complex(p(HGNC:RNF8),p(HGNC:MDC1))",
        "label": "complex(p(HGNC:RNF8),p(HGNC:MDC1))",
        "metadata": {
          "coordinate": [
            0.507983819459229,
            0.427279013280778
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08fb"
        }
      },
      {
        "id": "complex(p(HGNC:BRCA2),p(HGNC:FANCD2))",
        "label": "complex(p(HGNC:BRCA2),p(HGNC:FANCD2))",
        "metadata": {
          "coordinate": [
            0.496096799375488,
            0.516014097298492
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08fc"
        }
      },
      {
        "id": "p(HGNC:ATF2,pmod(P,S,498))",
        "label": "p(HGNC:ATF2,pmod(P,S,498))",
        "metadata": {
          "coordinate": [
            0.513483783975587,
            0.36657907174982
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08fd"
        }
      },
      {
        "id": "p(HGNC:MDM2)",
        "label": "p(HGNC:MDM2)",
        "metadata": {
          "coordinate": [
            0.579838194592293,
            0.514213675303929
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08fe"
        }
      },
      {
        "id": "complex(p(HGNC:SMC1A),p(HGNC:SMC3))",
        "label": "complex(p(HGNC:SMC1A),p(HGNC:SMC3))",
        "metadata": {
          "coordinate": [
            0.616918600525158,
            0.354490524072044
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe08ff"
        }
      },
      {
        "id": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
        "label": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
        "metadata": {
          "coordinate": [
            0.449080973671138,
            0.289160925983641
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0900"
        }
      },
      {
        "id": "p(HGNC:PARP2)",
        "label": "p(HGNC:PARP2)",
        "metadata": {
          "coordinate": [
            0.483677524661131,
            0.798937553586855
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0901"
        }
      },
      {
        "id": "cat(p(HGNC:PARP2))",
        "label": "cat(p(HGNC:PARP2))",
        "metadata": {
          "coordinate": [
            0.431871407281243,
            0.759585472848564
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0902"
        }
      },
      {
        "id": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6))",
        "label": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6))",
        "metadata": {
          "coordinate": [
            0.344759066070542,
            0.223574124753156
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0903"
        }
      },
      {
        "id": "complex(p(HGNC:BRCA1),p(HGNC:TP53))",
        "label": "complex(p(HGNC:BRCA1),p(HGNC:TP53))",
        "metadata": {
          "coordinate": [
            0.503903200624512,
            0.539419583227802
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0904"
        }
      },
      {
        "id": "complex(p(HGNC:CCND1),p(HGNC:RAD51))",
        "label": "complex(p(HGNC:CCND1),p(HGNC:RAD51))",
        "metadata": {
          "coordinate": [
            0.651515151515152,
            0.387669729400407
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0905"
        }
      },
      {
        "id": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1))",
        "label": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1))",
        "metadata": {
          "coordinate": [
            0.329678518203108,
            0.640243214923291
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0906"
        }
      },
      {
        "id": "cat(p(HGNC:ERCC3))",
        "label": "cat(p(HGNC:ERCC3))",
        "metadata": {
          "coordinate": [
            0.233872684692357,
            0.825172274079048
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0907"
        }
      },
      {
        "id": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1))",
        "label": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1))",
        "metadata": {
          "coordinate": [
            0.131857213824427,
            0.816684570390398
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0908"
        }
      },
      {
        "id": "cat(p(HGNC:PARP1))",
        "label": "cat(p(HGNC:PARP1))",
        "metadata": {
          "coordinate": [
            0.405968348591299,
            0.611179259868214
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0909"
        }
      },
      {
        "id": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2))",
        "label": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2))",
        "metadata": {
          "coordinate": [
            0.504258037044922,
            0.478976844838924
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe090a"
        }
      },
      {
        "id": "p(HGNC:ERCC3)",
        "label": "p(HGNC:ERCC3)",
        "metadata": {
          "coordinate": [
            0.190582641402314,
            0.868639605090624
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe090b"
        }
      },
      {
        "id": "complex(p(HGNC:XRCC6),p(HGNC:SIRT1))",
        "label": "complex(p(HGNC:XRCC6),p(HGNC:SIRT1))",
        "metadata": {
          "coordinate": [
            0.302888368462139,
            0.0873850610216217
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe090c"
        }
      },
      {
        "id": "p(HGNC:ERCC2)",
        "label": "p(HGNC:ERCC2)",
        "metadata": {
          "coordinate": [
            0.287098147753886,
            0.901047200992746
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe090d"
        }
      },
      {
        "id": "p(HGNC:XRCC5)",
        "label": "p(HGNC:XRCC5)",
        "metadata": {
          "coordinate": [
            0.373663611604902,
            0.220555349815542
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe090e"
        }
      },
      {
        "id": "p(HGNC:SMARCB1)",
        "label": "p(HGNC:SMARCB1)",
        "metadata": {
          "coordinate": [
            0.284614292811014,
            0.380982447706318
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe090f"
        }
      },
      {
        "id": "p(HGNC:XRCC6)",
        "label": "p(HGNC:XRCC6)",
        "metadata": {
          "coordinate": [
            0.344226811439926,
            0.150014026118182
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0910"
        }
      },
      {
        "id": "p(HGNC:TP63)",
        "label": "p(HGNC:TP63)",
        "metadata": {
          "coordinate": [
            0.167873110496061,
            0.235662672430932
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0911"
        }
      },
      {
        "id": "tscript(p(HGNC:TP63))",
        "label": "tscript(p(HGNC:TP63))",
        "metadata": {
          "coordinate": [
            0.212937335888156,
            0.269099080901375
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0912"
        }
      },
      {
        "id": "p(HGNC:PARP1)",
        "label": "p(HGNC:PARP1)",
        "metadata": {
          "coordinate": [
            0.38893620041161,
            0.649245324896103
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0913"
        }
      },
      {
        "id": "p(HGNC:BRCA2)",
        "label": "p(HGNC:BRCA2)",
        "metadata": {
          "coordinate": [
            0.455645447448726,
            0.571312772845763
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0914"
        }
      },
      {
        "id": "cat(p(HGNC:ERCC2))",
        "label": "cat(p(HGNC:ERCC2))",
        "metadata": {
          "coordinate": [
            0.293485203321269,
            0.845234119161314
          ],
          "bel_function_type": "catalyticActivity",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0915"
        }
      },
      {
        "id": "p(HGNC:BRCA1,pmod(P,S,1524))",
        "label": "p(HGNC:BRCA1,pmod(P,S,1524))",
        "metadata": {
          "coordinate": [
            0.402774820807608,
            0.442968404947678
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "55775d252f9e24174cfe0916"
        }
      },
      {
        "id": "bp(\"DNA Repair\")",
        "label": "bp(\"DNA Repair\")",
        "metadata": {
          "coordinate": [
            0.861651021922776,
            0.289011052478576
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "ndiaz",
          "nodeId": "55775d252f9e24174cfe0918"
        }
      },
      {
        "id": "bp(GOBP:\"response to osmotic stress\")",
        "label": "bp(GOBP:\"response to osmotic stress\")",
        "metadata": {
          "coordinate": [
            0.277099656070163,
            0.495119113239981
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "susana.martinez.arbas",
          "nodeId": "55775d252f9e24174cfe0919"
        }
      },
      {
        "id": "p(HGNC:HDAC2)",
        "label": "p(HGNC:HDAC2)",
        "metadata": {
          "coordinate": [
            0.145676138412988,
            0.158228577653984
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "mzelikman",
          "nodeId": "55775d252f9e24174cfe091c"
        }
      },
      {
        "id": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "metadata": {
          "coordinate": [
            0.112023467715841,
            0.606573495365015
          ],
          "bel_function_type": "pathology",
          "createdBy": "susana.martinez.arbas",
          "nodeId": "55775d252f9e24174cfe091b"
        }
      }
    ],
    "edges": [
      {
        "source": "p(HGNC:RIF1)",
        "relation": "decreases",
        "target": "p(HGNC:BRCA1)",
        "directed": false,
        "label": "p(HGNC:RIF1) decreases p(HGNC:BRCA1)",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775d252f9e24174cfe091d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RIF1) decreases p(HGNC:BRCA1)",
              "summary_text": "The inappropriate accumulation of RIF1 at DSBs in S phase is antagonized by BRCA1, and deletion of Rif1 suppresses toxic nonhomologous end joining (NHEJ) induced by PARP inhibition in Brca1-deficient cells.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "23333305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe51"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:SIRT1)",
        "relation": "decreases",
        "target": "p(HGNC:NBN,pmod(A))",
        "directed": false,
        "label": "p(HGNC:SIRT1) decreases p(HGNC:NBN,pmod(A))",
        "metadata": {
          "casual": true,
          "createdBy": "edwardsanders",
          "edgeId": "55775d252f9e24174cfe091e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:SIRT1) decreases p(HGNC:NBN,pmod(A))",
              "summary_text": "\"In agreement with the finding that SIRT1 binds NBS1 [coded for by NBN], acetylation of both Myc-NBS1 and endogenous NBS1 was significantly increased as a result of SIRT1 knockdown...Collectively, our data strongly support that SIRT1 modulates the acetylation status of NBS1 via its deacetylase activity\" (p. 152)",
              "citation": {
                "type": "Other",
                "name": "Yuan Z, Zhang X, Sengupta N, et al., \"SIRT1 regulates the function of the Nijmegen breakage syndrome protein,\" Mol Cell, 2007, 27:149-52.",
                "id": "17612497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b8"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "293T human embryonic kidney cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XRCC6),p(HGNC:SIRT1))",
        "relation": "hasComponent",
        "target": "p(HGNC:SIRT1)",
        "directed": false,
        "label": "complex(p(HGNC:XRCC6),p(HGNC:SIRT1)) hasComponent p(HGNC:SIRT1)",
        "metadata": {
          "casual": false,
          "createdBy": "edwardsanders",
          "edgeId": "55775d252f9e24174cfe091f",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XRCC6),p(HGNC:SIRT1)) hasComponent p(HGNC:SIRT1)",
              "summary_text": "\"...immunoprecipitation of SIRT1 from the lysates of U2OS cells etopically (sic) overexpressing SIRT1 resulted in coimmuno-precipitation of Ku70 [XRCC6].  This interaction was reciprocally further confirmed by immunoprecipitating the lysate with anti-Ku70 antibody and subsequently probing the blotted precipitate with SIRT1 antibody.\" (p. 11)",
              "citation": {
                "type": "Other",
                "name": "Jeong J, Juhn K, Lee H, et al., \"SIRT1 promotes DNA repair activity and deacetylation of Ku70,\" Exp Mol Med, 2007, 39:8-13.",
                "id": "17334224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b9"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "U2OS osteosarcoma cell line",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XRCC6),p(HGNC:SIRT1))",
        "relation": "hasComponent",
        "target": "p(HGNC:XRCC6)",
        "directed": false,
        "label": "complex(p(HGNC:XRCC6),p(HGNC:SIRT1)) hasComponent p(HGNC:XRCC6)",
        "metadata": {
          "casual": false,
          "createdBy": "edwardsanders",
          "edgeId": "55775d252f9e24174cfe0920",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XRCC6),p(HGNC:SIRT1)) hasComponent p(HGNC:XRCC6)",
              "summary_text": "\"...immunoprecipitation of SIRT1 from the lysates of U2OS cells etopically (sic) overexpressing SIRT1 resulted in coimmuno-precipitation of Ku70 [XRCC6].  This interaction was reciprocally further confirmed by immunoprecipitating the lysate with anti-Ku70 antibody and subsequently probing the blotted precipitate with SIRT1 antibody.\" (p. 11)",
              "citation": {
                "type": "Other",
                "name": "Jeong J, Juhn K, Lee H, et al., \"SIRT1 promotes DNA repair activity and deacetylation of Ku70,\" Exp Mol Med, 2007, 39:8-13.",
                "id": "17334224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ba"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "U2OS osteosarcoma cell line",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:EP300,pmod(P,S,106))",
        "relation": "increases",
        "target": "p(HGNC:NBN)",
        "directed": false,
        "label": "p(HGNC:EP300,pmod(P,S,106)) increases p(HGNC:NBN)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0921",
          "evidences": [
            {
              "bel_statement": "p(HGNC:EP300,pmod(P,S,106)) increases p(HGNC:NBN)",
              "summary_text": "Importantly, expression of nonphosphorylatable serine to alanine form of p300 (S106A) destabilized both p300 and NBS1 proteins, after DNA damage. These data demonstrate that ATM transduces a DNA damage signal to p300, and that ATM-dependent phosphorylation of p300 is required for stabilization of NBS1 proteins in response to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jul 9 397(4) 637-43",
                "id": "20471956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC2))",
        "relation": "increases",
        "target": "tscript(p(SFAM:\"GTF2H Family\"))",
        "directed": false,
        "label": "cat(p(HGNC:ERCC2)) increases tscript(p(SFAM:\"GTF2H Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0922",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC2)) increases tscript(p(SFAM:\"GTF2H Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0800"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC2))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:ERCC2)) increases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0923",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC2)) increases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC2))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\")",
        "directed": false,
        "label": "cat(p(HGNC:ERCC2)) increases bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0924",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC2)) increases bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\")",
              "summary_text": "Two components of core TFIIH, i.e., the XPB and XPD proteins, are helicases responsible for unwinding the DNA helix in NER",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 213-24",
                "id": "11511374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0801"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:DNMT3A)",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:DNMT3A) directlyDecreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0925",
          "evidences": [
            {
              "bel_statement": "p(HGNC:DNMT3A) directlyDecreases tscript(p(HGNC:TP53))",
              "summary_text": " In this report, we show that Dnmt3a interacts with p53 directly and represses p53-mediated transactivation of the p21 gene ... from full text, MEFs",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2005 Oct 4(10) 1138-43",
                "id": "16131836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0802"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA1)",
        "relation": "hasModification",
        "target": "p(HGNC:BRCA1,pmod(P,S,1423))",
        "directed": false,
        "label": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1423))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0926",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1423))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0803"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:NET1))",
        "relation": "increases",
        "target": "gtp(p(HGNC:RHOA))",
        "directed": false,
        "label": "cat(p(HGNC:NET1)) increases gtp(p(HGNC:RHOA))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0927",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:NET1)) increases gtp(p(HGNC:RHOA))",
              "summary_text": "NET1 is a guanine nucleotide exchange factor for RhoA NET1 is important for the increase of Rho activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 4 276(18) 15362-8",
                "id": "11278519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0804"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:NET1)) increases gtp(p(HGNC:RHOA))",
              "summary_text": "We further demonstrate that a fraction of RhoA resides in the nucleus, and can also be found in a GTP-bound active form and that Net1 plays a role in the activation of nuclear RhoA. In addition, we show that ionizing radiation (IR) specifically promotes the activation of the nuclear pool of RhoA in a Net1-dependent manner, while the cytoplasmic activity remains unchanged. ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(2) e17380",
                "id": "21390328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:NET1)) increases gtp(p(HGNC:RHOA))",
              "summary_text": "The regulation of Net1 activity is poorly understood. PAK1-dependent phosphorylation of Net1 on Ser152 and Ser153 inhibits its GEF activity and abolishes Net1-dependent RhoA activation and stress fiber induction [15].",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2008 3(5) e2254",
                "id": "18509476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP63))",
        "relation": "decreases",
        "target": "bp(MESHPP:Apoptosis)",
        "directed": false,
        "label": "tscript(p(HGNC:TP63)) decreases bp(MESHPP:Apoptosis)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0928",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP63)) decreases bp(MESHPP:Apoptosis)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0805"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MDM4)",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:MDM4) directlyDecreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0929",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MDM4) directlyDecreases tscript(p(HGNC:TP53))",
              "summary_text": "We found that MDMX binds to the casein kinase 1 alpha isoform (CK1alpha) and is phosphorylated by CK1alpha. Expression of CK1alpha stimulates the ability of MDMX to bind to p53 and inhibit p53 transcriptional function. Regulation of MDMX-p53 interaction requires CK1alpha binding to the central region of MDMX and phosphorylation of MDMX on serine 289. Inhibition of CK1alpha expression by isoform-specific small interfering RNA (siRNA) activates p53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Aug 25(15) 6509-20",
                "id": "16024788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe56"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MDM4) directlyDecreases tscript(p(HGNC:TP53))",
              "summary_text": "from full text - MdmX blocks p53 transactivation and degradation ...MdmX is capable of associating with p53 ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Feb 20(3) 1001-7",
                "id": "10629057"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:RHOA))",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "gtp(p(HGNC:RHOA)) increases kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe092a",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:RHOA)) increases kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Induction of DNA DSBs stimulates the activation of the MAPK p38 in a RhoA-dependent manner; and this is required to delay cell death in response to toxin treatment or ?-irradiation (Guerra et al., 2008a).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2011 Aug 15 124(Pt 16) 2735-42",
                "id": "21807938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0806"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAD51)",
        "relation": "hasModification",
        "target": "p(HGNC:RAD51,pmod(P,Y,315))",
        "directed": false,
        "label": "p(HGNC:RAD51) hasModification p(HGNC:RAD51,pmod(P,Y,315))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe092b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAD51) hasModification p(HGNC:RAD51,pmod(P,Y,315))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0807"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC6))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:ERCC6)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe092c",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC6)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "Recently, evidence for a role of CSB in base excision repair of oxidative DNA lesions has accumulated.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Sep 25(17) 7625-36",
                "id": "16107709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0808"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC6))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:ERCC6)) increases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe092d",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC6)) increases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "The known nucleotide excision repair (NER) defects of xeroderma pigmentosum (XP) and Cockayne syndrome (CS) cells can be exploited to analyze mechanisms of repair of UV-induced cyclobutane pyrimidine dimers (CPDs) at nucleotide (nt.) resolution. The two gene products of the CS complementation groups (CSA and CSB) have been implicated in the preferential repair of the transcribed strand of human genes. ",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 1998 May 25 400(1-2) 143-51",
                "id": "9685618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:EP300))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "cat(p(HGNC:EP300)) directlyIncreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe092e",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:EP300)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "In this study, we describe the application of the same strategy for the identification of p300 acetyltransferase-mediated acetylation sites on p53. Consistent with the previous finding, lysines 370, 372, 373, 381, and 382 were detected by this modified selected ion tracing method as the target sites of p300 in vitro. Moreover, two novel acetylation sites, Lys-292 and Lys-305, were also found.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 25568-76",
                "id": "12724314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:EP300)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "We demonstrate that Skp2 forms a complex with p300 through the CH1 and the CH3 domains of p300 to which p53 is thought to bind and antagonizes the interaction between p300 and p53 in cells and in vitro. As Skp2 antagonizes the interaction between p300 and p53, Skp2 suppresses p300-mediated acetylation of p53 and the transactivation ability of p53. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2008 Feb 1 29(2) 217-31",
                "id": "18243116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Cadmium)",
        "relation": "decreases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "a(SCHEM:Cadmium) decreases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe092f",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Cadmium) decreases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "In summary, our data indicate a general nucleotide excision repair inhibition by cadmium compounds, which is most likely caused by a diminished assembly and disassembly of the NER machinery. These data reveal new insights into the mechanisms involved in cadmium carcinogenesis and provide further evidence that DNA repair inhibition may be one predominant mechanism in cadmium induced carcinogenicity.",
              "citation": {
                "type": "PubMed",
                "name": "Chem Res Toxicol 2010 Feb 15 23(2) 432-42",
                "id": "20092276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XRCC1),p(HGNC:APTX))",
        "relation": "hasComponent",
        "target": "p(HGNC:XRCC1)",
        "directed": false,
        "label": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) hasComponent p(HGNC:XRCC1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0930",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) hasComponent p(HGNC:XRCC1)",
              "summary_text": "APTX interacts with XRCC1.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Dec 24 325(4) 1279-85",
                "id": "15555565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) hasComponent p(HGNC:XRCC1)",
              "summary_text": "Affinity Capture-Western; Reconstituted Complex; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2004 May 15 13(10) 1081-93",
                "id": "15044383"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe58"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) hasComponent p(HGNC:XRCC1)",
              "summary_text": "These results strongly support the possibility that aprataxin and XRCC1 constitute a multiprotein complex and are involved in single-strand DNA break repair",
              "citation": {
                "type": "PubMed",
                "name": "Ann Neurol 2004 Feb 55(2) 241-9",
                "id": "14755728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XRCC1),p(HGNC:APTX))",
        "relation": "hasComponent",
        "target": "p(HGNC:APTX)",
        "directed": false,
        "label": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) hasComponent p(HGNC:APTX)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0931",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) hasComponent p(HGNC:APTX)",
              "summary_text": "Affinity Capture-Western; Reconstituted Complex; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2004 May 15 13(10) 1081-93",
                "id": "15044383"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) hasComponent p(HGNC:APTX)",
              "summary_text": "These results strongly support the possibility that aprataxin and XRCC1 constitute a multiprotein complex and are involved in single-strand DNA break repair",
              "citation": {
                "type": "PubMed",
                "name": "Ann Neurol 2004 Feb 55(2) 241-9",
                "id": "14755728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) hasComponent p(HGNC:APTX)",
              "summary_text": "APTX interacts with XRCC1.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Dec 24 325(4) 1279-85",
                "id": "15555565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XRCC1),p(HGNC:APTX))",
        "relation": "increases",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) increases bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0932",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XRCC1),p(HGNC:APTX)) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "These results strongly support the possibility that aprataxin and XRCC1 constitute a multiprotein complex and are involved in single-strand DNA break repair",
              "citation": {
                "type": "PubMed",
                "name": "Ann Neurol 2004 Feb 55(2) 241-9",
                "id": "14755728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA2)",
        "relation": "increases",
        "target": "cat(p(HGNC:PARP1))",
        "directed": false,
        "label": "p(HGNC:BRCA2) increases cat(p(HGNC:PARP1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0933",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA2) increases cat(p(HGNC:PARP1))",
              "summary_text": "We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis ... from full text, embryonic stem cells",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Apr 14 434(7035) 917-21",
                "id": "15829967"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": "embryo"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATF2,pmod(P,T,69))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:ATF2))",
        "directed": false,
        "label": "p(HGNC:ATF2,pmod(P,T,69)) directlyIncreases tscript(p(HGNC:ATF2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0934",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,69)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "JNK, which phosphorylates ATF2 in Thr-69 and Thr-71,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 25 279(26) 27458-65",
                "id": "15105425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,69)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "pp60(v-src) induction of ATF-2 was abolished by the c-Jun N-terminal kinase inhibitor JNK-interacting protein-1 or by mutation of ATF-2 at Thr69 and Thr71.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 12 274(11) 7341-50",
                "id": "10066798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,69)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "Mutation of either Thr69 or Thr71, or both, led to an almost complete loss of inducibility. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Apr 18 14(8) 1798-811",
                "id": "7737130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,69)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "Mutation of either Thr69 or Thr71, or both, led to an almost complete loss of inducibility. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Apr 18 14(8) 1798-811",
                "id": "7737130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:LIG1))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "directed": false,
        "label": "cat(p(HGNC:LIG1)) increases bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0935",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:LIG1)) increases bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
              "summary_text": "After a 24- to 32-residue oligonucleotide is released, the gap is filled in by PCNA-dependent POL epsilon or delta and sealed by a DNA ligase, presumably LIG1.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:LIG1))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:LIG1)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0936",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:LIG1)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "DNA strand displacement may instead occur, involving either POL b or a larger polymerase such as POL d, for filling-in of gaps a few nucleotides long (37). The FEN1 structure-specific nuclease removes the displaced flap and the PCNA protein stimulates these reactions (38), acting as a scaffold protein in this alternative pathway in a way similar to that of XRCC1 in the main pathway. Another replication factor, DNA ligase I (LIG1) then completes this longer patch form of repair.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:RHOB))",
        "relation": "increases",
        "target": "p(HGNC:RAD51)",
        "directed": false,
        "label": "gtp(p(HGNC:RHOB)) increases p(HGNC:RAD51)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0937",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:RHOB)) increases p(HGNC:RAD51)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:RHOB))",
        "relation": "increases",
        "target": "p(HGNC:CCND1)",
        "directed": false,
        "label": "gtp(p(HGNC:RHOB)) increases p(HGNC:CCND1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0938",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:RHOB)) increases p(HGNC:CCND1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "deg(p(HGNC:TP53))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:TP53)",
        "directed": false,
        "label": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0939",
          "evidences": [
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2002 Aug 2(2) 103-12",
                "id": "12204530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "We investigated the role of the ubiquitin-conjugating enzyme UBCH7 in nuclear receptor transactivation. Using transient transfection assays, we demonstrated that UBCH7 modulates the transcriptional activity of progesterone receptor (PR) and glucocorticoid, androgen, and retinoic acid receptors in a hormone-dependent manner and that the ubiquitin conjugation activity of UBCH7 is required for its ability to potentiate transactivation by steroid hormone receptors (SHR). However, UBCH7 showed no significant effect on the transactivation functions of p53 and VP-16 activation domain. Depletion of endogenous UBCH7 protein by small interfering RNAs suggests that UBCH7 is required for the proper function of SHR. Furthermore, a chromatin immunoprecipitation assay demonstrated the hormone-dependent recruitment of UBCH7 onto estrogen receptor- and PR-responsive promoters. Additionally, we show that UBCH7 and E6-associated protein (E6-AP) synergistically enhance PR transactivation. We also demonstrate that UBCH7 interacts with steroid receptor coactivator 1 (SRC-1) and that UBCH7 coactivation function is dependent on SRC-1. Taken together, our results reveal the possible role of UBCH7 in steroid receptor transactivation and provide insights into the mechanism of action of UBCH7 in receptor function.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Oct 24(19) 8716-26",
                "id": "15367689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "The cytosolic quinone oxidoreductases [NRH:quinone oxidoreductase 2 (NQO2) and NAD(P)H:quinone oxidoreductase 1 (NQO1)] interacted with p53 and protected p53 against 20S proteasomal degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Jun 1 67(11) 5380-8",
                "id": "17545619"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "% UbcH7 is a ubiquitin-conjugating enzyme mediating c-fos degradation, transcription factor NF-kappaB maturation, human papilloma virus-mediated p53 and Myc protein degradation, in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2000 Apr 25 1491(1-3) 57-64",
                "id": "10760570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "We now show that p53 and its inhibitor MDM2 (HDM2 in human cells) are together in the nuclei of H7-treated cells and can be co-immunoprecipitated. Despite this association of p53 with the ubiquitin ligase MDM2, ubiquitinated p53 was not detected in H7-treated cells. Furthermore, co-treatment with H7 and the proteosome inhibitor LLnL prevented the accumulation of ubiquitinated p53 that was observed in cells treated solely with LLnL.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 24 276(34) 31819-24",
                "id": "11431470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "we find that expression of Akt reduces the protein levels of p53, at least in part by enhancing the degradation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 14 277(24) 21843-50",
                "id": "11923280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "The turnover rate of p53 is normally high in HeLa cells, but in the presence of miR-29 miRNAs (MIR29A, MIR29B1, MIR29C) p53 became more stable.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Struct Mol Biol 2009 Jan 16(1) 23-9",
                "id": "19079265"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "ultimate carcinogen benzo[a]pyrene diol epoxide (BPDE) Analyses of proteins in treated cells indicated that p53 was phosphorylated at Ser15 but not at Ser20 within 30 min of treatment, and this correlated with an increase in the total amount of p53 protein.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Feb 24(2) 225-34",
                "id": "12584171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "p14ARF tumour suppressor stabilises and activates p53 by directly interacting with (H)Mdm2 [(human) murine double minute 2 homologue] and inhibiting its E3 ubiquitin ligase activity. Expression of p14ARF protects p53 from (H)Mdm2-mediated ubiquitylation but has no effect on the auto-ubiquitylation activity of (H)Mdm2 [18].",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 Sep 25 528(1-3) 207-11",
                "id": "12297306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "We found that 14-3-3 sigma interacted with p53 in response to the DNA-damaging agent adriamycin. Importantly, 14-3-3 sigma expression led to stabilized expression of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Oct 23(20) 7096-107",
                "id": "14517281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "It has been proposed that ARF is expressed only when an E2F signaling threshold is exceeded following oncogenic activation. The main activity of ARF is its ability to bind to p53 inhibitors and to control ribosome biogenesis. Human double minute (HDM2) [mouse double minute 2 (Mdm2) in mouse] and ARF protein binding 1 (BP1)/Mule are two specific E3 ubiquitin ligases that mediate p53 degradation through ubiquitination.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2007 Jan 13(1) 4-11",
                "id": "17118707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "We report here that enforced Bcl-2 expression in MCF7 cells stabilizes p53, induces phosphorylation of p53 serine 15 (p53pSer15) and inhibits MCF7 cell growth. Bcl-2-positive MCF7 cells proliferate slower than those of Bcl-2 negative.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Sep 14 25(41) 5601-11",
                "id": "16636671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Using the proteasome-specific inhibitors, MG132 and lactacystin, we show that the p53, the cdk inhibitors p21 and p27, and cyclin A are degraded by the ubiquitin-proteasome pathway in human osteosarcoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jun 11 318(4) 868-72",
                "id": "15147952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Here, we report that Synoviolin targets tumor suppressor gene p53 for ubiquitination. Synoviolin sequestrated and metabolized p53 in the cytoplasm and negatively regulated its cellular level and biological functions, including transcription, cell cycle regulation and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2007 Jan 10 26(1) 113-22",
                "id": "17170702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "The abundance of an essential downstream effecter of this pathway, the tumor suppressor protein p53, is tightly regulated by controlled degradation through COP1 and other E3 ubiquitin ligases, such as MDM2 and Pirh2;",
              "citation": {
                "type": "PubMed",
                "name": "Science 2006 Aug 25 313(5790) 1122-6",
                "id": "16931761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "MDM2 functions as an E3 ubiquitin ligase to degrade p53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Dec 1(14) 993-1000",
                "id": "14707282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Table 1 Substrates of DNA-PK",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Feb 3 24(6) 949-61",
                "id": "15592499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "YY1 overexpression stimulates p53 ubiquitination and degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Jun 25 117(7) 859-72",
                "id": "15210108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "together to form a ternary complex. We show that, when overexpressed, L23 inhibits HDM2-induced p53 polyubiquitination and degradation and causes a p53-dependent cell cycle arrest.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Sep 24(17) 7669-80",
                "id": "15314174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Substitution of Thr-55 with an alanine residue (T55A) stabilizes p53 and impairs the ability of TAF1 to induce G1 progression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2004 Mar 26 13(6) 867-78",
                "id": "15053879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "In addition, treatment of cells with the PKC activator phorbol ester stimulated the ubiquitination of p53 and reduced its ability to accumulate after stress. H7 did not induce the phosphorylation of human p53 on Ser-15 (Ser-18 in mouse protein), a modification that occurs in response to DNA damage and leads to the release of MDM2 and to transactivation by p53",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 24 276(34) 31819-24",
                "id": "11431470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Western blots revealed that p53 was stabilized in HCT116 PTEN(-/-) cells via an Akt1-dependent and p14(ARF)-independent mechanism",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Jan 27(2) 662-77",
                "id": "17060456"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Furthermore, we found that FIP200 could interact with exogenous and endogenous p53 protein and significantly increase its half-life compared with the control cells ... from full text, U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Aug 1 65(15) 6676-84",
                "id": "16061648"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "the central module is the interplay between p53 and the Mdm2 protein, which inactivates p53 and targets it for rapid proteolysis.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Nov 973 374-83",
                "id": "12485897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Mdm2 binds to p53 and promotes its degradation",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2008 Jun 7(6) 845-52",
                "id": "18340116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "<p30> p53 is rapidly degraded by the process of ubiquitiation and proteasome. <p31> mdm2 stimulates p53 degradation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "p19ARF antagonizes the ability of mdm2 to degrade p53, leading to p53 stabilization (p19ARF = CDKN2A)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Treat Res 2003 115 209-39",
                "id": "12613199"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "The COP9 signalosome (CSN) purified from human erythrocytes possesses kinase activity that phosphorylates proteins such as c-Jun and p53 with consequence for their ubiquitin (Ub)-dependent degradation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Mar 17 22(6) 1302-12",
                "id": "12628923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "erythrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Mdm2 has long been considered a major p53 regulator that inhibits p53 mainly through ubiquitination followed by proteasomal degradation ( 1",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Aug 1 68(15) 6031-4",
                "id": "18676821"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "despite being expressed at comparable levels (see Fig. 6A), S395D was far less capable of promoting p53 degradation",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 May 1 15(9) 1067-77",
                "id": "11331603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "The complex of E6-AP and E6 specifically interacts with p53 and mediates ubiquitination of p53 in concert with the E1 ubiquitin-activating enzyme and the E2 ubiquitin-conjugating enzyme UbcH5.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Feb 2 271(5) 2795-800",
                "id": "8576257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "To investigate possible pathways linking Gas2 to p53, a yeast two-hybrid screen swas performed, indicating m-calpain as a strong Gas2- interacting protein. Moreover, we demonstrate that Gas2 physically interacts with m-calpain in vivo and that recombinant Gas2 inhibits calpain-dependent processing of p53.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jun 1 20(11) 2702-14",
                "id": "11387205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Furthermore, by coimmunoprecipitaton and cotransfection assays, we found that PTEN physically binds p53 in vitro as well as in vivo. Binding of PTEN to p53 attenuated MDM2-mediated p53 inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Oct 1 63(19) 6357-62",
                "id": "14559824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "acute lymphoblastic leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "# Ariadne: Our results indicate that NQO1 regulates  degradation of p53 in the proteasomes by a mechanism that is independent of  both Mdm-2 and ubiquitin. [Regulation] # Ariadne: Inhibition of NQO1 Activity  Induces Mdm-2-Independent p53 Degradation That Is Blocked by p14 ARF . [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Oct 1 99(20) 13125-30",
                "id": "12232053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "p16(INK4a) is a critical component in retinoblastoma protein (Rb)-mediated growth regulatory pathway, p14(ARF) plays a pivotal role in the activation of p53 upon oncogenic stress signals. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 12 26(32) 4627-34",
                "id": "17297463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Interaction of Jab1 with the tumor suppressor p53 induces CSN-mediated phosphorylation and subsequent degradation of p53 (Bech Otschir et al., 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Nov 25 23(55) 8868-75",
                "id": "15480426"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Akt (PKB) directly phosphorylates multiple protein targets of relevance to apoptosis (Figure 2B), suppressing cell death clearly within the intrinsic pathway (e.g., BAD inactivation, human caspase-9 suppression) and possibly also the extrinsic pathway (e.g., FasL expression) in some types of cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Jan 3(1) 17-22",
                "id": "12559172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "In vitro phosphorylation of p53 by JNK abolished Mdm2 binding and targeting of p53 ubiquitination",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Sep 1 95(18) 10541-6",
                "id": "9724739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Finally, the uba domain is necessary for the ability of full-length hPLIC-2 to interfere with the ubiquitin-mediated proteolysis of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Sep 14(9) 3868-75",
                "id": "12972570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "The COP9 signalosome (CSN) purified from human erythrocytes possesses kinase activity that phosphorylates proteins such as c-Jun and p53 with consequence for their ubiquitin (Ub)-dependent degradation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Mar 17 22(6) 1302-12",
                "id": "12628923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Moreover, the binding of beta-arrestin 2 to Mdm2 suppressed the self-ubiquitination of Mdm2 and consequently reduced the Mdm2-mediated p53 degradation and ubiquitination. Further experiments revealed that overexpression of beta-arrestin 2 enhanced the p53-mediated apoptosis while suppression of endogenous beta-arrestin 2 expression by RNA interference technology considerably attenuated the p53-mediated apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 6363-70",
                "id": "12488444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "MDM2 is an E3 ubiquitin ligase which mediates ubiquitylation and proteasome-dependent degradation of the p53 tumor suppressor protein",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Nov 5 577(1-2) 270-6",
                "id": "15527798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Ubiquitination and degradation of p53 is dependent on MDM2...stimulates",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 May 268(10) 2773-8",
                "id": "11358491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "In vitro, nuclear p14arf stabilizes nuclear p53 nuclear p14arf binds Hdm2 to block Hdm2-dependent nucleocytoplasmic shuttling of p53, which is required before cytoplasmic degradation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2004 6(5) R571-85",
                "id": "15318938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Furthermore, hEcd interacts with murine double minute-2 and stabilizes p53 by inhibiting murine double minute-2-mediated degradation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Jul 15 66(14) 7167-75",
                "id": "16849563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "from full text - MdmX blocks p53 transactivation and degradation ...MdmX is capable of associating with p53 ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Feb 20(3) 1001-7",
                "id": "10629057"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "PCNA and DDB1/CUL4A complexes were found to physically interact with p53 tumor suppressor and its regulator MDM2/HDM2. The isolated CUL4A complexes display potent and robust polyubiquitination activity towards p53 and this activity is dependent on L2DTL, PCNA, DDB1, ROC1 and MDM2/HDM2.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2006 Aug 5(15) 1719-29",
                "id": "16861890"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "auroraA is known to phosphorylate p53, which leads to its ubiquitylation by MDM2 and subsequent proteolysis",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "PML-RAR causes deacetylation and degradation of p53, resulting in repression of p53 transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Mar 10 23(5) 1144-54",
                "id": "14976551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Upon DNA damage, the amino terminus of p53 is phosphorylated at a number of serine residues including S20, a site that is particularly important in regulating stability and function of the protein.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 289-300",
                "id": "10673501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Both L11 and L23 have been shown to activate p53 by inhibiting MDM2-mediated p53 suppression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 44475-82",
                "id": "15308643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "to elucidate the role of nonactive JNK2 in regulating p53 stability the amount of p53-JNK complex was inversely correlated with the p53 level a peptide corresponding to the JNK binding site on p53 efficiently blocked ubiquitination of p53",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1998 Sep 1 12(17) 2658-63",
                "id": "9732264"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Both VRK2 isoforms have an identical catalytic N-terminal domain and phosphorylate p53 in vitro uniquely in Thr18. Phosphorylation of the p53 protein in response to cellular stresses results in its stabilization by modulating its binding to other proteins.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS J 2006 Jun 273(11) 2487-504",
                "id": "16704422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "ATM-mediated phosphorylation of p53 stabilizes this tumor suppressor protein by reducing constitutive interactions with MDM2, which usually promotes the degradation of p53 (Figure 1) (Giaccia and Kastan, 1998; Chin et al., 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "HER-2/neu-mediated resistance to DNA-damaging agents requires the activation of Akt, which enhances MDM2-mediated ubiquitination and degradation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Nov 3(11) 973-82",
                "id": "11715018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "Inactivation of endogenous YY1 enhances the accumulation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Aug 17 101(33) 12165-70",
                "id": "15295102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "In concert with these results, Lyn reverses Mdm2-mediated degradation of p53 and increases p53-dependent apoptosis. Our findings support a previously undefined role for nuclear Lyn in both activation and Mdm2-mediated regulation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 1(6) 703-8",
                "id": "12642697"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:TP53)) directlyDecreases p(HGNC:TP53)",
              "summary_text": "In vitro sumoylation of Mdm2 abrogates its self-ubiquitination and increases its ubiquitin ligase activity toward p53",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2000 Jun 23 101(7) 753-62",
                "id": "10892746"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATF2,pmod(P,T,71))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:ATF2))",
        "directed": false,
        "label": "p(HGNC:ATF2,pmod(P,T,71)) directlyIncreases tscript(p(HGNC:ATF2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe093a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,71)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "Mutation of either Thr69 or Thr71, or both, led to an almost complete loss of inducibility. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Apr 18 14(8) 1798-811",
                "id": "7737130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,71)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "pp60(v-src) induction of ATF-2 was abolished by the c-Jun N-terminal kinase inhibitor JNK-interacting protein-1 or by mutation of ATF-2 at Thr69 and Thr71.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 12 274(11) 7341-50",
                "id": "10066798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,71)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "Consistent with this, both Gal4-c-Jun- and Gal4-ATF2-fusion proteins were activated by RalA signalling through phosphorylation of their activation domains at Ser63 and Ser73 of c-Jun or Thr69 and Thr71 of ATF2.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Apr 5 20(15) 1816-24",
                "id": "11313929"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,71)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "The transacting capacity of ATF4 depends on its expression level and that of ATF2 on its phosphorylation state.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 13 279(7) 5288-97",
                "id": "14630918"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,71)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "JNK, which phosphorylates ATF2 in Thr-69 and Thr-71,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 25 279(26) 27458-65",
                "id": "15105425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2,pmod(P,T,71)) directlyIncreases tscript(p(HGNC:ATF2))",
              "summary_text": "Mutation of either Thr69 or Thr71, or both, led to an almost complete loss of inducibility. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Apr 18 14(8) 1798-811",
                "id": "7737130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfe9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:POLA1))",
        "relation": "increases",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "cat(p(HGNC:POLA1)) increases bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe093b",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:POLA1)) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA1)",
        "relation": "hasModification",
        "target": "p(HGNC:BRCA1,pmod(P,S,1330))",
        "directed": false,
        "label": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1330))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe093c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1330))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP73,pmod(P,S,47))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "p(HGNC:TP73,pmod(P,S,47)) directlyIncreases tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe093d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP73,pmod(P,S,47)) directlyIncreases tscript(p(HGNC:TP73))",
              "summary_text": "Consistent with this, we discovered that endogenous p73alpha interacts with Chk1 and is phosphorylated by Chk1 at serine 47 in vitro and in vivo. In contrast, Chk2 does not phosphorylate p73alpha in vitro. Moreover, mutation of serine 47 abolishes both Chk1-dependent phosphorylation of p73alpha upon DNA damage in vivo and the ability of Chk1 to upregulate the transactivation capacity of p73alpha. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(22) 8161-71",
                "id": "14585975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ERCC8)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:ERCC8))",
        "directed": false,
        "label": "p(HGNC:ERCC8) actsIn cat(p(HGNC:ERCC8))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe093e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ERCC8) actsIn cat(p(HGNC:ERCC8))",
              "summary_text": "The known nucleotide excision repair (NER) defects of xeroderma pigmentosum (XP) and Cockayne syndrome (CS) cells can be exploited to analyze mechanisms of repair of UV-induced cyclobutane pyrimidine dimers (CPDs) at nucleotide (nt.) resolution. The two gene products of the CS complementation groups (CSA and CSB) have been implicated in the preferential repair of the transcribed strand of human genes. ",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 1998 May 25 400(1-2) 143-51",
                "id": "9685618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ERCC8) actsIn cat(p(HGNC:ERCC8))",
              "summary_text": "In transcription-coupled NER (TC-NER), blockage of transcribing RNA Polymerase II (RNA-Pol II) on the damaged DNA template is thought to initiate the repair reaction in a process that requires, in addition to TFIIH, XPA, XPG, and ERCC1-XPF, the TCR-specific proteins CSB and CSA [9] (Figure 2). ",
              "citation": {
                "type": "PubMed",
                "name": "J Nucleic Acids 2010 2010",
                "id": "20725631"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:POLE)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:POLE))",
        "directed": false,
        "label": "p(HGNC:POLE) actsIn cat(p(HGNC:POLE))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe093f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:POLE) actsIn cat(p(HGNC:POLE))",
              "summary_text": "After a 24- to 32-residue oligonucleotide is released, the gap is filled in by PCNA-dependent POL epsilon or delta and sealed by a DNA ligase, presumably LIG1.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:POLE) actsIn cat(p(HGNC:POLE))",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:POLE) actsIn cat(p(HGNC:POLE))",
              "summary_text": " Pol delta/epsilon-mediated BER (long-patch BER) is the mode of repair when lesions persist or are formed at replication",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 2003 Oct 29 531(1-2) 127-39",
                "id": "14637250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfea8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:SP1,pmod(P,S,101))",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "p(HGNC:SP1,pmod(P,S,101)) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0940",
          "evidences": [
            {
              "bel_statement": "p(HGNC:SP1,pmod(P,S,101)) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "the Ser-101 phosphorylation did not affect transcriptional activity from the Sp1 responsive promoter. Confocal laser microscopy analysis revealed co-localization of phosphorylated Sp1 at Ser-101 with phosphorylated ATM at Ser-1981, the affected sites representing DSBs. These observations suggest that phosphorylated Sp1 might play a role in DNA repair at damage sites rather than functioning in transcriptional regulation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Oct 20(10) 1795-803",
                "id": "18619531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:camptothecin)",
        "relation": "directlyDecreases",
        "target": "cat(p(HGNC:TOP1))",
        "directed": false,
        "label": "a(CHEBI:camptothecin) directlyDecreases cat(p(HGNC:TOP1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0941",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:camptothecin) directlyDecreases cat(p(HGNC:TOP1))",
              "summary_text": " The compound [camptothecin] exhibits high specificity for topoisomerase I (topo I), which it inhibits by preventing the religation step of this enzymes DNA relaxing activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Mar 15 64(6) 2096-104",
                "id": "15026349"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PARP1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PARP1))",
        "directed": false,
        "label": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0942",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "FIGURE 2. MMR-dependent apoptotic proteolysis of caspase-8, caspase-9, and PARP-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Aug 1 283(31) 21394-403",
                "id": "18480060"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0819"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Cisplatin significantly increased inflammation (leukocyte infiltration, CXCL1/2, MCP-1, TNFalpha, and IL-1beta levels) and expression of adhesion molecule ICAM-1 and superoxide-generating enzymes NOX2, NOX4, and NOX1 and enhanced ROS generation, iNOS expression, nitrotyrosine formation, and apoptotic and poly(ADP-ribose) polymerase-dependent cell death in the kidneys of mice, associated with marked histopathological damage and impaired renal function (elevated serum BUN and creatinine levels) 3 days after the administration of the drug.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2010 Feb 1 48(3) 457-67",
                "id": "19969072"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0815"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Besides downregulation of Bcl-XL, upregulation of Bak, and activation of both PARP [poly (ADP-ribose) polymerase] and DFF45 (DNA fragmentation factor), LIGHT-induced, IFNg-mediated apoptosis of HT-29 cells involves extensive caspase activation",
              "citation": {
                "type": "PubMed",
                "name": "Cell Res 2004 Apr 14(2) 117-24",
                "id": "15115612"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0814"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Using antioxidants, local irradiation, chromatin immunoprecipitation and in vitro PARP assays, we identified that ultraviolet radiation-induced direct DNA damage, such as thymine dimers, cause the initial PARP activation, whereas ultraviolet B-induced oxidative damage cause the second PARP activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2005 Feb 1 118(Pt 3) 589-99",
                "id": "15657079"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0811"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Re-expression of CRYL1 in the SK-Hep1 cell line, where biallelic loss of CRYL1 was found, induced profound inhibition of cellular proliferation and cell growth (p < 0.0015). By Annexin V staining, CRYL1 restoration readily increased pro-apoptotic cells with an induction of PARP cleavage.",
              "citation": {
                "type": "PubMed",
                "name": "J Pathol 2010 Feb 220(3) 348-60",
                "id": "19927314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0810"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "hepatocellular carcinoma",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Figure 2 | Extrinsic and intrinsic apoptotic signalling pathways in neurons. Black lines represent apoptotic pathways, blue lines represent survival pathways. The extrinsic death pathway is initiated by binding of the extracellular ligands, TNFa (tumour necrosis factor-a) or FAS (apoptosis antigen-1) ligand (FASL), to death receptors TNFR1 (TNF-receptor1) and FAS. TNFR1 activation leads to the formation of a TRADD RIP TRAF2 (TNF receptor death domain receptor interacting protein TNF associated factor 2) complex, which signals through the NFkB (nuclear factorkB) survival pathway (blue lines) or the JNK (cJun N teminal kinase)death pathway (black lines). RIP activates procaspase 2 and cleaves BID (BH3 (BCL2 (B-cell leukaemia/lymphoma-2) homology domain 3) interacting agonist). The TRADD FADD FLICE (TNF receptor death domain FAS associated death domain FADD like interleukin 1b) complex activates procaspase 8, triggering apoptosis through caspase 3 or cleavage of BID to tBID (truncated BID). FAS-mediated death occurs through a FADD-mediated activation of procaspase 8 or DAXX (death-associated protein )-mediated activation of JNK. JNK modifies BID to jBID, allowing its translocation to the mitochondrion and release of SMAC/DIABLO (second-mitochondrialderived activator of caspases). The intrinsic apoptotic pathway is initiated at the mitochondrion by diverse stimuli. Membrane permeabilization is mediated by BH3-only proteins, which sequester and inhibit the supression of BAX (B-cell lymphoma 2-associated protein X) by BCL2, allowing mitochondrial BAX translocation and the release of cytochrome c (Cyto c), SMAC/DIABLO, AIF (apoptosis-inducing factor) and HTRA2/OMI (high temperature requirement serine protease 2).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Neurosci 2004 Sep 5(9) 686-700",
                "id": "15322527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Here, we report on the transient and stable transfection of cDNA coding for the putative truncated protein product of the BRCA1 185delAG mutant gene into BRCA1 wild-type human ovarian surface epithelial cells and ovarian cancer cells, resulting in cells with a heterozygous background containing two BRCA1 wild-type alleles and the BRCA1 185delAG transcript. The BRCA1 185delAG truncation (BRAt) protein did not alter epithelial cell morphology or induce tumorigenesis. However, upon treatment with staurosporine, BRAt cells showed increased levels of active caspase-3 and increased cleavage of caspase-3 substrates, PARP and DFF45",
              "citation": {
                "type": "PubMed",
                "name": "In Vitro Cell Dev Biol Anim 44(8-9) 357-67",
                "id": "18594935"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Pretreatment with an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1), NU1025, nearly doubled the DNA damage produced by 5 microM 3MI, implying that PARP1, which among other activities, functions to repair single-strand breaks in DNA, repaired at least some of the 3MI-induced DNA fragmentation. A key cellular response to DNA damage, phosphorylation, and nuclear localization of p53 was seen at subtoxic levels of 3MI exposure ... from Fig 6, TP53 P@S20",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2009 Nov 112(1) 59-67",
                "id": "19700606"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Extensive oxidative and/or nitrosative stress triggers the third pathway by inducing extensive DNA breakage, overactivation of PARP, and consequent depletion of the cellular stores of its substrate NAD+, impairing glycolysis, Krebs cycle, and mitochondrial electron transport, and eventually resulting in ATP depletion and consequent cell dysfunction and death by necrosis. In this case, pharmacological inhibition of PARP or genetic deletion of the PARP-1 preserves cellular NAD+ and ATP pools in oxidatively and/or nitrosatively stressed cardiomyocytes, endothelial or other cell types, thereby allowing them to function normally, or, if the apoptotic process has initiated, to utilize the apoptotic machinery and die by apoptosis instead of necrosis",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Drug Rev 2007 25(3) 235-60",
                "id": "17919258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Here, we report on the transient and stable transfection of cDNA coding for the putative truncated protein product of the BRCA1 185delAG mutant gene into BRCA1 wild-type human ovarian surface epithelial cells and ovarian cancer cells, resulting in cells with a heterozygous background containing two BRCA1 wild-type alleles and the BRCA1 185delAG transcript. The BRCA1 185delAG truncation (BRAt) protein did not alter epithelial cell morphology or induce tumorigenesis. However, upon treatment with staurosporine, BRAt cells showed increased levels of active caspase-3 and increased cleavage of caspase-3 substrates, PARP and DFF45",
              "citation": {
                "type": "PubMed",
                "name": "In Vitro Cell Dev Biol Anim 44(8-9) 357-67",
                "id": "18594935"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Repair mechanisms activated by ROS-induced DNA damage require cell cycle arrest, which is mediated by several damage checkpoints (Abraham 2001). Following recognition of DNA damage by PARP-1, a simultaneous 9-1-1 alert complex is formed, consisting of Rad9, Rad1 and Hus1, which are activated under the control of Rad17 to initiate a downstream DNA damage-signaling cascade (Figure 1) (Melo et al., 2001; Kondo et al., 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Next, we sought to analyse whether the decrease in FADD-FLICE association caused by PED overexpression affected FLICE protease activity. To this end, we incubated identical amounts of in vitro translated 35S-PARP, a death substrate cleaved by the active FLICE, with extracts from control or PED-overexpressing cells stimulated with IgMFAS. A major band, corresponding to the 26 kDa cleavage product of 35S-PARP was identified after incubation with extracts from IgMFAS-stimulated control cells (Figure 8). The intensity of the band was fivefold lower after PARP incubation with extracts from FAS-unstimulated cells. Most important, in this assay, PARP cleavage was threefold less effective in PED overexpressing than in control cells. No 26 kDa band was detectable in the absence of cell extract addition. Thus, cleavage of death substrates by active FLICE occurs less efficiently in cells overexpressing PED.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Aug 5 18(31) 4409-15",
                "id": "10442631"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "the activity of phospholipases, the activity of poly-ADPribose polymerase (PARP),",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 1999 Oct 79(4) 1431-568",
                "id": "10508238"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Western blotting of whole-cell lysates prepared from untreated or TNFalpha/CHX-treated NIH 3T3 cells showed no detectable cleavage of ROCK II (Fig. 2a) but significant cleavage of ROCK I, as well as cleavage of the well characterized caspase substrate poly-ADP ribose polymerase (PARP) after treatment with TNFalpha ( Fig. 2b). ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Apr 3(4) 339-45",
                "id": "11283606"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "In hyperoxic lungs, there was a significant increase in the amount of cleaved caspase-3 (17 kD) and cleaved PARP-1 (85 kD) in WT mice, whereas in NOX1-deficient mice only small increases were observed (Figures 6A26C).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2009 Nov 15 180(10) 972-81",
                "id": "19661248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "3-Aminobenzamide inhibits the catalytic activity of PARP-1 (41). However, it has no effect on ORE reporter activity in HEK 293 cells (Fig. 5C), except for an increase of 20% at 300 mosmol/kgH2O.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2007 Mar 292(3) F981-92",
                "id": "17148781"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Poly(ADP-ribose) polymerase activation in turn depletes the intracellular concentration of its substrate NAD(+), slowing the rate of glycolysis, electron transport, and ATP formation, and produces an ADP-ribosylation of the GAPDH.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes Care 2003 May 26(5) 1589-96",
                "id": "12716823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfecf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "In response to 10 mM MNNG, an increase in PARP activity as judged by immunoblot analysis of nuclear lysates with anti-PAR was observed 72 h after drug addition in YZ-5 cells (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2007 Sep 26(9) 683-94",
                "id": "17678437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfece"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Lovastatin also stimulated proteolytic cleavage of poly-(ADP-ribose) polymerase (PARP), and followed by the appearance of caspase activity and DNA fragmentation.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Toxicol 2000 Feb 86(2) 83-91",
                "id": "10728920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfecd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Table 1 Substrates of DNA-PK",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Feb 3 24(6) 949-61",
                "id": "15592499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfecc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "In addition, unlike in response to oxidants (21, 22, 24), the presence of a PARP inhibitor, 3-aminobenzinamide, did not alter the relative levels of apoptosis and necrosis in response to SS and CSC (data not shown) implying that depletion of ATP as a result of PARP activation is not involved in CSC-mediated cell death.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Nov 29(5) 562-70",
                "id": "12748058"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfecb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "The DNA damage-dependent poly(ADP-ribose) polymerase-2 (PARP-2) is, together with PARP-1, an active player of the base excision repair process, thus defining its key role in genome surveillance and protection.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(4) 1595-607",
                "id": "14749375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "The activation of PARP-1 also leads to ATP depletion, a condition that is permissive for necrosis (81, 82).",
              "citation": {
                "type": "PubMed",
                "name": "Sci Signal 2010 3(115) re4",
                "id": "20354226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Curcumin-induced cleavage of PARP and DFF45 was inhibited by hsp70 but enhanced in Ashsp70 cells",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2004 Feb 25(2) 179-87",
                "id": "14604899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": " Inhibition of poly(ADP-ribose)-polymerase-1 (PARP-1) attenuated CS-induced autophagy via SIRT1 activation (Fig. 5).",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2010 Aug 15 500(2) 203-9",
                "id": "20493163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "We find that CSB is present at sites of activated PARP-1 after oxidative stress, identify CSB as a new substrate of PARP-1, and demonstrate that poly(ADP-ribosyl)ation of CSB inhibits its DNA-dependent ATPase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Sep 25(17) 7625-36",
                "id": "16107709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "cell death was blocked by repletion of cellular NAD levels as well as by activation of the longevity factor Sir2alpha deacetylase",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2006 Oct 291(4) H1545-53",
                "id": "16632544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 40974-80",
                "id": "11016934"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Indeed, pifithrin-alpha significantly diminished acrolein-induced cleavage of PARP (Figs. 8B, 8C).",
              "citation": {
                "type": "PubMed",
                "name": "Can J Physiol Pharmacol 2010 Mar 88(3) 353-68",
                "id": "20393600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "The activation of PARP-1 also leads to ATP depletion, a condition that is permissive for necrosis (81, 82).",
              "citation": {
                "type": "PubMed",
                "name": "Sci Signal 2010 3(115) re4",
                "id": "20354226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Poly(ADP-ribose) polymerase-1 (PARP), a chromatin-bound enzyme, is activated by cell oxidative stress.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2006 Oct 291(4) H1545-53",
                "id": "16632544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2002 Sep 54(3) 375-429",
                "id": "12223530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfec0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Myocyte cell death induced by PARP activation was prevented by repletion of cellular NAD levels",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 43121-30",
                "id": "16207712"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfebf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "We reveal that receptor-interacting protein 1 (RIP1) and tumor necrosis factor receptor-associated factor 2 (TRAF2), are upstream of JNK in PARP-1 hyperactivated cells, because PARP-1-induced JNK activation was attenuated in RIP1-/- and TRAF2-/- mouse embryonic fibroblast cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 31 281(13) 8788-95",
                "id": "16446354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfebe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "depletion of myocyte NAD levels and the subsequent reduction of Sir2alpha deacetylase activity are the sequential steps contributing to PARP-mediated myocyte cell death.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 43121-30",
                "id": "16207712"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfebd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Activation of SIRT1 by resveratrol leads to reduced PARP-1 activity and there is a drastic increase in PAR synthesis in sirt1-null cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2006 Apr 5(8) 873-7",
                "id": "16628003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfebc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "First, smoke-induced activation of PARP was assessed by Western blot. Second, PARP activity was blocked using the inhibitor 3-aminobenzamide (3-ABA). Cigarette smoke stimulated intact PARP (116 kD) protein synthesis in a concentration-dependent manner, whereas CPT decreased intact PARP by cleaving it into a smaller molecular mass (23 kD; Figure 9). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2005 Aug 33(2) 121-9",
                "id": "15845867"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfebb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "To determine whether these findings extend to other forms of PARP-1-dependent cell death, fibrobast cultures were exposed to H2O2, which induces oxidative stress leading to DNA damage and PARP-1 activation (17-19). H2O2 also induces AIF translocation and cell death in a PARP-1-dependent, but caspase-independent manner (fig. S2, A to D).",
              "citation": {
                "type": "PubMed",
                "name": "Science 2002 Jul 12 297(5579) 259-63",
                "id": "12114629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeba"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "The pSR-miR-15a/16-1-WT-transfected MEG-01 cells showed the activation of intrinsic apoptosis pathway as identified by activation of the APAF-1-caspase9-PARP pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 27 102(39) 13944-9",
                "id": "16166262"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "We repeated the PARP sensitivity assay in HeLa cells, a cervical carcinoma cell line. Silencing of CDK5, MAPK12, PNPK and STK22C significantly sensitised to PARP inhibitor in this cell line (Supplementary Figure 3), confirming the effects we had seen in CAL51 cells.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 May 7 27(9) 1368-77",
                "id": "18388863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis ... from full text, embryonic stem cells",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Apr 14 434(7035) 917-21",
                "id": "15829967"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": "embryo"
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Activation of poly(ADP-ribose) polymerase (PARP) by DNA breaks catalyzes poly(ADP-ribosyl)ation and results in depletion of NAD+ and ATP, which is thought to induce necrosis. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jul 19(7) 5124-33",
                "id": "10373561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "We found, based on genetic knockouts and pharmacological inhibition, that c-Jun N-terminal kinase (JNK), especially JNK1, but not the other groups of mitogen-activated protein kinase, is required for PARP-1-induced mitochondrial dysfunction, apoptosis-inducing factor translocation, and subsequent cell death.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 31 281(13) 8788-95",
                "id": "16446354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Immunoprecipitation and Western blot analyses demonstrate that Cenpa, Cenpb, and Bub3, but not Cenpc, interacted with PARP-1, and are poly(ADP-ribosyl)ated following induction of DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jul 26 277(30) 26921-6",
                "id": "12011073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": " cadmium generated reactive oxygen species (ROS) at relatively low levels, and caused poly(ADP-ribose) polymerase-1 (PARP) activation and ATP depletion.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2011 Sep 15 255(3) 287-96",
                "id": "21767558"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Poly(ADP-ribose) polymerase (PARP) is a critical DNA repair enzyme involved in DNA single-strand break repair via the base excision repair pathway",
              "citation": {
                "type": "PubMed",
                "name": "Curr Drug Targets 2011 Jul 21",
                "id": "21777194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Under normal conditions, >90% PARP was cleaved within 4.5 hr after TRAIL addition, but overexpression of Bcl2 reduced PARP cleavage to <5% at 4.5 hr (Fig. 3D)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2008 Apr 11 30(1) 11-25",
                "id": "18406323"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "FHIT overexpression disrupted mitochondrial membrane integrity and activated multiple pro-apoptotic proteins in NSCLC cell. The activation of caspase 3, caspase 8, caspase 9 and PARP is indicated by detected cleavage of these proteins. FHIT overexpression also activated the apoptosis initiator BID in A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Apr 20 355(4) 993-9",
                "id": "17328863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "In addition, epidermis of parp-1(-/-) mice did not show increased proliferation rates after treatment with DMBA or TPA carcinogens.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jul 8 23(31) 5275-83",
                "id": "15077172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeaf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Both IL-3 withdrawal (Fig. 4 C, left) and forkhead activity (Fig. 4 C, right) resulted in PARP cleavage with kinetics similar to caspase activation. (Western Blot)",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Feb 4 156(3) 531-42",
                "id": "11815629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "Here, we show that PARP inhibitors trigger gamma-H2AX and RAD51 foci formation.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Apr 14 434(7035) 913-7",
                "id": "15829966"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfead"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP1) actsIn cat(p(HGNC:PARP1))",
              "summary_text": "We treated MEF cells with MNNG, a DNA alkylating agent widely used to activate PARP-1 in studying PARP-1-mediated cell death",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 31 281(13) 8788-95",
                "id": "16446354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeac"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
        "relation": "hasComponent",
        "target": "p(HGNC:RAD50)",
        "directed": false,
        "label": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:RAD50)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0943",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:RAD50)",
              "summary_text": "The Mre11/Rad50/NBS1 (MRN) complex is mutated in inherited genomic instability syndromes featuring cancer predisposition, mental retardation and immunodeficiency.  It functions both in DNA double-strand break repair and in controlling the ataxia telangiectasia mutated (ATM) kinase during the response to these lesions",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2005 Sep 15 14(18) 2685-93",
                "id": "16087684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:RAD50)",
              "summary_text": "We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA molecules. Inactive ATM dimers were activated in vitro with DNA in the presence of MRN",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Apr 22 308(5721) 551-4",
                "id": "15790808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:RAD50)",
              "summary_text": "In mammalian cells, DSB ends are recognized by the MRE11/Rad50/NBS1 (MRN) and the KU70/KU80 complexes that function as sensors of DSBs but are also involved in processing the DNA break ends [32,33].",
              "citation": {
                "type": "PubMed",
                "name": "Genome Integr 2010 1(1) 15",
                "id": "21054854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:RAD50)",
              "summary_text": "Phosphorylation of Nbs1 is critical for MRN stimulation of ATM activity toward Chk2",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Apr 2 304(5667) 93-6",
                "id": "15064416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:RAD50)",
              "summary_text": "Second, BRCA1 interacts with various different proteins50, which include the mismatch-repair enzymes MSH2 and MSH6, the DNA helicase BLM and the MRE11-RAD50-NBS1 complex51 that is implicated in homologous recombination.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:RAD50)",
              "summary_text": "phosphorylated H2AX recruits 53BP1, BRCA1, MDC1 and the MRE11-RAD50-NBS1 complex to the site of DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:RAD50)",
              "summary_text": "In pursuit of the involvement of HIF-alpha in chromosomal instability, we report here that HIF-1alpha, specifically its PAS-B, induces DNA double-strand breaks at least in part by repressing the expression of NBS1, a crucial DNA repair gene constituting the MRE11A-RAD50-NBS1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4784-94",
                "id": "17024177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfed4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
        "relation": "hasComponent",
        "target": "p(HGNC:NBN)",
        "directed": false,
        "label": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:NBN)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0944",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:NBN)",
              "summary_text": "We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA molecules. Inactive ATM dimers were activated in vitro with DNA in the presence of MRN",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Apr 22 308(5721) 551-4",
                "id": "15790808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:NBN)",
              "summary_text": "In mammalian cells, DSB ends are recognized by the MRE11/Rad50/NBS1 (MRN) and the KU70/KU80 complexes that function as sensors of DSBs but are also involved in processing the DNA break ends [32,33].",
              "citation": {
                "type": "PubMed",
                "name": "Genome Integr 2010 1(1) 15",
                "id": "21054854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:NBN)",
              "summary_text": "The Mre11/Rad50/NBS1 (MRN) complex is mutated in inherited genomic instability syndromes featuring cancer predisposition, mental retardation and immunodeficiency.  It functions both in DNA double-strand break repair and in controlling the ataxia telangiectasia mutated (ATM) kinase during the response to these lesions",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2005 Sep 15 14(18) 2685-93",
                "id": "16087684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfedf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:NBN)",
              "summary_text": "Phosphorylation of Nbs1 is critical for MRN stimulation of ATM activity toward Chk2",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Apr 2 304(5667) 93-6",
                "id": "15064416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfede"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:NBN)",
              "summary_text": "In pursuit of the involvement of HIF-alpha in chromosomal instability, we report here that HIF-1alpha, specifically its PAS-B, induces DNA double-strand breaks at least in part by repressing the expression of NBS1, a crucial DNA repair gene constituting the MRE11A-RAD50-NBS1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4784-94",
                "id": "17024177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfedd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:NBN)",
              "summary_text": "phosphorylated H2AX recruits 53BP1, BRCA1, MDC1 and the MRE11-RAD50-NBS1 complex to the site of DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfedc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:NBN)",
              "summary_text": "Second, BRCA1 interacts with various different proteins50, which include the mismatch-repair enzymes MSH2 and MSH6, the DNA helicase BLM and the MRE11-RAD50-NBS1 complex51 that is implicated in homologous recombination.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfedb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
        "relation": "hasComponent",
        "target": "p(HGNC:MRE11A)",
        "directed": false,
        "label": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:MRE11A)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0945",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:MRE11A)",
              "summary_text": "We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA molecules. Inactive ATM dimers were activated in vitro with DNA in the presence of MRN",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Apr 22 308(5721) 551-4",
                "id": "15790808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:MRE11A)",
              "summary_text": "In mammalian cells, DSB ends are recognized by the MRE11/Rad50/NBS1 (MRN) and the KU70/KU80 complexes that function as sensors of DSBs but are also involved in processing the DNA break ends [32,33].",
              "citation": {
                "type": "PubMed",
                "name": "Genome Integr 2010 1(1) 15",
                "id": "21054854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:MRE11A)",
              "summary_text": "Phosphorylation of Nbs1 is critical for MRN stimulation of ATM activity toward Chk2",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Apr 2 304(5667) 93-6",
                "id": "15064416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:MRE11A)",
              "summary_text": "In pursuit of the involvement of HIF-alpha in chromosomal instability, we report here that HIF-1alpha, specifically its PAS-B, induces DNA double-strand breaks at least in part by repressing the expression of NBS1, a crucial DNA repair gene constituting the MRE11A-RAD50-NBS1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4784-94",
                "id": "17024177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:MRE11A)",
              "summary_text": "Second, BRCA1 interacts with various different proteins50, which include the mismatch-repair enzymes MSH2 and MSH6, the DNA helicase BLM and the MRE11-RAD50-NBS1 complex51 that is implicated in homologous recombination.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:MRE11A)",
              "summary_text": "The Mre11/Rad50/NBS1 (MRN) complex is mutated in inherited genomic instability syndromes featuring cancer predisposition, mental retardation and immunodeficiency.  It functions both in DNA double-strand break repair and in controlling the ataxia telangiectasia mutated (ATM) kinase during the response to these lesions",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2005 Sep 15 14(18) 2685-93",
                "id": "16087684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) hasComponent p(HGNC:MRE11A)",
              "summary_text": "phosphorylated H2AX recruits 53BP1, BRCA1, MDC1 and the MRE11-RAD50-NBS1 complex to the site of DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0946",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "The Mre11/Rad50/NBS1 (MRN) complex is mutated in inherited genomic instability syndromes featuring cancer predisposition, mental retardation and immunodeficiency.  It functions both in DNA double-strand break repair and in controlling the ataxia telangiectasia mutated (ATM) kinase during the response to these lesions",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2005 Sep 15 14(18) 2685-93",
                "id": "16087684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfee9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) directlyIncreases kin(p(HGNC:ATM))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0947",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN)) directlyIncreases kin(p(HGNC:ATM))",
              "summary_text": "MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Apr 2 304(5667) 93-6",
                "id": "15064416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP63)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:TP63))",
        "directed": false,
        "label": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0948",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the action of TAp63 is mediated at the molecular level by direct and indirect transactivation of IKKalpha and Ets-1, respectively. We also found that DeltaNp63 upregulates IKKalpha indirectly, through GATA-3 { both TAp63{alpha} and {Delta}Np63{alpha} significantly increased luciferase activity of the GATA-3 promoter (Fig. 4A, lanes 2, 5)}",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2006 Nov 15 119(Pt 22) 4617-22",
                "id": "17093266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "To explore the mechanism by which mTOR activation leads to the upregulation of Jagged1/Notch/Hes1 signaling, we examined the expression of p63, a TP53 family member, since p63 is a positive regulator of Jagged1 or Jagged2 expression and Notch activity (4042) and PI3K is an inducer of p63 expression (43). The p63 gene has 2 promoter regions generating TA-p63 and ?N-p63 isoforms, each of which has 3 splicing variants on its C terminus as ?/?/? of TA-p63 and ?N-p63 isoforms (41). The TA-p63 isoform has been observed to activate the expression of ?N-p63 isoform (44). Both TA-p63 and ?N-p63 were overexpressed in cells with mTOR activation because of",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2010 Jan 120(1) 103-14",
                "id": "20038814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We tested 7 p53-related proteins of the p63 and p73 families for their ability to induce maspin expression. The p63 splice form TAp63gamma can substitute for p53 in activating the maspin promoter. TAp63gamma activates the promoter through the same consensus site as p53. In the DLD-1 colorectal adenocarcinoma cell line, harboring a tet-off regulated transgene, induction of TAp63gamma leads to an upregulation of maspin mRNA from the chromosomal gene.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 Apr 20 114(4) 555-62",
                "id": "15578720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we describe the identification of an HMG1-like protein SSRP1 as a co-activator of p63. Over expression of wild-type, but not deletion mutant, SSRP1 remarkably enhanced p63gamma-dependent luciferase activity, G(1) arrest, apoptosis and expression of endogenous PIG3, p21(Waf1/cip1) and MDM2 in human p53-deficient lung carcinoma H1299 cells and mouse embryonic fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 15 21(20) 5487-97",
                "id": "12374749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we identified FDXR as a target gene of the p53 family, that is, p53, p63, and p73. We found that FDXR can be induced by DNA damage in cells in a p53-dependent manner and by a mutated form of p53 that is competent in inducing apoptosis. In addition, we identified a p53 response element located within the FDXR promoter that is responsive to wild-type p53, p63alpha, p63gamma, p73alpha, and p73beta.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 17 21(47) 7195-204",
                "id": "12370809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the action of TAp63 is mediated at the molecular level by direct and indirect transactivation of IKKalpha and Ets-1, respectively. We also found that DeltaNp63 upregulates IKKalpha indirectly, through GATA-3 { both TAp63{alpha} and {Delta}Np63{alpha} significantly increased luciferase activity of the GATA-3 promoter (Fig. 4A, lanes 2, 5)}",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2006 Nov 15 119(Pt 22) 4617-22",
                "id": "17093266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p300, but not its acetylase-defective mutant AT2, stimulated p63gamma-dependent transcription and induction of p21 in cells, consequently leading to G1 arrest. Inversely, the deltaN-p63gamma isoform as well as p300AT2 inhibited the induction of p21 by p63gamma. These results suggest that p300 regulates p63-dependent transcription of p21.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 26 280(34) 30604-10",
                "id": "15965232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here we show that silencing of DeltaNp63 in primary mouse keratinocytes results in a marked down-regulation of Claudin-1 expression (-80%). DeltaNp63alpha binds in vivo to the Claudin-1 promoter and activates both the endogenous Claudin-1 gene and a reporter vector containing a -1.4 Kb promoter fragment of the Claudin-1 gene.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS ONE 2008 3(7) e2715",
                "id": "18648642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "By using oligonucleotide expression microarray analysis and analyzing the promoters of p63-induced genes, we have identified novel p63-specific response elements (p63-REs) in the promoter regions of EVPL and SMARCD3. # TABLE 1. List of genes induced over fourfold by TAp63y in 293 inducible cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jul 25(14) 6077-89",
                "id": "15988020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "To explore the mechanism by which mTOR activation leads to the upregulation of Jagged1/Notch/Hes1 signaling, we examined the expression of p63, a TP53 family member, since p63 is a positive regulator of Jagged1 or Jagged2 expression and Notch activity (4042) and PI3K is an inducer of p63 expression (43). The p63 gene has 2 promoter regions generating TA-p63 and ?N-p63 isoforms, each of which has 3 splicing variants on its C terminus as ?/?/? of TA-p63 and ?N-p63 isoforms (41). The TA-p63 isoform has been observed to activate the expression of ?N-p63 isoform (44). Both TA-p63 and ?N-p63 were overexpressed in cells with mTOR activation because of",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2010 Jan 120(1) 103-14",
                "id": "20038814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06cd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We tested 7 p53-related proteins of the p63 and p73 families for their ability to induce maspin expression. The p63 splice form TAp63gamma can substitute for p53 in activating the maspin promoter. TAp63gamma activates the promoter through the same consensus site as p53. In the DLD-1 colorectal adenocarcinoma cell line, harboring a tet-off regulated transgene, induction of TAp63gamma leads to an upregulation of maspin mRNA from the chromosomal gene.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 Apr 20 114(4) 555-62",
                "id": "15578720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p63 is a master regulator of stratified epithelial development that is both necessary and sufficient for specifying this multifaceted program. We show here that Perp, a tetraspan membrane protein originally identified as an apoptosis-associated target of the p53 tumor suppressor, is the first direct target of p63 clearly involved in mediating this developmental program in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Mar 25 120(6) 843-56",
                "id": "15797384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06cb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "However, our results indicate that TAp63gamma has a very low ability to bind to the EGFRp53RE and surprisingly represses both basal EGFR promoter activity and endogenous EGFR expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 41717-24",
                "id": "11546792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Nevertheless, several groups recently reported that TAp63 can induce cell cycle arrest and apoptosis in DNA-damaged cells, alone or in synergy with chemotherapeutic agents, and thus appears as a chemosensitivity factor. ",
              "citation": {
                "type": "PubMed",
                "name": "Bull Cancer 2006 Dec 93(12) E126-35",
                "id": "17182369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "During embryogenesis, REDD1 expression mirrors the tissue-specific pattern of the p53 family member p63, and TP63 null embryos show virtually no expression of REDD1, which is restored in mouse embryo fibroblasts following p63 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Nov 10(5) 995-1005",
                "id": "12453409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff23"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "however, other p63 isoforms that contain the 5' region homologous to the p53 transactivation domain have been shown to activate p53-responsive promoters such as the p21/WAF1, BAX, and MDM2 promoters (13 , 21) ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 1 60(15) 4016-20",
                "id": "10945600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p300, but not its acetylase-defective mutant AT2, stimulated p63gamma-dependent transcription and induction of p21 in cells, consequently leading to G1 arrest. Inversely, the deltaN-p63gamma isoform as well as p300AT2 inhibited the induction of p21 by p63gamma. These results suggest that p300 regulates p63-dependent transcription of p21.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 26 280(34) 30604-10",
                "id": "15965232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Furthermore, we have demonstrated that TAp63?, but not ?Np63?, is able to transactivate DIx3 gene promoter",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Apr 15 8(8) 1185-95",
                "id": "19282665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here we show that silencing of DeltaNp63 in primary mouse keratinocytes results in a marked down-regulation of Claudin-1 expression (-80%). DeltaNp63alpha binds in vivo to the Claudin-1 promoter and activates both the endogenous Claudin-1 gene and a reporter vector containing a -1.4 Kb promoter fragment of the Claudin-1 gene.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS ONE 2008 3(7) e2715",
                "id": "18648642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we have identified EphA2 as a target gene of the p53 family, that is, p53, p73, and p63.  We found that EphA2 expression resulted in an increase in apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6503-15",
                "id": "11641774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "By using oligonucleotide expression microarray analysis and analyzing the promoters of p63-induced genes, we have identified novel p63-specific response elements (p63-REs) in the promoter regions of EVPL and SMARCD3. # TABLE 1. List of genes induced over fourfold by TAp63y in 293 inducible cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jul 25(14) 6077-89",
                "id": "15988020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Experiments involving transient transfection, mobility shift assay, and site-directed mutagenesis demonstrated that p53 specifically binds and transactivates the M-PGAM promoter. The p53-related proteins p51A and p73L also transactivated M-PGAM.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 May 10(5) 295-306",
                "id": "10359011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Reintroduction of wild-type TAp63gamma into HEK 293 cells, induced transcription of hOGG1 promoter, leading to increase in RNA and protein. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 May 18 356(4) 823-8",
                "id": "17399686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Transient expression of p63 transactivated the maspin promoter with remarkable fold changes in cells expressing the TAp63, suggesting that TAp63 might be a novel stimulator of the maspin promoter in lung cancer. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Oct 1 64(19) 6900-5",
                "id": "15466179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the expression of apoD was specifically up-regulated by either TAp73 or TAp63 but not significantly by p53. I",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 9 284(2) 872-83",
                "id": "19001418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We show here that like p53, the p63alpha and p63gamma isoforms are able to associate with human MDM2 (HDM2). Overexpression of HDM2 increased the steady-state level of intracellular p63 and enhanced its transcriptional activity. Both effects appeared to be counteracted by ARF coexpression. These data indicate that p63 can be activated by HDM2 under conditions in which p53 is inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2674-81",
                "id": "11714701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "In vitro studies using two human TEC lines demonstrated that p63 was capable of up-regulating intercellular adhesion molecule-1 (ICAM-1) and enhancing the production of IL-6 and IL-8.",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunol 2004 Jun 16(6) 831-41",
                "id": "15126418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Table 2 Gene expression confirmed by RT-PCR/Northern blot analysis  ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 May 15 63(10) 2351-7",
                "id": "12750249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p73 belongs to a family of transcription factors, including p53 and p63, that mediate response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2007 Jan 1095 315-24",
                "id": "17404044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Therefore, our study reveals that SCF(betaTrCP1) is an E3 ligase that activates p63 through ubiquitylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 4 283(1) 66-75",
                "id": "17965458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the Jagged1 (JAG1) and Jagged2 (JAG2) genes, encoding ligands for the Notch receptors, are up-regulated by p63 and p73.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 4 277(1) 719-24",
                "id": "11641404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p63 is a master regulator of stratified epithelial development that is both necessary and sufficient for specifying this multifaceted program. We show here that Perp, a tetraspan membrane protein originally identified as an apoptosis-associated target of the p53 tumor suppressor, is the first direct target of p63 clearly involved in mediating this developmental program in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Mar 25 120(6) 843-56",
                "id": "15797384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff12"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 13 20(41) 5818-25",
                "id": "11593387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "TAp63 belongs to the p53-tumour suppressor family and is capable of transactivating a set of target genes to induce cell cycle arrest and apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jan 22 391(4) 1748-51",
                "id": "20043870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Supplemental table 4 ",
              "citation": {
                "type": "PubMed",
                "name": "Genome Res 2008 Jun 18(6) 939-48",
                "id": "18441228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "As expected, the transcriptional activity of p53 was strongly activated by cotransfection with ING1b. We found that the transcriptional activities of p73? and p63? were also enhanced by ING1b, albeit not as robust as p53.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Oct 23 553(3) 277-85",
                "id": "14572637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Because ASPP-1 and ASPP-2 are specific activators of the apoptotic function of all p53 family members, E2F1 might use this pathway to increase the apoptotic function of p63 and p73 independently of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "e show that the interaction of p63 with PML increases the levels of p63 in cultured cells as well as its ability to transactivate the p53-responsive elements of the GADD45, p21 and bax promoters.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Oct 20 24(46) 6982-6",
                "id": "16007146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We describe here identification of ITGA3 encoding integrin alpha(3) as a target of its trans-activating function, proposing that p51/p63 allows epidermal stem cells to express laminin receptor alpha(3)beta(1) for anchorage to the basement membrane.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 26 279(48) 50069-77",
                "id": "15361520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we found that GPX2, which encodes a glutathione peroxidase, is up-regulated by p63 but not p53. Accordingly, a unique responsive element was found in the promoter of the GPX2 gene that can be activated and bound by p63 but not p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 24 281(12) 7856-62",
                "id": "16446369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "However, our results indicate that TAp63gamma has a very low ability to bind to the EGFRp53RE and surprisingly represses both basal EGFR promoter activity and endogenous EGFR expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 41717-24",
                "id": "11546792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Nevertheless, several groups recently reported that TAp63 can induce cell cycle arrest and apoptosis in DNA-damaged cells, alone or in synergy with chemotherapeutic agents, and thus appears as a chemosensitivity factor. ",
              "citation": {
                "type": "PubMed",
                "name": "Bull Cancer 2006 Dec 93(12) E126-35",
                "id": "17182369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "During embryogenesis, REDD1 expression mirrors the tissue-specific pattern of the p53 family member p63, and TP63 null embryos show virtually no expression of REDD1, which is restored in mouse embryo fibroblasts following p63 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Nov 10(5) 995-1005",
                "id": "12453409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff02"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "however, other p63 isoforms that contain the 5' region homologous to the p53 transactivation domain have been shown to activate p53-responsive promoters such as the p21/WAF1, BAX, and MDM2 promoters (13 , 21) ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 1 60(15) 4016-20",
                "id": "10945600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Furthermore, we have demonstrated that TAp63?, but not ?Np63?, is able to transactivate DIx3 gene promoter",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Apr 15 8(8) 1185-95",
                "id": "19282665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we have identified EphA2 as a target gene of the p53 family, that is, p53, p73, and p63.  We found that EphA2 expression resulted in an increase in apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6503-15",
                "id": "11641774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Experiments involving transient transfection, mobility shift assay, and site-directed mutagenesis demonstrated that p53 specifically binds and transactivates the M-PGAM promoter. The p53-related proteins p51A and p73L also transactivated M-PGAM.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 May 10(5) 295-306",
                "id": "10359011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefe"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Reintroduction of wild-type TAp63gamma into HEK 293 cells, induced transcription of hOGG1 promoter, leading to increase in RNA and protein. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 May 18 356(4) 823-8",
                "id": "17399686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Transient expression of p63 transactivated the maspin promoter with remarkable fold changes in cells expressing the TAp63, suggesting that TAp63 might be a novel stimulator of the maspin promoter in lung cancer. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Oct 1 64(19) 6900-5",
                "id": "15466179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the expression of apoD was specifically up-regulated by either TAp73 or TAp63 but not significantly by p53. I",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 9 284(2) 872-83",
                "id": "19001418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We show here that like p53, the p63alpha and p63gamma isoforms are able to associate with human MDM2 (HDM2). Overexpression of HDM2 increased the steady-state level of intracellular p63 and enhanced its transcriptional activity. Both effects appeared to be counteracted by ARF coexpression. These data indicate that p63 can be activated by HDM2 under conditions in which p53 is inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2674-81",
                "id": "11714701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "In vitro studies using two human TEC lines demonstrated that p63 was capable of up-regulating intercellular adhesion molecule-1 (ICAM-1) and enhancing the production of IL-6 and IL-8.",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunol 2004 Jun 16(6) 831-41",
                "id": "15126418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Table 2 Gene expression confirmed by RT-PCR/Northern blot analysis  ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 May 15 63(10) 2351-7",
                "id": "12750249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p73 belongs to a family of transcription factors, including p53 and p63, that mediate response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2007 Jan 1095 315-24",
                "id": "17404044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Therefore, our study reveals that SCF(betaTrCP1) is an E3 ligase that activates p63 through ubiquitylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 4 283(1) 66-75",
                "id": "17965458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the Jagged1 (JAG1) and Jagged2 (JAG2) genes, encoding ligands for the Notch receptors, are up-regulated by p63 and p73.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 4 277(1) 719-24",
                "id": "11641404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 13 20(41) 5818-25",
                "id": "11593387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "TAp63 belongs to the p53-tumour suppressor family and is capable of transactivating a set of target genes to induce cell cycle arrest and apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jan 22 391(4) 1748-51",
                "id": "20043870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Supplemental table 4 ",
              "citation": {
                "type": "PubMed",
                "name": "Genome Res 2008 Jun 18(6) 939-48",
                "id": "18441228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we describe the identification of an HMG1-like protein SSRP1 as a co-activator of p63. Over expression of wild-type, but not deletion mutant, SSRP1 remarkably enhanced p63gamma-dependent luciferase activity, G(1) arrest, apoptosis and expression of endogenous PIG3, p21(Waf1/cip1) and MDM2 in human p53-deficient lung carcinoma H1299 cells and mouse embryonic fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 15 21(20) 5487-97",
                "id": "12374749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "As expected, the transcriptional activity of p53 was strongly activated by cotransfection with ING1b. We found that the transcriptional activities of p73? and p63? were also enhanced by ING1b, albeit not as robust as p53.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Oct 23 553(3) 277-85",
                "id": "14572637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Because ASPP-1 and ASPP-2 are specific activators of the apoptotic function of all p53 family members, E2F1 might use this pathway to increase the apoptotic function of p63 and p73 independently of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "e show that the interaction of p63 with PML increases the levels of p63 in cultured cells as well as its ability to transactivate the p53-responsive elements of the GADD45, p21 and bax promoters.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Oct 20 24(46) 6982-6",
                "id": "16007146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We describe here identification of ITGA3 encoding integrin alpha(3) as a target of its trans-activating function, proposing that p51/p63 allows epidermal stem cells to express laminin receptor alpha(3)beta(1) for anchorage to the basement membrane.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 26 279(48) 50069-77",
                "id": "15361520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we identified FDXR as a target gene of the p53 family, that is, p53, p63, and p73. We found that FDXR can be induced by DNA damage in cells in a p53-dependent manner and by a mutated form of p53 that is competent in inducing apoptosis. In addition, we identified a p53 response element located within the FDXR promoter that is responsive to wild-type p53, p63alpha, p63gamma, p73alpha, and p73beta.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 17 21(47) 7195-204",
                "id": "12370809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we found that GPX2, which encodes a glutathione peroxidase, is up-regulated by p63 but not p53. Accordingly, a unique responsive element was found in the promoter of the GPX2 gene that can be activated and bound by p63 but not p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 24 281(12) 7856-62",
                "id": "16446369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeeb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAD52)",
        "relation": "hasModification",
        "target": "p(HGNC:RAD52,pmod(P,Y,104))",
        "directed": false,
        "label": "p(HGNC:RAD52) hasModification p(HGNC:RAD52,pmod(P,Y,104))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0949",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAD52) hasModification p(HGNC:RAD52,pmod(P,Y,104))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP63))",
        "relation": "increases",
        "target": "bp(MESHPP:Apoptosis)",
        "directed": false,
        "label": "tscript(p(HGNC:TP63)) increases bp(MESHPP:Apoptosis)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe094a",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP63)) increases bp(MESHPP:Apoptosis)",
              "summary_text": "Here, we describe the identification of an HMG1-like protein SSRP1 as a co-activator of p63. Over expression of wild-type, but not deletion mutant, SSRP1 remarkably enhanced p63gamma-dependent luciferase activity, G(1) arrest, apoptosis and expression of endogenous PIG3, p21(Waf1/cip1) and MDM2 in human p53-deficient lung carcinoma H1299 cells and mouse embryonic fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 15 21(20) 5487-97",
                "id": "12374749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:TP63)) increases bp(MESHPP:Apoptosis)",
              "summary_text": "TAp63 belongs to the p53-tumour suppressor family and is capable of transactivating a set of target genes to induce cell cycle arrest and apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jan 22 391(4) 1748-51",
                "id": "20043870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:TP63)) increases bp(MESHPP:Apoptosis)",
              "summary_text": "Nevertheless, several groups recently reported that TAp63 can induce cell cycle arrest and apoptosis in DNA-damaged cells, alone or in synergy with chemotherapeutic agents, and thus appears as a chemosensitivity factor. ",
              "citation": {
                "type": "PubMed",
                "name": "Bull Cancer 2006 Dec 93(12) E126-35",
                "id": "17182369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:TP63)) increases bp(MESHPP:Apoptosis)",
              "summary_text": "The full-length transcriptionally active TAp63 isoforms are capable of transactivating the majority of the p53 target promoters thus inducing cell cycle arrest and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Oct 20 24(46) 6982-6",
                "id": "16007146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP63)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:TP63))",
        "directed": false,
        "label": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe094b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the action of TAp63 is mediated at the molecular level by direct and indirect transactivation of IKKalpha and Ets-1, respectively. We also found that DeltaNp63 upregulates IKKalpha indirectly, through GATA-3 { both TAp63{alpha} and {Delta}Np63{alpha} significantly increased luciferase activity of the GATA-3 promoter (Fig. 4A, lanes 2, 5)}",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2006 Nov 15 119(Pt 22) 4617-22",
                "id": "17093266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "To explore the mechanism by which mTOR activation leads to the upregulation of Jagged1/Notch/Hes1 signaling, we examined the expression of p63, a TP53 family member, since p63 is a positive regulator of Jagged1 or Jagged2 expression and Notch activity (4042) and PI3K is an inducer of p63 expression (43). The p63 gene has 2 promoter regions generating TA-p63 and ?N-p63 isoforms, each of which has 3 splicing variants on its C terminus as ?/?/? of TA-p63 and ?N-p63 isoforms (41). The TA-p63 isoform has been observed to activate the expression of ?N-p63 isoform (44). Both TA-p63 and ?N-p63 were overexpressed in cells with mTOR activation because of",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2010 Jan 120(1) 103-14",
                "id": "20038814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We tested 7 p53-related proteins of the p63 and p73 families for their ability to induce maspin expression. The p63 splice form TAp63gamma can substitute for p53 in activating the maspin promoter. TAp63gamma activates the promoter through the same consensus site as p53. In the DLD-1 colorectal adenocarcinoma cell line, harboring a tet-off regulated transgene, induction of TAp63gamma leads to an upregulation of maspin mRNA from the chromosomal gene.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 Apr 20 114(4) 555-62",
                "id": "15578720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we describe the identification of an HMG1-like protein SSRP1 as a co-activator of p63. Over expression of wild-type, but not deletion mutant, SSRP1 remarkably enhanced p63gamma-dependent luciferase activity, G(1) arrest, apoptosis and expression of endogenous PIG3, p21(Waf1/cip1) and MDM2 in human p53-deficient lung carcinoma H1299 cells and mouse embryonic fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 15 21(20) 5487-97",
                "id": "12374749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we identified FDXR as a target gene of the p53 family, that is, p53, p63, and p73. We found that FDXR can be induced by DNA damage in cells in a p53-dependent manner and by a mutated form of p53 that is competent in inducing apoptosis. In addition, we identified a p53 response element located within the FDXR promoter that is responsive to wild-type p53, p63alpha, p63gamma, p73alpha, and p73beta.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 17 21(47) 7195-204",
                "id": "12370809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the action of TAp63 is mediated at the molecular level by direct and indirect transactivation of IKKalpha and Ets-1, respectively. We also found that DeltaNp63 upregulates IKKalpha indirectly, through GATA-3 { both TAp63{alpha} and {Delta}Np63{alpha} significantly increased luciferase activity of the GATA-3 promoter (Fig. 4A, lanes 2, 5)}",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2006 Nov 15 119(Pt 22) 4617-22",
                "id": "17093266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p300, but not its acetylase-defective mutant AT2, stimulated p63gamma-dependent transcription and induction of p21 in cells, consequently leading to G1 arrest. Inversely, the deltaN-p63gamma isoform as well as p300AT2 inhibited the induction of p21 by p63gamma. These results suggest that p300 regulates p63-dependent transcription of p21.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 26 280(34) 30604-10",
                "id": "15965232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here we show that silencing of DeltaNp63 in primary mouse keratinocytes results in a marked down-regulation of Claudin-1 expression (-80%). DeltaNp63alpha binds in vivo to the Claudin-1 promoter and activates both the endogenous Claudin-1 gene and a reporter vector containing a -1.4 Kb promoter fragment of the Claudin-1 gene.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS ONE 2008 3(7) e2715",
                "id": "18648642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "By using oligonucleotide expression microarray analysis and analyzing the promoters of p63-induced genes, we have identified novel p63-specific response elements (p63-REs) in the promoter regions of EVPL and SMARCD3. # TABLE 1. List of genes induced over fourfold by TAp63y in 293 inducible cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jul 25(14) 6077-89",
                "id": "15988020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "To explore the mechanism by which mTOR activation leads to the upregulation of Jagged1/Notch/Hes1 signaling, we examined the expression of p63, a TP53 family member, since p63 is a positive regulator of Jagged1 or Jagged2 expression and Notch activity (4042) and PI3K is an inducer of p63 expression (43). The p63 gene has 2 promoter regions generating TA-p63 and ?N-p63 isoforms, each of which has 3 splicing variants on its C terminus as ?/?/? of TA-p63 and ?N-p63 isoforms (41). The TA-p63 isoform has been observed to activate the expression of ?N-p63 isoform (44). Both TA-p63 and ?N-p63 were overexpressed in cells with mTOR activation because of",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2010 Jan 120(1) 103-14",
                "id": "20038814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06cd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We tested 7 p53-related proteins of the p63 and p73 families for their ability to induce maspin expression. The p63 splice form TAp63gamma can substitute for p53 in activating the maspin promoter. TAp63gamma activates the promoter through the same consensus site as p53. In the DLD-1 colorectal adenocarcinoma cell line, harboring a tet-off regulated transgene, induction of TAp63gamma leads to an upregulation of maspin mRNA from the chromosomal gene.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 Apr 20 114(4) 555-62",
                "id": "15578720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p63 is a master regulator of stratified epithelial development that is both necessary and sufficient for specifying this multifaceted program. We show here that Perp, a tetraspan membrane protein originally identified as an apoptosis-associated target of the p53 tumor suppressor, is the first direct target of p63 clearly involved in mediating this developmental program in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Mar 25 120(6) 843-56",
                "id": "15797384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06cb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "However, our results indicate that TAp63gamma has a very low ability to bind to the EGFRp53RE and surprisingly represses both basal EGFR promoter activity and endogenous EGFR expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 41717-24",
                "id": "11546792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Nevertheless, several groups recently reported that TAp63 can induce cell cycle arrest and apoptosis in DNA-damaged cells, alone or in synergy with chemotherapeutic agents, and thus appears as a chemosensitivity factor. ",
              "citation": {
                "type": "PubMed",
                "name": "Bull Cancer 2006 Dec 93(12) E126-35",
                "id": "17182369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "During embryogenesis, REDD1 expression mirrors the tissue-specific pattern of the p53 family member p63, and TP63 null embryos show virtually no expression of REDD1, which is restored in mouse embryo fibroblasts following p63 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Nov 10(5) 995-1005",
                "id": "12453409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff23"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "however, other p63 isoforms that contain the 5' region homologous to the p53 transactivation domain have been shown to activate p53-responsive promoters such as the p21/WAF1, BAX, and MDM2 promoters (13 , 21) ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 1 60(15) 4016-20",
                "id": "10945600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p300, but not its acetylase-defective mutant AT2, stimulated p63gamma-dependent transcription and induction of p21 in cells, consequently leading to G1 arrest. Inversely, the deltaN-p63gamma isoform as well as p300AT2 inhibited the induction of p21 by p63gamma. These results suggest that p300 regulates p63-dependent transcription of p21.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 26 280(34) 30604-10",
                "id": "15965232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Furthermore, we have demonstrated that TAp63?, but not ?Np63?, is able to transactivate DIx3 gene promoter",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Apr 15 8(8) 1185-95",
                "id": "19282665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here we show that silencing of DeltaNp63 in primary mouse keratinocytes results in a marked down-regulation of Claudin-1 expression (-80%). DeltaNp63alpha binds in vivo to the Claudin-1 promoter and activates both the endogenous Claudin-1 gene and a reporter vector containing a -1.4 Kb promoter fragment of the Claudin-1 gene.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS ONE 2008 3(7) e2715",
                "id": "18648642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we have identified EphA2 as a target gene of the p53 family, that is, p53, p73, and p63.  We found that EphA2 expression resulted in an increase in apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6503-15",
                "id": "11641774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "By using oligonucleotide expression microarray analysis and analyzing the promoters of p63-induced genes, we have identified novel p63-specific response elements (p63-REs) in the promoter regions of EVPL and SMARCD3. # TABLE 1. List of genes induced over fourfold by TAp63y in 293 inducible cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jul 25(14) 6077-89",
                "id": "15988020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Experiments involving transient transfection, mobility shift assay, and site-directed mutagenesis demonstrated that p53 specifically binds and transactivates the M-PGAM promoter. The p53-related proteins p51A and p73L also transactivated M-PGAM.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 May 10(5) 295-306",
                "id": "10359011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Reintroduction of wild-type TAp63gamma into HEK 293 cells, induced transcription of hOGG1 promoter, leading to increase in RNA and protein. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 May 18 356(4) 823-8",
                "id": "17399686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Transient expression of p63 transactivated the maspin promoter with remarkable fold changes in cells expressing the TAp63, suggesting that TAp63 might be a novel stimulator of the maspin promoter in lung cancer. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Oct 1 64(19) 6900-5",
                "id": "15466179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the expression of apoD was specifically up-regulated by either TAp73 or TAp63 but not significantly by p53. I",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 9 284(2) 872-83",
                "id": "19001418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We show here that like p53, the p63alpha and p63gamma isoforms are able to associate with human MDM2 (HDM2). Overexpression of HDM2 increased the steady-state level of intracellular p63 and enhanced its transcriptional activity. Both effects appeared to be counteracted by ARF coexpression. These data indicate that p63 can be activated by HDM2 under conditions in which p53 is inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2674-81",
                "id": "11714701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "In vitro studies using two human TEC lines demonstrated that p63 was capable of up-regulating intercellular adhesion molecule-1 (ICAM-1) and enhancing the production of IL-6 and IL-8.",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunol 2004 Jun 16(6) 831-41",
                "id": "15126418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Table 2 Gene expression confirmed by RT-PCR/Northern blot analysis  ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 May 15 63(10) 2351-7",
                "id": "12750249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p73 belongs to a family of transcription factors, including p53 and p63, that mediate response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2007 Jan 1095 315-24",
                "id": "17404044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Therefore, our study reveals that SCF(betaTrCP1) is an E3 ligase that activates p63 through ubiquitylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 4 283(1) 66-75",
                "id": "17965458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the Jagged1 (JAG1) and Jagged2 (JAG2) genes, encoding ligands for the Notch receptors, are up-regulated by p63 and p73.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 4 277(1) 719-24",
                "id": "11641404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p63 is a master regulator of stratified epithelial development that is both necessary and sufficient for specifying this multifaceted program. We show here that Perp, a tetraspan membrane protein originally identified as an apoptosis-associated target of the p53 tumor suppressor, is the first direct target of p63 clearly involved in mediating this developmental program in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Mar 25 120(6) 843-56",
                "id": "15797384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff12"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 13 20(41) 5818-25",
                "id": "11593387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "TAp63 belongs to the p53-tumour suppressor family and is capable of transactivating a set of target genes to induce cell cycle arrest and apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jan 22 391(4) 1748-51",
                "id": "20043870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Supplemental table 4 ",
              "citation": {
                "type": "PubMed",
                "name": "Genome Res 2008 Jun 18(6) 939-48",
                "id": "18441228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "As expected, the transcriptional activity of p53 was strongly activated by cotransfection with ING1b. We found that the transcriptional activities of p73? and p63? were also enhanced by ING1b, albeit not as robust as p53.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Oct 23 553(3) 277-85",
                "id": "14572637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Because ASPP-1 and ASPP-2 are specific activators of the apoptotic function of all p53 family members, E2F1 might use this pathway to increase the apoptotic function of p63 and p73 independently of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "e show that the interaction of p63 with PML increases the levels of p63 in cultured cells as well as its ability to transactivate the p53-responsive elements of the GADD45, p21 and bax promoters.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Oct 20 24(46) 6982-6",
                "id": "16007146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We describe here identification of ITGA3 encoding integrin alpha(3) as a target of its trans-activating function, proposing that p51/p63 allows epidermal stem cells to express laminin receptor alpha(3)beta(1) for anchorage to the basement membrane.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 26 279(48) 50069-77",
                "id": "15361520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we found that GPX2, which encodes a glutathione peroxidase, is up-regulated by p63 but not p53. Accordingly, a unique responsive element was found in the promoter of the GPX2 gene that can be activated and bound by p63 but not p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 24 281(12) 7856-62",
                "id": "16446369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "However, our results indicate that TAp63gamma has a very low ability to bind to the EGFRp53RE and surprisingly represses both basal EGFR promoter activity and endogenous EGFR expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 41717-24",
                "id": "11546792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Nevertheless, several groups recently reported that TAp63 can induce cell cycle arrest and apoptosis in DNA-damaged cells, alone or in synergy with chemotherapeutic agents, and thus appears as a chemosensitivity factor. ",
              "citation": {
                "type": "PubMed",
                "name": "Bull Cancer 2006 Dec 93(12) E126-35",
                "id": "17182369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "During embryogenesis, REDD1 expression mirrors the tissue-specific pattern of the p53 family member p63, and TP63 null embryos show virtually no expression of REDD1, which is restored in mouse embryo fibroblasts following p63 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Nov 10(5) 995-1005",
                "id": "12453409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff02"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "however, other p63 isoforms that contain the 5' region homologous to the p53 transactivation domain have been shown to activate p53-responsive promoters such as the p21/WAF1, BAX, and MDM2 promoters (13 , 21) ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 1 60(15) 4016-20",
                "id": "10945600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Furthermore, we have demonstrated that TAp63?, but not ?Np63?, is able to transactivate DIx3 gene promoter",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Apr 15 8(8) 1185-95",
                "id": "19282665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we have identified EphA2 as a target gene of the p53 family, that is, p53, p73, and p63.  We found that EphA2 expression resulted in an increase in apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6503-15",
                "id": "11641774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Experiments involving transient transfection, mobility shift assay, and site-directed mutagenesis demonstrated that p53 specifically binds and transactivates the M-PGAM promoter. The p53-related proteins p51A and p73L also transactivated M-PGAM.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 May 10(5) 295-306",
                "id": "10359011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefe"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Reintroduction of wild-type TAp63gamma into HEK 293 cells, induced transcription of hOGG1 promoter, leading to increase in RNA and protein. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 May 18 356(4) 823-8",
                "id": "17399686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Transient expression of p63 transactivated the maspin promoter with remarkable fold changes in cells expressing the TAp63, suggesting that TAp63 might be a novel stimulator of the maspin promoter in lung cancer. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Oct 1 64(19) 6900-5",
                "id": "15466179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the expression of apoD was specifically up-regulated by either TAp73 or TAp63 but not significantly by p53. I",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 9 284(2) 872-83",
                "id": "19001418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We show here that like p53, the p63alpha and p63gamma isoforms are able to associate with human MDM2 (HDM2). Overexpression of HDM2 increased the steady-state level of intracellular p63 and enhanced its transcriptional activity. Both effects appeared to be counteracted by ARF coexpression. These data indicate that p63 can be activated by HDM2 under conditions in which p53 is inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2674-81",
                "id": "11714701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfefa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "In vitro studies using two human TEC lines demonstrated that p63 was capable of up-regulating intercellular adhesion molecule-1 (ICAM-1) and enhancing the production of IL-6 and IL-8.",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunol 2004 Jun 16(6) 831-41",
                "id": "15126418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Table 2 Gene expression confirmed by RT-PCR/Northern blot analysis  ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 May 15 63(10) 2351-7",
                "id": "12750249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "p73 belongs to a family of transcription factors, including p53 and p63, that mediate response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2007 Jan 1095 315-24",
                "id": "17404044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Therefore, our study reveals that SCF(betaTrCP1) is an E3 ligase that activates p63 through ubiquitylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 4 283(1) 66-75",
                "id": "17965458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We found that the Jagged1 (JAG1) and Jagged2 (JAG2) genes, encoding ligands for the Notch receptors, are up-regulated by p63 and p73.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 4 277(1) 719-24",
                "id": "11641404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 13 20(41) 5818-25",
                "id": "11593387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "TAp63 belongs to the p53-tumour suppressor family and is capable of transactivating a set of target genes to induce cell cycle arrest and apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jan 22 391(4) 1748-51",
                "id": "20043870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Supplemental table 4 ",
              "citation": {
                "type": "PubMed",
                "name": "Genome Res 2008 Jun 18(6) 939-48",
                "id": "18441228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we describe the identification of an HMG1-like protein SSRP1 as a co-activator of p63. Over expression of wild-type, but not deletion mutant, SSRP1 remarkably enhanced p63gamma-dependent luciferase activity, G(1) arrest, apoptosis and expression of endogenous PIG3, p21(Waf1/cip1) and MDM2 in human p53-deficient lung carcinoma H1299 cells and mouse embryonic fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Oct 15 21(20) 5487-97",
                "id": "12374749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "As expected, the transcriptional activity of p53 was strongly activated by cotransfection with ING1b. We found that the transcriptional activities of p73? and p63? were also enhanced by ING1b, albeit not as robust as p53.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Oct 23 553(3) 277-85",
                "id": "14572637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfef0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Because ASPP-1 and ASPP-2 are specific activators of the apoptotic function of all p53 family members, E2F1 might use this pathway to increase the apoptotic function of p63 and p73 independently of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "e show that the interaction of p63 with PML increases the levels of p63 in cultured cells as well as its ability to transactivate the p53-responsive elements of the GADD45, p21 and bax promoters.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Oct 20 24(46) 6982-6",
                "id": "16007146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "We describe here identification of ITGA3 encoding integrin alpha(3) as a target of its trans-activating function, proposing that p51/p63 allows epidermal stem cells to express laminin receptor alpha(3)beta(1) for anchorage to the basement membrane.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 26 279(48) 50069-77",
                "id": "15361520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we identified FDXR as a target gene of the p53 family, that is, p53, p63, and p73. We found that FDXR can be induced by DNA damage in cells in a p53-dependent manner and by a mutated form of p53 that is competent in inducing apoptosis. In addition, we identified a p53 response element located within the FDXR promoter that is responsive to wild-type p53, p63alpha, p63gamma, p73alpha, and p73beta.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 17 21(47) 7195-204",
                "id": "12370809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP63) actsIn tscript(p(HGNC:TP63))",
              "summary_text": "Here, we found that GPX2, which encodes a glutathione peroxidase, is up-regulated by p63 but not p53. Accordingly, a unique responsive element was found in the promoter of the GPX2 gene that can be activated and bound by p63 but not p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 24 281(12) 7856-62",
                "id": "16446369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfeeb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:DDB1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:DDB1))",
        "directed": false,
        "label": "p(HGNC:DDB1) actsIn cat(p(HGNC:DDB1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe094c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:DDB1) actsIn cat(p(HGNC:DDB1))",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:YY1)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:YY1))",
        "directed": false,
        "label": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe094d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Yy1 contains distinct domains that regulate, either by transactivation or transrepression the expression of a number of genes Yy1 protein levels decreased during skeletal and cardiac myocyte differentiation, consistent with an earlier proposal that down-regulation of Yy1 was essential for the expression of the sarcomeric alpha-actin genes Yy1 inhibited muscle-restricted expression of the skeletal alpha-actin gene by excluding serum response factor from the serum response element in the proximal promoter of the alpha-actin gene",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 14 274(20) 14508-13",
                "id": "10318878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Our results showed that YY1 binds to the cytokine genes in a differential way; the Ifng promoter and CNS1 were only bound in Th1 cells whereas the Il4 regulatory elements, the promoter, VA enhancer, site II, site IV, and RHS7/RAD50-C were bound strikingly more strongly in Th2 cells (Fig. 1B). YY1 binds to the regulatory elements even under resting conditions, but at most sites the binding is increased upon stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 May 9 283(19) 13471-81",
                "id": "18285333"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Fig.1- shows proteins that interact with CBP/300 Transciptional activators= STAT1, (already).  SF1, TAL1, p73, Mdm2, HIF2?, ETS1, RXR, p65, Pit1 (POU1F1), HNF4, Stat2, EBNA2 (virus), HPV E2?, BRCA1, p45/NF-E2, c-JUN, c-myb, Tax?, Sap1, YY1, SREBP, ATF-1, ATF-4, Cubitus interuptusm GII3?, vIRF?, JMY, dMAD?, Py LT?, HPV E6, CIITA, Tat(HIV), SF-1, E2F, Ets-1, junB, C/EBPb, (already) GATA-1, Neuro D, Microphthalmia, E1A, Twist, p53 (already), Myo D, pp90 RSK, SMAD (already), ATF-2, c-Fos, SC40?, Large T? p300 k.o. are defective for RXR signal but not CREB",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13505-8",
                "id": "11279224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Co-transfection of the YY1 and HLJ1 basal promoter regions, site-directed mutagenesis, and electrophoretic mobility shift assay confirmed that YY1 could upregulate HLJ1 basal promoter activity. Furthermore, we also demonstrated that overexpression of YY1 in CL1-0 cells can increase HLJ1 expression and reduce cell invasive capability.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jun 9 24(25) 4081-93",
                "id": "15782117"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "metastasis",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Here we show that the dystrophin CArG box is also recognized by the zinc finger nuclear factor YY1. Transient transfection experiments show that YY1 negatively regulates dystrophin transcription in C2C12 muscle cells. On the dystrophin CArG element YY1 competes with the structural factor DPBF. We further show that YY1 and DPBF binding to the CArG element induce opposite DNA bends suggesting that their binding induces alternative promoter structures.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Dec 11 273(50) 33708-13",
                "id": "9837957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "The current study was designed to examine whether the multifunctional transcription factor Yin Yang 1 (YY1) was able to repress activation of the StAR gene. YY1 bound to three putative YY1-binding sites in the rat StAR promoter. Cotransfection of the StAR promoter linked to a luciferase reporter gene and YY1 in the presence or absence of sterol regulatory element binding protein-1a (SREBP-1a) resulted in transcriptional repression. YdY1 was found to colocalize in the nucleus with SREPB-1a. YY1 inhibited SREBP-1a/nuclear factor Y (NF-Y) enhancement of StAR activation and YY1 decreased SREBP-1a binding to a sterol regulatory element in the presence or absence of NF-Y. YY1 also decreased NF-Y binding to a nonconsensus NF-Y-binding motif in the StAR promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 Mar 143(3) 1085-96",
                "id": "11861536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06dd"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Here we demonstrate that both basal- and endothelin-1-dependent stimulation of human (h) BNP gene transcription requires the presence of an intact Yin Yang 1 (YY1) binding site positioned at -62 bp relative to the transcription start site. Mutation of this site reduced both basal and stimulated hBNP promoter activity. This site was shown to bind YY1 both in vitro and within the context of the intact cell. The latter interaction increased after endothelin-1 treatment.Exposure to endothelin-1 also resulted in increased nuclear localization of YY1 and a reduction in acetylation of the YY1 protein. Overexpression of wild-type YY1 increased both basal and endothelin-stimulated hBNP promoter activity, whereas a carboxy-terminal deletion mutant of YY1 was devoid of activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2009 Jan 12",
                "id": "19139378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "We have cloned the OTK18 promoter region proximal to the transcriptional start site and determined the region responsible (-884/+1) for the basal transcriptional activity in a microglia cell line. Sequential deletion mutation analyses reveal three important response elements: Yingyang-1 (YY1; -805/-777), an HIV-1 response element for promoter activation; FoxD3 (-743/-725), a negative regulatory element; and Ets response element (-725/-707), a basal transcriptional activity response element. HIV-1 infection-induced upregulation of YY1 and c-Ets-1 protein, binding to the promoter region as determined by immunoblotting and chromatin immunoprecipitation and polymerase chain reaction (PCR) assays, and induction of YY1 was also observed in virus-infected monocyte-derived macrophages. Silencing of FoxD3 and YY1 in the cell line by small interfering RNA duplexes specific to these molecules significantly up- and downregulated basal OTK18 promoter activity in FoxD3 and YY1 response element-dependent manners, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "J Neuroimmune Pharmacol 2008 Nov 25",
                "id": "19034670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Using the adenovirus E1A oncoprotein, we show that p300/CBP acts as a coactivator in the USF2-dependent activation of the Cox5b Inr. We also demonstrate that although expression of multifunctional regulatory factor, Yin Yang 1 (YY1), can stimulate transcription of the Cox5b Inr to a modest extent, expression of YY1 together with USF2 greatly reduces the level of activation of the Cox5b Inr. Furthermore, we show that the transcription factor, Sp1, represses both the YY1- and the USF2-dependent activation of the Cox5b Inr, indicating competition among Sp1, YY1, and USF2.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2000 Dec 15 1517(1) 119-27",
                "id": "11118624"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06da"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Three sites contained an identical core sequence, CCAAGATGG and were identified as Yin Yang 1 (YY1) binding sites Electrophoretic mobility supershift assays, with an anti-YY1 antibody, were used to confirm YY1 binding to these four putative YY1 binding sites. Site-directed deletion of all three upstream YY1 sites but not the iYY1 site, or the iYY1 site alone, showed a approximately 60% decrease in transcriptional activity of the hGR promoter in HeLa cells but had no effect in NIH 3T3 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Steroid Biochem Mol Biol 1998 Dec 67(5-6) 369-81",
                "id": "10030686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Putative recognition sequences for an additional ubiquitous factor YY1 which can have positive or negative regulatory effects, were also identified in both promoter sequences (Fig. 1A,B). The functionality of these YY1 sites was addressed by cotransfection of an expression plasmid harbouring the full-length cDNA for YY1 together with the human or mouse procathepsin E promoter/luciferase constructs.....a reduction of ? 85% (P < 0.0001) was measured in the relative luciferase activity when the cDNA for YY1 was cotransfected into human AGS cells along with construct H (Fig. 4). A similar 90% reduction (P < 0.0001) in the promoter activity of construct H was quantified in mouse P1-HTR cells in the presence of YY1 compared to its absence (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 May 268(9) 2658-68",
                "id": "11322887"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "gastric epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Because the expression and function of YY1 are known to be intimately associated with cell-cycle progression, the physiological significance of YY1 activity has recently been applied to models of cancer biology",
              "citation": {
                "type": "PubMed",
                "name": "Expert Opin Ther Targets 2006 Apr 10(2) 253-66",
                "id": "16548774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff4f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Three Sp1 sites and one YY1 site were identified in this minimal promoter. Through gel shift analysis, all sites were shown to bind to their cognate transcription factors.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2002 Mar 19 1574(2) 164-74",
                "id": "11955626"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "YY1, a constitutively expressed multifunctional transcription factor, activates the Grp78 promoter only under ER stress conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jun 25(11) 4529-40",
                "id": "15899857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "These results demonstrate that transcription factor YY1 negatively regulates dynamin I expression via binding to the negative regulatory element.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 May 4 283(2) 340-3",
                "id": "11327704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff4c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "We report that USF/c-Myc and YY1 bind to the upstream  region of the CXCR4 promoter, and positively or negatively regulate the CXCR4  promoter, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 May 15 162(10) 5986-92",
                "id": "10229837"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff4b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Investigations of the possible effect of MNDA on the interaction between YY1 and NPM, showed that MNDA bound YY1 directly under both in vitro and in vivo conditions. The MNDA-YY1 interaction enhanced the affinity of YY1 for its target DNA and decreased its rate of dissociation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 1998 Sep 15 70(4) 489-506",
                "id": "9712147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "AML3 binding to the consensus AML site and YY1 binding to the Inr sequence, both elements functioning as silencers in the gal-10 promoter",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2001 Jun 1 69(2) 201-12",
                "id": "11441910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff49"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "In the present study, we demonstrate that the 2B.4 promoter haplotype of FCGR2B has increased binding capacity for GATA4 and Yin-Yang1 (YY1) transcription factors in both B lymphocytes and monocytes, and that overexpression of GATA4 or YY1 enhances the FCGR2B promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jun 1 172(11) 7192-9",
                "id": "15153544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Co-immunoprecipitation and immunostaining of cells further indicated that YY1AP co-localizes with YY1 in the nucleus. Furthermore, YY1AP was shown to be capable of enhancing the transcriptional activation of an YY1 responsive promoter. Subsequent analysis by glutathione S-transferase pull-down assay showed that YY1AP contained two YY1 binding regions.YYY",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17750-5",
                "id": "14744866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "2.1.1 binding sites for the transcription factor SP-1. Promoter 1B contains several YY1 sites and a putative NF-kB-binding site and propmter 1C putative AP-2 site.",
              "citation": {
                "type": "PubMed",
                "name": "J Steroid Biochem Mol Biol 2002 Dec 83(1-5) 37-48",
                "id": "12650700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Overexpression of YY1 in macrophages treated with either LPS or live Pseudomonas aeruginosa increased COX-2 transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 May 292(5) L1219-26",
                "id": "17220375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "GABPalpha/GABPbeta heterodimer transactivated the HRS promoter, YY1 functioned as a repressor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Dec 25 273(52) 35208-15",
                "id": "9857059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff44"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "repression of occludin in lung endothelium was associated with the binding of YY1 to a remote site in the promoter region, which was functionally inactive in brain endothelium.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2009 Mar 1789(3) 175-84",
                "id": "19437620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "By using oligonucleotide competition and a specific antibody we demonstrated that the transcription factor YY1 is responsible for the formation of complex BIII. Also in this case, the transient expression of the YY1 cDNA in CHO cells resulted in an increased transcription from the FE65 minimal promoter {Official Gene Symbol Apbb1 - SE}. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1997 Nov 15 328 ( Pt 1) 293-300",
                "id": "9359867"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff42"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "We also show that YY1 participated in the repression of p16(INK4a) expression in 293T cells through an epigenetic mechanism involving histone acetylation modification. Specifically, HDAC3 and HDAC4 inhibited the p16(INK4a) promoter activity",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2008 Oct 1783(10) 1876-83",
                "id": "18558095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Analysis of the regulation of YY1 localization in vitro demonstrated that polymerized gamma-actin sequestered EGFP-YY1 in the cytoplasm and that YY1 activation of c-myc promoter activity was inhibited by LIM kinase, which increases actin polymerization.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2005 Dec 167(6) 1497-509",
                "id": "16314465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "the induction of 2 other reporter genes, FPPS and LDLR, in response to cellular sterol depletion, was attenuated by coexpressed wild-type Yy1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 14 274(20) 14508-13",
                "id": "10318878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "repression of HLA-DRA promoter activation by HDAC activity likely involves a Yy1 binding element located in the first exon of the HLA-DRA gene chromatin immunoprecipitation experiments localized Yy1 to the HLA-DRA gene in Rb-defective tumor cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Oct 21(19) 6495-506",
                "id": "11533238"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff3e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Here we report that the sequence-specific DNA-binding transcription factor Yin Yang 1 (YY1) binds to and recruits the histone H4 (Arg 3)-specific methyltransferase, PRMT1, to a YY1-activated promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Apr 15 17(8) 1019-29",
                "id": "12704081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "YY1 interacts with the conserved N-terminal Mad homology 1 domain of Smad4 and to a lesser extent with Smad1, Smad2, and Smad3. The YY1 zinc finger domain mediates the association with Smads and is necessary for the repressive effect of YY1 on Smad transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jul 23(13) 4494-510",
                "id": "12808092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "the putative Srebf-binding site could also act as a recognition site for Yy1 mutations of the Yy1-binding site enhanced Srebf1a-dependent Star promoter activity",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2001 Jan 142(1) 28-36",
                "id": "11145563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff3b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": " Basal OX40 promoter activity is regulated by Sp1/Sp3 and YY1 as positive regulators",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Aug 1 179(3) 1760-7",
                "id": "17641042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Moreover, mTOR and raptor interacted with YY1, and inhibition of mTOR resulted in a failure of YY1 to interact with and be coactivated by PGC-1alpha. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2007 Nov 29 450(7170) 736-40",
                "id": "18046414"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Glycosylated YY1 no longer binds the retinoblastoma protein (Rb). Upon dissociation from Rb, the glycosylated YY1 is free to bind DNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 18 278(16) 14046-52",
                "id": "12588874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "The results of YY1-silencing and E2F1-silencing alone revealed that both factors are involved in the doxorubicin-induced activation of p73 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2008 Jan 4 365(1) 75-81",
                "id": "17980704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "We demonstrated that Nrf2 promotes YY1 nuclear localization and increases its binding to the CFTR promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2010 Jul 67(13) 2297-309",
                "id": "20309604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "These observations suggest that the interaction of YY1 with hypophosphorylated Rb in resting B cells prevents interaction of YY1 with DNA. After stimulation with class-switching activators, such as LPS, Rb becomes hyperphosphorylated and YY1 is released and can then bind to the hs3 enhancer and E mu.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Jun 1 170(11) 5549-57",
                "id": "12759432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff35"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Yin Yang 1 physically interacts with Hoxa11 and represses Hoxa11-dependent transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 3 281(44) 33226-32",
                "id": "16963455"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Ariadne: In cotransfection studies, YY1 specifically enhanced the transcriptional activation of the grp78 promoter under a variety of stress conditions: depletion of the endoplasmic reticulum calcium stores, protein glycosylation block, and formation of aberrant proteins by azetidine treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Jan 17(1) 54-60",
                "id": "8972185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "The discovery of NF-Y and YY1 as regulatory determinants of DEK expression is consistent with the well-documented roles of these two factors in cellular proliferation and transformation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Dec 12 21(57) 8862-70",
                "id": "12483538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff32"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "The ubiquitous transcription factor Yin Yang 1 (YY1) is known to have a fundamental role in normal biologic processes such as embryogenesis, differentiation, replication, and cellular proliferation",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Feb 23 25(8) 1125-42",
                "id": "16314846"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "using the 25% expression of YY1 gene target list using minimum 1.7 fold change upregulates",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 May 26(9) 3565-81",
                "id": "16611997"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff30"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2003 Jan 284(1) L160-8",
                "id": "12388348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "CEBPG expression vector transfected into H23 or H460 cell lines up-regulated endogenous ERCC5 and also luciferase from a reporter construct containing 589 bp of ERCC5 5' regulatory region. A recognition site for CEBPG and a region containing sites for YY1 on the sense strand and E2F1 on the anti-sense strand participated in CEBPG up-regulation of ERCC5. ",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2007 Dec 28(12) 2552-9",
                "id": "17893230"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "YY1 knockdown reduced transferrin receptor expression in brain endothelium, but not in dermal endothelium, implying that YY1 is involved in tissue-specific regulation of the transferrin receptor. ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2007 Feb 2 365(5) 1271-84",
                "id": "17125792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "These observations suggest that the interaction of YY1 with hypophosphorylated Rb in resting B cells prevents interaction of YY1 with DNA. After stimulation with class-switching activators, such as LPS, Rb becomes hyperphosphorylated and YY1 is released and can then bind to the hs3 enhancer and E mu.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Jun 1 170(11) 5549-57",
                "id": "12759432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff2c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Overexpression of either YY1 at promoter or AP-1 at enhancer results in a 3-fold increase in the transcriptional activity of HLJ1. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 May 15 67(10) 4816-26",
                "id": "17510411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "regulator of protein phosphatase 2A contains two yin-yang 1 (YY1)-binding sites, positively regulating promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 7 275(27) 20488-95",
                "id": "10787423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "In the present study, we demonstrate that the 2B.4 promoter haplotype of FCGR2B has increased binding capacity for GATA4 and Yin-Yang1 (YY1) transcription factors in both B lymphocytes and monocytes, and that overexpression of GATA4 or YY1 enhances the FCGR2B promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jun 1 172(11) 7192-9",
                "id": "15153544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Here, we demonstrate that the transcription factor Yin Yang 1 (YY1) interacts with p53 and inhibits its transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Aug 17 101(33) 12165-70",
                "id": "15295102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Yin-yang 1 activates the c-myc promoter",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1993 Dec 13(12) 7487-95",
                "id": "8246966"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff27"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:YY1) actsIn tscript(p(HGNC:YY1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Dev Biol 2004 Mar 15 267(2) 505-16",
                "id": "15013809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:XPA))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "directed": false,
        "label": "cat(p(HGNC:XPA)) increases bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe094e",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:XPA)) increases bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHEK2,pmod(P,S,19))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:CHEK2))",
        "directed": false,
        "label": "p(HGNC:CHEK2,pmod(P,S,19)) directlyIncreases kin(p(HGNC:CHEK2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe094f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK2,pmod(P,S,19)) directlyIncreases kin(p(HGNC:CHEK2))",
              "summary_text": "Compared to the wild-type form, Chk2 with alanine substitutions at S19, S33, and S35 (Chk2(S3A)) showed impaired dimerization, defective auto- and trans-phosphorylation activities, and reduced ability to promote degradation of Hdmx, a phosphorylation target of Chk2 and regulator of p53 activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Nov 26(21) 7832-45",
                "id": "16940182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PCNA)",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "p(HGNC:PCNA) increases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0950",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PCNA) increases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "Fractionation of extracts from human cell lines allows nucleotide excision repair of damaged DNA to be resolved into discrete incision and polymerization stages. Generation of incised intermediates depends on the XP-A protein, a polypeptide that recognizes sites of damaged DNA, and on the human single-stranded DNA-binding protein HSSB. The proliferating cell nuclear antigen (PCNA) is required for the DNA synthesis that converts the nicked intermediates to completed repair events. This need for PCNA implies that repair synthesis is carried out by DNA polymerase delta or epsilon.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1992 Apr 17 69(2) 367-74",
                "id": "1348971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NBN)",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "p(HGNC:NBN) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0951",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NBN) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "In pursuit of the involvement of HIF-alpha in chromosomal instability, we report here that HIF-1alpha, specifically its PAS-B, induces DNA double-strand breaks at least in part by repressing the expression of NBS1, a crucial DNA repair gene constituting the MRE11A-RAD50-NBS1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4784-94",
                "id": "17024177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PRKDC)",
        "relation": "hasModification",
        "target": "p(HGNC:PRKDC,pmod(P,T,2638))",
        "directed": false,
        "label": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,T,2638))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0952",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,T,2638))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA1)",
        "relation": "increases",
        "target": "cat(p(HGNC:PARP1))",
        "directed": false,
        "label": "p(HGNC:BRCA1) increases cat(p(HGNC:PARP1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0953",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA1) increases cat(p(HGNC:PARP1))",
              "summary_text": "Here, we report on the transient and stable transfection of cDNA coding for the putative truncated protein product of the BRCA1 185delAG mutant gene into BRCA1 wild-type human ovarian surface epithelial cells and ovarian cancer cells, resulting in cells with a heterozygous background containing two BRCA1 wild-type alleles and the BRCA1 185delAG transcript. The BRCA1 185delAG truncation (BRAt) protein did not alter epithelial cell morphology or induce tumorigenesis. However, upon treatment with staurosporine, BRAt cells showed increased levels of active caspase-3 and increased cleavage of caspase-3 substrates, PARP and DFF45",
              "citation": {
                "type": "PubMed",
                "name": "In Vitro Cell Dev Biol Anim 44(8-9) 357-67",
                "id": "18594935"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BRCA1) increases cat(p(HGNC:PARP1))",
              "summary_text": "Here, we report on the transient and stable transfection of cDNA coding for the putative truncated protein product of the BRCA1 185delAG mutant gene into BRCA1 wild-type human ovarian surface epithelial cells and ovarian cancer cells, resulting in cells with a heterozygous background containing two BRCA1 wild-type alleles and the BRCA1 185delAG transcript. The BRCA1 185delAG truncation (BRAt) protein did not alter epithelial cell morphology or induce tumorigenesis. However, upon treatment with staurosporine, BRAt cells showed increased levels of active caspase-3 and increased cleavage of caspase-3 substrates, PARP and DFF45",
              "citation": {
                "type": "PubMed",
                "name": "In Vitro Cell Dev Biol Anim 44(8-9) 357-67",
                "id": "18594935"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BRCA1) increases cat(p(HGNC:PARP1))",
              "summary_text": "We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis ... from full text, embryonic stem cells",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Apr 14 434(7035) 917-21",
                "id": "15829967"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": "embryo"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA1)",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:BRCA1) directlyIncreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0954",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA1) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "<p47> p53 binds BRCA1. This binding enhances the transcriptional activity of P53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA1)",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "directed": false,
        "label": "p(HGNC:BRCA1) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0955",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA1) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
              "summary_text": "Their connection with RAD51 indicates that BRCA1, BRCA2 and FA proteins such as FANCD2 could also be important for homologous recombination and, indeed, there is evidence that BRCA1 and/or BRCA2 participate in the three processes that are described above.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:WWP1))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:TP63)",
        "directed": false,
        "label": "cat(p(HGNC:WWP1)) directlyDecreases p(HGNC:TP63)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0956",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:WWP1)) directlyDecreases p(HGNC:TP63)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:WWP1)) directlyDecreases p(HGNC:TP63)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:WWP1))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:TP63)",
        "directed": false,
        "label": "cat(p(HGNC:WWP1)) directlyDecreases p(HGNC:TP63)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0957",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:WWP1)) directlyDecreases p(HGNC:TP63)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:WWP1)) directlyDecreases p(HGNC:TP63)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RPA1)",
        "relation": "increases",
        "target": "kin(p(HGNC:ATR))",
        "directed": false,
        "label": "p(HGNC:RPA1) increases kin(p(HGNC:ATR))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0958",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RPA1) increases kin(p(HGNC:ATR))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FHIT)",
        "relation": "decreases",
        "target": "kin(p(HGNC:ATR))",
        "directed": false,
        "label": "p(HGNC:FHIT) decreases kin(p(HGNC:ATR))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0959",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FHIT) decreases kin(p(HGNC:ATR))",
              "summary_text": "We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Oct 1 65(19) 8613-6",
                "id": "16204026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff59"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FHIT) decreases kin(p(HGNC:ATR))",
              "summary_text": "Fhit overexpression leads to apoptosis in many cancer cell lines. We report in this study that Fhit-/- cells derived from gene knockout mice show much stronger S and G2 checkpoint responses than their wild type counterparts. The strong checkpoint responses are regulated by the ATR/CHK1 pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Feb 202(2) 518-23",
                "id": "15389587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff58"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FHIT)",
        "relation": "increases",
        "target": "p(HGNC:CHEK1,pmod(P,S,317))",
        "directed": false,
        "label": "p(HGNC:FHIT) increases p(HGNC:CHEK1,pmod(P,S,317))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe095a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FHIT) increases p(HGNC:CHEK1,pmod(P,S,317))",
              "summary_text": "In PFB, the introduction of FHIT induced Hus1 expression and Chk1 phosphorylation (Fig. S2B). Slides were incubated with primary antisera against Fhit (Zymed, Carlsbad, CA), Bax (2772, Cell Signaling; N-20, Santa Cruz Biotechnology), Hus1 (Santa Cruz Biotechnology), or pChk1(Ser317) (Cell Signaling),",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Dec 1 66(23) 11287-92",
                "id": "17145874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "esophageal adenocarcinoma",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:WRN)",
        "relation": "hasModification",
        "target": "p(HGNC:WRN,pmod(P,S,1141))",
        "directed": false,
        "label": "p(HGNC:WRN) hasModification p(HGNC:WRN,pmod(P,S,1141))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe095b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:WRN) hasModification p(HGNC:WRN,pmod(P,S,1141))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TRIM28,pmod(P,S,824))",
        "relation": "decreases",
        "target": "cat(p(HGNC:TRIM28))",
        "directed": false,
        "label": "p(HGNC:TRIM28,pmod(P,S,824)) decreases cat(p(HGNC:TRIM28))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe095c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TRIM28,pmod(P,S,824)) decreases cat(p(HGNC:TRIM28))",
              "summary_text": "KAP-1 is phosphorylated in an ATM-dependent manner on Ser 824. KAP-1 is phosphorylated exclusively at the damage sites, from which phosphorylated KAP-1 spreads rapidly throughout the chromatin. Ablation of the phosphorylation site of KAP-1 leads to loss of DSB-induced chromatin decondensation and renders the cells hypersensitive to DSB-inducing agents. Knocking down KAP-1, or mimicking a constitutive phosphorylation of this protein, leads to constitutive chromatin relaxation. These results suggest that chromatin relaxation is a fundamental pathway in the DNA-damage response and identify its primary mediators.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2006 Aug 8(8) 870-6",
                "id": "16862143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TRIM28)",
        "relation": "hasModification",
        "target": "p(HGNC:TRIM28,pmod(P,S,824))",
        "directed": false,
        "label": "p(HGNC:TRIM28) hasModification p(HGNC:TRIM28,pmod(P,S,824))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe095d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TRIM28) hasModification p(HGNC:TRIM28,pmod(P,S,824))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to UV\")",
        "relation": "increases",
        "target": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "directed": false,
        "label": "bp(GOBP:\"response to UV\") increases bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe095e",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to UV\") increases bp(GOBP:\"cellular response to DNA damage stimulus\")",
              "summary_text": "DNA damage caused by UV irradiation ... from full text, HeLa cells and normal human fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Jun 13",
                "id": "17567951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"response to UV\") increases bp(GOBP:\"cellular response to DNA damage stimulus\")",
              "summary_text": "This type of radiation generates reactive oxygen species and consequently induces DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2001 Dec 3 1522(2) 89-96",
                "id": "11750059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"response to UV\") increases bp(GOBP:\"cellular response to DNA damage stimulus\")",
              "summary_text": "Using antioxidants, local irradiation, chromatin immunoprecipitation and in vitro PARP assays, we identified that ultraviolet radiation-induced direct DNA damage, such as thymine dimers, cause the initial PARP activation, whereas ultraviolet B-induced oxidative damage cause the second PARP activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2005 Feb 1 118(Pt 3) 589-99",
                "id": "15657079"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff5e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"response to UV\") increases bp(GOBP:\"cellular response to DNA damage stimulus\")",
              "summary_text": "DNA damage caused by UV irradiation ... from full text, HeLa cells and normal human fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Jun 13",
                "id": "17567951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to UV\")",
        "relation": "increases",
        "target": "a(SCHEM:\"double-stranded DNA break\")",
        "directed": false,
        "label": "bp(GOBP:\"response to UV\") increases a(SCHEM:\"double-stranded DNA break\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe095f",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to UV\") increases a(SCHEM:\"double-stranded DNA break\")",
              "summary_text": "We show that the stability of UV-arrested RFs depends directly on functional p53, and indirectly on NER and pol eta. In p53-deficient cells, the stalled sites give rise to double-strand DNA breaks (DSBs)",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 Dec 3(12) 1543-57",
                "id": "15539956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:DDB1))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "directed": false,
        "label": "cat(p(HGNC:DDB1)) increases bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0960",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:DDB1)) increases bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP73)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0961",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "The p53 TSG serves as a major cellular barrier against cancer development by way of apoptosis induction. P53 gene mutations and/or protein accumulation are the most common genetic changes in human tumors [88,  89]. The p53 gene is frequently inactivated by loss of heterozygosity (LOH), missense mutations and frameshift deletions, and in addition to the loss of wild-type p53, a high percentage of tumor cells accumulate mutant P53 protein isoforms [12,  88]. Whilst wild-type P53 functions as a tumor-suppressor, tumor-associated P53 proteins acquire novel functions enabling them to regulate gene expression and promote a large spectrum of cancer phenotypes [88]. P53 gene mutations are more frequent in intestinal than in diffuse type tumors, and alterations have been reported to occur at the premalignant stages of dysplasia and IM. Thus, p53 mutations have a crucial and early role in gastric carcinogenesis of the intestinal type; an immunohistochemical and genetic analysis revealed that early tumors with the poorest prognosis (i.e. that deeply penetrated the submucosa), showed the highest frequency of both p53 gene mutation and of nonmutated protein accumulation. However, p53 mutations and nuclear accumulation are late events in diffuse-type GC [89]. P53 belongs to a small family of sequence-specific nuclear transcription factors, to which p63 and p73 also belong [90]. P53 and P73 share structural and functional similarities; both are potent tumor suppressors with different isoforms that accumulate in response to DNA damage and have altered functions which often oppose those of the wild-type. Isoforms of P73 can inhibit both p53 and p73, thus assisting in tumor progression in contrast to the wild-type role of tumor suppression. In the absence of functional p53, p73 can be responsible for regulating the cell cycle, promoting apoptotic cell death in tumor cells and regulating the response of tumor cells to drugs; however, the regulatory mechanisms of the pro-apoptotic activity of p73 are distinct from those used by p53. The complexity of p73?s activity results in contradiction in its role as an important member of the p53 TSG family, thus further investigations are needed to fully verify its role in cancer [90,  91]. The Puma protein (p53-upregulated modulator of apoptosis) belongs to the BH3-only group of proteins along with Bcl-2. It is a potent mediator of the p53 apoptotic response that dimerizes with other BH3-only proteins resulting in release of cytochrome C from the mitochondria and induction of apoptosis by the activation of caspases 3 and 9 [84]. However, Puma expression is transactivated by p53 and p73 and its expression is increased in gastric carcinomas whilst remaining absent in normal gastric mucosa, suggesting it may have a potential oncogenic role and could possibly be used as a diagnostic marker [92].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Genomics 2007 Sep 8(6) 379-97",
                "id": "19412438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe080d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "ZNF143 knockdown in prostate cancer caused increased sensitivity for cisplatin, but not for oxaliplatin, etoposide and vincristine. p73 could stimulate the binding of ZNF143 to both ZNF143 binding site and cisplatin-modified DNA. We provide a direct evidence that both Rad51 and flap endonuclease-1 are target genes of ZNF143 and overexpressed in cisplatin-resistant cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Aug 9 26(36) 5194-203",
                "id": "17297437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Consistent with this, we discovered that endogenous p73alpha interacts with Chk1 and is phosphorylated by Chk1 at serine 47 in vitro and in vivo. In contrast, Chk2 does not phosphorylate p73alpha in vitro. Moreover, mutation of serine 47 abolishes both Chk1-dependent phosphorylation of p73alpha upon DNA damage in vivo and the ability of Chk1 to upregulate the transactivation capacity of p73alpha. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(22) 8161-71",
                "id": "14585975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Figure 5. Regulation of the core cell-death machinery by E2F-1 and the p53 family. E2F-1 can regulate apoptosis in many ways. It can induce cell death by stabilizing the levels of p53 through activating the ARF tumor suppressor, which suppresses Mdm2, a negative regulator of p53. The p53 protein regulates the transcription of several celldeath genes including BH3-only proteins, proapoptotic Bcl-2 protein Bax and the caspase-9 adaptor Apaf-1. In cells lacking p53, E2F-1 can act through p73, a member of p53 family that activates some of the same target genes as p53. E2F-1 can also directly regulate the transcription of several different caspases and suppress cell survival pathways by suppressing Mcl-1 expression or by inhibiting NFkB-mediated antiapoptotic signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Biochem Sci 2004 Apr 29(4) 193-9",
                "id": "15082313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Here, we identified FDXR as a target gene of the p53 family, that is, p53, p63, and p73. We found that FDXR can be induced by DNA damage in cells in a p53-dependent manner and by a mutated form of p53 that is competent in inducing apoptosis. In addition, we identified a p53 response element located within the FDXR promoter that is responsive to wild-type p53, p63alpha, p63gamma, p73alpha, and p73beta.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 17 21(47) 7195-204",
                "id": "12370809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Despite these limitations, three categories of GOF have been selected, where data were available for more than 50 distinct mutants and for more than 70 experiments measuring: 1) interference with p73 activity; 2) transactivation of genes repressed by wild-type p53; and 3) cooperation with oncogene for transformation of rat embryonic fibroblast (REF) or mouse embryonic fibroblast (MEF) cells (Supplementary Table S2).For example, R175H, which is the most frequently reported mutant (reported 944 times), has GOF properties in all categories. However, two rare (reported less than 20 times) mutants, V143A and D281G, have also been shown to have GOF properties in the three categories.",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mutat 2007 Jun 28(6) 622-9",
                "id": "17311302"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Fig.1- shows proteins that interact with CBP/300 Transciptional activators= STAT1, (already).  SF1, TAL1, p73, Mdm2, HIF2?, ETS1, RXR, p65, Pit1 (POU1F1), HNF4, Stat2, EBNA2 (virus), HPV E2?, BRCA1, p45/NF-E2, c-JUN, c-myb, Tax?, Sap1, YY1, SREBP, ATF-1, ATF-4, Cubitus interuptusm GII3?, vIRF?, JMY, dMAD?, Py LT?, HPV E6, CIITA, Tat(HIV), SF-1, E2F, Ets-1, junB, C/EBPb, (already) GATA-1, Neuro D, Microphthalmia, E1A, Twist, p53 (already), Myo D, pp90 RSK, SMAD (already), ATF-2, c-Fos, SC40?, Large T? p300 k.o. are defective for RXR signal but not CREB",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13505-8",
                "id": "11279224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "In this study, we have found that Plk1 (polo-like kinase 1) associates with p73, phosphorylates p73 at Thr-27, and thereby inhibits its pro-apoptotic activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Mar 28 283(13) 8555-63",
                "id": "18174154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Nov 27 22(54) 8738-48",
                "id": "14647469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "c-Myc induces and activates p73alpha and they bind each other",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39769-76",
                "id": "12167641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff8f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "While less is known about p73, recent studies have shown that it induces cellular autophagy and multiple autophagy-associated genes downstream of mTOR. Chromatin immunoprecipitation analyses demonstrate that endogenous p73 binds the regulatory regions of genes such as ATG5, ATG7 and UVRAG. ",
              "citation": {
                "type": "PubMed",
                "name": "Autophagy 2009 Jan 1 5(1) 114-6",
                "id": "19001857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Eight p53 mutations, present in 19 cases, were found that efficiently inhibit TAp73 (i.e., 175H, 220C, 245S, 245D, 248W, 248Q, 266E, and 273H). Patients with p53 mutations that efficiently inhibit TAp73 function had a significantly shorter overall survival than patients with p53 mutations of unknown effect on TAp73 (P = 0.044). in the responsiveness to platinum-based chemotherapy and survival in ovarian cancer",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2005 Dec 1 11(23) 8372-83",
                "id": "16322298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Yes-associated protein (YAP), also containing WW domains, was shown to associate with p73 and enhance its transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Aug 1 65(15) 6764-72",
                "id": "16061658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "p73 belongs to a family of transcription factors, including p53 and p63, that mediate response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2007 Jan 1095 315-24",
                "id": "17404044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "siRNA-mediated knockdown of p73 induces hTERT expression.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Feb 9 25(6) 813-26",
                "id": "16205639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "TAp73 induces arrest and apoptosis, while in most systems ?Np73 counteracts these pathways in response to ionizing radiation and genotoxic agents in vitro ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cancer 2007 7 127",
                "id": "17626635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.\\\" We demonstrate here that the p53 family protein p73alpha represses PDGF beta-receptor transcription essentially by the same mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39769-76",
                "id": "12167641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Using p73 antisense oligonucleotides or dominant-negative p73 mutants that lack the N-terminus of the p73 protein (DTA-p73), E2F1-induced cell death was significantly disrupted; this demonstrates that p73 is an important mediator of E2F1 induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 Jun 15 59(12) 2810-4",
                "id": "10383137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "As expected, the transcriptional activity of p53 was strongly activated by cotransfection with ING1b. We found that the transcriptional activities of p73? and p63? were also enhanced by ING1b, albeit not as robust as p53.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Oct 23 553(3) 277-85",
                "id": "14572637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "transcriptionally active p73 isoforms (TAp73alpha and TAp73beta) bound to this DNA sequence and, at variance with DeltaNp73alpha, stimulated PTEN promoter activity to an extent similar to that of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2008 Dec 11",
                "id": "19173293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of thyroid gland",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurooncol 2002 Sep 59(2) 143-9",
                "id": "12241107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "We also found that BMP7 was highly induced by p53, p73{beta}, and {delta}Mp73{beta}, but little, if any, by mutant p53(R249S) and p73{alpha} (Fig. 1B and C). ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Oct 1 67(19) 9117-24",
                "id": "17909016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 29 278(35) 32507-16",
                "id": "12748190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 May 19(5) 3885-94",
                "id": "10207112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "However, phosphorylation of YAP by MST2/LATS1 has also been shown to enhance p73 binding and subsequent apoptosis downstream from Fas in human breast cancer cells and chemotherapy in leukemia cells, as well as overexpression of pathway members in HEK293 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Dis 2010 1 e29",
                "id": "21364637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Mar 25(5) 2014-30",
                "id": "15713654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Here, we report that SIRT1 also binds to p73 and suppresses p73-dependent transcriptional activity. SIRT1 in human cells reduces the transcriptional activity of p73",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2007 Jan 210(1) 161-6",
                "id": "16998810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Second, TAp73 induces the mitochondrial pathway by directly transactivating both Bax and the BH3 only protein PUMA promoters. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jun 10 331(3) 713-7",
                "id": "15865927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "endogenous p73 alpha and beta proteins are up-regulated in p53-deficient tumor cells in response to overexpressed E2F1, c-Myc, and E1A. E2F1, c-Myc, and E1A-mediated p73 up-regulation leads to activation of the p73 transcription function, as shown by p73-responsive reporter activity and by induction of known endogenous p73 target gene products such as p21 and HDM2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 6 276(14) 11310-6",
                "id": "11115495"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Here, we show that S100A2 gene, whose transcript and protein are induced during keratinocyte differentiation of HaCaT cells, is a direct transcriptional target of p73beta and DeltaNp63alpha and is required for proper keratinocyte differentiation",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jun 22 25(26) 3628-37",
                "id": "16449968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Jul 20 19(31) 3470-6",
                "id": "10918605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 May 2 21(19) 3050-7",
                "id": "12082536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Importantly, TAp73 triggers a transcriptional programme to prevent anchorage-independent growth",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Mar 5 27(5) 792-803",
                "id": "18239687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "c-Jun stabilizes p73, a p53 family member leading to apoptotic cell death.39 Consistently, enzastaurin induced p73, but not p53, in a dose- and time-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Feb 12 113(7) 1513-21",
                "id": "19018094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Here, we have identified EphA2 as a target gene of the p53 family, that is, p53, p73, and p63.  We found that EphA2 expression resulted in an increase in apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6503-15",
                "id": "11641774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "The induction of ER stress by p73 was further supported by the transcriptional induction of Gadd 153, a transcription factor induced under ER stress conditions",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 29 23(20) 3721-5",
                "id": "15116103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2951-7",
                "id": "11706030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "We found that the expression of apoD was specifically up-regulated by either TAp73 or TAp63 but not significantly by p53. I",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 9 284(2) 872-83",
                "id": "19001418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jun 3;18(22):3415-21",
                "id": "10362363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "In contrast, Fontemaggi et al. showed that ectopic expression of both p53 and p73 increased the expression of PRL-3 in H1299 non-small cell lung cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2005 Nov 4(11) 1653-61",
                "id": "16275986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Fig. 10 shows that E4.ICD is able to inhibit the transcriptional activation of Bax promoter induced by p73 and YAP, in a doseresponse manner. The ability of E4.ICD to interfere with the Bax-luciferase activity can be explained as the ability to titrate out binding of YAP to p73.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 Apr 1 294(2) 469-79",
                "id": "15023535"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "our results imply that cyclin G is transcriptionally activated by p53 or p73, and, in turn, cyclin G negatively regulates the stabilization of p53 family proteins",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Mar 20 22(11) 1678-87",
                "id": "12642871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "p73-mediated induction of Bax expression following DNA damage requires YAP function and is attenuated by Akt phosphorylation of YAP.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Jan 11(1) 11-23",
                "id": "12535517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Consistent with the previous reports, p73 was accumulated after the treatment with cisplatin. Intriguingly, we found a putative p53/p73-binding site in the 5'-upstream region of the human DAN gene. A luciferase reporter assay and an in vitro DNA-binding experiment revealed that this canonical p53/p73-binding site was a functional responsive element and was specific for p73. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Jul 12 295(2) 501-7",
                "id": "12150978"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "In p53-null cell lines, the level of MDM2 was increased by p73 due to increases in transcription and protein stability of MDM2.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Feb 15 61(4) 1598-603",
                "id": "11245471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "the ability of p73beta to activate expression of the cyclin-dependent kinase inhibitor p57(KIP) and KvLQT1",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Mar 19 99(6) 3529-34",
                "id": "11891335"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Exogenously expressed as well as cellular Hck and p73 interact in vivo. In vitro binding assays show that SH3 domain of Hck interacts with p73. Co-expression of p73 with Hck or c-Src in mammalian cells resulted in tyrosine phosphorylation of p73, Ectopically expressed Hck repressed the transcriptional activity of p73 as determined by promoter assays and semi-quantitative RT-PCR analysis of the p73 target, Ipaf and MDM2.",
              "citation": {
                "type": "PubMed",
                "name": "BMC Mol Biol 2007 8 45",
                "id": "17535448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Using reporter assays and Electrophoretic Mobility Shift Assays (EMSA), our findings suggest that TAp73-mediated activation of the p21(cip/waf), 14-3-3sigma and Bax gene promoters is abrogated by expressed PLK1 for which post-translational modification of TAp73 Thr-27 appears to be a key step in MCF7 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2008 May 1 7(9) 1214-23",
                "id": "18418051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Table I - Target genes modulated by p73 and p53",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 43359-68",
                "id": "12213815"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "We found that the Jagged1 (JAG1) and Jagged2 (JAG2) genes, encoding ligands for the Notch receptors, are up-regulated by p63 and p73.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 4 277(1) 719-24",
                "id": "11641404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Induction of DDA3 was found in adriamycin treated normal mouse embryonic fibroblast cells (MEF) Overexpression of p73 induced DDA3 mRNA expression,",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 May 2 21(19) 3050-7",
                "id": "12082536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff65"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "XDH, TSC1, and INSR are three examples of a larger subset of genes whose regulation by mTOR is p73 dependent at the transcriptional level. An increase in all three genes after treatment with rapamycin in the absence of serum is abrogated by p73 knockdown,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Oct 28(19) 5951-64",
                "id": "18678646"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "Dissociation of p73 and HDM2 leads to increased p73 transcriptional activity with upregulation of p73 target genes noxa, puma and p21 (RT-PCR and Western Blot)  Noxa, puma and p21waf1/cip1 mRNA levels increased by 2.5-, 2.3- and 3.2- fold, respectively, following Nutlin-3 treatment (Figures 3a and b and Supplementary Figure S1",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Feb 7 27(7) 997-1003",
                "id": "17700533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP73) actsIn tscript(p(HGNC:TP73))",
              "summary_text": "TAp73 also activated the bradykinin B2 receptor (B2R) promoter, a developmentally regulated gene involved in regulation of sodium excretion.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jun 17 280(24) 23094-102",
                "id": "15805112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:UNG))",
        "relation": "increases",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "cat(p(HGNC:UNG)) increases bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0962",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:UNG)) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe080e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:POLA1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:POLA1))",
        "directed": false,
        "label": "p(HGNC:POLA1) actsIn cat(p(HGNC:POLA1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0963",
          "evidences": [
            {
              "bel_statement": "p(HGNC:POLA1) actsIn cat(p(HGNC:POLA1))",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:POLA1) actsIn cat(p(HGNC:POLA1))",
              "summary_text": "interacts with a catalytic subunit of DNA polymerase alpha and stimulates its polymerase activity... MSSP stimulated DNA polymerase activity in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2000 Jun 23 475(3) 209-12",
                "id": "10869558"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RPS6KB1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:RPS6KB1))",
        "directed": false,
        "label": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0964",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "In vivo, endogenous FAP68 can be coimmunoprecipitated with the HGF receptor in the absence of stimuli and not upon HGF stimulation. Thus, FAP68 represents a novel type of effector that interacts with the inactive HGF receptor and is released upon receptor phosphorylation. # Ariadne: Significantly, nonphosphorylated HGF receptor prevents FAP68 from stimulating  p70S6K . [Regulation] # Ariadne: FAP68  interacts specifically with the inactive form of HGF receptor, such as a kinase- defective receptor or a dephosphorylated wild type receptor. [Binding] # Ariadne: Significantly, nonphosphorylated HGF receptor prevents FAP68 from stimulating  p70S6K . [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 46632-8",
                "id": "11571281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "We demonstrate that leukocyte chemotaxis is prevented by the macrolide immunosupressant rapamycin, a specific inhibitor of the mammalian target of rapamycin (mTOR)/ribosomal p70S6 kinase (S6K) pathway. Both neutrophil chemotaxis and chemokinesis elicited by granulocyte-macrophage colony-stimulating factor (GM-CSF) were strongly inhibited by the immunosuppressant drug rapamycin with an IC50  of 0.3 nM. Inhibition, although at a higher dose, was also observed when the chemoattractant was IL-8. As for the mechanism, rapamycin targeted the increase of phosphorylation of p70S6K due to GM-CSF treatment, as demonstrated with specific anti-p70S6K immunoprecipitation and subsequent immunoblotting with anti-T421/S424  antibodies.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Aug 28 550(1-3) 94-100",
                "id": "12935893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "protein kinase MAP4K3 [mitogen-activated protein kinase kinase kinase kinase-3, a Ste20 family protein kinase also known as GLK (germinal centre-like kinase)] is a new component of the nutrient-responsive pathway. MAP4K3 activity is stimulated by administration of amino acids, but not growth factors, and this is insensitive to rapamycin, most likely placing MAP4K3 upstream of mTOR. Indeed, MAP4K3 is required for phosphorylation of known mTOR targets such as S6K1 (S6 kinase 1), and overexpression of MAP4K3 promotes the rapamycin-sensitive phosphorylation of these same targets  mTOR = FRAP1 S6K1 = RPS6KB1",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2007 Apr 1 403(1) e1-3",
                "id": "17346240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Tuberin interferes with insulin-like growth factor-1-induced BAD Ser136 phosphorylation and cell survival. Our work proposes a model in which tuberin-mediated inhibition of p70S6K activates BAD to heterodimerize with BCL-2 and BCL-XL to promote apoptosis. A mutation of TSC2--as it occurs in TSC patients--attenuates this proapoptotic potential, underscoring the relevance of our findings for human pathophysiology.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Oct 19 25(49) 6467-79",
                "id": "16702951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "To test whether mTOR would also phosphorylate Ser371 in vitro, Myc-S6K-WT derived from 293 cells pretreated with rapamycin was used as a direct substrate for HA-tagged mTOR immunopurified from 293 cells. The results show that Myc-mTOR-WT induces increased Ser371 phosphorylation in vitro as assessed by Western blot analysis with the Ser371 anti-phosphospecific antibody following electrophoresis on low acrylamide gels (Fig. 5A), consistent with in vivo findings (Fig. 2A). In contrast, HA-mTOR-KI had no effect. More importantly, in the presence of rapamycin and FKBP12, but not in the presence of either component alone, phosphorylation of Ser371 by mTOR is abolished (Fig. 5A), consistent with the in vivo finding (Fig. 4). In parallel, incubation of S6K1-E389D3E with HA-mTOR-WT also led to increased S6K1-E389D3E activation and Ser371 phosphorylation, in an FKBP-12/rapamycin-sensitive manner (Fig. 5B and data not shown). Furthermore, the extent of both responses was similar to those observed in vivo (compare Figs. 4B and 5B). Therefore, Ser371 phosphorylation appears to be directly regulated by mTOR in vitro and in vivo. (From full text)   Incubation of either S6 kinase variant with wild type, but not kinase-inactive, mTOR led to increased Thr389 phosphorylation, with the extent of Thr389 phosphorylation much higher in S6K1-S371A than in wild type S6K1 (Fig. 6B). However, to achieve the same level of activity as S6K1-WT, S6K1-S371A apparently requires much higher levels of Thr389 phosphorylation (Fig. 6B), consistent with detailed titration studies (data not shown). Although unexpected, these findings are compatible with Ser371 phosphorylation regulating Thr389 phosphorylation and with its ability to directly affect S6K1 activity. (From full text)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 31 277(22) 20104-12",
                "id": "11914378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Activation of S6K1 also occurs within minutes of initiation of signalling through mTOR. S6K1 phosphorylates ribosomal protein S6, which reportedly enhances the translation of mRNA with an uninterrupted string of pyrimidine residues adjacent to the 5k-cap structure (terminal oligopyrimidine mRNA; Meyuhas, 2000). Proteins encoded by such mRNA include ribosomal proteins, translation elongation factors and poly(A) binding protein. Thus, activation of S6K1 results in a rapid increase in the synthesis of a subset of proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 351-6",
                "id": "15294054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "altered glucose availability, which regulates AMPK activity, also modulates the activity of p70 S6k. AICAR treatment also inhibits phosphorylation of Thr-412 in the p70 S6 kinase (p70 S6k), which is indispensable for the activity. In addition to the mTOR signal acting as a priming switch that modulates p70 S6k activation, AMPK appears to provide an overriding switch linking p70 S6k regulation to cellular energy metabolism.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2003 Jan 8(1) 65-79",
                "id": "12558800"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "PI3K regulates the mTORC1 pathway via the activation of AKT which directly phosphorylates the negative regulators of mTOR activation, TSC1 and TSC2 (tuberin), thereby inactivating its inhibitory activity. This allows mTOR activation resulting in the phosphorylation of p70 ribosomal S6 kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein1 (4E-BP1) [78,79]. These events lead to mTOR-dependent gene transcription that regulates cell growth, protein synthesis, and metabolism in response to a variety of environmental stimuli [80].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2008 Oct 29(10) 493-501",
                "id": "18775670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "from full text - T229 is situated in the catalytic domain of p70S6K, and in addition to T389, its phosphorylation is necessary for full activation of the protein. Residues T421 and S424 are situated in the autoinhibitory/pseudosubstrate domain of the C-terminus, and phosphorylation of these residues is proposed to be one of the early steps of p70S6K activation (2).",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2005 Nov 8 44(44) 14595-605",
                "id": "16262259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Activation of S6K1 also occurs within minutes of initiation of signalling through mTOR. S6K1 phosphorylates ribosomal protein S6, which reportedly enhances the translation of mRNA with an uninterrupted string of pyrimidine residues adjacent to the 5k-cap structure (terminal oligopyrimidine mRNA; Meyuhas, 2000). Proteins encoded by such mRNA include ribosomal proteins, translation elongation factors and poly(A) binding protein. Thus, activation of S6K1 results in a rapid increase in the synthesis of a subset of proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 351-6",
                "id": "15294054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The initially identified sites of phosphorylation (of RPS6KBP1), S411, S418, T421 and S424 are all flanked by a proline in the +1 position and reside within the putative autoinhibitory domain of Module IV [22]. Peptides which correspond in sequence to this domain inhibit the kinase [51], consistent with the hypothesis that Module IV acts as an autoinhibitory domain. These four residues are hypophosphorylated in quiescent cells, and become hyperphosphorylated in response to serum [23]. Substitution of these S/T-P sites with alanines [23] suppresses activation of the kinase, whilst the corresponding acidic residue replacements raise basal kinase activity [10]. ",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1997 Jun 23 410(1) 78-82",
                "id": "9247127"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "TSC2 S1798A mutant.Thi s mutant was used to prove that RSK-dependent phosphorylation of tuberin on Ser1798 inhibits its potential to turn off Rheb and to downregulate the activities of mTOR and p70S6K.Mu tation of Ser1798 inhibited most of tuberin phosphorylation and inactivation by RSK (Roux et al., 2004).Invest igating PARP cleavage, caspase 3 cleavage, the percentage of HOPI-positive cells and the percentage of subG1 cells demonstrated that the cell survival effects of activated Ras over tuberin-induced apoptosis are significantly diminished by this mutation in TSC2 (Figures 5ac).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Mar 27 27(14) 2072-83",
                "id": "17922028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "conditional inactivation of Cdc2 reduces phosphorylation of S6K1 at S/TP sites while simultaneously increasing phosphorylation of Thr(389) and of the S6K1 substrate, RPS6.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 2 278(18) 16433-42",
                "id": "12586835"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0003"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Harrington et al. (2004) showed in the same study that a downstream target of mTORC1, S6K1 was able to phosphorylate and inhibit IRS-1 in Ser302.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0002"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Whereas treatment of wild type MEFs with insulin induced a marked increase in S6K1 activity, the basal activity of S6K1 isolated from Tsc1- and Tsc2-null MEFs was high and was not increased further by insulin (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 20816-23",
                "id": "14993219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0001"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "we found that S6K1, but not RSK1 or RSK2, was capable of phosphorylating rpS6 on Ser240/244.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 11 282(19) 14056-64",
                "id": "17360704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0000"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 45643-51",
                "id": "15337760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "In all three groups of rats, insulin significantly increased ERK2, RSK2, Akt, and p70S6k activities",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Jan 140(1) 106-11",
                "id": "9886813"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfffe"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "PRAS40 inhibits cell growth, S6K1 phosphorylation, and rheb-induced activation of the mTORC1 pathway, and in vitro it prevents the great increase in mTORC1 kinase activity induced by rheb1-GTP.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2007 Mar 23 25(6) 903-15",
                "id": "17386266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfffd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "LKB1-deficient tumors are shown here to exhibit elevated levels of S6K1 activity and phospho-4EBP1, indicative of hyperactivation of mTOR signaling",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2004 Jul 6(1) 91-9",
                "id": "15261145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfffc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "##from text## Phosphorylation of p70 S6 kinase on Thr389 is essential for the activation of the kinase [22]. In the presence of insulin, the intensity of the Thr389 p70 S6 kinase bands was significantly increased after 15 min exposure and reached 2.02  0.31 after 15 min and 1.36  0.17 after a 16 hour incubation period when compared to respective controls which were made equal to one (mean  SE, t-test, p < 0.05, n = 4).",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2002 3 27",
                "id": "12537604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfffb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "from full text:Phosphorylation of rpS6 is mediated by both S6K1 and p90RSK, whereby S6K1 phosphorylates two sets of sites, S235/236 and S240/244, and p90RSK phosphorylates only S235/236",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2006 Jun 1 573(Pt 2) 497-510",
                "id": "16543272"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfffa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "P70rsk activates ribosome biosynthesis by phosphorylating the ribosomal S6 protein, producing increased translation of mRNAs with a 58-terminal oligopyrimidine tract. P70rsk also requires a second PtdIns(3,4,5)P3-dependent phosphorylation, presumably catalysed by PDK1.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Ribosome biosynthesis is a key process for cell growth. Before entering the cycle, cells need to accumulate sufficient translational machinery, mainly ribosomes, to ensure the rapid processing of transcripts through the cycle. This is accomplished, at least in part, by phosphorylation of the ribosomal S6 protein by S6 kinase (S6K)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2001 Dec 1(3) 222-31",
                "id": "11902577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Our study extend recent findings which implicate PDK1 in the activation of protein kinases B and C and p70(S6K)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 17 274(38) 27168-76",
                "id": "10480933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Aug 15 20(16) 4370-9",
                "id": "11500364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Recombinant NEK6 phosphorylates p70 S6 kinase at Thr412 and other sites and activates the p70 S6 kinase in vitro and in vivo, in a manner synergistic with PDK1. Kinase-inactive NEK6 interferes with insulin activation of p70 S6 kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2001 Aug 7 11(15) 1155-67",
                "id": "11516946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "the phosphorylation of 40S ribosomal protein S6, a physiological substrate p70 S6 kinase, was highly increased by growth-stimulation of the cytolytic T cells (CTLL2) with interleukin 2 (IL2), which was accompanied with the increased phosphorylation of p70 S6K.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2004 Apr 13(4) 601-5",
                "id": "15010863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2001 Nov 15 360(Pt 1) 117-26",
                "id": "11695998"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Jun 28 271(26) 15762-8",
                "id": "8663120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The translation factor eIF4B, which stimulates the activity of eIF4A in unwinding dublex RNA, is phosphorylated by S6K1 on serine 422 (Raugh et al, 2004).",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2006 Jan 30 94(2) 195-9",
                "id": "16404421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1996 Dec 79(6) 1167-76",
                "id": "8943955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdfff0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Rheb to stimulate S6 kinase (S6K) phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Sep 24(18) 7965-75",
                "id": "15340059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "members of the FOXO family can inhibit PP2A phosphatase, thereby increasing AKTphos phorylation (Ni et al., 2007), and activated S6K can overcome the effect of AKTinactivat ion through direct phosphorylation of GSK3 (Zhang et al., 2006a).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "TNF-alpha secretion of LPS-treated macrophages occurred after mTORC1-S6K activation",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(12) e14399",
                "id": "21200439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Thus, rapamycin inhibits BCR-induced S6K1 activation and DNA synthesis in mouse B cells [139]",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 May 9(5) 324-37",
                "id": "19390566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffec"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "We found that KGF induced rapid activation of Akt, p70 S6K, JNK, and extracellular signal-regulated (ERK) ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2005 Dec 46(12) 2624-35",
                "id": "16162944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffeb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jan 21 100(2) 633-8",
                "id": "12524457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "We have previously shown that induction of p70S6K activity was critical for IL-6-induced myeloma cell growth.26",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Apr 15 101(8) 3126-35",
                "id": "12515720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "the treatment of SV40-immortalized human corneal epithelial cells (HCE-T cells) with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), widely used as an AMPK  activator, inhibits p70 S6 kinase a (p70a) activities. AICAR treatment also inhibits phosphorylation of Thr-412 in p70a, which is indispensable for its activity.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jan 9 313(2) 443-6",
                "id": "14684182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 18 275(33) 25572-6",
                "id": "10849422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The most notable impact on IGF-I signaling was a significant blunting of IGF-I induced increase in S6K1 phosphorylation by PD-98059 coinfusion  approximately 5-fold,",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2004 Jan 96(1) 203-10",
                "id": "12959952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "MTOR complex 1 (mTORC1) phosphorylates S6K1, while mTOR complex 2 (mTORC2) phosphorylates Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Apr 14",
                "id": "18411301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "we identified p70 S6 kinase as a major signal transduction pathway activated by OPN-1",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2005 Apr 15 94(6) 1218-33",
                "id": "15696579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Upon growth factor stimulation, RSK1 and S6K1 kinases are activated to phosphorylate DEPTOR, which is then recognized by the F box protein, beta TrCP, via its degron sequence for subsequent ubiquitination and degradation by SCF E3. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2011 Oct 21 44(2) 304-16",
                "id": "22017876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "We then examined the change of the kinase activity of p70S6K which was known to be phosphorylated and activated by PDK1 (Vanhaesebroeck and Alessi, 2000).....treatment of the cells with UCN-01 suppressed p70S6K kinase activity in a dose-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Mar 7 21(11) 1727-38",
                "id": "11896604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "fibrosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Ser422 phosphorylation appears to be regulated by the S6Ks: (a) Ser422 phosphorylation is sensitive to pharmacological inhibitors of phosphoinositide-3 kinase and the mammalian target of rapamycin; (b) S6K1/S6K2 specifically phosphorylate Ser422 in vitro; and (c) rapamycin-resistant S6Ks confer rapamycin resistance upon Ser422",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Apr 21 23(8) 1761-9",
                "id": "15071500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "once Akt1 is activated, it initiates a cascade of phosphorylation events targeting mammalian target of rapamycin, mTOR, which in turn phosphorylates the p70S6 kinase and GSK3B",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11",
                "id": "15292521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffe0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "In addition, two proteins that interact with mTOR to target it to two important substrates, eukaryotic initiation factor 4E binding protein 1 and ribosomal protein S6 kinase, have been identified.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Clin Nutr Metab Care 2004 Jan 7(1) 39-44",
                "id": "15090902"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The CREB analogue CREM can also be  phosphorylated by PKC and p70 S6 kinase .",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": " In contrast to S6K2, S6K1 was activated in both SCLC cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Nov 15 20(52) 7658-67",
                "id": "11753643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Although the levels of b-tubulin remained unchanged, the induction of CHOP by amino acid depletion was blocked by rapamycin in a dose-dependent manner at concentrations that completely inhibited the activity of p70S6K (Fig. 4AGo). ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2001 Jan 142(1) 221-8",
                "id": "11145585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffdc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Dec 15 14(24) 3093-101",
                "id": "11124802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffdb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "PDPK1 selectively phosphorylates the 70-kD ribosomal protein S6 kinase (p70-RPS6K) at thr229, which is required for its activation. Thr229 of p70-RPS6K is homologous to thr308 of the PKB protein.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Jan 30 279(5351) 707-10",
                "id": "9445476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "inhibition of PI3K activity partially inhibits cell adhesion and spreading while largely inhibiting microspike formation in cells adherent to galectin-8",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 18 278(16) 14533-42",
                "id": "12569102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "from full text hVps34 siRNA-treated cells showed a marked decrease in insulin-stimulated phosphorylation of S6K1 at Thr389.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Sep 23 280(38) 33076-82",
                "id": "16049009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Components of these pathways (Shc, p44/42 MAPK kinase, Akt/protein kinase B and p70s6k) are phosphorylated in response to progranulin7,10 and have been previously implicated in the ability of progranulin to stimulate cell division.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Feb 9(2) 225-9",
                "id": "12524533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "On the other hand, inactivation of phosphorylase by insulin is mediated through the PI-3 kinase pathway involving a rapamycin-sensitive p70(s6k) and PP-1G.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2000 Aug 211(1-2) 123-36",
                "id": "11055555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Consistent with this, epidermal growth factor-induced Thr(389) phosphorylation in wild type S6K1 persisted for up to 120 min, whereas kinase-inactive mutants of S6K1 displayed only a reduced and transient increase in Thr(389) phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 25 277(43) 40281-9",
                "id": "12183455"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "TOR activity leads to phosphorylation and activation of ribosomal S6 kinase-1 (S6K1), and phosphorylation and inhibition of translation initiation factor eIF-4E binding protein-1 (4E-BP1).",
              "citation": {
                "type": "PubMed",
                "name": "Trends Biochem Sci 2003 Nov 28(11) 573-6",
                "id": "14607085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2002 Apr 51(4) 966-76",
                "id": "11916914"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "These effects were completely prevented by calphostin C, a protein kinase C inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2001 May 33(5) 1130-40",
                "id": "11343241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "U-266 cells were incubated in the presence or absence of IFNalpha, and, after immunoprecipitation of cell lysates with an anti-p70 S6K antibody, immunoprecipitates were subjected to an in vitro kinase assay (52). As shown in Fig. 6B, Type I IFN treatment resulted in an activation of the catalytic domain of the p70 S6 kinase (Fig. 6B)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 25 278(30) 27772-80",
                "id": "12759354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The activation of p70S6K by insulin or EGF resulted in the phosphorylation of ribosomal protein S6 (RPS6), elongation initiation factor 4E (elF4E) and 4E binding protein1 (4E-BP1)",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2006 7 34",
                "id": "16984645"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffd0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Activated S6K1, the main effector of uninhibited mTORC1, negatively regulates input from PI3K-AKT to mTORC1 [19], [27-29]  by phosphorylating and initiating the degradation of insulin receptor substrate 1 (IRS1), which is the molecular intermediate between the insulin receptor and PI3K [19, 27-31].",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 May 9(5) 324-37",
                "id": "19390566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffcf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The tuberous sclerosis complex (TSC1-2) suppresses cell growth by negatively regulating a protein kinase, p70S6K (S6K1), which generally requires PI3K signals for its activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Jul 19 166(2) 213-23",
                "id": "15249583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffce"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Removal of mTORC1 inhibition results in its phosphorylation of S6 kinase 1 (S6K1) and the eukaryotic initiation factor 4EBP1 (eIF4E binding protein 1). ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 May 9(5) 324-37",
                "id": "19390566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffcd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "p70/p85S6K was rapidly stimulated by EGF in both cell lines....More notable was the result obtained with NDF, which led to a higher and much more sustained activation of p70/p85S6K in the T47D/ puro cells than in the T47D/5R cells (Fig. 9B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Mar 15(3) 1182-91",
                "id": "7532277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffcc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "S6K1-deficient mice develop hyperglycemia in response to glucose challenge because of impaired insulin secretion and decreased insulin content in the beta-cells",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2003 Feb 24(1) 91-101",
                "id": "12588811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffcb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "As a result, the cytosolic lipid content was severely reduced (Valverde et al. 1997a). Among the PI3K downstream targets, the role of p70S6K has been studied by using rapamycin (a macrolide immunosuppressant that selectively inhibits the phosphorylation and activation of the enzyme) (Ferrari et al. 1992).",
              "citation": {
                "type": "PubMed",
                "name": "Mini Rev Med Chem 2005 Mar 5(3) 269-78",
                "id": "15777261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "We found that association of FIP200 with the TSC1-TSC2 complex correlated with its ability to increase cell size and up-regulate S6 kinase phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 Aug 1 170(3) 379-89",
                "id": "16043512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Rheb, a mediator of mTOR/S6K/4E-BP signaling",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Jun 11(6) 1457-66",
                "id": "12820960"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Another PI3K effector, the cell survival protein Akt, displayed increased activity in T19N cells, which did not express active RhoA, compared with TRAMP and Q63L cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 May 1 62(9) 2630-6",
                "id": "11980660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Mouse embryonic stem (ES) cells in which both copies of the PDK1 gene were disrupted were viable. In PDK1(-/-) ES cells, PKB, p70 S6 kinase and p90 Rsk were not activated by stimuli that induced strong activation in PDK1(+/+) cells.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2000 Apr 20 10(8) 439-48",
                "id": "10801415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36750-7",
                "id": "10973962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36750-7",
                "id": "10973962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 24 274(52) 37147-53",
                "id": "10601276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Upstream regulators of S6K, such as PDK1 and protein kinase B (PKB/Akt), are recruited to the membrane via their pleckstrin homology (PH) or protein-protein interaction domains.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS J 2006 May 273(9) 2023-36",
                "id": "16640565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "16083285;15071500",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Thus, mTOR appears to have an important and central function in integrating a variety of growth signals, from simple nutritional stimulation to activation by protein growth factors, resulting in protein synthesis (Fig. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffc0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Thus, rather than enhancing the intrinsic GEF activity of Tiam1, it is likely that spinophilin increases Tiam1 activation of p70S6K1 by targeting activated Rac to S6K1. # spinophilin = PPP1R9B # p70 S6 kinase = RPS6KB1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18833-41",
                "id": "12531897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffbf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The increased translation is probably signalled, in part, through the enzyme p70S6K, which ultimately leads to enhanced protein synthesis",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2002 Sep 1 543(Pt 2) 399-411",
                "id": "12205177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffbe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "mTOR activity increased phosphorylation of S6 kinase and the translation repressor 4EBP-1, which were sensitive to inhibition of both PI 3 kinase and Akt. mTOR inhibitor rapamycin and a dominant negative mutant of mTOR suppressed TGFbeta-induced phosphorylation of S6 kinase and 4EBP-1. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Feb 20(2) 409-23",
                "id": "18068336"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffbd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Aug 283(2) L354-63",
                "id": "12114197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffbc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Nov 15 20(52) 7658-67",
                "id": "11753643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "FSH-stimulated HIF-1 activity is inhibited by the PI 3-kinase inhibitor LY294002, the Rheb inhibitor FTI-277 (farnesyltransferase inhibitor-277), and the mTOR inhibitor rapamycin. These results show that FSH enhances HIF-1 activity downstream of the PI 3-kinase/AKT/Rheb/mTOR pathway in GCs and that HIF-1 activity is necessary for FSH to induce multiple follicular differentiation markers.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 7 279(19) 19431-40",
                "id": "14982927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffba"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Raptor-mTOR and S6K1 are required for phosphorylation of IRS1 at a subset of serine residues frequently associated with insulin resistance, including S307, S312, S527, S616, and S636 (of human IRS1).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Sep 26(17) 6425-34",
                "id": "16914728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "S6K2, is up-regulated in all tissues examined in S6K1-deficient mice (111).",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2003 Feb 24(1) 91-101",
                "id": "12588811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "We report here that a mammalian recombinant p70alpha polypeptide, extracted in an inactive form from rapamycin-treated cells, can be directly phosphorylated by the mTOR kinase in vitro predominantly at the rapamycin-sensitive site Thr-412. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 26 274(48) 34493-8",
                "id": "10567431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "FGF-1-induced PN expression was blocked by the FGF-1 receptor antagonist PD-166866 and by inhibitors of phosphatidylinositol 3-kinase (PI3K) (LY-294002, wortmannin), p70S6K (rapamycin), MEK1/2 (U-0126, PD-98059), and p38MAPK (SB-203580) but not of JNK (SP-600125)",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2004 Oct 97(4) 1550-8; discussion 1549",
                "id": "15121739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "By 3 hours, SB-stimulated cells showed considerably increased phosphorylation of p70S6K at Thr421/Ser424, and ribosomal kinase S6, compared with unstimulated controls, or cells stimulated with rhTpo (Figure 2B).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 Jan 7 115(1) 89-93",
                "id": "19880492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Time-course studies also revealed that mTOR and S6K1 activation by insulin was accelerated in tissues of obese rats",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2005 Mar 146(3) 1473-81",
                "id": "15604215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 14 275(15) 11389-96",
                "id": "10753954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2004 Sep 9 431(7005) 200-5",
                "id": "15306821"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Such activation of p70 S6 kinase is blocked by pharmacological inhibitors of the PI 3' kinase and mTOR,",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 Apr 15 295(1) 173-82",
                "id": "15051500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Interestingly, 4EHP over-expression instigates a negative feedback loop that inhibits upstream signaling to 4E-BP1 and ribosomal protein S6 kinase 1 (S6K1)..Thus, the interaction of 4EHP with 4E-BP1 is necessary for this observed impaired signaling to 4E-BP1 and S6K1.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Apr 23 564(1-2) 58-62",
                "id": "15094042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "We found that overexpression of WT Akt1 promoted insulin-stimulated p70S6 kinase (p70S6K) activity and increased the basal activity of GSK3 beta, but did not promote insulin-stimulated GLUT4 translocation or glucose uptake.",
              "citation": {
                "type": "PubMed",
                "name": "J Med Invest 2000 Feb 47(1-2) 47-55",
                "id": "10740979"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffaf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The present study indicated that exposure of mouse epidermal Cl41 cells to either Ni(3)S(2) or NiCl(2) resulted in activation of phosphatidylinositol 3-kinase (PI-3K), Akt, and p70 S6 kinase (p70(S6k))",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jan 1 64(1) 94-101",
                "id": "14729612"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "the platelet-derived growth factor receptor-alpha (PDGFRalpha)-p70S6K signal transduction pathway in mesenchymal cells, which is required for functional angiogenesis induced by fibroblast growth factor-2",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2004 May 14 94(9) 1186-94",
                "id": "15059936"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffad"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Furthermore, in insulin- or serum stimulated cells, activation of p70S6K is inhibited by expression of the Tsc1 Tsc2 complex",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffac"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "leucine stimulates p70a phosphorylation via mTOR pathway, in part, by serving both as a mitochondrial fuel through oxidative carboxylation and an allosteric activation of glutamate dehydrogenase.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jan 9 313(2) 443-6",
                "id": "14684182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Loss of DEPTOR activates S6K1, Akt, and SGK1, promotes cell growth and survival, and activates mTORC1 and mTORC2 kinase activities. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2009 May 29 137(5) 873-86",
                "id": "19446321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The activation of p70S6K1 depends on the phosphorylation of several residues in the pseudosubstrate region, such as Ser389  and Ser421/Thr424. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Aug 287(2) C281-91",
                "id": "15028555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Although the p70s6kE389 construct has high basal activity, its overexpression in the absence of mitogen stimulation does not induce the translational up-regulation of eEF-1a transcripts, indicating that p70s6k activation is not sufficent to induce this response.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Jun 16 16(12) 3693-704",
                "id": "9218810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "IL-10 may potentiate GM-CSF-induced CCR1 protein expression in U937 cells via activation of PKB/Akt and p70(S6k).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 May 2 304(2) 417-24",
                "id": "12711332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin...Taken together, these results suggest that activation of p70S6K contributes to cisplatin resistance in small cell lung cancer H69 cells, and inhibition/downregulation of p70S6K as well as activation of ERK1/2 could circumvent cisplatin resistance.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2008 May 32(5) 1133-7",
                "id": "18425342"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "In addition, overexpression of a constitutively active protein kinase B increased p85alphaPI 3-K mRNA levels. These results indicate that the phosphatidylinositol 3-kinase/PKB/p70S6 kinase pathway is required for the stimulation by insulin of p85alphaPI 3-K gene expression in human muscle cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 26 274(48) 34005-10",
                "id": "10567366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The kinase activity of this protein leads to an increase in protein synthesis and cell proliferation",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Oct 16(10) 1105-12",
                "id": "15240005"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Dec 13 271(50) 31824-30",
                "id": "8943224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "PDK1 has now been shown to play a central role in activating many of the AGC subfamily members (reviewed in [150,151]). Apart from phosphorylating PKB on Thr308, PDK1 phosphorylates the equivalent residues on PKC isoforms [48,152,153], p70-S6K [32,154], the three isoforms of SGK [27,28,155] and PKA [156] (Figure 6).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Mar 15 346 Pt 3 561-76",
                "id": "10698680"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2003 Aug 163(2) 591-607",
                "id": "12875979"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "after orally administration of leucine to rats, phosphorylation at Ser-293 declines gradually with increasing leucine dose, with a half-maximal dose of 1000 lM, while Thr-412 phosphorylation of p70a is more sensitive to leucine concentration and increased to a maximal level",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jan 9 313(2) 443-6",
                "id": "14684182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdffa0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "The p70 S6 kinase, an enzyme critical for cell-cycle progression through the G1 phase, is activated in vivo by insulin",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1998 Jan 15 8(2) 69-81",
                "id": "9427642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "growth factors, cytokines and other signalling molecules stimulate HIF-1a synthesis via activation of the phosphatidylinositol 3-kinase (PI3K) or mitogen- activated protein kinase (MAPK) pathways (FIG. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 721-32",
                "id": "13130303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "GSK3 is inhibited by serine phosphorylation in response to insulin or growth factors and in vitro by either MAP kinase-activated protein (MAPKAP) kinase-1 (also known as p90rsk) or p70 ribosomal S6 kinase (p70S6k).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 378(6559) 785-9",
                "id": "8524413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Yeast two hybrid and protein precipitation experiments identified binding of diacylglycerol kinase-z interacts via ankyrin repeats with the cytoplasmic domain of obRb (not obRa) [120]. The p90 ribosomal protein S6 and p70S6K are activated by leptin in human mononuclear cells [62].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 Aug 14(8) 655-63",
                "id": "12020765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "RESULTS: Here we identify SKAR as a novel and specific binding partner and substrate of S6K1 but not S6K2. We find that serines 383 and 385 of human SKAR are insulin-stimulated and rapamycin-sensitive S6K1 phosphorylation sites.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2004 Sep 7 14(17) 1540-9",
                "id": "15341740"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jan 1 64(1) 229-35",
                "id": "14729629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Further analysis revealed that HABP induced phosphorylation of other cellular proteins including the protein kinase Akt/PKB and the p70S6 kinase (p70 S6K).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Dec 17(12) 1486-94",
                "id": "16153533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "ndeed, p75/p85 S6 kinase (S6K), a downstream target of cytosolic P-ERK, is phosphorylated in response to both catecholamine and EGF stimulation in an AG 1478-sensitive (sp) manner (Fig. 1E).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 24 284(30) 20375-86",
                "id": "19509284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "##from text## Upon the silencing of p70S6K2 by siRNA, significant reduction of GLI1 protein level was observed compared with the control (Fig. 4B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2009 8 44",
                "id": "19575820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "insulin gene transcription is promoted by signaling through insulin receptor type A, PI3K class Ia and p70s6k insulin stimulates the betaGK gene via insulin receptor B type, PI3K class II-like activity and PKB (Akt)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Mar 7(3) 559-70",
                "id": "11463381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 28 275(17) 12889-95",
                "id": "10777587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff95"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RPS6KB1) actsIn kin(p(HGNC:RPS6KB1))",
              "summary_text": "On the other hand, inactivation of phosphorylase by insulin is mediated through the PI-3 kinase pathway involving a rapamycin-sensitive p70(s6k) and PP-1G.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2000 Aug 211(1-2) 123-36",
                "id": "11055555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfdff94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "increases",
        "target": "p(HGNC:TP53BP1,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) increases p(HGNC:TP53BP1,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775d252f9e24174cfe0965",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) increases p(HGNC:TP53BP1,pmod(P))",
              "summary_text": "RIF1 protein translocates to damage sites via ATM-dependent 53BP1 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "23486525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0004"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "HeLa",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "increases",
        "target": "p(HGNC:SP1,pmod(P,S,101))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) increases p(HGNC:SP1,pmod(P,S,101))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0966",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) increases p(HGNC:SP1,pmod(P,S,101))",
              "summary_text": "We have identified serine 101 as a critical site phosphorylated by ATM; Sp1 with serine 101 mutated to alanine (S101A) is not significantly phosphorylated in response to damage and cannot restore increased sensitivity to DNA damage of cells depleted of Sp1.",
              "citation": {
                "type": "Other",
                "name": "Olofsson BA, Kelly CM, Kim J, Hornsby SM, Azizkhan-Clifford J. Phosphorylation of Sp1 in response to DNA damage by ataxia telangiectasia-mutated kinase. Mol Cancer Res. 2007 Dec;5(12):1319-30.",
                "id": "18171990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06fb"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "normal human diploid fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) increases p(HGNC:SP1,pmod(P,S,101))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0005"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:ABL1,pmod(P,S,446))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ABL1,pmod(P,S,446))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0967",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ABL1,pmod(P,S,446))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 May 29 387(6632) 516-9",
                "id": "9168116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0006"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK2,pmod(P,T,68))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0968",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))",
              "summary_text": "10973490;11901158;12493754",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe000c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))",
              "summary_text": "We therefore conclude that threonine 68 is the preferred site of phosphorylation in vitro and that other sites (possibly a combination of several) are phosphorylated at lower stoichiometry.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Oct 2(10) 762-5",
                "id": "11025670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe000b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))",
              "summary_text": "Substitution of threonine 68 by alanine in the full-length kinase-dead Chk2 dramatically reduced but did not abolish the ATM phosphorylation of Chk2/Cds1 in vitro (Fig. 4B; threonine 68 accounts for approximately 70% of the total phosphorylation).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe000a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))",
              "summary_text": "MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Apr 2 304(5667) 93-6",
                "id": "15064416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0009"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))",
              "summary_text": "ATM-dependent phosphorylation of numerous effectors in the ATM-signaling pathway, including Nbs1 (Ser(343)), SMC1 (Ser(957)), Chk1 (Ser(317) and Ser(345)), and Chk2 (Ser(33/35) and Thr(68)).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 17 279(51) 53272-81",
                "id": "15489221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0008"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))",
              "summary_text": "Thr383 (Fig. 5C) or Thr387 (data not shown). This suggests that ATM phosphorylation of Thr68 is required for the subsequent phosphorylation of Thr383 and Thr387 in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 30537-41",
                "id": "11390408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0007"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "increases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) increases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0969",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) increases tscript(p(HGNC:TP53))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway  for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-DCdk4 from phosphorylating Rb  unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 46,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) increases tscript(p(HGNC:TP53))",
              "summary_text": "We show here that E2F-1 elevates ATM promoter activity and induces an increase in ATM mRNA and protein levels. This is accompanied by an E2F-induced increase in p53 phosphorylation ... ATM activates the tumor suppressor p53",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jan 16 22(2) 161-7",
                "id": "12527885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe000f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) increases tscript(p(HGNC:TP53))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNAPK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe000e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) increases tscript(p(HGNC:TP53))",
              "summary_text": "The ATM (23) and ATR (24) protein kinases play key roles in p53 activation in response to IR and UV, respectively. Bulky chemical adducts have also been shown to induce stabilization and nuclear accumulation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Feb 24(2) 225-34",
                "id": "12584171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe000d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP53,pmod(P,S,15))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe096a",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "We show that doses of gamma-radiation (IR) as low as 0.25 Gy, which generate vast numbers of SSBs but only a few DSBs per cell (<8), promptly activate ATM kinase and induce the phosphorylation of the ATM substrates p53-Ser15, Nbs1-Ser343 and Chk2-Thr68. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Oct 7 23(46) 7691-700",
                "id": "15361830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0017"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Apr 2 304(5667) 93-6",
                "id": "15064416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0016"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "<p2> ATM phosphorylates P53 at Ser15",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0015"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "Highly purified ATM phosphorylated PHAS-I, the 32-kDa subunit of RPA, serine 15 of p53, and Chk2 in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 17 275(11) 7803-10",
                "id": "10713094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0014"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "11875057;10446957",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0013"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "In vitro substrates included the translation repressor PHAS-I and the p53 protein. ATM phosphorylated p53 in vitro on a single residue, serine-15, which is phosphorylated in vivo in response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Sep 11 281(5383) 1674-7",
                "id": "9733514"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0012"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "Serine 15 in the N terminus of p53 has been shown to be the preferred ATM phosphorylation site (27, 29, 30). As shown in Fig. 7A, ATM immunoprecipitated from irradiated cells was more active than that from control cells, and both ATM activities were inhibited by caffeine with IC50 at around 200 M.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0011"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "In this report, we utilized small interfering RNA to deplete BRCA1 and BARD1 to demonstrate that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated/ATM and Rad3-related)-mediated phosphorylation of p53(Ser-15) following IR- and UV radiation-induced DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31251-8",
                "id": "15159397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0010"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:H2AFX,pmod(P,S,140))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe096b",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))",
              "summary_text": "histone H2AX, 53BP1, BRCA1 and NBS1 are all targets of ATM and ATR",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe001b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))",
              "summary_text": "MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Apr 2 304(5667) 93-6",
                "id": "15064416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe001a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))",
              "summary_text": "The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6056-64",
                "id": "16880517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0019"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 42462-7",
                "id": "11571274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0018"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK1,pmod(P,S,345))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe096c",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe001e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "11390642;10859164;15533933;15674326",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe001d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "ATM-dependent phosphorylation of numerous effectors in the ATM-signaling pathway, including Nbs1 (Ser(343)), SMC1 (Ser(957)), Chk1 (Ser(317) and Ser(345)), and Chk2 (Ser(33/35) and Thr(68)).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 17 279(51) 53272-81",
                "id": "15489221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe001c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:ATF2,pmod(P,S,498))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ATF2,pmod(P,S,498))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe096d",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ATF2,pmod(P,S,498))",
              "summary_text": "In addition to its function as a transcription factor, ATF2 was found to play an important role in DNA damage response. This recently identified function requires ATF2 phosphorylation by PIKK (ATM, ATR or PI3K kinases), on two serine residues within the extreme C-terminal domain (Serine 490,498 of hATF2). ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0020"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ATF2,pmod(P,S,498))",
              "summary_text": "Here, we demonstrate that the protein kinase ATM phosphorylates ATF2 on serines 490 and 498",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 May 27 18(5) 577-87",
                "id": "15916964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe001f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:ATF2,pmod(P,S,490))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ATF2,pmod(P,S,490))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe096e",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ATF2,pmod(P,S,490))",
              "summary_text": "Here, we demonstrate that the protein kinase ATM phosphorylates ATF2 on serines 490 and 498",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 May 27 18(5) 577-87",
                "id": "15916964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0022"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ATF2,pmod(P,S,490))",
              "summary_text": "In addition to its function as a transcription factor, ATF2 was found to play an important role in DNA damage response. This recently identified function requires ATF2 phosphorylation by PIKK (ATM, ATR or PI3K kinases), on two serine residues within the extreme C-terminal domain (Serine 490,498 of hATF2). ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0021"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:FANCD2,pmod(P,S,222))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:FANCD2,pmod(P,S,222))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe096f",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:FANCD2,pmod(P,S,222))",
              "summary_text": "There is evidence that FANCD2,like BRCA1, participates in the events that are triggered by DNA damage during S and G2 phases and that lead to cell-cycle arrest. As well as modifying BRCA1, the ATM protein kinase can phosphorylate FANCD2 on several residues, including serine 222, following exposure to ionizing radiation77. Ser222 phosphorylation is required for the intra-S-phase arrest and is, in turn, dependent on the protein kinase NBS1, which is a component of the trimeric MRE11-RAD50-NBS1 complex78. FANCD2 can also be phosphorylated in an ATM-independent manner by the ATR kinase79,which signals an intra-S-phase arrest that is triggered by ultraviolet radiation or DNA-crosslinking agents46.Here, too, FANCD2 phosphorylation depends on NBS1, which is required to fully enforce the S-phase checkpoint. The participation of FANCD2 in ionizingradiation- activated checkpoint responses through phosphorylation on Ser222 seems to be independent78 of its mono-ubiquitylation on Lys561, which promotes the translocation of FANCD2 to damage-induced nuclear foci that contain BRCA1 and RAD51, and that are presumed sites of DNA repair. Similarly, FANCD2 foci do not require ATR-dependent phosphorylation79.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:FANCD2,pmod(P,S,222))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2002 May 17 109(4) 459-72",
                "id": "12086603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0023"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:BRCA1,pmod(P,S,1387))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1387))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0970",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1387))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Aug 15 62(16) 4588-91",
                "id": "12183412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0025"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1387))",
              "summary_text": "we show that ATM interacts with BRCA1, and this association is enhanced by radiation. We also demonstrate that BRCA1 is a substrate of ATM kinase in vitro and in vivo. Using phospho-specific antibodies against serines 1387, 1423, and 1457 of BRCA1, we demonstrate radiation-induced, ATM-dependent phosphorylation of BRCA1 at these sites ... from full text, A-T lymphoblastoid cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 15 60(12) 3299-304",
                "id": "10866324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0024"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:TP63)",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyDecreases p(HGNC:TP63)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0971",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyDecreases p(HGNC:TP63)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0026"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK1,pmod(P,S,317))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,317))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0972",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,317))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,317))",
              "summary_text": "ATM-dependent phosphorylation of numerous effectors in the ATM-signaling pathway, including Nbs1 (Ser(343)), SMC1 (Ser(957)), Chk1 (Ser(317) and Ser(345)), and Chk2 (Ser(33/35) and Thr(68)).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 17 279(51) 53272-81",
                "id": "15489221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0028"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,317))",
              "summary_text": "11252893;11390642",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0027"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:BRCA1,pmod(P,S,1466))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1466))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0973",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1466))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Nov 5 286(5442) 1162-6",
                "id": "10550055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0029"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:WRN,pmod(P,S,1292))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:WRN,pmod(P,S,1292))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0974",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:WRN,pmod(P,S,1292))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 31 274(53) 37538-43",
                "id": "10608806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe002a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:RASSF1,pmod(P,S,131))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:RASSF1,pmod(P,S,131))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0975",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:RASSF1,pmod(P,S,131))",
              "summary_text": "We show that, upon DNA damage, RASSF1A is phosphorylated by ATM on Ser131 and is involved in the activation of both MST2 and LATS1, leading to the stabilization of p73....As shown previously, expression of RASSF1A  enhances the stability of p73 [7], but this stabilization was further enhanced when combined with DNA damage (Figure 4C, left). In agreement with a role for the ATM phosphorylation site in pathway signaling, RASSF1A-S131A blocked the stabilization of p73 in response to cisplatin-mediated DNA damage (Figure 4C, right).",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2009 Dec 15 19(23) 2020-5",
                "id": "19962312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0700"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:ABL1,pmod(P,S,465))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ABL1,pmod(P,S,465))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0976",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ABL1,pmod(P,S,465))",
              "summary_text": "from full text - Fig 2 and 3 - ATM kinase activates c-Abl kinase.  Serine-465 of c-Abl is required for tyrosine kinase activation by ionizing radiation and ATM.  3T3 cells",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 May 29 387(6632) 516-9",
                "id": "9168116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe002c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:ABL1,pmod(P,S,465))",
              "summary_text": "<A2> ATM phosphorylates c-Abl on Ser465 and thereby activates the kinase (Baskaran et al., 1997b). <A3> Phosphorylation by ATM activates c-Abl (Baskaran et al., 1997b). c-Abl tyrosine kinase activity is stimulated in response to ionizing radiation (IR), 1-b-d-arabinofuransylcytosine, camptothecin, or etoposide (Yuan et al., 1996, 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe002b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:BRCA1,pmod(P,S,1524))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1524))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0977",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1524))",
              "summary_text": "10550055;11278964",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe002d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK2,pmod(P,S,33))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,S,33))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0978",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,S,33))",
              "summary_text": "ATM-dependent phosphorylation of numerous effectors in the ATM-signaling pathway, including Nbs1 (Ser(343)), SMC1 (Ser(957)), Chk1 (Ser(317) and Ser(345)), and Chk2 (Ser(33/35) and Thr(68)).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 17 279(51) 53272-81",
                "id": "15489221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe002f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,S,33))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Sep 12 97(19) 10389-94",
                "id": "10973490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe002e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "increases",
        "target": "p(HGNC:TRIM28,pmod(P,S,824))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) increases p(HGNC:TRIM28,pmod(P,S,824))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0979",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) increases p(HGNC:TRIM28,pmod(P,S,824))",
              "summary_text": "KAP-1 is phosphorylated in an ATM-dependent manner on Ser 824. KAP-1 is phosphorylated exclusively at the damage sites, from which phosphorylated KAP-1 spreads rapidly throughout the chromatin. Ablation of the phosphorylation site of KAP-1 leads to loss of DSB-induced chromatin decondensation and renders the cells hypersensitive to DSB-inducing agents. Knocking down KAP-1, or mimicking a constitutive phosphorylation of this protein, leads to constitutive chromatin relaxation. These results suggest that chromatin relaxation is a fundamental pathway in the DNA-damage response and identify its primary mediators.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2006 Aug 8(8) 870-6",
                "id": "16862143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0701"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:BRCA1,pmod(P,S,1423))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1423))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe097a",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1423))",
              "summary_text": "10550055;11278964;11114888",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0031"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1423))",
              "summary_text": "we show that ATM interacts with BRCA1, and this association is enhanced by radiation. We also demonstrate that BRCA1 is a substrate of ATM kinase in vitro and in vivo. Using phospho-specific antibodies against serines 1387, 1423, and 1457 of BRCA1, we demonstrate radiation-induced, ATM-dependent phosphorylation of BRCA1 at these sites ... from full text, A-T lymphoblastoid cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 15 60(12) 3299-304",
                "id": "10866324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0030"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:FANCD2,pmod(P,S,1257))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:FANCD2,pmod(P,S,1257))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe097b",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:FANCD2,pmod(P,S,1257))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2002 May 17 109(4) 459-72",
                "id": "12086603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0032"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:WRN,pmod(P,S,1141))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:WRN,pmod(P,S,1141))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe097c",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:WRN,pmod(P,S,1141))",
              "summary_text": "11252893;10839545",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0033"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:BRCA1,pmod(P,S,1457))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1457))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe097d",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1457))",
              "summary_text": "we show that ATM interacts with BRCA1, and this association is enhanced by radiation. We also demonstrate that BRCA1 is a substrate of ATM kinase in vitro and in vivo. Using phospho-specific antibodies against serines 1387, 1423, and 1457 of BRCA1, we demonstrate radiation-induced, ATM-dependent phosphorylation of BRCA1 at these sites ... from full text, A-T lymphoblastoid cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 15 60(12) 3299-304",
                "id": "10866324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0035"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1457))",
              "summary_text": "10550055;11278964",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0034"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:BRCA1,pmod(P,S,1330))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1330))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe097e",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1330))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Nov 5 286(5442) 1162-6",
                "id": "10550055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0036"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK2,pmod(P,S,35))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,S,35))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe097f",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,S,35))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Sep 12 97(19) 10389-94",
                "id": "10973490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0038"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,S,35))",
              "summary_text": "ATM-dependent phosphorylation of numerous effectors in the ATM-signaling pathway, including Nbs1 (Ser(343)), SMC1 (Ser(957)), Chk1 (Ser(317) and Ser(345)), and Chk2 (Ser(33/35) and Thr(68)).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 17 279(51) 53272-81",
                "id": "15489221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0037"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:EP300,pmod(P,S,106))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:EP300,pmod(P,S,106))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0980",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:EP300,pmod(P,S,106))",
              "summary_text": ". ATM-phosphorylated p300 in vitro and in vivo, in response to DNA damage. Phosphorylation of p300 proteins was observed upon gamma-irradiation in ATM(+) cells but not ATM(-) cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jul 9 397(4) 637-43",
                "id": "20471956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0039"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK2,pmod(P,S,19))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,S,19))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0981",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases p(HGNC:CHEK2,pmod(P,S,19))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Sep 12 97(19) 10389-94",
                "id": "10973490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe003a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:UBE2N)",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "directed": false,
        "label": "p(HGNC:UBE2N) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0982",
          "evidences": [
            {
              "bel_statement": "p(HGNC:UBE2N) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
              "summary_text": "Remarkably, Ubc13-deficient cells are also compromised for DNA double-strand break (DSB) repair by homologous recombination (HR)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2007 Mar 9 25(5) 663-75",
                "id": "17349954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe003b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHEK1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:CHEK1))",
        "directed": false,
        "label": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0983",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Phosphorylation of Chk1 controls Cdc25A stability through phosphorylation, leading to interaction of Cdc25A with SCF?-TrCP  ubiquitin ligase and acceleration of Cdc25A turnover ( 30). The resulting reduction of Cdc25A levels is instrumental in slowing progression through S phase, allowing time for DNA repair; if cell elimination is required, apoptosis can be induced through checkpoint termination ( 30).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Dec 1 66(23) 11287-92",
                "id": "17145874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0703"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0702"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Fhit overexpression leads to apoptosis in many cancer cell lines. We report in this study that Fhit-/- cells derived from gene knockout mice show much stronger S and G2 checkpoint responses than their wild type counterparts. The strong checkpoint responses are regulated by the ATR/CHK1 pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Feb 202(2) 518-23",
                "id": "15389587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0064"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "CHK1 heterozygosity modestly enhances the tumorigenesis phenotype of WNT-1 transgenic mice. Chk1 plays an essential role in the mammalian DNA damage checkpoint, embryonic development, and tumor suppression",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jun 15 14(12) 1448-59",
                "id": "10859164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0063"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Finally, we show that bypass of the G2/M checkpoint by the CHK1 kinase inhibitor UCN-01 results in the activation of Aurora-A and phosphorylation of CDC25B on S353.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2005 Sep 4(9) 1233-8",
                "id": "16082213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0062"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "phosphorylation of Cdc25A on Ser-75 by Chk1 and its subsequent degradation is required to delay cell cycle progression in response to UV-induced DNA lesions.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29824-9",
                "id": "12759351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0061"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Conversely, BRCA1 itself controls subsequent steps in checkpoint activation through regulation of kinases such as CHK1 (REF. 50) and PLK1 (REF. 51).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0060"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": " Silencing of ATR or ATM and inhibition of ATM activity by KU-55933 blocked Chk1 activation and RRM2 up-regulation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 3 284(27) 18085-95",
                "id": "19416980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe005f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Here we show that the oncogenic p53-induced serine/threonine phosphatase, PPM1D (or Wip1), dephosphorylates two ATM/ATR targets, Chk1 and p53. PPM1D binds Chk1 and dephosphorylates the ATR-targeted phospho-Ser 345, leading to decreased Chk1 kinase activity. PPM1D also dephosphorylates p53 at phospho-Ser 15",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2005 May 15 19(10) 1162-74",
                "id": "15870257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe005e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNAPK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe005d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "When ATM and ATR are recruited to sites of damage, they target many substrates, including checkpoint kinase-2 (CHK2) and CHK1, respectively (FIG. 2; BOX 2).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe005c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The ubiquitination of Chk1 is mediated by E3 ligase complexes containing Cul1 or Cul4A. Treatment of cells with the anticancer agent camptothecin (CPT) triggers Chk1 destruction, which blocks recovery from drug-induced S phase arrest and leads to cell death.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Sep 2 19(5) 607-18",
                "id": "16137618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe005b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Depletion of beta-TRCP stabilizes Cdc25A, leading to hyperactive Cdk2 activity. SCFbeta-TRCP promotes Chk1-dependent Cdc25A ubiquitination in vitro, and this involves serine 76, a known Chk1 phosphorylation site. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Dec 15 17(24) 3062-74",
                "id": "14681206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe005a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "activation of ATM and ATR in turn activates CHK2 and CHK1, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0059"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Furthermore, we show that CHK2 is hyperphosphorylated at later times following 6-TG treatment and the phosphorylation of CHK2 seems to be ATM independent but up-regulated when ATR or CHK1 is reduced.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Sep 3(9) 1147-57",
                "id": "15367709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0058"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Oct 1 65(19) 8613-6",
                "id": "16204026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0057"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The lithium-induced phosphorylation of cdc2 and G2/M arrest was abrogated largely by SB218078, a potent Chk1 inhibitor, as well as by Chk1 siRNA or the over-expression of kinase dead Chk1.  Furthermore, lithium-induced cdc25C phosphorylation in 7721 cells and in vitro kinase assay showed that the activity of Chk1 was enhanced after lithium treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2008 Feb 4",
                "id": "18247328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0056"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(21) 7488-97",
                "id": "14559997"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0055"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "In both the MT-1 and HCC1937/BRCA1wt cell lines, the suppression of PLK mRNA expression 6 h after IR exposure was completely abolished by UCN-01 (Figure 5).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Dec 4 22(55) 8952-5",
                "id": "14654792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0054"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We confirmed that recombinant hCHK1, but not a kinase-defective version of hCHK1, can phosphorylate p53 in vitro at S20. Additional inducible amino- and carboxy-terminal sites in p53 are also phosphorylated by hCHK1, indicating that this is an unusually versatile protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 289-300",
                "id": "10673501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0053"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "In vitro Chk1 bound to and phosphorylated the dual-specificity protein phosphatases Cdc25A, Cdc25B, and Cdc25C",
              "citation": {
                "type": "PubMed",
                "name": "Science 1997 Sep 5 277(5331) 1497-501",
                "id": "9278511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0052"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": " Chk1, a fission yeast kinase involved in the DNA damage checkpoint response, phosphorylated Cdc25C in vitro on serine-216",
              "citation": {
                "type": "PubMed",
                "name": "Science 1997 Sep 5 277(5331) 1501-5",
                "id": "9278512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0051"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Using a small interfering RNA that enables the specific elimination of Chk1 expression, we show that the observed proteolysis of Cdc25A is mediated through Chk1. Moreover, Cdc25A overexpression abrogates the Chk1-mediated degradation and overcomes the doxorubicin-induced G2 arrest through dephosphorylation and activation of Cdc2/Cdk1 in a dose-dependent manner ... from full text, H1299 cells and tyrosine 15 phosphorylation of CDC2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 13 278(24) 21767-73",
                "id": "12676925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0050"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "inhibition of ERK1/2 signaling resulted in marked attenuation in IR-induced ATR activity with little, if any, effect on IR-induced ATM activation. Furthermore, inhibition of ERK1/2 signaling resulted in >/=85% attenuation in IR-induced G2/M arrest and concomitant diminution of IR-induced activation of ataxia telangiectasia mutated- and rad3-related (ATR), Chk1 and Wee1 kinases as well as phosphorylation of Cdc25A-Thr506, Cdc25C-Ser216 and Cdc2-Tyr15.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 12 26(32) 4689-98",
                "id": "17297454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe004f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Figure 5. Centrosome?targeted inhibition of Chk1 abrogates G2/M arrest after DNA damage. U2OS cells conditionally expressing wild?type or kinase?dead GFP?Chk1?PACT(AKAP) were induced to express the transgene by tetracycline for 72 h, irradiated with 20 J/m2 UV and harvested 1 h after UV.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2007 Oct 15 6(20) 2541-8",
                "id": "17726372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe004e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We have shown recently that DNA damage effector kinase Chk1 is phosphorylated in vitro by protein kinase B/Akt (PKB/Akt) on serine 280. Activation of Chk1 by DNA damage in vivo is suppressed in presence of activated PKB. In this study we show that Chk1 is phosphorylated by PKB in vivo, and that increased phosphorylation by PKB on serine 280 correlates with impairment of Chk1 activation by DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe004d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns. Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4129-39",
                "id": "11390642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe004c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "12399544;12676583;12759351;11298456",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe004b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Consistent with this, we discovered that endogenous p73alpha interacts with Chk1 and is phosphorylated by Chk1 at serine 47 in vitro and in vivo. In contrast, Chk2 does not phosphorylate p73alpha in vitro. Moreover, mutation of serine 47 abolishes both Chk1-dependent phosphorylation of p73alpha upon DNA damage in vivo and the ability of Chk1 to upregulate the transactivation capacity of p73alpha. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(22) 8161-71",
                "id": "14585975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe004a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We show that caffeine's ability to inhibit ATR (but not ATM) causes PCC, that ATR (but not ATM) prevents PCC, and that ATR prevents PCC via Chk-1 regulation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Jul 31 98(16) 9092-7",
                "id": "11481475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0049"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We also show that senescent cells contain activated forms of the DNA damage checkpoint kinases CHK1 and CHK2",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Nov 13 426(6963) 194-8",
                "id": "14608368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0048"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Mutation of these phosphorylation sites on Claspin inhibited Claspin-Chk1 interaction in vivo, impaired Chk1 activation, and induced premature chromatin condensation in cells, indicating a defect in replication checkpoint.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 3 281(44) 33276-82",
                "id": "16963448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0047"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 4 278(27) 24644-50",
                "id": "12714602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0046"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "<C38> Chk1 binds and phosphorylates Cdc25A-C in vitro (Sanchez et al., 1997). Cdc25C becomes phosphorylated at Ser216.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0045"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Here we demonstrate that ARF induces the ATR- and Chk1-dependent phosphorylation of the RelA transactivation domain at threonine 505, a site required for ARF-dependent repression of RelA transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Mar 23 24(6) 1157-69",
                "id": "15775976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0044"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "from full text - Fig. 3 BRCA1 activates Chk1 kinase activity. a, Endogenous Chk1 was immunoprecipitated from parental and transfected HCC1937 cell extracts",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2002 Mar 30(3) 285-9",
                "id": "11836499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0043"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Both Chk1 and Chk2/Cds1 have been shown to localize to the nucleus and to phosphorylate serine 216 of Cdc25C in vitro (13, 15) (1821).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0042"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Apr 1 22(7) 1676-87",
                "id": "12660173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0041"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Phosphorylation by Chk1 and Cds1/Chk2 down-regulates Cdc25A levels in response to genotoxic stresses",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 31838-42",
                "id": "12801928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0040"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Our results suggest that Chk1 associates with BAD and phosphorylates the BAD protein at serine-155",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 24(6) 3907-10",
                "id": "15736430"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe003f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "CDC25B interacts at a low level with 14-3-3beta, epsilon, zeta, eta, and Theta isoforms. This interaction is not increased upon phosphorylation of CDC25B by CHK1 and is not abolished by dephosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Mar 2 19(10) 1257-65",
                "id": "10713667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe003e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Moreover, we showed that Chk1 is a negative regulator of polo-like kinase 1 (Plk1), in either the absence or presence of DNA damage. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Aug 8 103(32) 11964-9",
                "id": "16873548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe003d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The DNA-bound 9-1-1 complex then facilitates ATR-mediated phosphorylation and activation of Chk1, a protein kinase that regulates S-phase progression, G2/M arrest, and replication fork stabilization. ",
              "citation": {
                "type": "PubMed",
                "name": "DNA Repair (Amst) 3(8-9) 1009-14",
                "id": "15279787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe003c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "deg(p(HGNC:CDC25A))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:CDC25A)",
        "directed": false,
        "label": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0984",
          "evidences": [
            {
              "bel_statement": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0704"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
              "summary_text": "Mitotic stabilization of Cdc25A reflects its phosphorylation on Ser17 and Ser115 by cyclin B-Cdk1, modifications required to uncouple Cdc25A from its ubiquitin-proteasome-mediated turnover",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Nov 1 21(21) 5911-20",
                "id": "12411508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe006c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
              "summary_text": "phosphorylation of Cdc25A on Ser-75 by Chk1 and its subsequent degradation is required to delay cell cycle progression in response to UV-induced DNA lesions.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29824-9",
                "id": "12759351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe006b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
              "summary_text": "beta-TrCP2 siRNA also inhibits Smad3-induced Cdc25A degradation. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Apr 25(8) 3338-47",
                "id": "15798217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe006a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
              "summary_text": "Depletion of beta-TRCP stabilizes Cdc25A, leading to hyperactive Cdk2 activity. SCFbeta-TRCP promotes Chk1-dependent Cdc25A ubiquitination in vitro, and this involves serine 76, a known Chk1 phosphorylation site. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Dec 15 17(24) 3062-74",
                "id": "14681206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0069"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNAPK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0068"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
              "summary_text": "Transfection with dominant-negative Cdk mutants demonstrated that only a Cdk2 mutant increased Cdc25A protein levels; Cdk1 and Cdk3 mutants had no effect. The increased Cdc25A protein levels were the result of an increase in the half-life of the protein",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 31838-42",
                "id": "12801928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0067"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
              "summary_text": "beta-TRCP is a versatile F-box protein that recognizes several cell-cycle regulators EMI1-2, WEE1A and CDC25A-B in addition to its classical substrates, beta-catenin and IkappaB. In some cancers, beta-TRCP mutation or overexpression is found.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2006 May 6(5) 369-81",
                "id": "16633365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0066"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDC25A)) directlyDecreases p(HGNC:CDC25A)",
              "summary_text": "Using a small interfering RNA that enables the specific elimination of Chk1 expression, we show that the observed proteolysis of Cdc25A is mediated through Chk1. Moreover, Cdc25A overexpression abrogates the Chk1-mediated degradation and overcomes the doxorubicin-induced G2 arrest through dephosphorylation and activation of Cdc2/Cdk1 in a dose-dependent manner ... from full text, H1299 cells and tyrosine 15 phosphorylation of CDC2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 13 278(24) 21767-73",
                "id": "12676925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0065"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HIPK2)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:HIPK2))",
        "directed": false,
        "label": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0985",
          "evidences": [
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "Here we demonstrate that homeodomain-interacting protein kinase-2 (HIPK2), a member of a novel family of nuclear serine/threonine kinases, binds to and activates p53 by directly phosphorylating it at Ser 46",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jan 4(1) 11-9",
                "id": "11780126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "We also show that HIPK2 is able to phosphorylate the HMGI(Y) protein by an in vitro kinase assay.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 27 20(43) 6132-41",
                "id": "11593421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0076"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "HIPK2 activates the apoptotic arm of the DNA damage response by phosphorylating tumor suppressor p53 at serine 46",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2011 Mar 15 71(6) 2350-9",
                "id": "21248071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0075"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "Here, we report that homeodomain-interacting protein kinase-2 (HIPK2) forms a complex with AML1 and p300, and phosphorylates both AML1 and p300 to stimulate transcription activation as well as HAT activities.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Sep 6 25(17) 3955-65",
                "id": "16917507"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0074"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "FHL2 showed autonomous transcriptional activity that was enhanced by wild-type HIPK2",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jan 27 339(4) 1056-62",
                "id": "16343438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0073"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "SUMO-1 modification inhibited HIPK2-induced JNK activation and p53-independent antiproliferative function",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 12 280(32) 29224-32",
                "id": "15958389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0072"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "11875057;16729035",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0071"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "Here we show that HIPK2 phosphorylates the activation domain of Pax6, which augments Pax6 transactivation by enhancing its interaction with p300.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 17 281(11) 7489-97",
                "id": "16407227"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0070"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "HIPK2 is activated by ultraviolet (UV) radiation and selectively phosphorylates p53 at Ser 46 ... Accordingly, the kinase function of HIPK2 mediates the increased expression of p53 target genes",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jan 4(1) 1-10",
                "id": "11740489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe006f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "The protein kinase that phosphorylates p53 Ser(46) in response to DNA double-strand breaks is currently unknown. The identification of this kinase is of particular interest because it may contribute to the outcome of cancer therapy. Here, we report that ionizing radiation (IR) provokes homeodomain-interacting protein kinase 2 (HIPK2) accumulation, activation ... from full text, HEPG2, HCT116, WI38 cells (Figs 1 and 2)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Mar 1 67(5) 2274-9",
                "id": "17332358"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe006e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HIPK2) actsIn kin(p(HGNC:HIPK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Dec 1 63(23) 8271-7",
                "id": "14678985"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe006d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CDK2)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:CDK2))",
        "directed": false,
        "label": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0986",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Site-directed mutagenesis identified phenylalanine 79 and tyrosine 80 within the 3(10) helix region of p57 as crucial residues for kinase inhibition, supporting the structural evidence that the 3(10) helix binds deep inside the catalytic cleft of Cdk2, mimicking ATP. Mutations within the 3(10) helix region of the p57 molecule completely abolished the ability to arrest the cell cycle at G1 in vivo. These results indicate that this region is specifically utilized by p57 in selectively inhibiting cyclin A or E/Cdk2+ activities. Thus the 3(10) helix motif may confer a specific regulatory mechanism by which p57 differentially regulates Cdk2 and Cdk4 activities.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jun 26 273(26) 16544-50",
                "id": "9632724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0713"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Cancer arises from a stepwise accumulation of genetic changes that liberates neoplastic cells from the homeostatic mechanisms that govern normal cell proliferation. In humans, at least four to six mutations are required to reach this state, but fewer seem to be required in mice. By rationalizing the shared and unique elements of human and mouse models of cancer, we should be able to identify the molecular circuits that function differently in humans and mice, and use this knowledge to improve existing models of cancer.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 May 2(5) 331-41",
                "id": "12044009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0712"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Recently, we and others have identified an ubiquitin E3 ligase, the SCF(SKP2) complex, that mediates p27 ubiquitin-dependent proteolysis [5-7]. Here we report that PTEN and the PI 3-kinase pathway regulate p27 protein stability.We found that ectopic expression of SKP2 alone is sufficient to reverse PTEN-induced p27 accumulation, restore the kinase activity of cyclin E/CDK2, and partially overcome the PTEN-induced G1 cell cycle arrest.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2001 Feb 20 11(4) 263-7",
                "id": "11250155"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0711"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "C/EBP{alpha} has been demonstrated to interact directly with the cyclin-dependent kinases (cdks) 2 and 4, two critical regulators of cell cycle progression (75). Interaction occurs through a short region of the C/EBP{alpha} polypeptide and prevents interaction of these kinases with their cognate cyclins. As the cyclin-cdk interaction is necessary for activity of the cdks and progression through the cell cycle, this provides a potential mechanism for the growth arrest mediated by C/EBP{alpha}",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2003 Oct 285(4) L773-81",
                "id": "12959923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0710"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Phosphorylation of cyclin-dependent kinases (CDKs) by the CDK-activating kinase is required for the activation of CDK enzymes. Members of two families of CDK inhibitors, p16/p18 and p21/p27, become physically associated with and inhibit the activity of CDKs in response to a variety of growth-modulating signals. Here, we show that the representative members of both families of CDK inhibitors, p21waf1,cip1, p27kip1, and p18, can prevent the phosphorylation of their CDK partners, CDK2 and CDK6, by CDK-activating kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Aug 4 270(31) 18195-7",
                "id": "7629134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe070f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "p300 also serves as a transducer of the cell cycle, acting both as a target of repression by p21CIP1/WAF1 and as a regulator of nuclear transcription through cyclin E/CDK2 [14]. Furthermore, the site of repression within p300 targeted by p21CIP1/WAF1 includes the CRD1 domain, again, a site not involved in regulation by cyclin D1. E2F5 is phosphorylated by cyclin E/CDK2 but not by cyclin D1/CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe070e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Our goal was to identify potential cyclin A-CDK2 substrates on a proteome-wide scale. To reduce the sample complexity, we fractionated the whole cell lysate of HEK293 cells into 11 fractions using ion-exchange chromatography and ammonium sulfate precipitation (Additional data file 1). We then carried out in vitro kinase assays on each fraction... The recovered peptides were subjected to liquid chromatography-MS/MS analysis and database searching.",
              "citation": {
                "type": "PubMed",
                "name": "Genome Biol 2008 9(10) R149",
                "id": "18847512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe070d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Loss of p27kip1 expression in cancer primarily occurs through sustained protein degradation, a four-step process that requires phosphorylation of p27kip1 at threonine 187 by cyclin E/cdk, recognition of T187-phosphorylated p27kip1 by the ubiquitin ligase SCFSkp2, ubiquitylation, and degradation by the 26S proteasome of T187-phosphorylated p27kip1. Cytoplasmic retention of p27kip1 may occur through increased export or reduced import. Interaction of p27kip1 with JAB1/CNS5 or phosphorylation of serine 10 (S10) by the hKIS kinase promotes p27kip1 export from the nucleus, whereas phosphorylation of threonine 157 (T157) by the protein kinase B/AKT (AKT) impairs its import.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2005 Mar 166(3) 737-49",
                "id": "15743786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe070c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "In addition, arsenite induced CDK inhibitor p21(CIP1/WAF1) and enhanced its binding to the CDK2, which resulted in inhibition of CDK2 activity. The levels of cyclin D1 expression and the CDK4 kinase activity were also significantly reduced. pRB was hypophosphorylated by sodium arsenite.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2002 Jan 190(1) 29-37",
                "id": "11807808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe070b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "In these cells, dexamethasone, a synthetic glucocorticoid, stimulated a rapid and selective increase in expression of the p21 cyclin-dependent kinase (CDK) inhibitor mRNA and protein and virtually abolished CDK2 phosphorylation of the retinoblastoma protein. Expression of the p27 CDK inhibitor, and other G1-acting cell cycle proteins, remained unaffected.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 23 273(4) 1998-2007",
                "id": "9442036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe070a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Phosphorylation of cyclin-dependent kinases (CDKs) by the CDK-activating kinase is required for the activation of CDK enzymes. Members of two families of CDK inhibitors, p16/p18 and p21/p27, become physically associated with and inhibit the activity of CDKs in response to a variety of growth-modulating signals. Here, we show that the representative members of both families of CDK inhibitors, p21waf1,cip1, p27kip1, and p18, can prevent the phosphorylation of their CDK partners, CDK2 and CDK6, by CDK-activating kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Aug 4 270(31) 18195-7",
                "id": "7629134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0709"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "During late G1 and throughout S-phase, p27 phosphorylation at T187 leads to its subsequent degradation.  Utilizing recombinant proteins, we demonstrate that human Speedy (Spy1) activates CDK2 to phosphorylate p27 at T187 in vitro.  Our studies provide evidence that Spy1 expression enhances CDK2-dependent p27 degradation during late G1 and throughout S-phase.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2007 Aug 1 6(15) 1937-45",
                "id": "17671428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0708"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "We have identified an interaction between two components of the mammalian SWI-SNF complex and cyclin E, an essential cell cycle regulatory protein required for G1/S transition. BRG1 and BAF155, mammalian homologs of yeast SWI2 and SWI3, respectively, are found in cyclin E complexes and are phosphorylated by cyclin E-associated kinase activity. In this report, we show that overexpression of BRG1 causes growth arrest and induction of senescence-associated beta-galactosidase activity, which can be overcome by cyclin E. Our results suggest that cyclin E may modulate the activity of the SWI-SNF apparatus to maintain the chromatin in a transcriptionally permissive state.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Feb 19(2) 1460-9",
                "id": "9891079"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0707"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Activating phosphorylation within the activation segment (also called the T-loop) on a conserved threonine residue (Thr-160 in Cdk2) is required for CDK activities in vitro and in vivo and is carried out by the Cdk-activating kinase (CAK), which is composed of Cdk7, cyclin H, and Mat1 in most eukaryotes. ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Biochem 2005 6 19",
                "id": "16191191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0706"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "transcription factor HiNF-P, which is required for E2F-independent activation of the histone H4 multigene family. HiNF-P interacts with conserved H4 cell cycle regulatory sequences in vivo. Antisense inhibition of HiNF-P reduces endogenous histone H4 gene expression. Furthermore, we find that HiNF-P utilizes NPAT/p220, a substrate of the cyclin E/cyclin-dependent kinase 2 (CDK2) kinase complex, as a key coactivator to enhance histone H4 gene transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(22) 8110-23",
                "id": "14585971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0705"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "It has been shown that dissociation of centro-somal nucleophosmin (NPM)/B23 triggered by CDK2/cyclin E-mediated phosphorylation is required for initiation of centrosome duplication.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2002 Jan 1(1) 75-81",
                "id": "12429912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Cables enhanced cdk2 tyrosine 15 phosphorylation by the Wee1 protein kinase, an inhibitory phosphorylation, which led to decreased cdk2 kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Oct 1 61(19) 7325-32",
                "id": "11585773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNAPK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The molecular mechanism by which PKCh induces G1 arrest was demonstrated in our recent study. PKCh associates with the cyclin E/cdk2/p21 complex in the cytoplasm of normal human keratinocytes. This association results in the inhibition of cdk2 kinase activity, leading to the dephosphorylation of Rb proteins and thereby G1 arrest",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 2002 Dec 132(6) 853-7",
                "id": "12473186"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "cyclin E/Cdk2 was shown to increase HAT activity of CBP",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13505-8",
                "id": "11279224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1999 Mar 260(2) 384-91",
                "id": "10095772"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "As shown here, IPTG-induced cdk2  inactivation also markedly repressed the expression of IL-2Ralpha protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21984-9",
                "id": "11274205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2003 Jun 3(3) 163-75",
                "id": "12769686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Feb 5 274(6) 3396-401",
                "id": "9920882"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Molecular analysis indicated that myostatin down-regulated the protein levels of Cdk2 and up-regulated the levels of its inhibitor p21, thereby rendering Cdk2 inactive.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Oct 22(20) 7066-82",
                "id": "12242286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ec"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The activity of cdk2 required for G2/M progression was reduced in COUP-TFII cells compared to parental cells",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2000 Apr 21 270(3) 1144-53",
                "id": "10772965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "this activity was mediated by the angiotensin II type-1 receptor",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 1998 Oct 30(10) 2069-80",
                "id": "9799660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The ubiquitination and subsequent degradation of p27 depend on its phosphorylation by cyclin-CDK complexes.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 1999 Aug 1(4) 193-9",
                "id": "10559916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "(From full text)  A Cdk2/4 inhibitor prevented down-regulation of PAI-1 mRNA expression in the cell cycle.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 Sep 268(18) 4969-78",
                "id": "11559366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "We have shown that activating CDK2 decreases hPXR-mediated CYP3A4 expression and inhibiting CDK2 increases hPXR-mediated CYP3A4 expression in HepG2 cells (Lin et al., 2008). ",
              "citation": {
                "type": "PubMed",
                "name": "Drug Metab Dispos 2010 Jun 10",
                "id": "20538721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Roscovitine inhibits CDK2/E, CDK2/A, CDK7 and CDK9",
              "citation": {
                "type": "PubMed",
                "name": "Drug Metab Dispos 2010 Jan 38(1) 177-86",
                "id": "19797611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Mar 9(3) 481-91",
                "id": "11931757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Consistent with this possibility, Tat binds to p300 ( 76-78 ), which in turn associates to cyclin E-Cdk2 to activate NFkappaB/rel transcription factors ( 79 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 31448-58",
                "id": "12055184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 16 276(11) 8475-83",
                "id": "11110801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Our data show that two distinct signals, one of which is supplied by Myc, are necessary for consecutive steps during growth factor-induced formation of active cyclin E-cdk2 complexes in G(o)-arrested rodent fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Oct 2 14(19) 4814-26",
                "id": "7588611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Consistent with this, the transcripts of hepatocyte nuclear factor-1 (HNF-1), a liver-specific transcription factor which transactivates these promoter and enhancer regions were reduced by butyrolactone I in a dose-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 18(6A) 4317-22",
                "id": "9891485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 1999 Aug 5(8) 2171-7",
                "id": "10473102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 9",
                "id": "16280325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Expression of HES-1 in T47D cells inhibited G1/S-phase transition and activation of Cdk2 elicited by estrogen.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Nov 18 23(54) 8826-33",
                "id": "15467735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "phosphorylation of pRB at residue Thr821 is often used as an indicator of Cdk2 activity in cells, while Thr826 phosphorylation is linked to Cdk4 activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem 2005 Mar 137(3) 381-6",
                "id": "15809340"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "In late G1, the Rb protein is inactivated through phosphorylation by Cdks (226). Equally important for the Rb phosphorylation is the inactivation of the Rb-associated pool of PP1-alpha, which results from the Cdk-mediated phosphorylation on Thr-320.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2004 Jan 84(1) 1-39",
                "id": "14715909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Myogenic transcription is repressed in myoblasts by serum-activated cyclin-dependent kinases, such as cdk2 and cdk4.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Jun 13 21(26) 4137-48",
                "id": "12037670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00db"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "cyclin-CDK2 demonstrate beta-catenin phosphorylation on residues Ser(33), Ser(37), Thr(41), and Ser(45). This phosphorylation promotes rapid degradation of cytosolic beta-catenin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 7 279(19) 19592-9",
                "id": "14985333"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Nov 20 98(24) 13631-6",
                "id": "11698641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Jan 15 16(2) 332-42",
                "id": "9029153"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 4 278(27) 24644-50",
                "id": "12714602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The effects of short interfering RNA (siRNA)-mediated downregulation of Id1 were the same as those following downregulation of c-Myc: decreased expression of cyclins D1 and E, reduced phosphorylation of pRb at Ser780 (a site targeted by cyclin D1-Cdk4) and reduced cyclin E-Cdk2 activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jan 13 24(3) 381-9",
                "id": "15489884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Recombinant cyclin E/Cdk2 was inhibited by extracts from quiescent liver, and cyclin D1 could titrate out this inhibitory activity.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1999 Dec 277(6 Pt 1) G1207-16",
                "id": "10600818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "CCNA2_CDK2=^E2F1{P@?} CNA2_CDK2=^E2F2{P@?} CCNA2_CDK2=^E2F3{P@?}",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "p27 can be phosphorylated on threonine 187 by Cdks, and cyclin E/Cdk2 overexpression can stimulate the degradation of wild-type p27",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 May 1 13(9) 1181-9",
                "id": "10323868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "By inhibiting selectively either cdk4/6 or cdk2, we show that endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb only partially, a process that is likely to be completed by cyclin E-cdk2 complexes. Furthermore, cyclin E-cdk2 is unable to phosphorylate pRb in the absence of prior phosphorylation by cyclin D-cdk4/6 complexes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Feb 18(2) 753-61",
                "id": "9447971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "In contrast, ectopic expression of cyclin A or cyclin E inhibits MCK expression only when they are co-expressed with their catalytic partner cyclin-dependent kinase 2 (Cdk2).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jan 10 272(2) 791-7",
                "id": "8995365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1996 May 10(5) 488-98",
                "id": "8732680"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Okadaic acid and calyculin A had no effect on pRB phosphatase activity even though PP2A was completely inhibited. The decrease in pRB phosphorylation correlated with inhibitor-induced suppression of G(1) cyclin-dependent kinases including CDK2, CDK4, and CDK6.  The inhibitors also caused decreases in the levels of cyclin D2 and cyclin E, and induction of the cyclin-dependent kinase inhibitors p21(Cip1) and p27(Kip1). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31917-24",
                "id": "10542219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "We found that expression of CDK2 and CDK4 genes were up-regulated within hours of androgen treatment as detected in Northern and Western blot analyses. Kinase assay also confirmed that there was increased CDK2 kinase activity upon androgen stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1997 Oct 15 57(20) 4511-6",
                "id": "9377562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Transfection with dominant-negative Cdk mutants demonstrated that only a Cdk2 mutant increased Cdc25A protein levels; Cdk1 and Cdk3 mutants had no effect. The increased Cdc25A protein levels were the result of an increase in the half-life of the protein",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 31838-42",
                "id": "12801928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "We first measured the levels of cdk1 and cdk2 phosphorylated at Tyr15, indicative of cdks inhibited after DNA damage because of cytoplasmic sequestration or degradation of cdc25 phosphatases.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2009 Aug 14 35(3) 327-39",
                "id": "19683496"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "treatment of young HDFs during the late G1 transition with a specific inhibitor of CDK2, roscovitine, blocked the induction of TK RNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biomed Sci 8(2) 176-83",
                "id": "11287748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Critical for this mechanism is E2F-dependent expression of cyclin A, and cyclin A/Cdk2-mediated phosphorylation of Cdh1, which prevents the activatory assembly of Cdh1 with APC, thus creating an environment permissive for accumulation of APC targets.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Oct 21 401(6755) 815-8",
                "id": "10548110"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "pharmacological inhibition of Cdk2 activity through roscovitine prevented blister formation and acantholysis in the mouse model of the disease.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Mar 28 283(13) 8736-45",
                "id": "18199752"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "E2 sensitivity is regulated by acetylation of lysines 302 and 303, by CREB-binding protein (CBP).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "hHR6A is phosphorylated in vitro by CDK-1 and -2 on Ser120, a residue conserved in all hHR6A homologues, resulting in a 4-fold increase in its ubiquitin-conjugating activity.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Apr 15 21(8) 2009-18",
                "id": "11953320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Previous reports showed that BCCIP alpha enhances the inhibitory activity of p21 toward CDK2 and that BCCIP alpha inhibits the growth of certain tumor cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 Mar 3(3) 343-8",
                "id": "14726710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Phosphoylation of pRb and concomitant release of E2F repres200 sion is catalyzed by cyclin D-dependent kinases, cdk4 , in response to extracellular signals and by the cyclin E- and A-dependent kinase, cdk2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Aug 8(2) 303-16",
                "id": "11545733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Three groups have reported that Cyclin E ubiquitinylation is mediated by the ubiquitin ligase SCFFbw7 The interaction between Fbw7 and Cyclin E is phosphorylation dependent since mutation on two residues phosphorylated by Cdk2 impairs Cyclin E ability to bind Fbw7. Furthermore, SCFFbw7 is able to ubiquitinylate Cyclin E in a phosphorylation-dependent manner in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Mar 15 23(11) 2037-49",
                "id": "15021891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The addition of IL-1alpha to NPA cells induced the expression of p27 protein and reduced the expression of Cdk2 protein, which leads to induction of p107 protein expression",
              "citation": {
                "type": "PubMed",
                "name": "J Endocrinol 1999 Jan 160(1) 67-73",
                "id": "9854178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "In addition to activation of cyclin D1Cdk4 complexes, estrogen also activates cyclin ECdk2 complexes within 3 h, substantially preceding entry into S phase",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Relat Cancer 2003 Jun 10(2) 179-86",
                "id": "12790780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "TGF-beta inhibited cdk2 enzyme activity and Rb phosphorylation and increased p15(Ink4b) protein levels. (p15 is CDKN2B)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2004 Dec 31(6) 679-86",
                "id": "15333329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "This residue is located near a cyclin-binding motif (Cy2) that plays an important role in the interaction between p21(WAF1/CIP1) and Cdk2, and its phosphorylation modulates the ability of p21(WAF1/CIP1) to associate with Cdk2. The phosphorylation of p21(WAF1/CIP1) is temporally related to the activation kinetics of Cdk2 activity during the apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jan 27 339(4) 1138-47",
                "id": "16343435"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "cyclin A/CDK2 phosphorylates Axin, thereby enhancing its association with beta-catenin",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Apr 30 317(2) 478-83",
                "id": "15063782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10542-57",
                "id": "15572662"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "As shown in Figure 4 (the upper panels in a and b), the kinase activities of CDK2 (Figure 4a) and CDK4 (Figure 4b) clearly decreased in Cx43-transfected cells compared with the parental and vector-transfected cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Jul 12 20(31) 4138-49",
                "id": "11464280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The human Cdc25A phosphatase plays a pivotal role at the G1/S transition by activating cyclin E and A/Cdk2 complexes through dephosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29824-9",
                "id": "12759351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The addition of anti-calmodulin drugs to normal rat kidney cells in early G1 inhibited cyclin-dependent kinase 4 (Cdk4) and Cdk2 activities, as well as retinoblastoma protein phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Dec 11 273(50) 33279-86",
                "id": "9837900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00bb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 May 15 273(20) 12095-100",
                "id": "9575153"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "This would permit the incremental activation of cyclin E-Cdk2 leading to cyclin E-Cdk2-mediated T187 phosphorylation and p27 proteolysis in late G1 and S phase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Jan 14(1) 201-13",
                "id": "12529437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "can block Skp2-cyclin A interaction but not p27-cyclin A interaction",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jun 14",
                "id": "16774918"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Treatment with estradiol alone resulted in a greater increase in cyclin D1 gene expression but markedly decreased p21 expression, with a concurrent increase in Cdk4 and Cdk2 activity and subsequent synchronous entry of cells into S phase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 13 276(28) 25823-33",
                "id": "11337496"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Induction of ERbeta reduces growth of exponentially proliferating cells with a concomitant decrease in components of the cell cycle associated with proliferation, namely cyclin E, Cdc25A (a key regulator of Cdk2), p45(Skp2) (a key regulator of p27(Kip1) proteolysis), and an increase in the Cdk inhibitor p27(Kip1). We also observed a reduced Cdk2 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Feb 10 101(6) 1566-71",
                "id": "14745018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Moreover, an inhibitor of HMG-CoA reductase, pravastatin, reduced cyclin E expression and Cdk2 activation and caused G1 arrest in the astrocytes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 9 273(41) 26772-8",
                "id": "9756921"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Protein levels of both p15 and p21 were induced, and p21 protein was recruited to a complex with cyclin-dependent kinase, CDK2, to inhibit its activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(1) 362-76",
                "id": "14673169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "and (iii) promotion by AKT of the removal of RAF-induced p21Cip1 from cdk2 complexes, leading to sustained cyclin E/cdk2 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10868-81",
                "id": "15572689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "To test which catalytic subunit of the Cyclin A complex is associated with CDC6, the membranes from the GST-binding assay described above were probed for CDK2 and CDC2 (Figure 3B; data not shown). Only the fast migrating, active form of CDK2 binds CDC6, whereas no association was found with the inactive form of CDK2 or CDC2 (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Jan 15 18(2) 396-410",
                "id": "9889196"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1999 May 25 96(11) 6193-8",
                "id": "10339564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "In this study, we examined the cell cycle-dependent phosphorylation of PP1alpha in vivo using three different antibodies. PP1alpha was phosphorylated at Thr-320 during M-phase and again in late G(1)- through early S-phase. Inhibition of Cdk2 led to a small increase in PP1 activity and also prevented PP1alpha phosphorylation. In vitro, PP1alpha was a substrate for Cdk2 but not Cdk4.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 8 274(41) 29470-5",
                "id": "10506210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "in vitro kinase assays showed that the kinase activity associated with cyclins D and E was greatly enhanced upon nicotine stimulation (Figure 1, E and F). Furthermore, nicotine stimulation led to the dissociation of E2F1 from Rb as assessed by IP/Western blot analysis (Figure 1G, top panel), correlating with the induction of cyclin D/cdk4 and cyclin E/cdk2 activity as well as Rb phosphorylation (Figure 1G, middle 2 panels).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2006 Aug 116(8) 2208-2217",
                "id": "16862215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Whereas cdk4/cdk6 inhibition and Rb dephosphorylation are expected on p16Ink4a expression, we have also observed indirect cdk2 inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 2000 Oct 11(10) 507-15",
                "id": "11063124"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 17 274(51) 36741-9",
                "id": "10593981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ad"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The kinase activities of CDC2, CDK2 and CDK4 were also much reduced (see Supplementary Information, Fig. S2), largely reflecting their reduced expression.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2006 May 8(5) 524-31",
                "id": "16604064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "cyclinE:cdk2 phosphorylates Rb",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 May 28 20(24) 3134-8",
                "id": "11420730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Inhibition of AR also prevented HG- and TNF-alpha-induced phosphorylation of cyclin-dependent kinase (cdk)-2 and expression of G1/S transition regulatory proteins such as cyclin D1, cyclin E, cdk-4, c-myc, and proliferative cell nuclear antigen",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2010 May 151(5) 2140-50",
                "id": "20308528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Mar 21(5) 1854-65",
                "id": "11238922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Most notably, increased p57(Kip2) levels resulted in marked inhibition of both cyclin E- and cyclin A-associated cdk2 kinase activities and a decrease in cyclin A amounts.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Aug 15 173(4) 2383-91",
                "id": "15294951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Cyclin E1 is expressed during the late G1 phase of the cell cycle and mediates the initiation of DNA synthesis by activating cyclin-dependent kinases 2 (CDK2)",
              "citation": {
                "type": "PubMed",
                "name": "Neurol Res 2006 Jul 28(5) 493-9",
                "id": "16808878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Dec 17(12) 6815-21",
                "id": "9372912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Additionally, the concomitant loss of D-type cyclins allows a redistribution of p27Kip1 to cyclin E/cdk2, which results in inactivation of the complex and a G1 block",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Mar 10 284(1) 99-110",
                "id": "12648469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "In addition, cells overexpressing either PRL-1 or PRL-2 exhibited enhanced cyclin-dependent kinase 2 (CDK2) activity and significantly lower p21 (Cip1/Waf1) protein levels,",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2003 Dec 30 202(2) 201-11",
                "id": "14643450"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Feb 1 20(3) 422-32",
                "id": "11157749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Moreover, purified recombinant PP2C alpha and PP2C beta 2 proteins efficiently dephosphorylated monomeric Cdk2/Cdk6 in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 3 275(44) 34744-9",
                "id": "10934208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Cables is a novel cell cycle regulatory protein that interacts with cdk2, cdk3, and cdk5. Cables inhibits cdk2 activity by enhancing cdk2 tyrosine 15 phosphorylation by Wee1, which consequently leads to inhibition of cell growth.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2005 Nov 4(11) 1211-5",
                "id": "16177568"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 25 278(30) 27421-31",
                "id": "12676926"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "We show that androgen-induced G1 cell cycle arrest of LNCaP cells coincides with inhibition of cyclin-dependent kinase 2 activity and p27 accumulation caused by reduced p27 ubiquitylation activity. At the same time, androgen decreased expression of SKP2",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2002 Aug 20 3(1) 22",
                "id": "12188931"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe009f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Most notably, increased p57(Kip2) levels resulted in marked inhibition of both cyclin E- and cyclin A-associated cdk2 kinase activities and a decrease in cyclin A amounts.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Aug 15 173(4) 2383-91",
                "id": "15294951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe009e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "C/EBPalpha directly interacts with cdk2 and cdk4 and arrests cell proliferation by inhibiting these kinases",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Oct 8(4) 817-28",
                "id": "11684017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe009d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Conversely, CDK2 and cdc2 can inactivate MyoD function  and inhibit myogenic differentiation by phosphorylation-triggered degradation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(18) 6373-84",
                "id": "12944466"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe009c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "TGF-beta inhibits Cdk2-cyclin E kinase activity by promoting the binding of cell cycle inhibitor Kip1 protein to the kinase complexes.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 5 23(5) 1064-75",
                "id": "14676846"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe009b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "CDK2 interacts with and phosphorylates FOXO1 at serine 249, leading to nuclear export and thereby inhibiting FOXO1 activity (Huang et al., 2006).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe009a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "We also show that Lyn phosphorylates Tyr15 of Cdk2 and that incubation of Lyn with Cdk2 results in inhibition of Cdk2 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1996 Sep 5 13(5) 939-46",
                "id": "8806683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0099"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 11 275(32) 24767-75",
                "id": "10825181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0098"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Depletion of beta-TRCP stabilizes Cdc25A, leading to hyperactive Cdk2 activity. SCFbeta-TRCP promotes Chk1-dependent Cdc25A ubiquitination in vitro, and this involves serine 76, a known Chk1 phosphorylation site. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Dec 15 17(24) 3062-74",
                "id": "14681206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0097"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "\\\"Ribonucleotide reductase R2 protein is phosphorylated at serine-20 by P34cdc2 kinase.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1999 Jan 11 1448(3) 363-71",
                "id": "9990288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0096"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "9889196;10339564",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0095"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Furthermore, the results of three different types of experiments showed that TOK-1alpha enhanced the inhibitory activity of p21 toward histone H1 kinase activity of CDK2. TOK-1alpha is thus thought to be a new type of CDK2 modulator.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 6 275(40) 31145-54",
                "id": "10878006"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0094"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Ectopic expression of Myc induces Cdk2 kinaseactivity in quiescent cells and antagonizes association of p27(kip1) with Cdk2.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Oct 1 18(19) 5321-33",
                "id": "10508165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0093"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "total p27KiP1 levels and cyclin E-associated p27Kip1 increased as cells arrested and the amount of the CAK activated cdk2 bound to cyclin E decreased",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Feb 3 19(5) 670-9",
                "id": "10698512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0092"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2000 Dec 11(12) 4159-71",
                "id": "11102515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0091"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Inhibition of cellular senescence in U2OS cells required phosphorylation of Myc at Ser-62 by cyclin E/cyclin-dependent kinase (Cdk) 2. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2010 Jan 5 107(1) 58-63",
                "id": "19966300"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0090"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The cyclin-dependent kinase 2 (Cdk2) inhibitors p21(CIP1) and p27(KIP1) are negatively regulated by anchorage during cell proliferation, but it is unclear how integrin signaling may affect these Cdk2 inhibitors.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jul 22(13) 4587-97",
                "id": "12052868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe008f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 2004 Apr 32(2) 397-414",
                "id": "15072547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe008e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "We show that p27 interacts with cyclin E-CDK2 in at least two distinct ways: one resulting in p27 phosphorylation and release, the other in tight binding and cyclin E-CDK2 inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1997 Jun 1 11(11) 1464-78",
                "id": "9192873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe008d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Overexpression of p21Cip1 significantly reduced the kinase activity of Cdk2 (35% +- 6% of vector-transfected cells; P < 0.001).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Aug 21(16) 5644-57",
                "id": "11463845"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe008c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Cdc25A dual specificity phosphatase controls entry into and progression through S phase by dephosphorylating sites of inhibitory phosphorylation on cyclin E-cdk2 (Thr14 and Tyr15). Immunoblotting reveals that a 3 hour treatment of U937 cells with 5 muM sodium arsenite results in a dramatic decrease in cdc25A protein levels. ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2007 Jun 1",
                "id": "17545210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe008b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jun 9 95(12) 6785-90",
                "id": "9618490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe008a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Titration of unbound p27Kip1 and p21Cip1 molecules into higher order complexes with assembling cyclin D-dependent kinases relieves cyclin E-CDK2 from Cip/Kip constraint, thereby facilitating cyclin E-CDK2 activation later in G1 phase.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Jun 15 13(12) 1501-12",
                "id": "10385618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0089"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The data are most consistent with a model in which cdk2 activity initiates cyclin E degradation by promoting the disassembly of cyclin E-cdk2 complexes, followed by the ubiquitination and degradation of free cyclin E.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1996 Aug 15 10(16) 1979-90",
                "id": "8769642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0088"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "CDK2-cyclin A1/E1 and CDK1-cyclin B1 phosphorylate BARD1 on its NH(2) terminus in vivo and in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jan 1 65(1) 6-10",
                "id": "15665273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0087"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "S224 matches a consensus site for cyclin-dependent kinase (CDK) phosphorylation and is phosphorylated by CDK2-cyclin A in vitro. S224 phosphorylation in cells is sensitive to CDK2 inhibitors. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Jul 15 67(14) 6685-90",
                "id": "17638878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0086"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Nov 26 17(21) 2679-89",
                "id": "9840932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0085"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Replacement of T160 with alanine abolishes the kinase activity of CDK2, indicating that phosphorylation at this site (as in CDC2) is required for kinase activity. Mutation of Y15 and T14 stimulates kinase activity, demonstrating that phosphorylation at these sites (as in CDC2) is inhibitory. Similarly, CDK2 is activated in vitro by dephosphorylation of Y15 and T14 by the phosphatase CDC25.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1992 Nov 11(11) 3995-4005",
                "id": "1396589"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0084"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Id2 enhancement of SMC growth and inhibition of p21 expression were dependent on phosphorylation of Id2 by cyclin E/cdk2, as an Id2 cDNA containing a mutation in the cdk2 phosphorylation site (serine 5) failed to regulate SMC cell cycle progression or p21 promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 1 277(9) 7293-7",
                "id": "11706002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0083"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Here we show that Smad3 is a major physiological substrate of the G1 cyclin-dependent kinases CDK4 and CDK2.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2004 Jul 8 430(6996) 226-31",
                "id": "15241418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0082"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "We show here for the first time that CDK2 can be activated by neuregulin (NRG) in differentiated C2C12 myotubes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jun 10 280(23) 21731-8",
                "id": "15824106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0081"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Cell cycle analysis confirms that Myostatin up-regulated p21, a Cdk inhibitor, and decreased the levels and activity of Cdk2 protein in satellite cells",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2003 Sep 15 162(6) 1135-47",
                "id": "12963705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0080"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Satellite Cells, Skeletal Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Aug 12(2) 381-92",
                "id": "14536078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe007f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The primary substrates of CDK4/6 and CDK2 in G1 progression are the members of the retinoblastoma protein family  RB,p107 and p130 The activity of the RB proteins is modulated by sequential phosphorylation by CDK4/6cyclinD and CDK2cyclinE complexes",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2001 Dec 1(3) 222-31",
                "id": "11902577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe007e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Ninjurin1-overexpressing clones exhibited strong growth inhibition due to G1 cell cycle arrest, which is associated with a posttranscriptional increase in p21WAF1/Cip1, a decrease of cyclin-dependent kinase 2 activity and the hypophosphorylation of Rb.",
              "citation": {
                "type": "PubMed",
                "name": "J Hepatol 2004 Oct 41(4) 637-43",
                "id": "15464245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe007d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The pRb phosphorylated in vitro by Cdk4 was inactive as a growth suppressor upon microinjection, but pRb phosphorylated by Cdk2 or Cdk3 retained cell cycle arrest activity. While these kinases efficiently phosphorylate a common set of residues, including S373 and S788, cyclin D1/Cdk4 was a much more efficient kinase for S795 than the other kinases examined.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1997 Feb 8(2) 287-301",
                "id": "9190208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe007c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "The effects of short interfering RNA (siRNA)-mediated downregulation of Id1 were the same as those following downregulation of c-Myc: decreased expression of cyclins D1 and E, reduced phosphorylation of pRb at Ser780 (a site targeted by cyclin D1-Cdk4) and reduced cyclin E-Cdk2 activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jan 13 24(3) 381-9",
                "id": "15489884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe007b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "cdk2-dependent phosphorylation of NF-Y and its involvement in transcription repression by the p53-p21 signaling pathway Cdk2 phosphorylates two serine residues near the DNA-binding domain of the YA subunit of NF-Y",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 36966-72",
                "id": "12857729"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe007a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 31834-41",
                "id": "12105215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0079"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "Cyclin A/Cdk2 phosphorylates several of the PR phosphorylation sites in vitro and there is evidence that it participates in PR phosphorylation in vivo. Cyclin A/Cdk2 also functions as a PR coactivator.",
              "citation": {
                "type": "PubMed",
                "name": "Steroids 2007 Feb 72(2) 202-9",
                "id": "17207508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0078"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDK2) actsIn kin(p(HGNC:CDK2))",
              "summary_text": "We determined the activity of cdk2, which is the CDK that is responsible for progression of cells into and through S phase. As shown in Figure 3A, treatment of cells with rolipram caused a >80% reduction in the enzymatic activity of this kinase",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 1(3) 268-76",
                "id": "12432276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0077"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Glioma",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to hypoxia\")",
        "relation": "decreases",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "bp(GOBP:\"response to hypoxia\") decreases bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0987",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to hypoxia\") decreases bp(GOBP:\"DNA repair\")",
              "summary_text": "hypoxia disrupts repair of DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Jan 2(1) 38-47",
                "id": "11902584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"response to hypoxia\") decreases bp(GOBP:\"DNA repair\")",
              "summary_text": "DNA mismatch repair (MMR) gene Mlh1 is specifically reduced in mammalian cells under hypoxia... hypoxia and DFX cause decreased Mlh1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 May 23(9) 3265-73",
                "id": "12697826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NET1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:NET1))",
        "directed": false,
        "label": "p(HGNC:NET1) actsIn cat(p(HGNC:NET1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0988",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NET1) actsIn cat(p(HGNC:NET1))",
              "summary_text": "expression of activated mNET1 also activates the SAPK/JNK pathway",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Jul 15 17(14) 4075-85",
                "id": "9670022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00fc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NET1) actsIn cat(p(HGNC:NET1))",
              "summary_text": "The regulation of Net1 activity is poorly understood. PAK1-dependent phosphorylation of Net1 on Ser152 and Ser153 inhibits its GEF activity and abolishes Net1-dependent RhoA activation and stress fiber induction [15].",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2008 3(5) e2254",
                "id": "18509476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NET1) actsIn cat(p(HGNC:NET1))",
              "summary_text": "NET1 is a guanine nucleotide exchange factor for RhoA NET1 is important for the increase of Rho activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 4 276(18) 15362-8",
                "id": "11278519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NET1) actsIn cat(p(HGNC:NET1))",
              "summary_text": "Rac1 stimulates serine 152 phosphorylation in a PAK1-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 1 280(13) 12152-61",
                "id": "15684429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NET1) actsIn cat(p(HGNC:NET1))",
              "summary_text": "We further demonstrate that a fraction of RhoA resides in the nucleus, and can also be found in a GTP-bound active form and that Net1 plays a role in the activation of nuclear RhoA. In addition, we show that ionizing radiation (IR) specifically promotes the activation of the nuclear pool of RhoA in a Net1-dependent manner, while the cytoplasmic activity remains unchanged. ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(2) e17380",
                "id": "21390328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53,pmod(P,S,20))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:TP53,pmod(P,S,20)) directlyIncreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0989",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,20)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Pretreatment with an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1), NU1025, nearly doubled the DNA damage produced by 5 microM 3MI, implying that PARP1, which among other activities, functions to repair single-strand breaks in DNA, repaired at least some of the 3MI-induced DNA fragmentation. A key cellular response to DNA damage, phosphorylation, and nuclear localization of p53 was seen at subtoxic levels of 3MI exposure ... from Fig 6, TP53 P@S20",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2009 Nov 112(1) 59-67",
                "id": "19700606"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0714"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,20)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Upon DNA damage, the amino terminus of p53 is phosphorylated at a number of serine residues including S20, a site that is particularly important in regulating stability and function of the protein.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 289-300",
                "id": "10673501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:SMARCB1)",
        "relation": "decreases",
        "target": "p(HGNC:TP53,pmod(P,S,15))",
        "directed": false,
        "label": "p(HGNC:SMARCB1) decreases p(HGNC:TP53,pmod(P,S,15))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe098a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:SMARCB1) decreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:HIPK2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP53,pmod(P,S,46))",
        "directed": false,
        "label": "kin(p(HGNC:HIPK2)) directlyIncreases p(HGNC:TP53,pmod(P,S,46))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe098b",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:HIPK2)) directlyIncreases p(HGNC:TP53,pmod(P,S,46))",
              "summary_text": "HIPK2 is activated by ultraviolet (UV) radiation and selectively phosphorylates p53 at Ser 46 ... Accordingly, the kinase function of HIPK2 mediates the increased expression of p53 target genes",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jan 4(1) 1-10",
                "id": "11740489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0101"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:HIPK2)) directlyIncreases p(HGNC:TP53,pmod(P,S,46))",
              "summary_text": "Here we demonstrate that homeodomain-interacting protein kinase-2 (HIPK2), a member of a novel family of nuclear serine/threonine kinases, binds to and activates p53 by directly phosphorylating it at Ser 46",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jan 4(1) 11-9",
                "id": "11780126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0100"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:HIPK2)) directlyIncreases p(HGNC:TP53,pmod(P,S,46))",
              "summary_text": "11875057;16729035",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe00ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53BP1)",
        "relation": "increases",
        "target": "p(HGNC:RIF1)",
        "directed": false,
        "label": "p(HGNC:TP53BP1) increases p(HGNC:RIF1)",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775d252f9e24174cfe098c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP53BP1) increases p(HGNC:RIF1)",
              "summary_text": "Here we report that Rif1(-/-) mice are severely compromised for 53BP1-dependent class switch recombination (CSR)",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "23333305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0102"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53BP1)",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "p(HGNC:TP53BP1) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "",
          "edgeId": "55775d252f9e24174cfe098d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP53BP1) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "We show that RNF8, a RING-finger ubiquitin ligase, rapidly assembles at DSBs via interaction of its FHA domain with the phosphorylated adaptor protein MDC1. This is accompanied by an increase in DSB-associated ubiquitylations and followed by accumulation of 53BP1 and BRCA1 repair proteins ... from full text, U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Nov 30 131(5) 887-900",
                "id": "18001824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0103"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53BP1)",
        "relation": "hasModification",
        "target": "p(HGNC:TP53BP1,pmod(P))",
        "directed": false,
        "label": "p(HGNC:TP53BP1) hasModification p(HGNC:TP53BP1,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "",
          "edgeId": "55775d252f9e24174cfe098e",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:PRKDC)",
        "relation": "hasModification",
        "target": "p(HGNC:PRKDC,pmod(P,T,2609))",
        "directed": false,
        "label": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,T,2609))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe098f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,T,2609))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0104"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GADD45G)",
        "relation": "directlyDecreases",
        "target": "kin(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(HGNC:GADD45G) directlyDecreases kin(p(HGNC:POLD1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0990",
          "evidences": [
            {
              "bel_statement": "p(HGNC:GADD45G) directlyDecreases kin(p(HGNC:POLD1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0105"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:EP300)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:EP300))",
        "directed": false,
        "label": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0991",
          "evidences": [
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Further analyses indicate that activation of SIRT1 (deacetylase) by resveratrol (a natural antioxidant) induces SIRT1-p300 association and acetyltransferase inactivation, leading to deacetylation of HA/CD44-induced beta-catenin and NFkappaB-p65, inhibition of beta-catenin-T-cell factor/lymphocyte enhancer factor and NFkappaB-specific transcriptional activation, and the impairment of MDR1 and Bcl-x(L) gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 30 284(5) 2657-71",
                "id": "19047049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe071b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "The p300/CBP-mediated acetylation of p53 significantly potentiates p53-mediated transactivation and growth inhibition. MDM2 inhibits the acetylation of p53 by p300/CBP through a mechanism that requires a stable p53-MDM2 interaction and that is sensitive to the deacetylase inhibitor, TSA. MDMX is an MDM2-like protein that shares with MDM2 the ability to interact with p53 and, in turn, inhibit p53-mediated transcription. It was therefore of interest to determine if MDMX could also inhibit the acetylation of p53 by p300/CBP. We demonstrate that MDMX dramatically inhibits the acetylation of p53 induced by both endogenous and ectopically expressed p300/CBP. We also demonstrate that the p53-binding domain of MDMX is required for the MDMX-mediated inhibition of p53 acetylation. Our results indicate that MDMX shares with MDM2 the ability to regulate a potentially important post-translational modification of p53. These results may have important biologic implications with respect to the MDMX-mediated regulation of p53 activity during development.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2002 Jul 21(7) 519-25",
                "id": "12162806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe071a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Contrary to the corepressors, the p160 NR coactivators bind to liganded NRs to mediate transcriptional activation through recruitment of histone acetyltransferases (10). The p160 coactivators include SRC-1 (11), GRIP1/TIF2 (12-14), and RAC3/ACTR/AIB1/pCIP/TRAM-1 (15-19). These coactivators also interact with histone acetyltransferases such as CREB-binding protein/p300 and P/CAF (22,23), tethering histone acetyltransferase activity to target promoters.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 6 279(32) 33799-805",
                "id": "15184363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0719"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Nuclear factor kappaB (NF-kappaB) plays an important role in the transcriptional regulation of genes involved in inflammation and cell survival. In this study, we demonstrated that NF-kappaB-dependent gene expression was inhibited by E1A in poly(ADP)-ribose polymerase-1 knock out (PARP-1 (-/-)) cells complemented with wild type PARP-1 after tumor necrosis factor alpha (TNFalpha) or lipopolysaccharide (LPS) treatment. PARP-1 and p300 synergistically coactivated NF-kappaB-dependent gene expression in response to TNFalpha and LPS. Furthermore, PARP-1 interacted directly with p300 and enhanced the interaction of NF-kappaB1/p50 to p300. The C terminus, harboring the catalytic domain of PARP-1 but not its enzymatic activity, was required for complete transcriptional coactivation of NF-kappaB by p300 in response to TNFalpha and LPS. Together, these results indicate that PARP-1 acts synergistically with p300 and plays an essential regulatory role in NF-kappaB-dependent gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45145-53",
                "id": "12960163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0718"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Here, we show that DNA damage induces the acetylation of p73 by the acetyltransferase p300....As shown in Figure 1C, exogenously expressed HA-tagged p73? is acetylated by cotransfected p300 (Figure 2A, lane 3). Treatment of cells with the anticancer drug doxorubicin  strongly potentiates the acetylation of p73? by p300 (Figure 2A, lane 4).SDS-PAGE and immunoblotted using an antiacetylated lysines polyclonal antibody (Upstate Biotechnology, Inc.)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Jan 9(1) 175-86",
                "id": "11804596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0717"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "The interaction of RB and E2F transcription factors represents a functional interaction that has been the predominant focus in the field. RB and the related family members p107 and p130 can each bind E2F to repress genes that are otherwise important for progression from G1 to S phase. The binding of RB, p107, or p130 has two simultaneous consequences: (1) binding prevents E2F from interacting with transcriptional co-activators (e.g., p300); and (2) binding recruits chromatin-modifying enzymes [e.g., histone deacetylases (HDACs)] to silence transcription. E2F itself is a family of transcription factors that include six E2F and three DP proteins, which together form the heterodimeric complex that comprises E2F transcriptional activity (reviewed in Trimarchi and Lees, 2002 and Yee and Wang, 2003). While there is considerable complexity, gene repression in G1 phase utilizes RB and E2Fs 1, 2, 3, and 4, while gene repression in G0 utilizes primarily p130 and E2Fs 4 and 5. binding prevents E2F from interacting with transcriptional co-activators (e.g., p300); and",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2004 Jul 7 336(1) 1-13",
                "id": "15225871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0716"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "To determine whether p300 is involved in inducible NO synthase (iNOS) transcriptional regulation, we evaluated the effect of p300 overexpression on iNOS expression and characterized p300 binding to iNOS promoter in RAW 264.7 cells. p300 overexpression increased iNOS expression which was abrogated by deletion of the histone acetyltransferase (HAT) domain (Delta1472-1522). DNA-binding and chromatin immunoprecipitation assays revealed binding of p300 to several DNA-bound transactivators at basal state. Following stimulation with LPS plus IFN-gamma, binding of p300, p50/p65 NF-kappaB, and IFN-regulatory factor-1 was increased by approximately 2-fold. Nuclear p50 was complexed with and acetylated by p300 at the basal binding state which was increased by LPS and IFN-gamma stimulation. p300 overexpression resulted in increased p50 acetylation which was reduced by HAT mutation. p50 acetylation correlated with increased NF-kappaB binding and enhanced p300 recruitment. Co-overexpression of E1A abolished the augmentation of p50 acetylation and p50 binding induced by p300 overexpression, and a correlative suppression of p300 recruitment to the complex. We conclude that p300 is essential for iNOS transcription. Our results suggest that p300 HAT acetylates the p50 subunit of NF-kappaB, thereby increasing NF-kappaB binding and NF-kappaB mediated transactivation.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Dec 15 171(12) 6581-8",
                "id": "14662860"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0715"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "<p22> Acetylation of Lys320 or Lys382 enhances sequence specific DNA binding by P53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0136"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "We demonstrate that Skp2 forms a complex with p300 through the CH1 and the CH3 domains of p300 to which p53 is thought to bind and antagonizes the interaction between p300 and p53 in cells and in vitro. As Skp2 antagonizes the interaction between p300 and p53, Skp2 suppresses p300-mediated acetylation of p53 and the transactivation ability of p53. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2008 Feb 1 29(2) 217-31",
                "id": "18243116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0135"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Using an antibody raised against an acetylated Rch1 peptide, we show that Rch1 was acetylated at Lys22 in vivo and that CBP or p300 could mediate this reaction Acetylation of Lys22 promoted interaction with importin-beta in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2000 Apr 20 10(8) 467-70",
                "id": "10801418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0134"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Interestingly, acetylated Polbeta showed a severely reduced ability to participate in a reconstituted BER assay. This was due to an impairment of the dRP-lyase activity of Polbeta.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Nov 10(5) 1213-22",
                "id": "12453427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0133"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Histone acetyltransferases (HATs) p300 and CREB-binding protein (CBP) function as co-activators for a variety of sequence-specific transcription factors, including AML1.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Sep 6 25(17) 3955-65",
                "id": "16917507"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0132"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Finally, it (AMPK) phosphorylates the ubiquitous co-activator p300 at a specific site (Ser89), reducing its ability to bind to nuclear hormone receptors and thus activate their target genes",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Nov 1 117(Pt 23) 5479-87",
                "id": "15509864"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0131"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "From review: p300/CBP binding protein MDM2 inhibits the intrinsic HAT activity of p300/CBP",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 May 268(10) 2773-8",
                "id": "11358491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0130"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Transient transfection of p300 increased its level, which was accompanied by a large increase in basal COX-2 promoter activity (Fig. 5)... However, p300 overexpression augmented COX-2 promoter activity stimulated with TNFalpha, and this augmenting effect was greatly attenuated when p300 HAT domain was deleted (Fig. 5).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 14 278(7) 4770-7",
                "id": "12471036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe012f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "They are both required for MyoD activity and muscle differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 1999 Nov 4(5) 725-34",
                "id": "10619020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe012e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "observation that IL6 stimulation increases histone H4 acetylation of the endogenous AGT promoter, and expression of p300 deficient in histone acetyltransferase activity down-regulates AGT promoter activity both suggest that p300 histone acetyltransferase activity is required for AGT expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Apr 16(4) 824-36",
                "id": "11923478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe012d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "In this study, we describe the application of the same strategy for the identification of p300 acetyltransferase-mediated acetylation sites on p53. Consistent with the previous finding, lysines 370, 372, 373, 381, and 382 were detected by this modified selected ion tracing method as the target sites of p300 in vitro. Moreover, two novel acetylation sites, Lys-292 and Lys-305, were also found.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 25568-76",
                "id": "12724314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe012c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Cyclin D1 inhibits histone acetyltransferase activity of p300 in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 19 280(33) 29728-42",
                "id": "15951563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe012b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 26 274(48) 34020-8",
                "id": "10567368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe012a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "A recent work has shown that NFkB-dependent transcription requires the function of transcriptional coactivator proteins (10 12). The CBP and its homologue, p300, are coactivators that interact with the p65 subunit of NFkB to enhance its ability to activate transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 4 279(23) 24873-80",
                "id": "15140884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0129"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "p300 specifically acetylates all sites of histones H2A and H2B known to be acetylated in bulk chromatin in vivo but preferentially acetylates lysines 14 and 18 of histone H3 and lysines 5 and 8 of histone H4.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jan 15 274(3) 1189-92",
                "id": "9880483"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0128"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "HMGI (Y) P300/CBP, P/CAF Up(P/CAF), Down(p300)",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0127"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "JDP2 has an inhibitory activity of acetylation of all core histones mediated by histone acetyltransferase (HAT) both of p300 and PCAF in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res Suppl 2003 (3) 305-6",
                "id": "14510502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0126"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Consistent with this observation, overexpression of p300/CREB binding protein-associated factor (P/CAF), a transcriptional coactivator with intrinsic HAT activity, activated the wild-type MDR1 promoter",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Jul 18(7) 4377-84",
                "id": "9632821"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0125"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Nov 24(22) 10083-98",
                "id": "15509808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0124"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "in hearts, the activity of CBP and p300 is stimulated by phenylephrine (PE) treatment and that they are required for the activation of atrial naturetic factor (ANF) gene expression by PE",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2517-24",
                "id": "11705990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0123"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Intrinsic histone acetyltransferase activity of p300 also plays a critical role in regulating DMP1 gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 44294-302",
                "id": "15308641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0122"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Recent studies indicate that FOXO transcription factors are acetylated by p300 and CREB-binding protein, co-activators possessing acetyltransferase activity, at several conserved lysine residues, many of which are located in the DNA-binding domain (Fukuoka et al., 2003; van derHor st et al., 2004).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2312-9",
                "id": "18391973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0121"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "A major site of Stat3 that is acetylated by its coactivator, p300/CREB-binding protein (CBP), resides in the C-terminal transcriptional activation domain at lysine 685.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11528-34",
                "id": "15649887"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0120"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Interestingly, WRN acetylation can increase its protein stability. SIRT1-mediated deacetylation of WRN reverses this effect.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(4) e10341",
                "id": "20428248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe011f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "p300 was detectable in nucleus and its binding to a COX-2 promoter probe was enhanced by phorbol 12-myristate 13-acetate (PMA), interleukin-1 beta(IL-1 beta),or lipopolysaccharide (LPS)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Mar 15 103(6) 2135-42",
                "id": "14630807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe011e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Remarkably, acetylation of the Fen1 C terminus by p300 significantly reduced Fen1's DNA binding and nuclease activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jun 7(6) 1221-31",
                "id": "11430825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe011d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "These data further indicate that the acetylase activity of p300 was indispensable to its function. Furthermore, we found that p300 was able to enhance the effect of the transcription factor c-Fos on activation of the IL-18 promoter. Data presented in this paper implicate important roles of p300 in the transcriptional regulation of IL-18.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2005 Feb 15 94(3) 566-72",
                "id": "15543578"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe011c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "The extent of the acetylation is up-regulated by the transforming growth factor-beta signaling pathway and down-regulated by histone deacetylase activities.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 9 279(28) 29409-17",
                "id": "15138260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe011b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Here we show that two APC/C components, APC5 and APC7, interact directly with the coactivators CBP and p300 through protein-protein interaction domains that are evolutionarily conserved in adenovirus E1A. This interaction stimulates intrinsic CBP/p300 acetyltransferase activity and potentiates CBP/p300-dependent transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Dec 1 438(7068) 690-5",
                "id": "16319895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe011a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Here, we demonstrate that ER81 is acetylated by two coactivators/acetyltransferases, p300 and p300- and CBP-associated factor (P/CAF) in vitro and in vivo. Whereas p300 acetylates two lysine residues (K33 and K116) within the ER81 N-terminal transactivation domain, P/CAF targets only K116. Acetylation of ER81 not only enhances its ability to transactivate but also increases its DNA binding activity and in vivo half-life.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(17) 6243-54",
                "id": "12917345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0119"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "the PKA responsive domain in CBP resides near its amino terminus..at this point PKA activation of p300/CBP remains egnimatic",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13505-8",
                "id": "11279224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0118"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "CSE-induced COX-2 expression was also mediated through the recruitment of p300 associated with NF-kappaB in HTSMCs, revealed by coimmunoprecipitation and Western blot analysis. In addition, pretreatment with the inhibitors of NF-kappaB (helenalin) and p300 (garcinol) or transfection with p65 siRNA and p300 siRNA markedly inhibited CSE-regulated COX-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 Nov 297(5) L892-902",
                "id": "19717552"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0117"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "p300-mediated acetylation results in increased Myc turnover.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Dec 25(23) 10220-34",
                "id": "16287840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0116"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Here we show that HIPK2 phosphorylates the activation domain of Pax6, which augments Pax6 transactivation by enhancing its interaction with p300.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 17 281(11) 7489-97",
                "id": "16407227"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0115"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Our ChIP assays demonstrate a dioxin-dependent recruitment of members of the p160 family of coactivator proteins (SRC-1 and SRC-2), the p300 coactivator protein, as well as BRG-1, an ATPasecontaining subunit of the SWI-SNF complex, to the CYP1A1 and CYP1B1 genes (Figs. 3AD).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2009 Jan 107(1) 1-8",
                "id": "18842620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0114"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Akt-mediated phosphorylation of p300 dramatically increases its acetyltransferase activity as measured by an increased acetylation of RelA/p65 at Lys(310), a modification that is required for full NF-kappaB transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 20 281(42) 31359-68",
                "id": "16926151"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0113"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Here we show that H3K56 is acetylated and that this modification is regulated in a cell cycle-dependent manner in mammalian cells. We also demonstrate that the histone acetyltransferase p300 acetylates H3K56 in vitro and in vivo, whereas hSIRT2 and hSIRT3 deacetylate H3K56ac in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Sep 10 285(37) 28553-64",
                "id": "20587414"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0112"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Our results demonstrate that phosphorylation of p65 determines whether it associates with either CBP or HDAC-1, ensuring that only p65 entering the nucleus from cytoplasmic NF-kappa B:Ikappa B complexes can activate transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Mar 9(3) 625-36",
                "id": "11931769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0111"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Indeed, acetylation on Lys 730 drives c-Abl accumulation in the cytoplasm and promotes differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2006 Jul 7(7) 727-33",
                "id": "16648821"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0110"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Cotransfection of an AhR promoter-luciferase reporter plasmid with a vector expressing the E1A(12s) oncoprotein, a negative regulator of p300, a protein with histone acetylase activity, decreased AhR promoter activity fivefold.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2000 Feb 15 374(2) 161-71",
                "id": "10666294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe010f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "In contrast, co-transfection of p300 and CBP with ESE-1 enhances the transcriptional activity of ESE-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 11 279(24) 25241-50",
                "id": "15075319"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe010e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "First, AMPK triggered the acetylation of importin alpha1 on Lys(22), a process dependent on the acetylase activity of p300. Second, AMPK phosphorylated importin alpha1 on Ser(105)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 12 279(46) 48376-88",
                "id": "15342649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe010d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "WRN can be acetylated by acetyltransferase CBP/p300, and SIRT1 can deacetylate WRN both in vitro and in vivo. WRN acetylation decreases its helicase and exonuclease activities, and SIRT1 can reverse this effect.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Mar 21 283(12) 7590-8",
                "id": "18203716"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe010c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": " By using immunoprecipitation and HAT activity assay we have found that p300 and CBP have similar tissue patterns of HAT activities, with the highest level in the brain, a relatively high level in the lung, spleen, and heart, an intermediate level in testes and muscle, and a lower level in liver and kidney",
              "citation": {
                "type": "PubMed",
                "name": "J Gerontol A Biol Sci Med Sci 2002 Mar 57(3) B93-8",
                "id": "11867645"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe010b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Surprisingly, NAP-1 potently inhibited acetylation of core histones by p300, suggesting that efficient assembly requires acetylation of either NAP-1 or p300 itself.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 May 22(9) 2974-83",
                "id": "11940655"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe010a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "SIRT1 Deacetylates Foxo3a and p300 and Represses p300-Mediated Activation of Foxo3a",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Feb 20 116(4) 551-63",
                "id": "14980222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0109"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "The CBP/p300-interacting transactivator with ED-rich tail 2 (CITED2) binds EP300 and CREBBP with high affinity and regulates gene transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2001 Dec 29(4) 469-74",
                "id": "11694877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0108"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "CBP and p300 are recruited by retinoic acid receptors (RARs)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Mar 21 302(4) 841-8",
                "id": "12646247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0107"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EP300) actsIn cat(p(HGNC:EP300))",
              "summary_text": "Here, we examine the functional mechanisms of JDP2 and show that it can inhibit p300-mediated acetylation of core histones in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Struct Mol Biol 2006 Mar 5",
                "id": "16518400"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0106"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:XPA)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:XPA))",
        "directed": false,
        "label": "p(HGNC:XPA) actsIn cat(p(HGNC:XPA))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0992",
          "evidences": [
            {
              "bel_statement": "p(HGNC:XPA) actsIn cat(p(HGNC:XPA))",
              "summary_text": "Figure 7. Model for the Assembly of the Human NER Incision Complex",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 213-24",
                "id": "11511374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe080c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:XPA) actsIn cat(p(HGNC:XPA))",
              "summary_text": "Finally, the XPA-RPA complex is shown to have a greater affinity for damaged DNA than XPA alone. Taken together, these results indicate that the interaction between XPA and RPA is required for NER but that only the interaction with RPA-70 is essential.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Oct 15(10) 5396-402",
                "id": "7565690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe080b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:XPA) actsIn cat(p(HGNC:XPA))",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe080a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ERCC2)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:ERCC2))",
        "directed": false,
        "label": "p(HGNC:ERCC2) actsIn cat(p(HGNC:ERCC2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0993",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ERCC2) actsIn cat(p(HGNC:ERCC2))",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe071c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ERCC2) actsIn cat(p(HGNC:ERCC2))",
              "summary_text": "Two components of core TFIIH, i.e., the XPB and XPD proteins, are helicases responsible for unwinding the DNA helix in NER",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 213-24",
                "id": "11511374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0137"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP73,pmod(P,Y,28))",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "p(HGNC:TP73,pmod(P,Y,28)) directlyDecreases tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0994",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP73,pmod(P,Y,28)) directlyDecreases tscript(p(HGNC:TP73))",
              "summary_text": "Co-expression of p73 with Hck or c-Src in mammalian cells resulted in tyrosine phosphorylation of p73. Using site directed mutational analysis, we determined that Tyr-28 was the major site of phosphorylation by Hck and c-Src, unlike c-Abl which phosphorylates Tyr-99. ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Mol Biol 2007 8 45",
                "id": "17535448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0138"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:HCK))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP73,pmod(P,Y,28))",
        "directed": false,
        "label": "kin(p(HGNC:HCK)) directlyIncreases p(HGNC:TP73,pmod(P,Y,28))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0995",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:HCK)) directlyIncreases p(HGNC:TP73,pmod(P,Y,28))",
              "summary_text": "Co-expression of p73 with Hck or c-Src in mammalian cells resulted in tyrosine phosphorylation of p73. Using site directed mutational analysis, we determined that Tyr-28 was the major site of phosphorylation by Hck and c-Src, unlike c-Abl which phosphorylates Tyr-99. ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Mol Biol 2007 8 45",
                "id": "17535448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0139"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "phos(p(HGNC:PNKP))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "phos(p(HGNC:PNKP)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0996",
          "evidences": [
            {
              "bel_statement": "phos(p(HGNC:PNKP)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "Human polynucleotide kinase/phosphatase (PNKP) is a dual specificity 5'-DNA kinase/3'-DNA phosphatase, with roles in base excision repair, DNA single-strand break repair and non-homologous end joining (NHEJ)",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2011 Aug 8",
                "id": "21824916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe013a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "phos(p(HGNC:PNKP))",
        "relation": "increases",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "phos(p(HGNC:PNKP)) increases bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0997",
          "evidences": [
            {
              "bel_statement": "phos(p(HGNC:PNKP)) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "Human polynucleotide kinase/phosphatase (PNKP) is a dual specificity 5'-DNA kinase/3'-DNA phosphatase, with roles in base excision repair, DNA single-strand break repair and non-homologous end joining (NHEJ)",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2011 Aug 8",
                "id": "21824916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe013b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ERCC3)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:ERCC3))",
        "directed": false,
        "label": "p(HGNC:ERCC3) actsIn cat(p(HGNC:ERCC3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0998",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ERCC3) actsIn cat(p(HGNC:ERCC3))",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe071d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ERCC3) actsIn cat(p(HGNC:ERCC3))",
              "summary_text": "Two components of core TFIIH, i.e., the XPB and XPD proteins, are helicases responsible for unwinding the DNA helix in NER",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 213-24",
                "id": "11511374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe013c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ABL1,pmod(P,S,465))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:ABL1))",
        "directed": false,
        "label": "p(HGNC:ABL1,pmod(P,S,465)) directlyIncreases kin(p(HGNC:ABL1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0999",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ABL1,pmod(P,S,465)) directlyIncreases kin(p(HGNC:ABL1))",
              "summary_text": "from full text - Fig 2 and 3 - ATM kinase activates c-Abl kinase.  Serine-465 of c-Abl is required for tyrosine kinase activation by ionizing radiation and ATM.  3T3 cells",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 May 29 387(6632) 516-9",
                "id": "9168116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe013e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1,pmod(P,S,465)) directlyIncreases kin(p(HGNC:ABL1))",
              "summary_text": "<A2> ATM phosphorylates c-Abl on Ser465 and thereby activates the kinase (Baskaran et al., 1997b). <A3> Phosphorylation by ATM activates c-Abl (Baskaran et al., 1997b). c-Abl tyrosine kinase activity is stimulated in response to ionizing radiation (IR), 1-b-d-arabinofuransylcytosine, camptothecin, or etoposide (Yuan et al., 1996, 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe013d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ABL1)",
        "relation": "hasModification",
        "target": "p(HGNC:ABL1,pmod(P,S,465))",
        "directed": false,
        "label": "p(HGNC:ABL1) hasModification p(HGNC:ABL1,pmod(P,S,465))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe099a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ABL1) hasModification p(HGNC:ABL1,pmod(P,S,465))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe013f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to ionizing radiation\")",
        "relation": "increases",
        "target": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "directed": false,
        "label": "bp(GOBP:\"response to ionizing radiation\") increases bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe099b",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to ionizing radiation\") increases bp(GOBP:\"cellular response to DNA damage stimulus\")",
              "summary_text": "The double-strand break (DSB) repair heterotrimeric complex DNA-PK interacts with the BRCT1 domain of XRCC1 and phosphorylates this domain at serine 371 after ionizing irradiation.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "16397295"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "55775d252f9e24174cfe07fa"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "hela cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"response to ionizing radiation\") increases bp(GOBP:\"cellular response to DNA damage stimulus\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to ionizing radiation\")",
        "relation": "increases",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "bp(GOBP:\"response to ionizing radiation\") increases kin(p(HGNC:ATM))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe099c",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to ionizing radiation\") increases kin(p(HGNC:ATM))",
              "summary_text": "We have demonstrated that ionizing radiation-associated DNA double-strand breaks (DSBs) induce phosphorylation of at least Ser-56 and Ser-101 residues on Sp1 in an ATM-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Oct 20(10) 1795-803",
                "id": "18619531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0141"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"response to ionizing radiation\") increases kin(p(HGNC:ATM))",
              "summary_text": "ATM is one of the major kinases that phosphorylate p53 at Ser15 after IR and that ATM also phosphorylates and activates Chk2 after IR, which then phosphorylates p53 at Ser20",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Jan 28(1) 448-56",
                "id": "17967874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0140"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to ionizing radiation\")",
        "relation": "decreases",
        "target": "p(HGNC:NET1,pmod(P,S,152))",
        "directed": false,
        "label": "bp(GOBP:\"response to ionizing radiation\") decreases p(HGNC:NET1,pmod(P,S,152))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe099d",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to ionizing radiation\") decreases p(HGNC:NET1,pmod(P,S,152))",
              "summary_text": "A 70% decrease in the levels of pS152-Net1A was observed within 30 min after irradiation....Thus, exposure to DNA damage induces dephosphorylation of Net1 on its negative regulatory site.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2008 3(5) e2254",
                "id": "18509476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0142"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to ionizing radiation\")",
        "relation": "increases",
        "target": "gtp(p(HGNC:RHOB))",
        "directed": false,
        "label": "bp(GOBP:\"response to ionizing radiation\") increases gtp(p(HGNC:RHOB))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe099e",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to ionizing radiation\") increases gtp(p(HGNC:RHOB))",
              "summary_text": "The increase in RhoB activity after genotoxic stress is associated with increased activity of the nuclear guanine nucleotide exchange factors (GEFs), Ect2 and Net1, but not the cytoplasmic GEFs p115 RhoGEF or Vav2.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(2) e17108",
                "id": "21373644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0143"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to ionizing radiation\")",
        "relation": "increases",
        "target": "a(SCHEM:\"double-stranded DNA break\")",
        "directed": false,
        "label": "bp(GOBP:\"response to ionizing radiation\") increases a(SCHEM:\"double-stranded DNA break\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe099f",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to ionizing radiation\") increases a(SCHEM:\"double-stranded DNA break\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0144"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to ionizing radiation\")",
        "relation": "increases",
        "target": "complex(p(HGNC:CCND1),p(HGNC:RAD51))",
        "directed": false,
        "label": "bp(GOBP:\"response to ionizing radiation\") increases complex(p(HGNC:CCND1),p(HGNC:RAD51))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a0",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to ionizing radiation\") increases complex(p(HGNC:CCND1),p(HGNC:RAD51))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0145"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:POLB))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:POLB)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a1",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:POLB)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates. ",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0147"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:POLB)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "We describe a novel regulatory mechanism for DNA polymerase beta (Polbeta), a protein involved in DNA base excision repair (BER).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Nov 10(5) 1213-22",
                "id": "12453427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0146"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:POLB))",
        "relation": "increases",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "cat(p(HGNC:POLB)) increases bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a2",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:POLB)) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0148"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53,pmod(P,S,15))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a3",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Fractionation of HeLa nuclear extracts and biochemical analyses indicate that this kinase is distinct from the DNA-dependent protein kinase (DNA-PK) and corresponds to the human cell cycle checkpoint protein ATR. Immunoprecipitation studies of recombinant ATR reveal that catalytic activity of this polypeptide is required for DNA-stimulated phosphorylation of p53 on serine-15.  These data suggest that ATR may function upstream of p53 in a signal transduction cascade initiated upon DNA damage and provide a biochemical assay system for ATR activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jul 8 18(27) 3989-95",
                "id": "10435622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe071f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "In addition, treatment of cells with the PKC activator phorbol ester stimulated the ubiquitination of p53 and reduced its ability to accumulate after stress. H7 did not induce the phosphorylation of human p53 on Ser-15 (Ser-18 in mouse protein), a modification that occurs in response to DNA damage and leads to the release of MDM2 and to transactivation by p53",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 24 276(34) 31819-24",
                "id": "11431470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe071e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Phosphorylation of serine 15 increases the transcriptional activity of p53 (ref. 22).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Oct 2(10) 762-5",
                "id": "11025670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe014d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "In this report, we utilized small interfering RNA to deplete BRCA1 and BARD1 to demonstrate that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated/ATM and Rad3-related)-mediated phosphorylation of p53(Ser-15) following IR- and UV radiation-induced DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31251-8",
                "id": "15159397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe014c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "In the present study, we demonstrate that PP-1 can dephosphorylate p53 at Ser-15 and Ser-37 through co-immunoprecipitation, in vitro and in vivo dephosphorylation assays, overexpression and silence of the gene encoding the catalytic subunit for PP-1. We further show that mutations mimicking constitutive dephosphorylation or phosphorylation of p53 at these sites attenuate or enhance its transcriptional activity, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 May 18 25(21) 3006-22",
                "id": "16501611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe014b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "PRPK phosphorylates serine-15 residue of p53 and enhances transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 May 26 344(1) 377-85",
                "id": "16600182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe014a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,15)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "The intrinsic transcriptional activity of p53 was up-regulated by a transient transfection of PRPK to COS-7 cells. PRPK was shown to bind to p53 and to phosphorylate p53 at Ser-15.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 23 276(47) 44003-11",
                "id": "11546806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0149"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAD51)",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "directed": false,
        "label": "p(HGNC:RAD51) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a4",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAD51) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
              "summary_text": "Like RecA, RAD51 coats singlestranded DNA (ssDNA) substrates to form a helical nucleoprotein filament, which then invades and pairs with homologous sequences in duplex DNA, initiating the strand-exchange reactions that underlie homologous recombination. There is compelling in vitro and in vivo evidence that the RAD51 nucleoprotein filament is an essential intermediate in these reactions.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0720"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAD51) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
              "summary_text": "Cell extracts from MEFs null for Rad51C and p53 show reduced in vitro HJ resolvase activities compared with controls.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe014e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "embryo"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAD51)",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "p(HGNC:RAD51) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a5",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAD51) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "The RAD52 epistasis group of proteins, including Rad51, Rad52, and Rad54, plays an important role in the homologous recombination repair of double strand breaks",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 13 277(50) 48944-8",
                "id": "12379650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe014f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAD51)",
        "relation": "hasComponent",
        "target": "complex(p(HGNC:CCND1),p(HGNC:RAD51))",
        "directed": false,
        "label": "p(HGNC:RAD51) hasComponent complex(p(HGNC:CCND1),p(HGNC:RAD51))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a6",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAD51) hasComponent complex(p(HGNC:CCND1),p(HGNC:RAD51))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0150"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:POLE2)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:POLE2))",
        "directed": false,
        "label": "p(HGNC:POLE2) actsIn cat(p(HGNC:POLE2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a7",
          "evidences": [
            {
              "bel_statement": "p(HGNC:POLE2) actsIn cat(p(HGNC:POLE2))",
              "summary_text": "After a 24- to 32-residue oligonucleotide is released, the gap is filled in by PCNA-dependent POL epsilon or delta and sealed by a DNA ligase, presumably LIG1.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0151"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2))",
        "relation": "hasComponent",
        "target": "p(HGNC:BRCA1)",
        "directed": false,
        "label": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2)) hasComponent p(HGNC:BRCA1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a8",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2)) hasComponent p(HGNC:BRCA1)",
              "summary_text": "Mono-ubiquitylation of FANCD2. Let's now return instead to the connection between BRCA1 and the FA proteins (FIG. 3). BRCA1 co-localizes with (and binds to) FANCD2 in nuclear foci that are induced by DNA damage. The movement of FANCD2 into these foci is promoted by the attachment of a single ubiquitin moiety to the side chain of a conserved lysine residue (Lys561); this modification does not occur in cells that are deficient in other FA proteins, which assemble together in a nuclear complex of uncertain stoichiometry and unknown function. The simplest interpretation of these observations is that the FA-protein nuclear complex is required for the mono-ubiquitylation of FANCD2 in response to DNA damage, and that FANCD2 is targeted to foci by a mono-ubiquitin-binding protein or complex.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0722"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2)) hasComponent p(HGNC:BRCA1)",
              "summary_text": "Thus, these proteins act upstream of BRCA1 in the assembly of DNA repair foci at double-strand breaks. Moreover, they all contain C-terminal BRCT domains, which have been identified as binding modules for phosphoserine peptides.(64-66) The BRCT domains of BRCA1 are important for its movement to repair foci (see next section). Additional proteins known to co-localize with BRCA1-BARD1 at damage-induced foci include TOP-BP1,(67) Replication Protein A,(68) FANCD2(69) and Bloom syndrome protein.(70) It is important to note that no studies have yet evaluated the impact of ionising radiation on more than a few different repair proteins within the same cell line.",
              "citation": {
                "type": "PubMed",
                "name": "Bioessays 2005 Sep 27(9) 884-93",
                "id": "16108063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0721"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2)) hasComponent p(HGNC:BRCA1)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Feb 7(2) 249-62",
                "id": "11239454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0152"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2))",
        "relation": "hasComponent",
        "target": "p(HGNC:FANCD2)",
        "directed": false,
        "label": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2)) hasComponent p(HGNC:FANCD2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09a9",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2)) hasComponent p(HGNC:FANCD2)",
              "summary_text": "Thus, these proteins act upstream of BRCA1 in the assembly of DNA repair foci at double-strand breaks. Moreover, they all contain C-terminal BRCT domains, which have been identified as binding modules for phosphoserine peptides.(64-66) The BRCT domains of BRCA1 are important for its movement to repair foci (see next section). Additional proteins known to co-localize with BRCA1-BARD1 at damage-induced foci include TOP-BP1,(67) Replication Protein A,(68) FANCD2(69) and Bloom syndrome protein.(70) It is important to note that no studies have yet evaluated the impact of ionising radiation on more than a few different repair proteins within the same cell line.",
              "citation": {
                "type": "PubMed",
                "name": "Bioessays 2005 Sep 27(9) 884-93",
                "id": "16108063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0724"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2)) hasComponent p(HGNC:FANCD2)",
              "summary_text": "Mono-ubiquitylation of FANCD2. Let's now return instead to the connection between BRCA1 and the FA proteins (FIG. 3). BRCA1 co-localizes with (and binds to) FANCD2 in nuclear foci that are induced by DNA damage. The movement of FANCD2 into these foci is promoted by the attachment of a single ubiquitin moiety to the side chain of a conserved lysine residue (Lys561); this modification does not occur in cells that are deficient in other FA proteins, which assemble together in a nuclear complex of uncertain stoichiometry and unknown function. The simplest interpretation of these observations is that the FA-protein nuclear complex is required for the mono-ubiquitylation of FANCD2 in response to DNA damage, and that FANCD2 is targeted to foci by a mono-ubiquitin-binding protein or complex.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0723"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:FANCD2)) hasComponent p(HGNC:FANCD2)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Feb 7(2) 249-62",
                "id": "11239454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0153"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATR)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:ATR))",
        "directed": false,
        "label": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09aa",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "inhibition of ERK1/2 signaling resulted in marked attenuation in IR-induced ATR activity with little, if any, effect on IR-induced ATM activation. Furthermore, inhibition of ERK1/2 signaling resulted in >/=85% attenuation in IR-induced G2/M arrest and concomitant diminution of IR-induced activation of ataxia telangiectasia mutated- and rad3-related (ATR), Chk1 and Wee1 kinases as well as phosphorylation of Cdc25A-Thr506, Cdc25C-Ser216 and Cdc2-Tyr15.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 12 26(32) 4689-98",
                "id": "17297454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe072c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Thus, stimuli that activate these kinases, including exposure to pro-inflammatory cytokines, UV irradiation, DNA damage or change in ROS, are among the classic inducers of ATF2 transcriptional activity (van Dam et al., 1995).ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe072b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In response to genotoxic stress (i.e. DNA-damaging agents), the E2F1 protein is stabilized through distinct mechanisms including: (i) direct phosphorylation by ataxia-telangiectasia- mutated (ATM) kinase, ATM- and RAD3-related (ATR) kinase and checkpoint 2 (CHK2) kinase and (ii) acetylation through p300/CREB-binding-proteinassociated factor (P/CAF)",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe072a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In this study, we show that BRCA1 phosphorylation is only partially ATM dependent in response to IR and ATM independent in response to treatment with UV light, or the DNA replication inhibitors hydroxyurea (HU) and aphidicolin (APH) We provide evidence that the kinase responsible for this phosphorylation is the ATM-related kinase, ATR. ATR phosphorylates BRCA1 on six Ser/Thr residues, including Ser 1423, in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Dec 1 14(23) 2989-3002",
                "id": "11114888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0729"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Fractionation of HeLa nuclear extracts and biochemical analyses indicate that this kinase is distinct from the DNA-dependent protein kinase (DNA-PK) and corresponds to the human cell cycle checkpoint protein ATR. Immunoprecipitation studies of recombinant ATR reveal that catalytic activity of this polypeptide is required for DNA-stimulated phosphorylation of p53 on serine-15.  These data suggest that ATR may function upstream of p53 in a signal transduction cascade initiated upon DNA damage and provide a biochemical assay system for ATR activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jul 8 18(27) 3989-95",
                "id": "10435622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0728"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In this report we provide evidence that the ATM-Rad3-related protein ATR regulates phosphorylation of Ser-15 in DNA-damaged cells. Overexpression of catalytically inactive ATR (ATRki) in human fibroblasts inhibited Ser-15 phosphorylation in response to gamma-irradiation and UV light. In gamma-irradiated cells, ATRki expression selectively interfered with late-phase Ser-15 phosphorylation, whereas ATRki blocked UV-induced Ser-15 phosphorylation in a time-independent manner. ATR phosphorylated p53 at Ser-15 and Ser-37 in vitro, suggesting that p53 is a target for phosphorylation by ATR in DNA-damaged cells.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Jan 15 13(2) 152-7",
                "id": "9925639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0727"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The nuclear staining pattern of BRCA1 is consistent with its nuclear functions in different types of DNA repair pathways,( 19,20) cell cyle control(2) and transcriptional activation.(21) The use of cell fractionation coupled withWestern blot analysis has revealed that BRCA1 is most frequently detected in the nuclear compartment, but that a portion of it can also be detected in the cytoplasm in different cell lines.(27,35,36) Immunohistochemistry has generally disclosed a loss of BRCA1 in breast tumour of increasing grade and from patients carrying germ-line BRCA1 mutations,(37) although, in many instances, the use of N-terminal antibodies such as Ab1 provide a non-specific cellular profile, in that they cross-react with other naturally occurring forms of BRCA1, such as the exon-11 splice variants(31) and possibly the novel truncated form of BRCA1, BRCA1-IRIS.(38) All forms of BRCA1 so far identified, except for the naturally occuring truncated form BRCA1-IRIS, have been detected in nuclear dots at Sphase (33,39) and in DNA-damage induced nuclear foci.(35,40) BRCA1-IRIS was found to associate with chromatin directly and, unlike wild-type BRCA1, it did not associate with BARD1 in vitro or in vivo in immunoprecipitation assays.(38) In meiotic cells, BRCA1 is detectable at the sex chromsomes and has been implicated in recruiting the ATR kinase to XY chromatin at the onset of the pachytene stage of meiotic prophase during mammalian spermatogenesis.(41) It was proposed that ATR then phosphorylates H2AX to signal meiotic sex chromosome inactivation.(41)",
              "citation": {
                "type": "PubMed",
                "name": "Bioessays 2005 Sep 27(9) 884-93",
                "id": "16108063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0726"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In this report we provide evidence that the ATM-Rad3-related protein ATR regulates phosphorylation of Ser-15 in DNA-damaged cells. Overexpression of catalytically inactive ATR (ATRki) in human fibroblasts inhibited Ser-15 phosphorylation in response to gamma-irradiation and UV light. In gamma-irradiated cells, ATRki expression selectively interfered with late-phase Ser-15 phosphorylation, whereas ATRki blocked UV-induced Ser-15 phosphorylation in a time-independent manner. ATR phosphorylated p53 at Ser-15 and Ser-37 in vitro, suggesting that p53 is a target for phosphorylation by ATR in DNA-damaged cells.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Jan 15 13(2) 152-7",
                "id": "9925639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0725"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "these kinases phosphorylate CDC25C, the molecule that is responsible for activating CDK1",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0183"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Fhit overexpression leads to apoptosis in many cancer cell lines. We report in this study that Fhit-/- cells derived from gene knockout mice show much stronger S and G2 checkpoint responses than their wild type counterparts. The strong checkpoint responses are regulated by the ATR/CHK1 pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Feb 202(2) 518-23",
                "id": "15389587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0182"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Significantly, ATR activity is also required for ARF-induced p53 activity and inhibition of proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Mar 23 24(6) 1157-69",
                "id": "15775976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0181"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show that Rad9's role in Chk1 activation is to bind TopBP1, which stimulates ATR-mediated Chk1 phosphorylation via TopBP1's activation domain (AD), a domain that binds and activates ATR. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Jun 15 21(12) 1472-7",
                "id": "17575048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0180"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In this report, we utilized small interfering RNA to deplete BRCA1 and BARD1 to demonstrate that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated/ATM and Rad3-related)-mediated phosphorylation of p53(Ser-15) following IR- and UV radiation-induced DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31251-8",
                "id": "15159397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe017f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": " Treatment with estrogen can block DNA damage-induced senescence. Moreover, WRN is suppressed by ATR that is activated by DNA damage, whereas WRN can be induced by ATR elimination. ",
              "citation": {
                "type": "PubMed",
                "name": "Horm Res Paediatr 2010 74(1) 33-40",
                "id": "20395656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe017e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns. Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4129-39",
                "id": "11390642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe017d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In the present study, we identify two novel DNA damage-inducible phosphorylation sites on FANCD2, threonine 691 and serine 717. ATR phosphorylates FANCD2 on these two sites, thereby promoting FANCD2 monoubiquitination and enhancing cellular resistance to DNA cross-linking agents",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Sep 26(18) 7005-15",
                "id": "16943440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe017c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show for the first time that MRN is required for ATR-dependent phosphorylation of structural maintenance of chromosomes 1 (Smc1)",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2005 Sep 15 14(18) 2685-93",
                "id": "16087684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe017b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe017a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": " ATR activation requires several factors, including the BRCT repeat-containing TopBP1 protein and the 9-1-1 clamp protein",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Sep 15 8(18) 2877-84",
                "id": "19652550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0179"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "When ATM and ATR are recruited to sites of damage, they target many substrates, including checkpoint kinase-2 (CHK2) and CHK1, respectively (FIG. 2; BOX 2).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0178"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": " Here we describe the FA protein FANCI, identified as an ATM/ATR kinase substrate required for resistance to mitomycin C.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Apr 20 129(2) 289-301",
                "id": "17412408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0177"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "ATR phosphorylates Chk2 on Thr68 in vitro, and phosphorylation of Thr68 in response to IR occurs later in cells lacking ATM (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Sep 12 97(19) 10389-94",
                "id": "10973490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0176"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Thr-26 is evidently a good ATR substrate in vitro (34).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 7 278(10) 8468-75",
                "id": "12493754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0175"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "caffeine, a widely used inhibitor to ATM/ATR",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jun 15 184(12) 6901-9",
                "id": "20488792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0174"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Nov 6 98(23) 13102-7",
                "id": "11687627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0173"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) kinases regulate cell cycle checkpoints by phosphorylating multiple substrates including the CHK1 and -2 protein kinases and p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 26 278(39) 37139-45",
                "id": "12847089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0172"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hum Genet 105(1-2) 17-27",
                "id": "10480350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0171"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Oct 29 323(4) 1197-202",
                "id": "15451423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0170"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Jul 15 15(14) 1833-44",
                "id": "11459832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe016f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Interestingly, this function of the FA-protein nuclear complex might be mediated through FANCD2, which is phosphorylated by ATR using a mechanism that requires FANCC79.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe016e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Evasion from apoptosis is a hallmark of cancer, and recent success using targeted therapeutics underscores the importance of identifying anti-apoptotic survival pathways. Here we utilize RNA interference (RNAi) to systematically screen the kinase and phosphatase component of the human genome.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Jun 7(6) 591-600",
                "id": "15864305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe016d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 41656-60",
                "id": "11514540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe016c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Phosphorylation of ATM/ATR substrates and H2AX in VSMCs increased with disease severity in vivo (Figure 1A), reaching 70% to 90% of intimal VSMCs in advanced disease.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Sep 26 103(7) 717-25",
                "id": "18723444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe016b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Phosphorylation on Chk1(Ser-345), Chk2(Thr-68), and p53(Ser-15)following oxidative damage by IR involved both ATM and ATR. phosphorylation on Chk1, Chk2, and p53 was found to be ATM-dependent, whereas ATR also contributed to Chk1 phosphorylation ... from full text, A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1186-92",
                "id": "15533933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe016a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Oct 1 65(19) 8613-6",
                "id": "16204026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0169"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "ATR-dependent activation of Chk1 is mediated by Claspin. Phosphorylation of Claspin at two sites (Thr916 and Ser945 in humans) in response to DNA replication arrest or DNA damage recruits Chk1 to Claspin.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2008 May 9 369(3) 973-6",
                "id": "18331829"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0168"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "UV transiently increased GSK-3beta activity, and this increase could be blocked by caffeine or by ATR small interfering RNA, indicating ATR-dependent activation of GSK-3beta.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Apr 27(8) 3187-98",
                "id": "17283049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0167"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Taken together, our data indicate that S407 phosphorylation of Mdm2 by ATR reduces Mdm2-dependent export of p53 from nuclei to cytoplasm",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Dec 4 22(55) 8870-80",
                "id": "14654783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0166"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Here, we report that replicative stress induces the polyubiquitination and degradation of Chk1 in human cells. This response is triggered by phosphorylation of Chk1 at Ser-345, a known target site for the upstream activating kinase ATR. These findings indicate that ATR-dependent phosphorylation of Chk1 delivers a signal that both activates Chk1 and marks this protein for proteolytic degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Sep 2 19(5) 607-18",
                "id": "16137618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0165"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Using chemical inhibitors and small interfering RNA of the signaling kinases, we show that a MMR-mediated 6-TG-induced G2 arrest is ATR/CHK1 dependent but ATM/CHK2 independent and that ATR/CHK1 signaling is responsible for both initiation and maintenance of the G2 arrest. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Sep 3(9) 1147-57",
                "id": "15367709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0164"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In response to stress, Atr participates in the down-regulation of FRAG1 expression, leading to the induction of apoptosis through the release of Rad9 from damaged chromatin during the S phase of the cell cycle, allowing Rad9-Bcl2 association and induction of proapoptotic Bax protein.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jul 5 102(27) 9655-60",
                "id": "15983387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0163"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": " Silencing of ATR or ATM and inhibition of ATM activity by KU-55933 blocked Chk1 activation and RRM2 up-regulation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 3 284(27) 18085-95",
                "id": "19416980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0162"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show that pure ATR is a protein kinase which is activated by circular single-stranded, double-stranded or linear DNA.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Nov 18 18(48) 6707-13",
                "id": "10597277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0161"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "TRF2 represses ATM, whereas POT1 prevents activation of ATR. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2007 Aug 30 448(7157) 1068-71",
                "id": "17687332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0160"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We demonstrate that activating ATR is sufficient to promote cell cycle arrest",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2008 Feb 1 22(3) 297-302",
                "id": "18245444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe015f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Here, we show that ATRIP contains a TopBP1-interacting region that is necessary for the association of TopBP1 and ATR, for TopBP1-mediated activation of ATR, and for cells to survive and recover DNA synthesis following replication stress.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2008 Jun 1 22(11) 1478-89",
                "id": "18519640"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe015e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show that caffeine's ability to inhibit ATR (but not ATM) causes PCC, that ATR (but not ATM) prevents PCC, and that ATR prevents PCC via Chk-1 regulation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Jul 31 98(16) 9092-7",
                "id": "11481475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe015d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "15073328;16293623",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe015c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show that recombinant TopBP1 induces a large increase in the kinase activity of both Xenopus and human ATR",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2006 Mar 10 124(5) 943-55",
                "id": "16530042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe015b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "heterogeneous nuclear ribonucleoprotein K (hnRNP K) as being rapidly induced by DNA damage in a manner that requires the DNA-damage signaling kinases ATM or ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Dec 16 123(6) 1065-78",
                "id": "16360036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe015a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "ATM and Rad3-related (ATR) is a regulatory kinase that, when activated by hydroxyurea, UV, or human immunodeficiency virus-1 Vpr, causes cell cycle arrest through Chk1-Ser(345) phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Mar 9 282(10) 7287-98",
                "id": "17210576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0159"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Initiation of these checkpoints is dependent on the transient recruitment of the MRE11/RAD50/NBS1 (MRN) complex at DSB sites, followed by the recruitment/activation of ataxiatelangiectasia mutated (ATM) a member of the family of phosphoinositide-3-kinase-related kinases (PIKKs) (Su, 2006). In addition, two other PIKKs, DNA-dependent protein kinase (DNAPK) and ATR (ATM and Rad3 related), are also activated and involved in the response to DSBs.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0158"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "ATR phosphorylates Chk1 at Ser317 and Ser345 in vitro, and phosphorylation of these sites in human cells in response to UV and hydroxyurea is ATR-dependent [1619].",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Jun 1 388(Pt 2) 705-12",
                "id": "15707391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0157"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6056-64",
                "id": "16880517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0156"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The ATM (23) and ATR (24) protein kinases play key roles in p53 activation in response to IR and UV, respectively. Bulky chemical adducts have also been shown to induce stabilization and nuclear accumulation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Feb 24(2) 225-34",
                "id": "12584171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0155"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0154"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1))",
        "relation": "hasComponent",
        "target": "p(HGNC:RAD1)",
        "directed": false,
        "label": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) hasComponent p(HGNC:RAD1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ab",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) hasComponent p(HGNC:RAD1)",
              "summary_text": " ATR activation requires several factors, including the BRCT repeat-containing TopBP1 protein and the 9-1-1 clamp protein",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Sep 15 8(18) 2877-84",
                "id": "19652550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0185"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) hasComponent p(HGNC:RAD1)",
              "summary_text": " These results reveal that the 9-1-1 complex plays a direct role in base excision repair",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Nov 15 400(1) 53-62",
                "id": "16879101"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0184"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1))",
        "relation": "hasComponent",
        "target": "p(HGNC:HUS1)",
        "directed": false,
        "label": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) hasComponent p(HGNC:HUS1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ac",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) hasComponent p(HGNC:HUS1)",
              "summary_text": " These results reveal that the 9-1-1 complex plays a direct role in base excision repair",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Nov 15 400(1) 53-62",
                "id": "16879101"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0187"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) hasComponent p(HGNC:HUS1)",
              "summary_text": " ATR activation requires several factors, including the BRCT repeat-containing TopBP1 protein and the 9-1-1 clamp protein",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Sep 15 8(18) 2877-84",
                "id": "19652550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0186"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1))",
        "relation": "increases",
        "target": "kin(p(HGNC:ATR))",
        "directed": false,
        "label": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) increases kin(p(HGNC:ATR))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ad",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) increases kin(p(HGNC:ATR))",
              "summary_text": " ATR activation requires several factors, including the BRCT repeat-containing TopBP1 protein and the 9-1-1 clamp protein",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Sep 15 8(18) 2877-84",
                "id": "19652550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0188"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1))",
        "relation": "hasComponent",
        "target": "p(HGNC:RAD9A)",
        "directed": false,
        "label": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) hasComponent p(HGNC:RAD9A)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ae",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) hasComponent p(HGNC:RAD9A)",
              "summary_text": " ATR activation requires several factors, including the BRCT repeat-containing TopBP1 protein and the 9-1-1 clamp protein",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Sep 15 8(18) 2877-84",
                "id": "19652550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe018a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) hasComponent p(HGNC:RAD9A)",
              "summary_text": " These results reveal that the 9-1-1 complex plays a direct role in base excision repair",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Nov 15 400(1) 53-62",
                "id": "16879101"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0189"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09af",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:RAD9A),p(HGNC:RAD1),p(HGNC:HUS1)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": " These results reveal that the 9-1-1 complex plays a direct role in base excision repair",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Nov 15 400(1) 53-62",
                "id": "16879101"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe018b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PARP1))",
        "relation": "decreases",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "cat(p(HGNC:PARP1)) decreases bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775d252f9e24174cfe09b0",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PARP1)) decreases bp(GOBP:\"DNA repair\")",
              "summary_text": "we determined the role of PARP-1 in p21-mediated DNA damage by administering a selective PARP-1 inhibitor 3-AB to p21-/- and WT mice prior to CS exposure. As expected, lung PARP-1 activity, which is reflected by PAR level, was inhibited after 3-AB treatment (Figure 3).",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "24244594"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe018c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PARP1))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:PARP1)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09b1",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PARP1)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "Poly(ADP-ribose) polymerase (PARP) is a critical DNA repair enzyme involved in DNA single-strand break repair via the base excision repair pathway",
              "citation": {
                "type": "PubMed",
                "name": "Curr Drug Targets 2011 Jul 21",
                "id": "21777194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe018e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:PARP1)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "The DNA damage-dependent poly(ADP-ribose) polymerase-2 (PARP-2) is, together with PARP-1, an active player of the base excision repair process, thus defining its key role in genome surveillance and protection.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(4) 1595-607",
                "id": "14749375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe018d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:YAP1)",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "p(HGNC:YAP1) directlyIncreases tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09b2",
          "evidences": [
            {
              "bel_statement": "p(HGNC:YAP1) directlyIncreases tscript(p(HGNC:TP73))",
              "summary_text": "Yes-associated protein (YAP), also containing WW domains, was shown to associate with p73 and enhance its transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Aug 1 65(15) 6764-72",
                "id": "16061658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe018f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BRCA1),p(HGNC:TP53))",
        "relation": "hasComponent",
        "target": "p(HGNC:BRCA1)",
        "directed": false,
        "label": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:BRCA1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09b3",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:BRCA1)",
              "summary_text": "The main downstream targets (of BRCA1) identified so far are p53-responsive genes, including p21 and BcIX13. BRCA1 binds to BRCA2, p53, RAD51 and many other proteins involved in cell cycling and DNA-damage response14,15 (Fig. 2a). The involvement of BRCA1 in response to DNA damage is supported by extensive data, including evidence that BRCA1 is phosphorylated by the ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) proteins in response to DNA damage16,17, that cells without functional BRCA1 do not arrest in G2 after DNA damage and are deficient in transcription-coupled repair18,19, and that BRCA1 is part of the RAD50-MRE11-p95 complex, an essential component of recombination- mediated repair of DNA double-stranded breaks20.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2001 May 7(5) 552-6",
                "id": "11329055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe072d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:BRCA1)",
              "summary_text": "BRCA1 physically associates with p53 and stimulates its transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Apr 2 16(13) 1713-21",
                "id": "9582019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0193"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:BRCA1)",
              "summary_text": "<p47> p53 binds BRCA1. This binding enhances the transcriptional activity of P53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0192"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:BRCA1)",
              "summary_text": "BRCA1a interacts with p53.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jan 7 18(1) 263-8",
                "id": "9926942"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0191"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:BRCA1)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Mar 3 95(5) 2302-6",
                "id": "9482880"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0190"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BRCA1),p(HGNC:TP53))",
        "relation": "hasComponent",
        "target": "p(HGNC:TP53)",
        "directed": false,
        "label": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:TP53)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09b4",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:TP53)",
              "summary_text": "The main downstream targets (of BRCA1) identified so far are p53-responsive genes, including p21 and BcIX13. BRCA1 binds to BRCA2, p53, RAD51 and many other proteins involved in cell cycling and DNA-damage response14,15 (Fig. 2a). The involvement of BRCA1 in response to DNA damage is supported by extensive data, including evidence that BRCA1 is phosphorylated by the ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) proteins in response to DNA damage16,17, that cells without functional BRCA1 do not arrest in G2 after DNA damage and are deficient in transcription-coupled repair18,19, and that BRCA1 is part of the RAD50-MRE11-p95 complex, an essential component of recombination- mediated repair of DNA double-stranded breaks20.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2001 May 7(5) 552-6",
                "id": "11329055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe072e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:TP53)",
              "summary_text": "BRCA1 physically associates with p53 and stimulates its transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Apr 2 16(13) 1713-21",
                "id": "9582019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0197"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:TP53)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Mar 3 95(5) 2302-6",
                "id": "9482880"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0196"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:TP53)",
              "summary_text": "<p47> p53 binds BRCA1. This binding enhances the transcriptional activity of P53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0195"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) hasComponent p(HGNC:TP53)",
              "summary_text": "BRCA1a interacts with p53.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jan 7 18(1) 263-8",
                "id": "9926942"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0194"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BRCA1),p(HGNC:TP53))",
        "relation": "increases",
        "target": "p(HGNC:CDKN1A)",
        "directed": false,
        "label": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) increases p(HGNC:CDKN1A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09b5",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BRCA1),p(HGNC:TP53)) increases p(HGNC:CDKN1A)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0198"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHEK2,pmod(P,S,33))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:CHEK2))",
        "directed": false,
        "label": "p(HGNC:CHEK2,pmod(P,S,33)) directlyIncreases kin(p(HGNC:CHEK2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09b6",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK2,pmod(P,S,33)) directlyIncreases kin(p(HGNC:CHEK2))",
              "summary_text": "Compared to the wild-type form, Chk2 with alanine substitutions at S19, S33, and S35 (Chk2(S3A)) showed impaired dimerization, defective auto- and trans-phosphorylation activities, and reduced ability to promote degradation of Hdmx, a phosphorylation target of Chk2 and regulator of p53 activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Nov 26(21) 7832-45",
                "id": "16940182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0199"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHEK2,pmod(P,S,35))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:CHEK2))",
        "directed": false,
        "label": "p(HGNC:CHEK2,pmod(P,S,35)) directlyIncreases kin(p(HGNC:CHEK2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09b7",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK2,pmod(P,S,35)) directlyIncreases kin(p(HGNC:CHEK2))",
              "summary_text": "Compared to the wild-type form, Chk2 with alanine substitutions at S19, S33, and S35 (Chk2(S3A)) showed impaired dimerization, defective auto- and trans-phosphorylation activities, and reduced ability to promote degradation of Hdmx, a phosphorylation target of Chk2 and regulator of p53 activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Nov 26(21) 7832-45",
                "id": "16940182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe019a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PRKDC)",
        "relation": "hasModification",
        "target": "p(HGNC:PRKDC,pmod(P,S,2612))",
        "directed": false,
        "label": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,S,2612))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09b8",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,S,2612))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe019b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA1)",
        "relation": "hasModification",
        "target": "p(HGNC:BRCA1,pmod(P,S,1387))",
        "directed": false,
        "label": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1387))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09b9",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1387))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe019c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MYC)",
        "relation": "increases",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "p(HGNC:MYC) increases kin(p(HGNC:ATM))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ba",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MYC) increases kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation of the ATM kinase and its downstream effectors, such as histone H2AX, were impaired in the myc null cell line HO15.19, compared to the myc positive TGR-1 and HOmyc3 cells. Nuclear foci formation of the Nijmegen Breakage Syndrome (Nbs) 1 protein, essential for efficient ATM activation, was also reduced in absence of myc",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(1) e8924",
                "id": "20111719"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe019d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MYC)",
        "relation": "increases",
        "target": "p(HGNC:NBN)",
        "directed": false,
        "label": "p(HGNC:MYC) increases p(HGNC:NBN)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09bb",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MYC) increases p(HGNC:NBN)",
              "summary_text": "Phosphorylation of the ATM kinase and its downstream effectors, such as histone H2AX, were impaired in the myc null cell line HO15.19, compared to the myc positive TGR-1 and HOmyc3 cells. Nuclear foci formation of the Nijmegen Breakage Syndrome (Nbs) 1 protein, essential for efficient ATM activation, was also reduced in absence of myc",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(1) e8924",
                "id": "20111719"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe019e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP73))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CDKN1A)",
        "directed": false,
        "label": "tscript(p(HGNC:TP73)) directlyIncreases p(HGNC:CDKN1A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09bc",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP73)) directlyIncreases p(HGNC:CDKN1A)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe019f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP73))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:MDM2)",
        "directed": false,
        "label": "tscript(p(HGNC:TP73)) directlyIncreases p(HGNC:MDM2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09bd",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP73)) directlyIncreases p(HGNC:MDM2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCND1)",
        "relation": "hasComponent",
        "target": "complex(p(HGNC:CCND1),p(HGNC:RAD51))",
        "directed": false,
        "label": "p(HGNC:CCND1) hasComponent complex(p(HGNC:CCND1),p(HGNC:RAD51))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09be",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CCND1) hasComponent complex(p(HGNC:CCND1),p(HGNC:RAD51))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCND1)",
        "relation": "increases",
        "target": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "directed": false,
        "label": "p(HGNC:CCND1) increases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09bf",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CCND1) increases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to oxidative stress\")",
        "relation": "decreases",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "bp(GOBP:\"response to oxidative stress\") decreases bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c0",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to oxidative stress\") decreases bp(GOBP:\"DNA repair\")",
              "summary_text": "Growth in physiological (3%) oxygen or in the presence of an antioxidant prevented the development of the DNA damage foci in WRN-depleted cells, whereas acute oxidative stress led to inefficient repair of the lesions. Furthermore, WRN RNAi-induced DNA damage was suppressed by overexpression of the telomere-binding protein TRF2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Dec 25(23) 10492-506",
                "id": "16287861"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe081c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "relation": "isA",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "bp(GOBP:\"double-strand break repair via homologous recombination\") isA bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c1",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"double-strand break repair via homologous recombination\") isA bp(GOBP:\"double-strand break repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:RAD50))",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "cat(p(HGNC:RAD50)) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c2",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:RAD50)) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "In pursuit of the involvement of HIF-alpha in chromosomal instability, we report here that HIF-1alpha, specifically its PAS-B, induces DNA double-strand breaks at least in part by repressing the expression of NBS1, a crucial DNA repair gene constituting the MRE11A-RAD50-NBS1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4784-94",
                "id": "17024177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:\"3-aminobenzoic acid\")",
        "relation": "decreases",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "a(CHEBI:\"3-aminobenzoic acid\") decreases bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c3",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:\"3-aminobenzoic acid\") decreases bp(GOBP:\"DNA repair\")",
              "summary_text": "In contrast to the repair observed when smoke-exposed cells were allowed to recover in control medium, in the presence of 3-ABA, DNA repair was completely blocked (Figure 10).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2005 Aug 33(2) 121-9",
                "id": "15845867"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHEK2)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:CHEK2))",
        "directed": false,
        "label": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c4",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The main downstream targets (of BRCA1) identified so far are p53-responsive genes, including p21 and BcIX13. BRCA1 binds to BRCA2, p53, RAD51 and many other proteins involved in cell cycling and DNA-damage response14,15 (Fig. 2a). The involvement of BRCA1 in response to DNA damage is supported by extensive data, including evidence that BRCA1 is phosphorylated by the ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) proteins in response to DNA damage16,17, that cells without functional BRCA1 do not arrest in G2 after DNA damage and are deficient in transcription-coupled repair18,19, and that BRCA1 is part of the RAD50-MRE11-p95 complex, an essential component of recombination- mediated repair of DNA double-stranded breaks20.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2001 May 7(5) 552-6",
                "id": "11329055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0732"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway  for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-DCdk4 from phosphorylating Rb  unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 46,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0731"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0730"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "from full text - To study the effects of SOCS1 in normal cells, we infected the human diploid fibroblast strain IMR90 with a retroviral vector encoding SOCS1 or a control vector. Expression of SOCS1 inhibited cell growth (Figure 3A) and induced senescence, characterized by senescence-associated ?-galactosidase staining (Figure S3A) and the accumulation of PML bodies (Figure S3B). In addition, SOCS1 induced high levels of p53 and its target, p21; a reduction in Rb phosphorylation; and the inhibition of E2F target genes such as Mcm6 (Figure 3B). Intriguingly, during SOCS1-induced senescence, the increase in p53 levels was accompanied with serine 15 phosphorylation of p53 (Figure 3B) and activation of the DNA damage-regulated kinases ATM and Chk2 (Figure 3C). Staining of SOCS1-expressing cells with an antibody against ?H2AX revealed numerous DNA damage foci (Figure S3C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2009 Dec 11 36(5) 754-67",
                "id": "20005840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe072f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "activation of ATM and ATR in turn activates CHK2 and CHK1, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Mutation of MDMX on S342, S367, and S403 each confers partial resistance to MDM2-mediated ubiquitination and degradation.  Phosphorylation of S342 and S367 in vivo require the Chk2 kinase. Chk2 also stimulates MDMX ubiquitination and degradation by MDM2",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Oct 5 24(19) 3411-22",
                "id": "16163388"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 278-88",
                "id": "10673500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "activated CHK2 can phosphorylate and therefore inactivate the phosphatases CDC25A, which controls S phase entry (Melo et al., 2001), and CDC25C, which is required for activation of the mitotic promoting force (MPF) complex of CDK2/ cyclin B to enter mitosis (Figure 1) (Takai et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "First, BRCA1 is a target for phosphorylation by several of the protein serine/threonine kinases (for example, ATM, ATR and CHK2) that signal the presence of DNA breakage46, and its modification by these enzymes seems essential for further participation in mechanisms that enforce cell-cycle checkpoints that are triggered by DNA damage in the S and G2 phases of the cell cycle47-49.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "As shown in Figure 1A, in response to IR, ATM (pS1981) was efficiently activated regardless of cell cycle phase. We observed both rapid phosphorylation of Chk2 on Thr-68, a known ATM phosphorylation site, and enhanced Chk2 kinase activity (Figure 1B,C), after irradiation of interphase cells.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS Biol 2010 8(1) e1000287",
                "id": "20126263"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Whereas one mutation within the Chk2 forkhead homology-associated (FHA) domain, R145W, retains some basal kinase activity, this mutant cannot be phosphorylated at an ATM-dependent phosphorylation site (Thr-68) and cannot be activated following gamma radiation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 26 276(4) 2971-4",
                "id": "11053450"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 30537-41",
                "id": "11390408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "However, activation of HA3-Cds1(T68A) was greatly compromised after irradiation.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Oct 2(10) 762-5",
                "id": "11025670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "from full text - Accordingly, activation of the checkpoint kinase CHK2 (encoded by CHEK2) by DNA damage stimulates a rapid discharge of the mitochondrial pool of survivin in the cytosol (40)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Jan 8(1) 61-70",
                "id": "18075512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Furthermore, FoxM1 protein is phosphorylated by checkpoint kinase 2 (Chk2) in response to DNA damage. This phosphorylation of FoxM1 on serine residue 361 caused increased stability of the FoxM1 protein with corresponding increased transcription of XRCC1 and BRCA2 genes",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Feb 27(3) 1007-16",
                "id": "17101782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "from full text - Consistent with a role of ATM in the phosphorylation of Chk2, Thr68 phosphorylation and Chk2 activation were not detected in ATM-deficient FT169A cells after IR, while Chk2 was phosphorylated and activated in the isogenic, wild-type ATM-reconstituted YZ5 cells ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 47755-8",
                "id": "11668173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Phosphorylation by Chk1 and Cds1/Chk2 down-regulates Cdc25A levels in response to genotoxic stresses",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 31838-42",
                "id": "12801928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Phosphorylation of Chk2 in vivo by ataxia telangiectasia-mutated (ATM) on threonine 68 (T68) initiates a phosphorylation cascade that promotes the full activity of Chk2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Nov 26(21) 7832-45",
                "id": "16940182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Using chemical inhibitors and small interfering RNA of the signaling kinases, we show that a MMR-mediated 6-TG-induced G2 arrest is ATR/CHK1 dependent but ATM/CHK2 independent and that ATR/CHK1 signaling is responsible for both initiation and maintenance of the G2 arrest. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Sep 3(9) 1147-57",
                "id": "15367709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Both Chk1 and Chk2/Cds1 have been shown to localize to the nucleus and to phosphorylate serine 216 of Cdc25C in vitro (13, 15) (1821).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNAPK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "When ATM and ATR are recruited to sites of damage, they target many substrates, including checkpoint kinase-2 (CHK2) and CHK1, respectively (FIG. 2; BOX 2).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "As shown in Fig. 6A, Thr383 and Thr387 were not phosphorylated in kinase-dead hCds1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 30537-41",
                "id": "11390408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The CHK2 phosphorylates p53 at S20 and in turn activates it.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 289-300",
                "id": "10673501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "12399544;12676583;12759351;11298456",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "We also show that senescent cells contain activated forms of the DNA damage checkpoint kinases CHK1 and CHK2",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Nov 13 426(6963) 194-8",
                "id": "14608368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The respective kinetics of p53-Ser15 phosphorylation versus ATM and Chk2 activation suggest that in response to DNA damage by TPT or MXT, Chk2 rather than ATM mediates p53 phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2008 Oct 7(19) 3048-55",
                "id": "18802408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Chk2-mediated phosphorylation of MDMX on S367 is important for stimulating 14-3-3 binding, MDMX nuclear import by a cryptic nuclear import signal, and degradation by MDM2. Mutation of MDMX S367 inhibits ubiquitination and degradation",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Mar 22 25(6) 1196-206",
                "id": "16511560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "oxidative stress has been shown to activate CHK2 (cell cycle checkpoint kinase), which in turn phosphorylated HuR (RNA binding protein) and triggered the dissociation of the HuR-SIRT1 protein-mRNA complex. Association of HuR with SIRT1 increases the stability and longevity of SIRT1 mRNA [61].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "In response to ionizing radiation, Cdc25A is phosphorylated by both Chk1 and Chk2 on Ser-123. This in turn leads to ubiquitylation and rapid degradation of Cdc25A by the proteasome resulting in cell cycle arrest",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29824-9",
                "id": "12759351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "In the p53-dependent pathway, p53 accumulates following E2F1 expression [29] through activation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) transcript p14ARF, which in turn interacts with mouse double minutes (MDM2), thereby preventing MDM2 from targeting p53 for ubiquitination and subsequent degradation",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Science 2000 Mar 10 287(5459) 1824-7",
                "id": "10710310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "ATM is one of the major kinases that phosphorylate p53 at Ser15 after IR and that ATM also phosphorylates and activates Chk2 after IR, which then phosphorylates p53 at Ser20",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Jan 28(1) 448-56",
                "id": "17967874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Jun 1(8) 598-609",
                "id": "12805407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 May 5(5) 401-9",
                "id": "12717439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "However, no such activation was found in A-T cells indicating that caffeine inhibited the ATM-dependent Chk2/Cds1 activation (Fig. 3A, lanes 6 and 8).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Two peptides derived from the DNA-binding domain of p53 bind to CHK2 and stimulate phosphorylation of full-length p53 at Thr 18 and Ser 20, thus identifying CHK2-docking sites. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2003 Aug 4(8) 787-92",
                "id": "12897801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Evasion from apoptosis is a hallmark of cancer, and recent success using targeted therapeutics underscores the importance of identifying anti-apoptotic survival pathways. Here we utilize RNA interference (RNAi) to systematically screen the kinase and phosphatase component of the human genome.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Jun 7(6) 591-600",
                "id": "15864305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ERCC5)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:ERCC5))",
        "directed": false,
        "label": "p(HGNC:ERCC5) actsIn cat(p(HGNC:ERCC5))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c5",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ERCC5) actsIn cat(p(HGNC:ERCC5))",
              "summary_text": "Formation of this open complex creates specific sites for cutting on the 3' side by the XPG nuclease and then on the  5' side by the ERCC1-XPF nuclease.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ERCC5) actsIn cat(p(HGNC:ERCC5))",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ERCC5) actsIn cat(p(HGNC:ERCC5))",
              "summary_text": "Figure 7. Model for the Assembly of the Human NER Incision Complex",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 213-24",
                "id": "11511374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATF2)",
        "relation": "increases",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "p(HGNC:ATF2) increases kin(p(HGNC:ATM))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c6",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATF2) increases kin(p(HGNC:ATM))",
              "summary_text": "from full text - Figure 6. ATF2 Is Important for IR-Induced Activation of ATM and Chk2 (A) ATF2 is important for activation of ATM. U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 May 27 18(5) 577-87",
                "id": "15916964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATF2)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:ATF2))",
        "directed": false,
        "label": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c7",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Fig.1- shows proteins that interact with CBP/300 Transciptional activators= STAT1, (already).  SF1, TAL1, p73, Mdm2, HIF2?, ETS1, RXR, p65, Pit1 (POU1F1), HNF4, Stat2, EBNA2 (virus), HPV E2?, BRCA1, p45/NF-E2, c-JUN, c-myb, Tax?, Sap1, YY1, SREBP, ATF-1, ATF-4, Cubitus interuptusm GII3?, vIRF?, JMY, dMAD?, Py LT?, HPV E6, CIITA, Tat(HIV), SF-1, E2F, Ets-1, junB, C/EBPb, (already) GATA-1, Neuro D, Microphthalmia, E1A, Twist, p53 (already), Myo D, pp90 RSK, SMAD (already), ATF-2, c-Fos, SC40?, Large T? p300 k.o. are defective for RXR signal but not CREB",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13505-8",
                "id": "11279224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0736"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "A luciferase reporter plasmid, in which the human PDGF receptor ? promoter was linked to the luciferase gene, (21) was co-transfected into Chinese hamster ovary cells along with the ATF-2 expression plasmid (Fig. 4  C). ATF-2 increased luciferase gene expression about 2.7-fold. In contrast, the ATF-2 mutant (?BR), in which the basic region of the b-zip DNA-binding domain was deleted, did not enhance the activity of the PDGF receptor ? promoter. Another mutant (C32S), in which the metal finger structure in the NH2-terminal activation domain was disrupted by changing the cysteine residue at amino acid 32 into serine, also did not stimulate the luciferase expression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 18 274(25) 17813-9",
                "id": "10364225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0735"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Phosphorylated c-Jun and ATF2 proteins crosslinked with DNA were readily detectable following treatment with cisplatin, but not following transplatin or mock stimulation of cells, and were not detected with nonspecific rabbit sera or when a nonimmune rabbit IgG control serum was used for ChIP (Figure 1C). In order to identify promoter elements specifically bound by phosphorylated c-Jun and phosphorylated ATF2, the ChIP-captured DNA was applied to the promoter array in competition with genomic DNA isolated from crosslinked cells and treated in parallel.  Significantly differentially hybridized DNA was identified by t test. This calculation revealed over 300 differences with p < 0.05. We also required a fold change >1.5, leading to 269 genes of the 3083 genes surveyed that meet both criteria for significant intensity change. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2004 Nov 19 16(4) 521-35",
                "id": "15546613"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0734"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Sorbitol-okadaic acid caused the appearance of at least three reduced-mobility bands: two closely migrating bands of apparent molecular mass approx. 76 kDa (bands 2}3) and one band of approx. 87 kDa (band 4) (Figures 2A and 2B). To demonstrate that bands 2, 3 and 4 resulted from phosphorylation of ATF2,nuclear extracts from cells stimulated with sorbitolokadaic acid for 30 min were incubated with PP2A. This resulted in the reappearance of primarily the 69 kDa ATF2 band, with only a trace of band 2 remaining (Figure 2A).The appearance of the 69 kDa ATF2 was inhibited by including okadaic acid in the PP2A incubation. Cells were treated with (A) 05 M sorbitol02 lM okadaic acid, (B) 05 M sorbitol or (C) 50 ng/ml anisomycin.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1997 Aug 1 325 ( Pt 3) 801-10",
                "id": "9271103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0733"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Thus, stimuli that activate these kinases, including exposure to pro-inflammatory cytokines, UV irradiation, DNA damage or change in ROS, are among the classic inducers of ATF2 transcriptional activity (van Dam et al., 1995).ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Phosphorylation of downstream mitogen-activated protein kinase-targeted transcription factors including c-Myc, Elk-1, c-Jun, and activating transcription factor (ATF) 2 was also differentially enhanced",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jun 1 64(11) 3855-64",
                "id": "15172994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01fd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Mutation of either Thr69 or Thr71, or both, led to an almost complete loss of inducibility. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Apr 18 14(8) 1798-811",
                "id": "7737130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "When tested by cotransfection with AR, cJun and ATF2 specifically rescued androgen-mediated suppression of the alphaGSU-reporter construct in a gonadotrope-derived cell line",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2001 Sep 15(9) 1496-504",
                "id": "11518798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "In this work we present evidence that v-Myc encoded by the avian retrovirus MC29 stimulates activating transcription factor 2 (ATF2)-dependent transcription. Analysis of the effect of Myc on ATF2 shows that v-Myc prolongs the half-life of ATF2 and induces the phosphorylation of N-terminal sites of ATF2 (Thr-69 and Thr-71) which have previously been identified as the target sites of stress-activated protein kinases and implicated in the regulation of ATF2 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Dec 6 20(56) 8116-24",
                "id": "11781825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "The ATF2 transcription factor is phosphorylated by the stress-activated mitogen-activated protein kinases (MAPKs) JNK and p38. We show that this phosphorylation is essential for ATF2 function in vivo, since a mouse carrying mutations in the critical phosphorylation sites has a strong phenotype identical to that seen upon deletion of the DNA-binding domain",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Aug 15 21(16) 2069-82",
                "id": "17699753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Sublethal exposure of IMR-90 hTERT cells to H2O2 resulted in a time dependent increase of ATF-2 and p53 DNA binding activity (Fig. 2). The presence of 20 ?M SB203580 prevented the increased DNA binding activity of ATF-2 and p53",
              "citation": {
                "type": "PubMed",
                "name": "Biogerontology 2009 Jun 10(3) 291-8",
                "id": "19082758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 May 15 59(10) 2445-50",
                "id": "10344756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "p38-beta has a strong substrate preference for ATF2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Jul 26 271(30) 17920-6",
                "id": "8663524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "From Cell Signaling Technologies Pathway Maps for p38 and JNK signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2001 Apr 81(2) 807-69",
                "id": "11274345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "pp60(v-src) induction of ATF-2 was abolished by the c-Jun N-terminal kinase inhibitor JNK-interacting protein-1 or by mutation of ATF-2 at Thr69 and Thr71.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 12 274(11) 7341-50",
                "id": "10066798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "However, TNF treatment did result in activation of the transcription factor, ATF-2, a primary downstream target of p38 MAP kinase. Use of the p38 MAP kinase inhibitors SB202190 and SB203580 did not interfere with the ability of TNF to activate ATF-2, suggesting that either the gamma isoform of p38 MAP kinase or a p38-independent pathway was utilized by TNF to increase the phosphorylated fraction of ATF-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 1999 Apr 179(1) 58-66",
                "id": "10082133"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "ATF-2 and c-Jun bind to the FasL  promoter and activate FasL gene transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2000 Mar 20 191(6) 1017-30",
                "id": "10727463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "TNFa (10 ng/ml) also increased ATF2 phosphorylation, with maximal stimulation within 515 min [Fig. 6(b)].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 1999 Dec 31(12) 2087-99",
                "id": "10640438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "VRK1 can activate the collagenase gene promoter that is regulated by ATF2 in a dose-dependent manner. Loss of kinase activity (K179E mutant) or the T73A substitution in ATF2 prevents both its accumulation and activation of transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 25 279(26) 27458-65",
                "id": "15105425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": " Thus, of all the hypoxia-inducible genes, ATF-2 appears to regulate ~30% (39/126) of them, suggesting that ATF-2 is a major inducer of gene expression during hypoxic stress.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Mar 27(5) 1730-44",
                "id": "17189429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "The promoter of the ATF3 gene contains functional binding sites for ATF family members as well as an AP1 consensus sequence, and both ATF2 and c-jun have been implicated in stress-induced increases in ATF3 transcription (43).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Feb 24(2) 225-34",
                "id": "12584171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "An increase in ATF2 phosphorylation was detected after a 3-h DPTA-NO challenge (Fig. 8A).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2010 Jan 15 48(2) 298-305",
                "id": "19892011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "MKK3(Glu) increased ATF2- and Elk-1-dependent reporter gene expression but caused only a small increase in Jun-dependent gene expression (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ec"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Consistent with this, both Gal4-c-Jun- and Gal4-ATF2-fusion proteins were activated by RalA signalling through phosphorylation of their activation domains at Ser63 and Ser73 of c-Jun or Thr69 and Thr71 of ATF2.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Apr 5 20(15) 1816-24",
                "id": "11313929"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Dec 21(24) 8398-413",
                "id": "11713276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Our data reveal that loss of ATF2 transcriptional activity serves to promote skin tumor formation, thereby indicating a suppressor activity of ATF2 in skin tumor formation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Feb 5 105(5) 1674-9",
                "id": "18227516"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Fig. 6C shows a Western blot measuring the amount of phosphorylated ATF2, the active form of the transcription factor, induced by LPS in both the control and OxLDL pre-treated whole cell lysates. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28781-8",
                "id": "15107417"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Overall, the data strongly indicate that transcriptional activation of the rhoB gene by genotoxic stress is regulated via a CCAAT box and that interaction of CCAAT-binding factor and ATF-2 triggers the stress-inducible expression of rhoB.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2001 Feb 1 29(3) 792-8",
                "id": "11160903"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "It was encoded by a single gene and various transcripts were expressed in all tested tissues of adult mice, as well as in embryos, albeit at different levels in various tissues. Furthermore, mouse JDP2 bound to the cAMP-response element (CRE) as a homodimer or as a heterodimer with ATF-2, and repressed CRE-dependent transcription that was mediated by ATF-2.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Jan 26 489(1) 34-41",
                "id": "11231009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "By phosphorylating activating transcription factor 2 (ATF-2) and peroxisome proliferator-activated receptor gamma (PPARgamma) coativator 1alpha (PGC-1alpha), members of two distinct nuclear factor families, p38 MAPK controls the expression of the UCP1 gene through their respective interactions with a cAMP response element and a PPAR response element that both reside within a critical enhancer motif of the UCP1 gene.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Apr 24(7) 3057-67",
                "id": "15024092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Western blot analysis revealed that TGF? increased ATF2 phosphorylation as early as 5 min after stimulation but did not alter total ATF2 levels (Fig. 6). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 May 30 283(22) 15003-14",
                "id": "18387947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "The transcription factor ATF2, which is phosphorylated and activated by JNK, is a critical mediator for inducible expression of DUSP1 and DUSP10 in this signaling pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Sep 28 282(39) 28395-407",
                "id": "17681939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Sep 15 96(6) 2140-8",
                "id": "10979959"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": " FIGURE 7. ATF2 and c-Jun bind to an AP-1 site on the pglyrp2 promoter in C3A hepatocytes and this site is required for the constitutive expression of pglyrp2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 28 281(30) 20738-48",
                "id": "16714290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "In addition, ATF-2 binds to the -2.4-kb element even without induction and c-Fos to the -6.9-kb element only after induction. Accordingly, overexpression of c-Fos caused induction from the -6.9-kb element, but reduced induction from the -2.4-kb element. The involvement of the Ets-2 transcription factor was shown by using expression plasmids for wild-type and dominant negative Ets-2.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 1997 Nov 12 201(1-2) 179-87",
                "id": "9409785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01e0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "We confirmed that treatment with NE markedly enhances TGF-beta-induced phosphorylation of activating transcription factor 2 (ATF-2). These results indicated that NE has a synergistic effect on TGF-beta signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2002 Aug 40(2) 148-54",
                "id": "12154105"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01df"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": " ATF-2 enhanced the promoter activity of IFN gamma gene",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res Suppl 2001 (1) 89-90",
                "id": "12836278"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "We show here that the absence of ATF-2 in growth plate chondrocytes corresponds to a decline in Bcl-2 promoter activity, as well as a reduction in Bcl-2 protein levels. In addition, we show that ATF-2 as well as CREB, a transcription factor that can heterodimerize with ATF-2, bind to the CRE within the Bcl-2 promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2007 May 15 101(2) 477-87",
                "id": "17219413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01dd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Chromosomal DNA immunoprecipitation assays revealed that SMAD-3 and ATF-2 bind to the endogenous p19 promoter in RAW264.7 cells and SJL/J SPM following challenge with TMEV. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Oct 1 181(7) 4523-33",
                "id": "18802055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01dc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1998 Mar 15 101(6) 1432-40",
                "id": "9502786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "DNA damage and pro-inflammatory cytokines can induce activation of ATF2 transcriptional activity by JNK .",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(8) e23802",
                "id": "21901137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "JNK phosphorylation was inhibited in cells stably expressing RASSF1A, and the phosphorylation inhibition of JNK substrates, such as c-Jun and ATF-2, was then accompanied (Fig. 2D).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "We show that inhibition of ATF2 or ATF4 expression impairs the transcriptional activation of CHOP by amino acid starvation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 13 279(7) 5288-97",
                "id": "14630918"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 28 275(17) 12948-53",
                "id": "10777595"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "JNK phosphorylates ATF2 to enhance its transcription potential, and ATF2 acts synergisitically with p53 to carry out DNA repair . ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(11) e7820",
                "id": "19918364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Cotransfection experiments showed that ATF2 and c-Jun activate the C/EBPbeta gene expression cooperatively through URE2 and URE4, and this activation was greatly increased under the treatment of low concentration of anisomycin.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2002 Aug 21(8) 551-60",
                "id": "12215258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Increased expression of GSTp coincided with increased phosphorylation of ATF2 (Fig. 1b ? ) but not c-Jun, probably because of an increase in p38 activity (Fig. 1a ? ).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 1 60(15) 4053-7",
                "id": "10945608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "LPS-mediated activation of ATF-2 was inhibited by HDAC3 in a time- and dose-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Sep 15 173(6) 3979-90",
                "id": "15356147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "With regard to Maspin, ATF-2 and p53 directly bind to different sites in the Maspin promoter to independently activate its transcription. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Feb 14 27(8) 1045-54",
                "id": "17700520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Sin1 over-expression enhanced osmotic stress-induced phosphorylation of ATF-2 and ATF-2-mediated transcription, whereas knockdown of Sin1 expression by siRNA suppressed these responses. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2006 Nov 11(11) 1239-51",
                "id": "17054722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Figure 7A  shows that ATF-2 phosphorylation on Thr71 was increased ~10-fold after 15 min of incubation with TNF-alpha  and that the effect was gone by 30 min of incubation, a time course similar to the TNF-alpha -induced increase in p38 MAPK phosphorylation. Anisomycin treatment of the cells greatly increased the phosphorylation of ATF-2 and modestly increased the phosphorylation of c-Jun (Ser73; Fig. 7). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Aug 283(2) L418-27",
                "id": "12114204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "the transcriptional activity of the ATF-2 transcription factor, as a direct p38 and JNK target in syndecan-4-null and wild type cells. In the absence of syndecan-4, both ATF-2 phosphorylation and transcriptional activity were significantly more elevated compared with wild type cells, and both activities were decreased either by the re-expression of syndecan-4 or by the expression of RacN17.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 47172-6",
                "id": "15371457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Using chromatin immunoprecipitation assays, we previously showed that ATF-2 bound to these sites in the PTEN promoter in vivo (15). Here, we showed that ATF-2 binding to site 1 of the PTEN promoter was significantly increased by the palmitic acid treatment (Fig. 7B),",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Aug 55(8) 2301-10",
                "id": "16873694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Sep 1 61(17) 6569-76",
                "id": "11522656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Mutation of either Thr69 or Thr71, or both, led to an almost complete loss of inducibility. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Apr 18 14(8) 1798-811",
                "id": "7737130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "Activating transcription factor 2 (ATF-2) and p300 cooperate in the activation of transcription of the c-jun gene during the differentiation of F9 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jul 22(13) 4815-26",
                "id": "12052888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01cb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "A dominant-negative (DN) ATF2 significantly inhibited the TGF-beta-induced up-regulation of MMP-2,",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2007 Jul 8 252(1) 147-56",
                "id": "17258390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATF2) actsIn tscript(p(HGNC:ATF2))",
              "summary_text": "p38 MAPK and its substrate, activating transcription factor (ATF)-2, in bronchoalveolar lavage fluid cells were phosphorylated by intratracheal exposure of bleomycin, and the phosphorylation of ATF-2 was inhibited by subcutaneous administration of a specific inhibitor of p38 MAPK, FR-167653.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Jul 283(1) L103-12",
                "id": "12060566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01c9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:PCNA)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:PCNA)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c8",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:PCNA)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe01ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "decreases",
        "target": "p(HGNC:TOP2B)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) decreases p(HGNC:TOP2B)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09c9",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) decreases p(HGNC:TOP2B)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0200"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "increases",
        "target": "p(HGNC:RPRM)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) increases p(HGNC:RPRM)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ca",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) increases p(HGNC:RPRM)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0201"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:SFN)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:SFN)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09cb",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:SFN)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0202"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CDKN1A)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:CDKN1A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09cc",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:CDKN1A)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0203"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:BRCA1)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) directlyDecreases p(HGNC:BRCA1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09cd",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) directlyDecreases p(HGNC:BRCA1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0204"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:MDM2)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:MDM2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ce",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:MDM2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0205"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:GADD45A)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:GADD45A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09cf",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:GADD45A)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0206"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:GADD45B)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:GADD45B)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d0",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) directlyIncreases p(HGNC:GADD45B)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0207"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:TP53))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:TOP2A)",
        "directed": false,
        "label": "tscript(p(HGNC:TP53)) directlyDecreases p(HGNC:TOP2A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d1",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:TP53)) directlyDecreases p(HGNC:TOP2A)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0208"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATM,pmod(P,S,1981))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "p(HGNC:ATM,pmod(P,S,1981)) directlyIncreases kin(p(HGNC:ATM))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d2",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATM,pmod(P,S,1981)) directlyIncreases kin(p(HGNC:ATM))",
              "summary_text": "Figure 3 Nbs1 modulates ATMactivation after low doses of IR. Human NBS-Tert cells expressing different Nbs1 mutant forms and the cells infected with empty vector were irradiated with 2Gy and lysed at the indicated times (5 min to 8 h) after irradiation. Phosphorylation of S1981 of ATMand S966 of SMC1 and the total level of SMC1 were examined by immunoblotting as described in Figure 1",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 15 23(17) 3122-7",
                "id": "15048089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe020a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM,pmod(P,S,1981)) directlyIncreases kin(p(HGNC:ATM))",
              "summary_text": "In the cells exposed to CS, there is strong and rather uniform IF revealing the presence of activated ATM throughout the nucleus (Fig. 7C).",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2007 8 26",
                "id": "17594478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0209"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATM)",
        "relation": "hasModification",
        "target": "p(HGNC:ATM,pmod(P,S,1981))",
        "directed": false,
        "label": "p(HGNC:ATM) hasModification p(HGNC:ATM,pmod(P,S,1981))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d3",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATM) hasModification p(HGNC:ATM,pmod(P,S,1981))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe020b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "phos(p(HGNC:PPP1R13B))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "phos(p(HGNC:PPP1R13B)) directlyIncreases tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d4",
          "evidences": [
            {
              "bel_statement": "phos(p(HGNC:PPP1R13B)) directlyIncreases tscript(p(HGNC:TP73))",
              "summary_text": "Because ASPP-1 and ASPP-2 are specific activators of the apoptotic function of all p53 family members, E2F1 might use this pathway to increase the apoptotic function of p63 and p73 independently of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe020c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAD50)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:RAD50))",
        "directed": false,
        "label": "p(HGNC:RAD50) actsIn cat(p(HGNC:RAD50))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d5",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAD50) actsIn cat(p(HGNC:RAD50))",
              "summary_text": "In pursuit of the involvement of HIF-alpha in chromosomal instability, we report here that HIF-1alpha, specifically its PAS-B, induces DNA double-strand breaks at least in part by repressing the expression of NBS1, a crucial DNA repair gene constituting the MRE11A-RAD50-NBS1 complex.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4784-94",
                "id": "17024177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe020d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ABL1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:ABL1))",
        "directed": false,
        "label": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d6",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "c-Abl is an upstream regulator of the profibrotic PKCdelta/phospho-Fli-1 pathway, via induction of PKCdelta nuclear localization. Additionally, the finding that Fli-1 is phosphorylated (Thr312 phosphorylation) at higher levels in SSc fibroblasts supports the notion that the c-Abl/PKCdelta/phospho-Fli-1 pathway is constitutively activated in these cells. Thus, blocking the TGFbeta/c-Abl/PKCdelta/phospho-Fli-1 pathway could be an attractive alternative approach to therapy for scleroderma.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2011 Jun 63(6) 1729-37",
                "id": "21321929"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe073d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "We currently demonstrate interactions between Shb and c-Abl and that Shb regulates c-Abl kinase activity. The data suggest that c-Abl binds to tyrosine phosphorylated Shb via a concerted effort involving both the c-Abl SH3 and SH2 domains. The biological significance of the Shb/c-Abl interaction was presently tested in overexpression experiments and was found to promote hydrogen peroxide-induced cell death. We also show by Shb knockdown experiments that Shb regulates c-Abl activity and modulates cell death in response to the genotoxic agent cisplatin and the endoplasmic reticulum stress-inducer tunicamycin.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Jan 15 313(2) 284-91",
                "id": "17112510"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe073c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Analysis with anti-TPP36 antiserum revealed that TPP36 was expressed ubiquitously and had an isoform with 236 amino acids, designated TPP32. TPP36/32 were localized mainly in cytoplasm despite the presence of a typical nuclear localization signal sequence. These proteins were phosphorylated preferentially by Abl among a panel of tyrosine kinases examined. Phosphorylation of tyrosine 120 in TPP36/32 led to an apparent mobility shift in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, suggesting conformational change in the phosphorylated protein.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Feb 27 537(1-3) 203-9",
                "id": "12606058"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe073b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The present studies demonstrate that nuclear c-Abl binds constitutively to the protein tyrosine phosphatase SHPTP1. Treatment with ionizing radiation is associated with c-Abl-dependent tyrosine phosphorylation of SHPTP1. The results demonstrate that the SH3 domain of c-Abl interacts with a WPDHGVPSEP motif (residues 417-426) in the catalytic domain of SHPTP1 and that c-Abl phosphorylates C terminal Y536 and Y564 sites. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1996 Jul 9 93(14) 6898-901",
                "id": "8692915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe073a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Protein kinase D (PKD) participates in activation of the transcription factor NF-kappaB (nuclear factor kappaB) in cells exposed to oxidative stress, leading to increased cellular survival. We previously demonstrated that phosphorylation of PKD at Tyr463 in the PH (pleckstrin homology) domain is mediated by the Src-Abl pathway and that it is necessary for PKD activation and subsequent NF-kappaB induction.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Apr 24(7) 2614-26",
                "id": "15024053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0739"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "BCR-ABL TYROSINE KINASE INHIBITORS Bcr-Abl Tyrosine Kinase The hallmark of chronic myelogenous leukemia (CML) is the Philadelphia (Ph) chromosome [136], which represents the product of a reciprocal translocation between chromosomes 9 and 22. The molecular consequence of this translocation is replacement of the first exon of C-abl with sequences from the bcr gene, resulting in a bcr-abl fusion gene product with dysregulated, enhanced, tyrosine kinase activity. This oncoprotein stimulates various key signaling pathways, including those that involve ras, JAK2, STAT5, MAPK, PI-3-kinase, and nuclear factor kappa B (NF-?B). STI-571 The rational design of a molecular targeted therapy for the treatment of a specific malignancy is well exemplified by the successful development of STI-571 (Gleevec, imatinib mesylate). The success of this agent validates almost forty years of cancer research into the molecular pathogenesis of CML. It is a potent inhibitor with multiple targets, including the Bcr-abl, platelet-derived growth factor receptor (PDGF-R), and c-kit tyrosine kinases.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0738"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "DOKL and p62(dok) bind through their PTB domains to the Abelson tyrosine kinase in a kinase-dependent manner in both yeast and mammalian cells. DOKL is phosphorylated by the Abl tyrosine kinase in vivo. In contrast to p62(dok), DOKL lacks YxxP motifs in the C terminus and does not bind to Ras GTPase-activating protein (RasGAP) upon phosphorylation. Overexpression of DOKL, but not p62(dok), suppresses v-Abl-induced mitogen-activated protein (MAP) kinase activation but has no effect on constitutively activated Ras- and epidermal growth factor-induced MAP kinase activation. T",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Dec 19(12) 8314-25",
                "id": "10567556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0737"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Sep 18(9) 5082-90",
                "id": "9710592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe025b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2006 Jul 24 580(17) 4288-95",
                "id": "16831423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe025a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "92065884",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0259"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Jak2 peptide substrate studies indicated that the Bcr-Abl and Abl tyrosine kinases specifically phosphorylated Y1007 of Jak2 but only poorly phosphorylated Y1008.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 27 20(43) 6188-95",
                "id": "11593427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0258"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "We show that Abi-2 is a substrate for the c-Abl tyrosine kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1995 Nov 1 9(21) 2569-82",
                "id": "7590236"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0257"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "9525940;9102067;12522270;11997497;10829062",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0256"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Feb 13 336(2) 307-11",
                "id": "14757045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0255"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1988 May 17 27(10) 3682-90",
                "id": "2457390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0254"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29667-75",
                "id": "12777400"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0253"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "c-Abl tyrosine kinase associates with and phosphorylates Rad52 on tyrosine 104",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 13 277(50) 48944-8",
                "id": "12379650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0252"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "PLoS Biol 2003 Nov 1(2) E53",
                "id": "14624253"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0251"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Jan 8 16(1) 141-6",
                "id": "9467953"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0250"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The human pag gene product is an inhibitor of the c-abl tyrosine kinase and belongs to a new family of proteins.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1998 Feb 13 423(1) 39-44",
                "id": "9506838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe024f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 21 279(21) 22084-91",
                "id": "15031292"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe024e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The FAK and Fyn/Shc pathways. Integrins activate various protein tyrosine kinases, including focal adhesion kinase (FAK), Srcfamily kinases, and Abl, and a serine-threonine kinase, integrin-linked kinase (ILK) (4, 7).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe024d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe024c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "We also find that the Src family kinase Hck phosphorylates the Abl and Arg activation loops, leading to an additional twofold stimulation of kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jun 23(11) 3884-96",
                "id": "12748290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe024b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "<N12> Rad51 binds to c-Abl directly (Yuan et al., 1998). c-Abl phosphorylates Rad51 Tyr54, as a consequence of which the binding of Rad51 to ssDNA is inhibited (Yuan et al., 1998). IR induces c-Abl-dependent phosphorylation of Rad51 (Yuan et al., 1998).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe024a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Caveolin-1 phosphorylation in Src/Fyn/Yes knockout cells demonstrated that Abl phosphorylates caveolin-1 independently from Src family members. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2007 Apr 3 46(13) 3998-4005",
                "id": "17348685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0249"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Jun 24 399(6738) 814-7",
                "id": "10391251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0248"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "We show that DNA-PK phosphorylates and activates c-Abl in vitro. Cells deficient in DNA-PK are defective in c-Abl activation induced by ionizing radiation. In a potential feedback mechanism, c-Abl phosphorylates DNA-PK, but not Ku, in vitro. Phosphorylation of DNA-PK by c-Abl inhibits the ability of DNA-PK to form a complex with DNA. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 Apr 17 386(6626) 732-5",
                "id": "9109492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0247"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jan 25 102(4) 1098-103",
                "id": "15657136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0246"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Feb 13 273(7) 3799-802",
                "id": "9461559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0245"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The nonreceptor tyrosine kinase, proto-oncogene cAbl is a substrate of Src and is a major mediator for ROS-dependent tyrosine phosphorylation of Cav1. ",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2005 Oct 14 97(8) 829-36",
                "id": "16151024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0244"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "In a similar study with a cell line that had been derived from an individual with CML, Ricci et al. selected for resistance against the Abl kinase inhibitor imatinib13. In a fraction of the amplified Abl alleles, the resistant cells had the gatekeeper T315I mutation13, also found in individuals with imatinib-resistant CML2, that prevents inhibitor binding.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2007 Jun 13(6) 675-677",
                "id": "17554333"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0243"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "chronic myeloid leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "We examined whether tyrosine 221, which has been shown to be phosphorylated by c-Abl, was phosphorylated also by other tyrosine kinases, such as epidermal growth factor (EGF) receptor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jul 3 273(27) 17186-91",
                "id": "9642287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0242"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "In the present study, treatment of rat mesenteric arteries with phenylephrine (PE) led to the increase in CAS tyrosine phosphorylation and the association of CAS with the adapter protein CrkII. CAS phosphorylation was catalyzed by Abl in an in vitro study.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jul 5",
                "id": "17615370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0241"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Caveolin-1 is a substrate for nonreceptor tyrosine kinases including Src, Fyn, and Abl.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 15 277(11) 8771-4",
                "id": "11805080"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0240"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Cables also binds to and is a substrate of the c-Abl tyrosine kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 2000 Jun 26(3) 633-46",
                "id": "10896159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe023f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "the major tyrosine phosphorylation sites of Cbl by Abl are localized at tyrosine 700 and 774",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Jun 6 97(12) 6439-44",
                "id": "10829062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe023e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 51851-61",
                "id": "15448168"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe023d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Rad51 is a key element of recombinational DNA repair and its activity is regulated by phosphorylation of the tyrosine residue at position 315 by cAbl kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Jun 11 339(4) 797-804",
                "id": "15165851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe023c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "We show that Abi promotes Abl-mediated phosphorylation of Cdc2 at tyrosine 15 and inactivation of Cdc2 kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biomed Sci 11(6) 902-10",
                "id": "15591787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe023b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 16 278(20) 17969-76",
                "id": "12637538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe023a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Nov 24(22) 10058-71",
                "id": "15509806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0239"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "from full text - Fig 2 and 3 - ATM kinase activates c-Abl kinase.  Serine-465 of c-Abl is required for tyrosine kinase activation by ionizing radiation and ATM.  3T3 cells",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 May 29 387(6632) 516-9",
                "id": "9168116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0238"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3715-27",
                "id": "12110584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0237"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Cotransfection of tau and kinases showed that Tyr-18 was the major site for Fyn phosphorylation, but Tyr-394 was the main residue for Abl.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Jul 13 25(28) 6584-93",
                "id": "16014719"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0236"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Following exposure to ionizing radiation (IR), the BRCA1-c-Abl complex is disrupted in an ATM-dependent manner, which correlates temporally with ATM-dependent phosphorylation of BRCA1 and ATM-dependent enhancement of the tyrosine kinase activity of c-Abl. In vivo, BRCA1 is phosphorylated at tyrosine residues in an ATM-dependent, radiation-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4020-32",
                "id": "12024016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0235"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "c-Src-induced c-Abl activation involves phosphorylation of Y245 and Y412, two residues required for c-Abl mitogenic function.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Feb 15 21(4) 514-24",
                "id": "11847100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0234"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The c-Abl and Arg tyrosine kinases are activated in the cellular response to oxidative stress",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39609-14",
                "id": "12893824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0233"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Full text: ABL was found to associate with and phosphorylate the SHB homologue SHD [5].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Mol Med 2003 Jun 3(4) 313-24",
                "id": "12776987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0232"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "we identify two previously unknown targets of v-Abl signaling: (1) cyclin D1 and D2 mRNAs are induced upon v-Abl activation; and (2) the CDK inhibitor p27 is decreased upon v-Abl activation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Feb 10 19(6) 801-9",
                "id": "10698498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0231"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The present studies demonstrate that treatment of cells with hydrogen peroxide (H(2)O(2)) induces binding of the PKCdelta isoform and the c-Abl protein-tyrosine kinase. The results show that c-Abl phosphorylates PKCdelta in the H(2)O(2) response. We also show that PKCdelta phosphorylates and activates c-Abl in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 17 275(11) 7470-3",
                "id": "10713049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0230"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Interestingly, treatment of COS cells and B35 neuronal-like cells with ephrin-B1 to activate endogenous EphB2 decreased the kinase activity of endogenous Abl. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Jul 5 20(30) 3995-4006",
                "id": "11494128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe022f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The results demonstrate that c-Abl phosphorylates MUC1 on Tyr-60 and forms a complex with MUC1 by binding of the c-Abl SH2 domain to the pTyr-60 site.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Aug 23 25(16) 3774-83",
                "id": "16888623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe022e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Although naturally occurring mutations of STAT3 have not been reported, constitutive activation of this transcription factor depends on dysregulated oncogene kinases such as SRC, break cluster region (BCR)abelson (ABL) or MET, or viral oncogenes such as large T",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2007 Jan 13(1) 4-11",
                "id": "17118707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe022d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The binding of beta-catenin to these partners is regulated by phosphorylation of at least three critical tyrosine residues. Each of these residues is targeted by one or more specific kinases: Y142 by Fyn, Fer and cMet; Y489 by Abl; and Y654 by Src and the epidermal growth factor receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Cell Biol 2005 Oct 17(5) 459-65",
                "id": "16099633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe022c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "c-Abl phosphorylates the cytoskeleton-associated adaptor protein, Crk, at tyrosine 221, causing disassociation of Crk from the Crk-associated substrate (CAS) and disassembly of Crk/CAS complexes. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Sep 4 22(38) 6071-80",
                "id": "12955086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe022b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2000 Dec 6(6) 1413-23",
                "id": "11163214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe022a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The ubiquitously expressed c-Abl tyrosine kinase localizes to the cytoplasm and nucleus. Nuclear c-Abl is activated by diverse genotoxic agents and induces apoptosis;",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Mar 7(3) 278-85",
                "id": "15696159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0229"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "The c-Abl tyrosine (Tyr) kinase is activated after platelet-derived-growth factor receptor (PDGFR) stimulation in a manner that is partially dependent on Src kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 Apr 5(4) 309-19",
                "id": "12652307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0228"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "jubilant",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1999 Feb 15 93(4) 1338-45",
                "id": "9949177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0227"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jun 27 272(26) 16374-81",
                "id": "9195944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0226"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Furthermore, we show that activated Abl allows the ligand-activated EGFR to escape Cbl-dependent down-regulation by inhibiting the accumulation of Cbl at the plasma membrane in response to epidermal growth factor stimulation and disrupting the formation of the EGFR.Cbl complex without affecting Cbl protein stability.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 27 281(43) 32714-23",
                "id": "16943190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0225"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Aug 16 271(33) 19637-40",
                "id": "8702661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0224"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1999 Apr 15 93(8) 2707-20",
                "id": "10194451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0223"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "c-Abl activation by apoptotic agents specifically promotes phosphorylation of Lasp-1 at tyrosine 171, which is associated with the loss of Lasp-1 localization to focal adhesions and induction of cell death.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 May 10 165(3) 421-32",
                "id": "15138294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0222"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Our results show that despite the presence of higher than normal levels of DNA-PK kinase activity, c-Abl fails to become activated after IR exposure in ATM-deficient cells. Conversely, normal activation of both ATM and c-Abl occurs in DNA-PKcs-deficient cells, indicating that ATM but not DNA-PK is required for activation of Abl in response to IR treatment.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 29 275(39) 30163-8",
                "id": "10906134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0221"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "This study shows for the first time that the Abl kinase inhibitor and LY294002 induced HOXA10, and HOXA10 had an important role in apoptosis or cell growth inhibition in CML cells in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Leuk Res 2008 Jun 32(6) 962-71",
                "id": "18190961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0220"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "chronic myeloid leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(18) 6385-95",
                "id": "12944467"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe021f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "In cultured myotubes, Abl kinase activity was required for agrin-induced AChR clustering and enhancement of MuSK tyrosine phosphorylation. Moreover, MuSK and Abl kinases effected reciprocal tyrosine phosphorylation and formed a complex after agrin engagement.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2003 Jul 6(7) 717-23",
                "id": "12796783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe021e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Both Abl and Ena can directly bind to Robo's cytoplasmic domain. A mutant form of Robo that interferes with Ena binding is partially impaired in Robo function, while a mutation in a conserved cytoplasmic tyrosine that can be phosphorylated by Abl generates a hyperactive Robo receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2000 Jun 23 101(7) 703-15",
                "id": "10892742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe021d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Caveolin-1 is phosphorylated at tyrosine 14 in response to cellular stress. Tyrosine 14 is a consensus Abl phosphorylation site suggesting that caveolin-1 may be an Abl substrate. We report here that expression of c-Abl is required for oxidative stress-induced caveolin-1 phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Mar 15(3) 289-98",
                "id": "12531427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe021c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "We conclude that BCR-ABL PTK activity drives the expression of specific target genes",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Apr 1 60(7) 2049-55",
                "id": "10766197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe021b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "In this study, we showed that c-Abl-PKCdelta-Rac1-p38 MAPK signaling is required for the conformational changes of Bak and Bax during ionizing radiation-induced apoptotic cell death in human non-small cell lung cancer cells. Ionizing radiation induced conformational changes and subsequent oligomerizations of Bak and Bax, dissipation of mitochondrial membrane potential, and cytochrome c release from mitochondria.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 17 281(11) 7049-59",
                "id": "16410245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe021a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Expression levels of the three known PIM serine/threonine kinases (PIM-1, PIM-2, and PIM-3) were determined in Ba/F3 cells stably transformed to IL-3 independent growth by six constitutively active PTKs. High levels of PIM-1 and PIM-2 mRNA levels were detected in cells transformed by TEL/JAK2, TEL/TRKC, TEL/ABL, BCR/ABL, H4/PDGFRh, and FLT3-ITD (Fig. 1A)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Apr 1 66(7) 3828-35",
                "id": "16585210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0219"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Pag, also known as MSP23 and peroxiredoxin-1 Pag, a member of the peroxiredoxin family, has been reported previously to bind to and inhibit the cytostatic properties of the c-Abl oncoprotein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 43175-84",
                "id": "12196529"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0218"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Using the specific Abl tyrosine kinase inhibitor STI 571, we purified unphosphorylated murine type IV c-Abl",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 10 275(45) 35631-7",
                "id": "10964922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0217"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 May 22(10) 3292-300",
                "id": "11971963"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0216"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "that loss of Abl kinase activity reduces TCR-induced Zap70 phosphorylation at tyrosine 319.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2004 Jul 27 14(14) 1222-31",
                "id": "15268851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0215"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Exposure of ES cells to genotoxins caused an ATM-dependent nuclear accumulation of Abl but not Abl muNLS. ES cells expressing Abl muNLS exhibited delayed Bax activation, reduced cytochrome c release and decreased caspase-9 activity in response to DNA damage. These results provide a genetic proof that Abl nuclear entry contributes to DNA damage-induced activation of the intrinsic apoptotic pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2007 Jun 14(6) 1139-48",
                "id": "17363963"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0214"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Using a system that expresses a constitutively kinase-active c-Abl protein [c-Abl(KA)], we identified the protein IkappaBalpha as a novel substrate of c-Abl.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Sep 22(17) 6079-88",
                "id": "12167702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0213"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Co-expression of p73 with Hck or c-Src in mammalian cells resulted in tyrosine phosphorylation of p73. Using site directed mutational analysis, we determined that Tyr-28 was the major site of phosphorylation by Hck and c-Src, unlike c-Abl which phosphorylates Tyr-99. ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Mol Biol 2007 8 45",
                "id": "17535448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0212"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "Taken together, these results demonstrate that the Abl tyrosine kinase functions as a negative regulator of Met-induced cell migration, and that it does so by inducing CrkII phosphorylation at the site Y221.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Aug 19(8) 1662-70",
                "id": "17399949"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0211"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "it was recently shown that in IMR-90 normal lung fibroblasts, TGF-b induces activation of the c-Abelson (c-Abl) protooncogene [30].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Rheumatol 2007 Nov 19(6) 568-73",
                "id": "17917537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0210"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11147-51",
                "id": "15657060"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe020f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ABL1) actsIn kin(p(HGNC:ABL1))",
              "summary_text": "In cells, v-Abl tyrosine kinase binds and strongly phosphorylates p62dok, which then binds rasGAP. A monoclonal antibody, 2C4, to the rasGAP-associated p62 reacts with p62dok. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1997 Jan 24 88(2) 205-11",
                "id": "9008161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe020e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCNA2)",
        "relation": "increases",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "p(HGNC:CCNA2) increases bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d7",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CCNA2) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe025c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC3))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:ERCC3)) increases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d8",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC3)) increases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe073e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC3))",
        "relation": "increases",
        "target": "tscript(p(SFAM:\"GTF2H Family\"))",
        "directed": false,
        "label": "cat(p(HGNC:ERCC3)) increases tscript(p(SFAM:\"GTF2H Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09d9",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC3)) increases tscript(p(SFAM:\"GTF2H Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe025d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC3))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\")",
        "directed": false,
        "label": "cat(p(HGNC:ERCC3)) increases bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09da",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC3)) increases bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\")",
              "summary_text": "Two components of core TFIIH, i.e., the XPB and XPD proteins, are helicases responsible for unwinding the DNA helix in NER",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 213-24",
                "id": "11511374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe025e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:APEX1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:APEX1))",
        "directed": false,
        "label": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09db",
          "evidences": [
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "We show that upon CD40 antibody-mediated cross-linking, APE/Ref-1 translocates from the cytoplasm to the nucleus of activated B cells, where it modulates the DNA binding activity of both Pax5a and EBF. Moreover, we show that the repression of APE/Ref-1 protein production is able to block CD40-mediated Pax5a activation. We also provide evidence that APE/Ref-1 can modulate the cooperative activation of the blk promoter operated by Pax5a and EBF and that APE/Ref-1 might directly regulate EBF functional activity. Finally, we show that the interaction between Pax5a and EBF enhances EBF binding activity to its consensus sequence, suggesting that Pax5a can physically interact with EBF and modulate its DNA binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 16 279(3) 1777-86",
                "id": "14594818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0741"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "We show that upon CD40 antibody-mediated cross-linking, APE/Ref-1 translocates from the cytoplasm to the nucleus of activated B cells, where it modulates the DNA binding activity of both Pax5a and EBF. Moreover, we show that the repression of APE/Ref-1 protein production is able to block CD40-mediated Pax5a activation. We also provide evidence that APE/Ref-1 can modulate the cooperative activation of the blk promoter operated by Pax5a and EBF and that APE/Ref-1 might directly regulate EBF functional activity. Finally, we show that the interaction between Pax5a and EBF enhances EBF binding activity to its consensus sequence, suggesting that Pax5a can physically interact with EBF and modulate its DNA binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 16 279(3) 1777-86",
                "id": "14594818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0740"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe073f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1998 Nov 9 252(1) 178-83",
                "id": "9813166"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe027c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "inhibition of APE/Ref-1 accelerated p53 protein turnover, resulting in a decrease in p53 levels and activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jun 2 24(24) 3853-63",
                "id": "15824742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe027b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "APE1/ref-1 upregulates H-ras expression",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2004 Oct 29 95(9) 902-10",
                "id": "15472121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe027a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "APE1/ref-1+/- mice have impaired endothelium-dependent vasorelaxation, reduced vascular NO levels, and are hypertensive.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2004 Oct 29 95(9) 902-10",
                "id": "15472121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0279"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Ref-1 is an important redox regulator of a number of transcription factors, including NF-kappaB and AP-1",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Jun 1 168(11) 5675-81",
                "id": "12023366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0278"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Although the N-terminal DNA-binding domain of HIF-1alpha can function in the absence of Ref-1, we found that the C-terminal region containing the transactivation domain requires Ref-1 for full activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Feb 18 275(7) 4618-27",
                "id": "10671489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0277"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39926-36",
                "id": "12161446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0276"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "exposure of SNB19 cells to HOCl, a generator of reactive oxygen species (ROS), results in elevated Ape1/Ref-1 protein and Ap endo activity",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2002 Sep 8(9) 3008-18",
                "id": "12231548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0275"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": " In addition to the repair role of Ape1, it also functions as a major redox-signaling factor to reduce and activate transcription factors such as AP1, p53, HIF-1alpha, and others that control the expression of genes important for cell survival and cancer promotion and progression.  ",
              "citation": {
                "type": "PubMed",
                "name": "Stem Cells 2009 Jun 27(6) 1455-62",
                "id": "19492297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0274"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "We previously demonstrated the stimulation of human apurinic/apyrimidinic endonuclease 1 (HAP1) by heat shock protein 70 (HSP70)",
              "citation": {
                "type": "PubMed",
                "name": "DNA Repair (Amst) 2003 Mar 1 2(3) 259-71",
                "id": "12547389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0273"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Strong downregulation of Ape1 stopped cell proliferation and activated apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Feb 4 17(3) 463-70",
                "id": "15694346"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0272"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "The co-transcription factor and DNA repair enzyme, Redox effector factor-1/apurinic/apyrimidinic endonuclease (Ref-1/Ape), facilitates DNA binding and transcriptional activity of a number of transactivating factors, including those governing hypoxia-induced gene expression HIF-1",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Jun 18(9) 986-8",
                "id": "15084519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0271"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "AP-1 transcriptional activity was enhanced by the overexpression of Ref-1 and attenuated by the introduction of antisense Ref-1",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2000 Nov 19 278(2) 462-9",
                "id": "11097859"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0270"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe026f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "the overexpression of APE protein disrupts the repair of DNA mismatches",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2005 33(16) 5073-81",
                "id": "16147991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe026e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Apurinic/apyrimidinic endonuclease-1 (APE-1)/redox factor-1 (Ref-1) repairs damaged DNA and reductively activates transcription factors, including activator protein-1",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2004 Sep 127(3) 845-58",
                "id": "15362040"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe026d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "The addition of GST-Ref-1 protein increased the level of IL-2-induced telomerase activity in the TRAP assay, while elimination of the endogenous Ref-1 protein by immunodepletion decreased it",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2003 Apr 15 88(6) 1120-8",
                "id": "12647295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe026c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "the ability of APE/Ref-1 to perform its in vivo redox function is correlated to its susceptibility to PKC phosphorylation that notably occurs in response to DNA damaging agents",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2001 Jul 15 29(14) 3116-22",
                "id": "11452037"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe026b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "APE1 cleaves the chain on the 59 side of the abasic site and recruits POL b",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe026a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Inhibition of CKII mediated phosphorylation of APE/Ref-1 blocked mutagen-stimulated increase in AP-1 binding. It also abrogated the induction of c-Jun protein and rendered cells more sensitive to induced DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jan 28 18(4) 1033-40",
                "id": "10023679"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0269"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 11 275(32) 24840-6",
                "id": "10823822"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0268"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21618-26",
                "id": "11290748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0267"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Oct 15 18(20) 5609-21",
                "id": "10523305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0266"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "the redox active apurinic/apyrimidinic endonuclease-1 has been shown to keep HIF1A in a reduced state that is necessary for its transcriptional function",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Jan 2(1) 38-47",
                "id": "11902584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0265"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Trx enhances the DNA binding activity of the activator protein 1 (AP1) transcription factor through an activation cascade beginning with Trx, proceeding to another regulatory protein, redox factor-1 (Ref1), and subsequently continuing to AP1 through direct cysteine mediated associations and reduction processes (Xanthoudakis and Curran, 1992; Xanthoudakis et al., 1994; Hirota et al., 1997).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Nov 25 23(55) 8868-75",
                "id": "15480426"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0264"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "APE1 is directly involved in Ca2+-dependent downregulation of parathyroid hormone (PTH) expression by binding to negative calcium response elements (nCaREs) present in the PTH promoter",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Dec 1 22(23) 6299-309",
                "id": "14633989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0263"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "overexpression of APE/Ref-1 enhanced NIS promoter activity 2-fold.  When the expression plasmid of APE/Ref-1 was transfected together with an expression plasmid for PAX8, a strong cooperative effect was detected with an increase of NIS promoter activity 9-fold over control.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2004 Mar 145(3) 1290-3",
                "id": "14630715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0262"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Using purified human proteins and an 8-oxo-G specificity assay, we prove that DNA pol ? preferentially forms A:8-oxo-G mispair during replication and that MUTYH recognizes this mispair thereby generating an apurinic (AP) site, subsequently processed by apurinic endonuclease 1 (APE1). ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2009 Oct 27 106(43) 18201-6",
                "id": "19820168"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0261"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 1 277(44) 41715-24",
                "id": "12200445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0260"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:APEX1) actsIn cat(p(HGNC:APEX1))",
              "summary_text": "Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21618-26",
                "id": "11290748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe025f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:TOP1))",
        "relation": "increases",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "cat(p(HGNC:TOP1)) increases bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09dc",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:TOP1)) increases bp(GOBP:\"DNA repair\")",
              "summary_text": "DNA topoisomerases I are ubiquitous enzymes that play a crucial role in DNA condensation, replication, transcription, and repair. ",
              "citation": {
                "type": "PubMed",
                "name": "Bull Cancer 1998 Dec Spec No 5-10",
                "id": "9932078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe027e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:TOP1)) increases bp(GOBP:\"DNA repair\")",
              "summary_text": "Covalent topoisomerase  IDNA complexes are normally transient but can be stabilized by the chemotherapeutic agent camptothecin and by various DNA lesions. p53 increases dissociation of topoisomerase I covalently bound to DNA, which represents the limiting step during topoisomerase  I-mediated repair, particularly, when it is trapped on damaged DNA. ",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2006 34(3) 1036-49",
                "id": "16473854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe027d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:LIG3))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:LIG3)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09dd",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:LIG3)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe027f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK1,pmod(P,S,345))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09de",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "ATR phosphorylates Chk1 at Ser317 and Ser345 in vitro, and phosphorylation of these sites in human cells in response to UV and hydroxyurea is ATR-dependent [1619].",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Jun 1 388(Pt 2) 705-12",
                "id": "15707391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0287"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "ATM and Rad3-related (ATR) is a regulatory kinase that, when activated by hydroxyurea, UV, or human immunodeficiency virus-1 Vpr, causes cell cycle arrest through Chk1-Ser(345) phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Mar 9 282(10) 7287-98",
                "id": "17210576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0286"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns. Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4129-39",
                "id": "11390642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0285"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "We show that Rad9's role in Chk1 activation is to bind TopBP1, which stimulates ATR-mediated Chk1 phosphorylation via TopBP1's activation domain (AD), a domain that binds and activates ATR. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Jun 15 21(12) 1472-7",
                "id": "17575048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0284"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "Consistently, the RNAi-mediated ablation of Claspin selectively abrogated ATR's ability to phosphorylate Chk1 but not other ATR targets.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6056-64",
                "id": "16880517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0283"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0282"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "11390642;10859164;15533933;15674326",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0281"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "Here, we report that replicative stress induces the polyubiquitination and degradation of Chk1 in human cells. This response is triggered by phosphorylation of Chk1 at Ser-345, a known target site for the upstream activating kinase ATR. These findings indicate that ATR-dependent phosphorylation of Chk1 delivers a signal that both activates Chk1 and marks this protein for proteolytic degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Sep 2 19(5) 607-18",
                "id": "16137618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0280"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:FANCD2,pmod(P,T,691))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:FANCD2,pmod(P,T,691))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09df",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:FANCD2,pmod(P,T,691))",
              "summary_text": "In the present study, we identify two novel DNA damage-inducible phosphorylation sites on FANCD2, threonine 691 and serine 717. ATR phosphorylates FANCD2 on these two sites, thereby promoting FANCD2 monoubiquitination and enhancing cellular resistance to DNA cross-linking agents",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Sep 26(18) 7005-15",
                "id": "16943440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0288"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP53,pmod(P,S,15))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e0",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "In this report we provide evidence that the ATM-Rad3-related protein ATR regulates phosphorylation of Ser-15 in DNA-damaged cells. Overexpression of catalytically inactive ATR (ATRki) in human fibroblasts inhibited Ser-15 phosphorylation in response to gamma-irradiation and UV light. In gamma-irradiated cells, ATRki expression selectively interfered with late-phase Ser-15 phosphorylation, whereas ATRki blocked UV-induced Ser-15 phosphorylation in a time-independent manner. ATR phosphorylated p53 at Ser-15 and Ser-37 in vitro, suggesting that p53 is a target for phosphorylation by ATR in DNA-damaged cells.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Jan 15 13(2) 152-7",
                "id": "9925639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0744"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "Fractionation of HeLa nuclear extracts and biochemical analyses indicate that this kinase is distinct from the DNA-dependent protein kinase (DNA-PK) and corresponds to the human cell cycle checkpoint protein ATR. Immunoprecipitation studies of recombinant ATR reveal that catalytic activity of this polypeptide is required for DNA-stimulated phosphorylation of p53 on serine-15.  These data suggest that ATR may function upstream of p53 in a signal transduction cascade initiated upon DNA damage and provide a biochemical assay system for ATR activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jul 8 18(27) 3989-95",
                "id": "10435622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0743"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "In this report we provide evidence that the ATM-Rad3-related protein ATR regulates phosphorylation of Ser-15 in DNA-damaged cells. Overexpression of catalytically inactive ATR (ATRki) in human fibroblasts inhibited Ser-15 phosphorylation in response to gamma-irradiation and UV light. In gamma-irradiated cells, ATRki expression selectively interfered with late-phase Ser-15 phosphorylation, whereas ATRki blocked UV-induced Ser-15 phosphorylation in a time-independent manner. ATR phosphorylated p53 at Ser-15 and Ser-37 in vitro, suggesting that p53 is a target for phosphorylation by ATR in DNA-damaged cells.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Jan 15 13(2) 152-7",
                "id": "9925639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0742"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "In this report, we utilized small interfering RNA to deplete BRCA1 and BARD1 to demonstrate that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated/ATM and Rad3-related)-mediated phosphorylation of p53(Ser-15) following IR- and UV radiation-induced DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31251-8",
                "id": "15159397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0289"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:BRCA1,pmod(P,S,1457))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1457))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e1",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1457))",
              "summary_text": "10550055;11278964",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe028a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:BRCA1,pmod(P,S,1423))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1423))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e2",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1423))",
              "summary_text": "10550055;11278964;11114888",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe028c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1423))",
              "summary_text": "In this study, we show that BRCA1 phosphorylation is only partially ATM dependent in response to IR and ATM independent in response to treatment with UV light, or the DNA replication inhibitors hydroxyurea (HU) and aphidicolin (APH) We provide evidence that the kinase responsible for this phosphorylation is the ATM-related kinase, ATR. ATR phosphorylates BRCA1 on six Ser/Thr residues, including Ser 1423, in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Dec 1 14(23) 2989-3002",
                "id": "11114888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe028b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:FANCD2,pmod(P,S,717))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:FANCD2,pmod(P,S,717))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e3",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:FANCD2,pmod(P,S,717))",
              "summary_text": "In the present study, we identify two novel DNA damage-inducible phosphorylation sites on FANCD2, threonine 691 and serine 717. ATR phosphorylates FANCD2 on these two sites, thereby promoting FANCD2 monoubiquitination and enhancing cellular resistance to DNA cross-linking agents",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Sep 26(18) 7005-15",
                "id": "16943440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe028d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:BRCA1,pmod(P,S,1524))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1524))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e4",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:BRCA1,pmod(P,S,1524))",
              "summary_text": "10550055;11278964",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe028e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:FANCI,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:FANCI,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e5",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:FANCI,pmod(P))",
              "summary_text": " Here we describe the FA protein FANCI, identified as an ATM/ATR kinase substrate required for resistance to mitomycin C.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Apr 20 129(2) 289-301",
                "id": "17412408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe028f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e6",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Fractionation of HeLa nuclear extracts and biochemical analyses indicate that this kinase is distinct from the DNA-dependent protein kinase (DNA-PK) and corresponds to the human cell cycle checkpoint protein ATR. Immunoprecipitation studies of recombinant ATR reveal that catalytic activity of this polypeptide is required for DNA-stimulated phosphorylation of p53 on serine-15.  These data suggest that ATR may function upstream of p53 in a signal transduction cascade initiated upon DNA damage and provide a biochemical assay system for ATR activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jul 8 18(27) 3989-95",
                "id": "10435622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0745"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(SCOMP:\"TFIIH Complex\")",
        "relation": "actsIn",
        "target": "tscript(p(SFAM:\"GTF2H Family\"))",
        "directed": false,
        "label": "complex(SCOMP:\"TFIIH Complex\") actsIn tscript(p(SFAM:\"GTF2H Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e7",
          "evidences": [
            {
              "bel_statement": "complex(SCOMP:\"TFIIH Complex\") actsIn tscript(p(SFAM:\"GTF2H Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:POLD1))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "directed": false,
        "label": "cat(p(HGNC:POLD1)) increases bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e8",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:POLD1)) increases bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
              "summary_text": "After a 24- to 32-residue oligonucleotide is released, the gap is filled in by PCNA-dependent POL epsilon or delta and sealed by a DNA ligase, presumably LIG1.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0290"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:POLD1))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:POLD1)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09e9",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:POLD1)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "DNA strand displacement may instead occur, involving either POL b or a larger polymerase such as POL d, for filling-in of gaps a few nucleotides long (37). The FEN1 structure-specific nuclease removes the displaced flap and the PCNA protein stimulates these reactions (38), acting as a scaffold protein in this alternative pathway in a way similar to that of XRCC1 in the main pathway. Another replication factor, DNA ligase I (LIG1) then completes this longer patch form of repair.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0746"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:POLD1)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": " Pol delta/epsilon-mediated BER (long-patch BER) is the mode of repair when lesions persist or are formed at replication",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 2003 Oct 29 531(1-2) 127-39",
                "id": "14637250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0291"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TOPBP1)",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:ATR))",
        "directed": false,
        "label": "p(HGNC:TOPBP1) directlyIncreases kin(p(HGNC:ATR))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ea",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TOPBP1) directlyIncreases kin(p(HGNC:ATR))",
              "summary_text": "Here, we show that ATRIP contains a TopBP1-interacting region that is necessary for the association of TopBP1 and ATR, for TopBP1-mediated activation of ATR, and for cells to survive and recover DNA synthesis following replication stress.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2008 Jun 1 22(11) 1478-89",
                "id": "18519640"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0293"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TOPBP1) directlyIncreases kin(p(HGNC:ATR))",
              "summary_text": "We show that recombinant TopBP1 induces a large increase in the kinase activity of both Xenopus and human ATR",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2006 Mar 10 124(5) 943-55",
                "id": "16530042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0292"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FANCD2)",
        "relation": "hasModification",
        "target": "p(HGNC:FANCD2,pmod(P,S,717))",
        "directed": false,
        "label": "p(HGNC:FANCD2) hasModification p(HGNC:FANCD2,pmod(P,S,717))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09eb",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FANCD2) hasModification p(HGNC:FANCD2,pmod(P,S,717))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0294"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:WWOX)",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "p(HGNC:WWOX) directlyDecreases tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ec",
          "evidences": [
            {
              "bel_statement": "p(HGNC:WWOX) directlyDecreases tscript(p(HGNC:TP73))",
              "summary_text": "We recently showed that WWOX interacts with p73 and AP-2gamma and suppresses their transcriptional activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Aug 1 65(15) 6764-72",
                "id": "16061658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0295"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:\"nitric oxide\")",
        "relation": "decreases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "a(CHEBI:\"nitric oxide\") decreases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ed",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:\"nitric oxide\") decreases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "Nitric oxide inhibits DNA-adduct excision in nucleotide excision repair.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2004 Apr 15 36(8) 1011-7",
                "id": "15059641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0296"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GADD45B)",
        "relation": "directlyDecreases",
        "target": "kin(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(HGNC:GADD45B) directlyDecreases kin(p(HGNC:POLD1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ee",
          "evidences": [
            {
              "bel_statement": "p(HGNC:GADD45B) directlyDecreases kin(p(HGNC:POLD1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0297"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53,pmod(P,S,46))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:TP53,pmod(P,S,46)) directlyIncreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09ef",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,46)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Through direct cloning of p53 binding sequences from human genomic DNA, we have isolated a novel gene, designated p53AIP1 (p53-regulated Apoptosis-Inducing Protein 1), whose expression is inducible by wild-type p53. Ectopically expressed p53AIP1, which is localized within mitochondria, leads to apoptotic cell death through dissipation of mitochondrial A(psi)m. We have found that upon severe DNA damage, Ser-46 on p53 is phosphorylated and apoptosis is induced. In addition, substitution of Ser-46 inhibits the ability of p53 to induce apoptosis and selectively blocks expression of p53AIP1. Our results suggest that p53AIP1 is likely to play an important role in mediating p53-dependent apoptosis, and phosphorylation of Ser-46 regulates the transcriptional activation of this apoptosis-inducing gene.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2000 Sep 15 102(6) 849-62",
                "id": "11030628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0747"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,46)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Co-exposure to C75 and Taxol induced a remarkable nuclear accumulation of activated p38 mitogen-activated protein kinase (p38 MAPK), which was accompanied by a synergistic nuclear accumulation of the p53 tumor-suppressor protein that was phosphorylated at Ser46, a p38 MAPK-regulated pro-apoptotic modification of p53",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 May 20 115(1) 19-35",
                "id": "15657900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe029d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,46)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "HIPK2 is activated by ultraviolet (UV) radiation and selectively phosphorylates p53 at Ser 46 ... Accordingly, the kinase function of HIPK2 mediates the increased expression of p53 target genes",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jan 4(1) 1-10",
                "id": "11740489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe029c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,46)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Recent studies revealed that phosphorylation of p53 on Ser(46) was associated with induction of p53AIP1 expression, resulting in the commitment of the cell fate into apoptotic cell death.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 3 281(9) 5734-40",
                "id": "16377624"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe029b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,46)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "TP53INP1 mediates phosphorylation of p53 on serine 46 (S46). ASPP-1 and ASPP-2 modulate the cellular apoptotic threshold by direct interaction with p53, thereby enhancing the DNA binding and trans-activation function of p53 on the promoters of pro-apoptotic genes in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe029a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,46)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Here we demonstrate that homeodomain-interacting protein kinase-2 (HIPK2), a member of a novel family of nuclear serine/threonine kinases, binds to and activates p53 by directly phosphorylating it at Ser 46",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jan 4(1) 11-9",
                "id": "11780126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0299"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,46)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Mutation of p53 Ser(58) (equivalent to human p53 Ser(46)) abrogates transcription of these genes",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Jan 1 69(1) 219-26",
                "id": "19118006"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0298"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CDC25A)",
        "relation": "actsIn",
        "target": "phos(p(HGNC:CDC25A))",
        "directed": false,
        "label": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f0",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "Fig. (1). Regulation of CDK1 by phosphorylation in the S phase. Cyclin B dimerizes with CDK1, and this complex is phosphorylated by CDK activity (CAK on Threonine161). wee1 and mik1 phosphorylate tyrosine15 and threonine14, which inactivates the complex. The G2/M transition cdc25 phosphatase dephosphorylates tyrosine15 and threonine14, but phosphorylation of threonine161 is retained, resulting in an active CDK1. Upon the completion of M phase, cyclin B is ubiquitinated and targeted for degradation. (reproduced with permission [64])",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0748"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "Therefore, through a combined upregulation of MYC, cyclin D1 and CDC25A, STAT3 induces S-phase progression through E2F activation and upregulation of DNA replication genes (Figure 1).",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2007 Jan 13(1) 4-11",
                "id": "17118707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "activated CHK2 can phosphorylate and therefore inactivate the phosphatases CDC25A, which controls S phase entry (Melo et al., 2001), and CDC25C, which is required for activation of the mitotic promoting force (MPF) complex of CDK2/ cyclin B to enter mitosis (Figure 1) (Takai et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "Cdk4 dephosphorylation experiments showed that Compound (Cpd) 5, a prototype arylating analogue, inhibited Cdc25A-mediated Cdk4 dephosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Oct 1 61(19) 7211-6",
                "id": "11585757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "G2/M checkpoint activation involves activation of Wee1 and Chk1 kinases and inhibition of Cdc25A and Cdc25C phosphatases, which results in inhibition of Cdc2 kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 12 26(32) 4689-98",
                "id": "17297454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "Furthermore, Chk1 also phosphorylates Cdc25A on serine 123 which accelerates its degradation through the ubiquitin-proteasome pathway and arrests cells in late G2-phase after DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 24(6) 3907-10",
                "id": "15736430"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "Using a small interfering RNA that enables the specific elimination of Chk1 expression, we show that the observed proteolysis of Cdc25A is mediated through Chk1. Moreover, Cdc25A overexpression abrogates the Chk1-mediated degradation and overcomes the doxorubicin-induced G2 arrest through dephosphorylation and activation of Cdc2/Cdk1 in a dose-dependent manner ... from full text, H1299 cells and tyrosine 15 phosphorylation of CDC2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 13 278(24) 21767-73",
                "id": "12676925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "Inhibitory phosphorylation of adjacent threonine and tyrosine residues (T14/Y15 in CDK1) is mediated by dualspecificity kinases (such as WEE1 and MYT1). This inhibition is relieved when the CDC25 phosphatases (CDC25A,CDC25B and CDC25C) dephosphorylate these residues, which triggers entry into mitosis",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2001 Dec 1(3) 222-31",
                "id": "11902577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "Fig. 2. Pim-1 is post-transcriptionally regulated by stabilization on the mRNA and protein level and degraded by PP2A.The phosphorylation by Pim-1 results in an inactivation of repressors or activation of transcription factors or regulatory proteins, in the stabilization of proteins, which are involved in signaling pathways and in the inactivation of pro-apoptotic proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Biochem Cell Biol 2005 Apr 37(4) 726-30",
                "id": "15694833"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "Cdc25A dual specificity phosphatase controls entry into and progression through S phase by dephosphorylating sites of inhibitory phosphorylation on cyclin E-cdk2 (Thr14 and Tyr15). Immunoblotting reveals that a 3 hour treatment of U937 cells with 5 muM sodium arsenite results in a dramatic decrease in cdc25A protein levels. ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2007 Jun 1",
                "id": "17545210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "Further, evidence is presented for TGF-beta-stimulated p160ROCK translocation to the nucleus and inhibitory phosphorylation of the cyclin-dependent kinase-activating phosphatase, Cdc25A.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Dec 23 100(26) 15548-53",
                "id": "14657354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02a0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "The human Cdc25A phosphatase plays a pivotal role at the G1/S transition by activating cyclin E and A/Cdk2 complexes through dephosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29824-9",
                "id": "12759351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe029f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDC25A) actsIn phos(p(HGNC:CDC25A))",
              "summary_text": "We found that Pim-1 physically interacts with Cdc25A both in vitro and in vivo and phosphorylates Cdc25A. We also observed that Pim-1-mediated phosphorylation of Cdc25A increases its phosphatase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 25 274(26) 18659-66",
                "id": "10373478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe029e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CDC25A)",
        "relation": "decreases",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "p(HGNC:CDC25A) decreases bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f1",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CDC25A) decreases bp(GOBP:\"DNA repair\")",
              "summary_text": "Phosphorylation of Chk1 controls Cdc25A stability through phosphorylation, leading to interaction of Cdc25A with SCF?-TrCP  ubiquitin ligase and acceleration of Cdc25A turnover ( 30). The resulting reduction of Cdc25A levels is instrumental in slowing progression through S phase, allowing time for DNA repair; if cell elimination is required, apoptosis can be induced through checkpoint termination ( 30).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Dec 1 66(23) 11287-92",
                "id": "17145874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe081a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53BP2)",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "p(HGNC:TP53BP2) directlyIncreases tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f2",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP53BP2) directlyIncreases tscript(p(HGNC:TP73))",
              "summary_text": "Because ASPP-1 and ASPP-2 are specific activators of the apoptotic function of all p53 family members, E2F1 might use this pathway to increase the apoptotic function of p63 and p73 independently of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:APEX1))",
        "relation": "increases",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "cat(p(HGNC:APEX1)) increases bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f3",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:APEX1)) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:WWP1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:WWP1))",
        "directed": false,
        "label": "p(HGNC:WWP1) actsIn cat(p(HGNC:WWP1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f4",
          "evidences": [
            {
              "bel_statement": "p(HGNC:WWP1) actsIn cat(p(HGNC:WWP1))",
              "summary_text": "WWP1 associated with Smad7 and induced its nuclear export, and enhanced binding of Smad7 to TGF-beta type I receptor to cause ubiquitination and degradation of the receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Sep 9 23(41) 6914-23",
                "id": "15221015"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WWP1) actsIn cat(p(HGNC:WWP1))",
              "summary_text": "WWP1 functions as a cofactor by binding LKLF and suppressing transactivation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 3 276(31) 29299-306",
                "id": "11375995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ac"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"single strand break repair\")",
        "relation": "increases",
        "target": "kin(p(HGNC:ATR))",
        "directed": false,
        "label": "bp(GOBP:\"single strand break repair\") increases kin(p(HGNC:ATR))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f5",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"single strand break repair\") increases kin(p(HGNC:ATR))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"single strand break repair\")",
        "relation": "increases",
        "target": "cat(p(HGNC:PARP1))",
        "directed": false,
        "label": "bp(GOBP:\"single strand break repair\") increases cat(p(HGNC:PARP1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f6",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"single strand break repair\") increases cat(p(HGNC:PARP1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"base-excision repair\")",
        "relation": "isA",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "bp(GOBP:\"base-excision repair\") isA bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f7",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"base-excision repair\") isA bp(GOBP:\"single strand break repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:WRN)",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "p(HGNC:WRN) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f8",
          "evidences": [
            {
              "bel_statement": "p(HGNC:WRN) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "nucleoplasmic translocation of WRN and were involved in DSB repair ... from full text, HEL (human embyo lung fibroblast) cells",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry (Mosc) 2011 May 76(5) 550-4",
                "id": "21639834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:cisplatin)",
        "relation": "increases",
        "target": "p(HGNC:TP53)",
        "directed": false,
        "label": "a(CHEBI:cisplatin) increases p(HGNC:TP53)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09f9",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:cisplatin) increases p(HGNC:TP53)",
              "summary_text": "Treatment of A549 cells with 20 microM gemcitabine, cisplatin, or taxol or with 50 microM camptothecin caused robust PARP cleavage, which was inhibited by 1 M nicotine (Fig. 1d). Drug treatment enhanced the levels of p53 and its transcriptional target, p21, as seen by Western blots; interestingly, this induction was also inhibited by nicotine.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Apr 18 103(16) 6332-7",
                "id": "16601104"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:cisplatin)",
        "relation": "directlyIncreases",
        "target": "a(SCHEM:\"double-stranded DNA break\")",
        "directed": false,
        "label": "a(CHEBI:cisplatin) directlyIncreases a(SCHEM:\"double-stranded DNA break\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09fa",
          "evidences": [
            {
              "bel_statement": "a(CHEBI:cisplatin) directlyIncreases a(SCHEM:\"double-stranded DNA break\")",
              "summary_text": "MitomycinC, cisplatin, etoposide and other drugs that produce complex double-stranded lesions in DNA. ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Agents Med Chem 2008 May 8(4) 448-60",
                "id": "18473729"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RPRM)",
        "relation": "decreases",
        "target": "kin(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(HGNC:RPRM) decreases kin(p(HGNC:POLD1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09fb",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RPRM) decreases kin(p(HGNC:POLD1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA1)",
        "relation": "hasModification",
        "target": "p(HGNC:BRCA1,pmod(P,S,1466))",
        "directed": false,
        "label": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1466))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09fc",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1466))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(SFAM:\"GTF2H Family\"))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "tscript(p(SFAM:\"GTF2H Family\")) increases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe09fd",
          "evidences": [
            {
              "bel_statement": "tscript(p(SFAM:\"GTF2H Family\")) increases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CDKN1A)",
        "relation": "increases",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "p(HGNC:CDKN1A) increases bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775d252f9e24174cfe09fe",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CDKN1A) increases bp(GOBP:\"DNA repair\")",
              "summary_text": "Deletion of p21 attenuates CS-induced DNA damage and NHEJ repair impairment",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "24244594"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CDKN1A)",
        "relation": "decreases",
        "target": "cat(p(HGNC:PARP1))",
        "directed": false,
        "label": "p(HGNC:CDKN1A) decreases cat(p(HGNC:PARP1))",
        "metadata": {
          "casual": true,
          "createdBy": "Tamiora",
          "edgeId": "55775d252f9e24174cfe09ff",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:CDKN1A)",
        "relation": "decreases",
        "target": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "directed": false,
        "label": "p(HGNC:CDKN1A) decreases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a00",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CDKN1A) decreases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:TRIM28))",
        "relation": "decreases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "cat(p(HGNC:TRIM28)) decreases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a01",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:TRIM28)) decreases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "KAP-1 is phosphorylated in an ATM-dependent manner on Ser 824. KAP-1 is phosphorylated exclusively at the damage sites, from which phosphorylated KAP-1 spreads rapidly throughout the chromatin. Ablation of the phosphorylation site of KAP-1 leads to loss of DSB-induced chromatin decondensation and renders the cells hypersensitive to DSB-inducing agents. Knocking down KAP-1, or mimicking a constitutive phosphorylation of this protein, leads to constitutive chromatin relaxation. These results suggest that chromatin relaxation is a fundamental pathway in the DNA-damage response and identify its primary mediators.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2006 Aug 8(8) 870-6",
                "id": "16862143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0749"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:SMC1A),p(HGNC:SMC3))",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "directed": false,
        "label": "complex(p(HGNC:SMC1A),p(HGNC:SMC3)) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a02",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:SMC1A),p(HGNC:SMC3)) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
              "summary_text": "During DSB repair, the Smc1-Smc3 cohesin complex is loaded onto chromatin around the DSB to support recombination-mediated DSB repair",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(15) 4989-5000",
                "id": "17636314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:SMC1A),p(HGNC:SMC3))",
        "relation": "hasComponent",
        "target": "p(HGNC:SMC1A)",
        "directed": false,
        "label": "complex(p(HGNC:SMC1A),p(HGNC:SMC3)) hasComponent p(HGNC:SMC1A)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a03",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:SMC1A),p(HGNC:SMC3)) hasComponent p(HGNC:SMC1A)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Oct 27 95(22) 12906-11",
                "id": "9789013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:SMC1A),p(HGNC:SMC3)) hasComponent p(HGNC:SMC1A)",
              "summary_text": "During DSB repair, the Smc1-Smc3 cohesin complex is loaded onto chromatin around the DSB to support recombination-mediated DSB repair",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(15) 4989-5000",
                "id": "17636314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:SMC1A),p(HGNC:SMC3))",
        "relation": "hasComponent",
        "target": "p(HGNC:SMC3)",
        "directed": false,
        "label": "complex(p(HGNC:SMC1A),p(HGNC:SMC3)) hasComponent p(HGNC:SMC3)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a04",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:SMC1A),p(HGNC:SMC3)) hasComponent p(HGNC:SMC3)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Oct 27 95(22) 12906-11",
                "id": "9789013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:SMC1A),p(HGNC:SMC3)) hasComponent p(HGNC:SMC3)",
              "summary_text": "During DSB repair, the Smc1-Smc3 cohesin complex is loaded onto chromatin around the DSB to support recombination-mediated DSB repair",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(15) 4989-5000",
                "id": "17636314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:FEN1))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:FEN1)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "Jamboree2014",
          "edgeId": "55775d252f9e24174cfe0a05",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:FEN1)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "DNA strand displacement may instead occur, involving either POL b or a larger polymerase such as POL d, for filling-in of gaps a few nucleotides long (37). The FEN1 structure-specific nuclease removes the displaced flap and the PCNA protein stimulates these reactions (38), acting as a scaffold protein in this alternative pathway in a way similar to that of XRCC1 in the main pathway. Another replication factor, DNA ligase I (LIG1) then completes this longer patch form of repair.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe074a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:FEN1)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "The structure specific flap endonuclease 1 (FEN1) plays an essential role in long-patch base excision repair (BER) and in DNA replication.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "22810208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02be"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:FEN1)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "The structure specific flap endonuclease 1 (FEN1) plays an essential role in long-patch base excision repair (BER) and in DNA replication.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": ""
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02bd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:UNG)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:UNG))",
        "directed": false,
        "label": "p(HGNC:UNG) actsIn cat(p(HGNC:UNG))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a06",
          "evidences": [
            {
              "bel_statement": "p(HGNC:UNG) actsIn cat(p(HGNC:UNG))",
              "summary_text": "The most abundant enzyme, UNG, which occurs both in nuclei and mitochondria, is partly sequestered in replication factories (16), where it is well placed to remove occasional U residues that have been incorporated instead of T by use of deoxyuridine triphosphate (dUTP) as a precursor for DNA synthesis. ",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:UNG) actsIn cat(p(HGNC:UNG))",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53,pmod(P,T,18))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:TP53,pmod(P,T,18)) directlyIncreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a07",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,T,18)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Thr18 residue phosphorylation, in the transactivation domain of p53, has been implicated in both disruption of p53-Mdm2 interaction and p300 coactivator recruitment, which acetylates the p53 carboxy terminus. This leads to a decrease in p53 degradation and its subsequent stabilization and to an increase in p53-dependent transactivation activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(23) 10366-80",
                "id": "15542844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,T,18)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Endogenous p53 is also phosphorylated in Thr18 by VRK2B, promoting its stabilization and transcriptional activation in A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "FEBS J 2006 Jun 273(11) 2487-504",
                "id": "16704422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6))",
        "relation": "hasComponent",
        "target": "p(HGNC:XRCC5)",
        "directed": false,
        "label": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC5)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a08",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC5)",
              "summary_text": "We demonstrate that BARD1 binds to unphosphorylated and serine-15 phosphorylated forms of p53 in several cell types and that the region required for binding comprises the region sufficient for apoptosis induction. BARD1 binds to Ku-70, the regulatory subunit of DNA-PK, suggesting that the mechanism of p53-induced apoptosis requires BARD1 for the phosphorylation of p53. Upregulation of BARD1 alone is sufficient for stabilization of p53 and phosphorylation on serine-15, as shown in nonmalignant epithelial cells and ovarian cancer cells, NuTu-19, which are defective in apoptosis induction and express aberrant splice variants of BARD1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 May 26 24(23) 3726-36",
                "id": "15782130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe074b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC5)",
              "summary_text": "Ku70 interacts with Ku80",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Aug 9 412(6847) 607-14",
                "id": "11493912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC5)",
              "summary_text": "in vitro; in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Aug 2 271(31) 18662-71",
                "id": "8702520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC5)",
              "summary_text": "We find that although DNA-PKcs alone does not affect the WRN exonuclease activity, the additional presence of Ku mediates a marked inhibition of it.  The inhibition of WRN exonuclease by DNA-PKcs requires the kinase activity of DNA-PKcs. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 24 277(21) 18291-302",
                "id": "11889123"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC5)",
              "summary_text": "the Ku heterodimer, which consists of Ku70 and Ku80, binds to the two ends of a DSB and recruits DNA-PK catalytic subunit and Ligase4?XRCC4 to ligate the termini and complete NHEJ (FIG. 3).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC5)",
              "summary_text": "Heterodimers of the 70 and 80 kDa Ku autoantigens (Ku70 and Ku80) activate the DNA-dependent protein kinase (DNA-PK)",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Nov 17 16(22) 6874-85",
                "id": "9362500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC5)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 May 19(5) 3267-77",
                "id": "10207052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC5)",
              "summary_text": "A reporter assay demonstrated that p50 transcription was positively mediated by NF-kappaB, Ku antigen, and RBP-Jkappa and that the binding elements for these proteins were required for optimal p50 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 2 279(1) 231-7",
                "id": "14570916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "gastric adenocarcinoma",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6))",
        "relation": "hasComponent",
        "target": "p(HGNC:XRCC6)",
        "directed": false,
        "label": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC6)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a09",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC6)",
              "summary_text": "We demonstrate that BARD1 binds to unphosphorylated and serine-15 phosphorylated forms of p53 in several cell types and that the region required for binding comprises the region sufficient for apoptosis induction. BARD1 binds to Ku-70, the regulatory subunit of DNA-PK, suggesting that the mechanism of p53-induced apoptosis requires BARD1 for the phosphorylation of p53. Upregulation of BARD1 alone is sufficient for stabilization of p53 and phosphorylation on serine-15, as shown in nonmalignant epithelial cells and ovarian cancer cells, NuTu-19, which are defective in apoptosis induction and express aberrant splice variants of BARD1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 May 26 24(23) 3726-36",
                "id": "15782130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe074c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC6)",
              "summary_text": "the Ku heterodimer, which consists of Ku70 and Ku80, binds to the two ends of a DSB and recruits DNA-PK catalytic subunit and Ligase4?XRCC4 to ligate the termini and complete NHEJ (FIG. 3).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC6)",
              "summary_text": "A reporter assay demonstrated that p50 transcription was positively mediated by NF-kappaB, Ku antigen, and RBP-Jkappa and that the binding elements for these proteins were required for optimal p50 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 2 279(1) 231-7",
                "id": "14570916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "gastric adenocarcinoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC6)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 May 19(5) 3267-77",
                "id": "10207052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC6)",
              "summary_text": "Heterodimers of the 70 and 80 kDa Ku autoantigens (Ku70 and Ku80) activate the DNA-dependent protein kinase (DNA-PK)",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Nov 17 16(22) 6874-85",
                "id": "9362500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC6)",
              "summary_text": "in vitro; in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Aug 2 271(31) 18662-71",
                "id": "8702520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC6)",
              "summary_text": "We find that although DNA-PKcs alone does not affect the WRN exonuclease activity, the additional presence of Ku mediates a marked inhibition of it.  The inhibition of WRN exonuclease by DNA-PKcs requires the kinase activity of DNA-PKcs. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 24 277(21) 18291-302",
                "id": "11889123"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) hasComponent p(HGNC:XRCC6)",
              "summary_text": "Ku70 interacts with Ku80",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Aug 9 412(6847) 607-14",
                "id": "11493912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6))",
        "relation": "increases",
        "target": "kin(p(HGNC:PRKDC))",
        "directed": false,
        "label": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) increases kin(p(HGNC:PRKDC))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a0a",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XRCC5),p(HGNC:XRCC6)) increases kin(p(HGNC:PRKDC))",
              "summary_text": "Heterodimers of the 70 and 80 kDa Ku autoantigens (Ku70 and Ku80) activate the DNA-dependent protein kinase (DNA-PK)",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Nov 17 16(22) 6874-85",
                "id": "9362500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHEK1,pmod(P,S,345))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:CHEK1))",
        "directed": false,
        "label": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a0b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe074d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "Here, we report that replicative stress induces the polyubiquitination and degradation of Chk1 in human cells. This response is triggered by phosphorylation of Chk1 at Ser-345, a known target site for the upstream activating kinase ATR. These findings indicate that ATR-dependent phosphorylation of Chk1 delivers a signal that both activates Chk1 and marks this protein for proteolytic degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Sep 2 19(5) 607-18",
                "id": "16137618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "Here we show that the oncogenic p53-induced serine/threonine phosphatase, PPM1D (or Wip1), dephosphorylates two ATM/ATR targets, Chk1 and p53. PPM1D binds Chk1 and dephosphorylates the ATR-targeted phospho-Ser 345, leading to decreased Chk1 kinase activity. PPM1D also dephosphorylates p53 at phospho-Ser 15",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2005 May 15 19(10) 1162-74",
                "id": "15870257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns. Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4129-39",
                "id": "11390642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:LIG3)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:LIG3))",
        "directed": false,
        "label": "p(HGNC:LIG3) actsIn cat(p(HGNC:LIG3))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a0c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:LIG3) actsIn cat(p(HGNC:LIG3))",
              "summary_text": "POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "phos(p(SFAM:\"PPP1R Family\"))",
        "relation": "decreases",
        "target": "p(HGNC:TP53,pmod(P,S,15))",
        "directed": false,
        "label": "phos(p(SFAM:\"PPP1R Family\")) decreases p(HGNC:TP53,pmod(P,S,15))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a0d",
          "evidences": [
            {
              "bel_statement": "phos(p(SFAM:\"PPP1R Family\")) decreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": " In vitro dephosphorylation assay showed that PP1 dephosphorylated ultraviolet C (UVC)-induced phospho-ser15 of p53, and that OA treatment inhibited it. One of the PP1 regulators, growth arrest and DNA damage 34 (GADD34), disturbed PP1 binding with p53, interfered with the dephosphorylation of p53 and increased the amount of phospho-p53 after UVC-treatment. This report provides the first evidence that PP1, but not PP2A, dephosphorylates phospho-serine 15 of p53.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Jun 4 567(2-3) 171-4",
                "id": "15178317"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe074e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "phos(p(SFAM:\"PPP1R Family\")) decreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "In the present study, we demonstrate that PP-1 can dephosphorylate p53 at Ser-15 and Ser-37 through co-immunoprecipitation, in vitro and in vivo dephosphorylation assays, overexpression and silence of the gene encoding the catalytic subunit for PP-1. We further show that mutations mimicking constitutive dephosphorylation or phosphorylation of p53 at these sites attenuate or enhance its transcriptional activity, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 May 18 25(21) 3006-22",
                "id": "16501611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "phos(p(SFAM:\"PPP1R Family\"))",
        "relation": "decreases",
        "target": "p(HGNC:TP53,pmod(P,S,37))",
        "directed": false,
        "label": "phos(p(SFAM:\"PPP1R Family\")) decreases p(HGNC:TP53,pmod(P,S,37))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a0e",
          "evidences": [
            {
              "bel_statement": "phos(p(SFAM:\"PPP1R Family\")) decreases p(HGNC:TP53,pmod(P,S,37))",
              "summary_text": "In the present study, we demonstrate that PP-1 can dephosphorylate p53 at Ser-15 and Ser-37 through co-immunoprecipitation, in vitro and in vivo dephosphorylation assays, overexpression and silence of the gene encoding the catalytic subunit for PP-1. We further show that mutations mimicking constitutive dephosphorylation or phosphorylation of p53 at these sites attenuate or enhance its transcriptional activity, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 May 18 25(21) 3006-22",
                "id": "16501611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FANCI)",
        "relation": "hasModification",
        "target": "p(HGNC:FANCI,pmod(P))",
        "directed": false,
        "label": "p(HGNC:FANCI) hasModification p(HGNC:FANCI,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a0f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FANCI) hasModification p(HGNC:FANCI,pmod(P))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:POLD1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(HGNC:POLD1) actsIn cat(p(HGNC:POLD1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a10",
          "evidences": [
            {
              "bel_statement": "p(HGNC:POLD1) actsIn cat(p(HGNC:POLD1))",
              "summary_text": "DNA strand displacement may instead occur, involving either POL b or a larger polymerase such as POL d, for filling-in of gaps a few nucleotides long (37). The FEN1 structure-specific nuclease removes the displaced flap and the PCNA protein stimulates these reactions (38), acting as a scaffold protein in this alternative pathway in a way similar to that of XRCC1 in the main pathway. Another replication factor, DNA ligase I (LIG1) then completes this longer patch form of repair.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe074f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:POLD1) actsIn cat(p(HGNC:POLD1))",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:POLD1) actsIn cat(p(HGNC:POLD1))",
              "summary_text": " Pol delta/epsilon-mediated BER (long-patch BER) is the mode of repair when lesions persist or are formed at replication",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 2003 Oct 29 531(1-2) 127-39",
                "id": "14637250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:PARP2))",
        "relation": "increases",
        "target": "bp(GOBP:\"base-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:PARP2)) increases bp(GOBP:\"base-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a11",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:PARP2)) increases bp(GOBP:\"base-excision repair\")",
              "summary_text": "The DNA damage-dependent poly(ADP-ribose) polymerase-2 (PARP-2) is, together with PARP-1, an active player of the base excision repair process, thus defining its key role in genome surveillance and protection.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(4) 1595-607",
                "id": "14749375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53,pmod(P,S,37))",
        "relation": "directlyIncreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:TP53,pmod(P,S,37)) directlyIncreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a12",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,37)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras ... Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression ... from full text, oncogenic ras is HRAS G12V and TP53 is phosphorylated at S37 ... human primary BJ fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Jan 26 128(2) 295-308",
                "id": "17254968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0750"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53,pmod(P,S,37)) directlyIncreases tscript(p(HGNC:TP53))",
              "summary_text": "In the present study, we demonstrate that PP-1 can dephosphorylate p53 at Ser-15 and Ser-37 through co-immunoprecipitation, in vitro and in vivo dephosphorylation assays, overexpression and silence of the gene encoding the catalytic subunit for PP-1. We further show that mutations mimicking constitutive dephosphorylation or phosphorylation of p53 at these sites attenuate or enhance its transcriptional activity, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 May 18 25(21) 3006-22",
                "id": "16501611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:YY1))",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "tscript(p(HGNC:YY1)) directlyDecreases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a13",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:YY1)) directlyDecreases tscript(p(HGNC:TP53))",
              "summary_text": "Here, we demonstrate that the transcription factor Yin Yang 1 (YY1) interacts with p53 and inhibits its transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Aug 17 101(33) 12165-70",
                "id": "15295102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XPC),p(HGNC:RAD23B))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "directed": false,
        "label": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) increases bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a14",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) increases bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
              "summary_text": "XPC-HR23B binds to a variety of NER lesions. These results resolve the function of XPC-HR23B, define the first NER stages, and suggest a two-step mechanism of damage recognition involving damage detection by XPC-HR23B followed by damage verification by XPA",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 1998 Aug 2(2) 223-32",
                "id": "9734359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XPC),p(HGNC:RAD23B))",
        "relation": "hasComponent",
        "target": "p(HGNC:RAD23B)",
        "directed": false,
        "label": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:RAD23B)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a15",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:RAD23B)",
              "summary_text": "in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 18665-72",
                "id": "11279143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:RAD23B)",
              "summary_text": "the present data indicate that XPC protein is required for genome-overall repair of UV- and AAF-induced lesions and that HHR23B stimulates the function of XPC.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Sep 16(9) 4852-61",
                "id": "8756644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:RAD23B)",
              "summary_text": "XPC-HR23B binds to a variety of NER lesions. These results resolve the function of XPC-HR23B, define the first NER stages, and suggest a two-step mechanism of damage recognition involving damage detection by XPC-HR23B followed by damage verification by XPA",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 1998 Aug 2(2) 223-32",
                "id": "9734359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:RAD23B)",
              "summary_text": "XPC-HR23B stimulated TDG activity by promoting the release of TDG from abasic sites that result from the excision of mismatched T bases.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Jan 2 22(1) 164-73",
                "id": "12505994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:RAD23B)",
              "summary_text": "<N1> XPC forms a tight complex with HR23B, a homologue of yeast Rad23. HR23B is present in large excess over XPC (Sugasawa et al., 1997).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:XPC),p(HGNC:RAD23B))",
        "relation": "hasComponent",
        "target": "p(HGNC:XPC)",
        "directed": false,
        "label": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:XPC)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a16",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:XPC)",
              "summary_text": "in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 18665-72",
                "id": "11279143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:XPC)",
              "summary_text": "XPC-HR23B stimulated TDG activity by promoting the release of TDG from abasic sites that result from the excision of mismatched T bases.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Jan 2 22(1) 164-73",
                "id": "12505994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:XPC)",
              "summary_text": "XPC-HR23B binds to a variety of NER lesions. These results resolve the function of XPC-HR23B, define the first NER stages, and suggest a two-step mechanism of damage recognition involving damage detection by XPC-HR23B followed by damage verification by XPA",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 1998 Aug 2(2) 223-32",
                "id": "9734359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:XPC)",
              "summary_text": "<N1> XPC forms a tight complex with HR23B, a homologue of yeast Rad23. HR23B is present in large excess over XPC (Sugasawa et al., 1997).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:XPC),p(HGNC:RAD23B)) hasComponent p(HGNC:XPC)",
              "summary_text": "the present data indicate that XPC protein is required for genome-overall repair of UV- and AAF-induced lesions and that HHR23B stimulates the function of XPC.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Sep 16(9) 4852-61",
                "id": "8756644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FEN1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:FEN1))",
        "directed": false,
        "label": "p(HGNC:FEN1) actsIn cat(p(HGNC:FEN1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a17",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FEN1) actsIn cat(p(HGNC:FEN1))",
              "summary_text": "DNA strand displacement may instead occur, involving either POL b or a larger polymerase such as POL d, for filling-in of gaps a few nucleotides long (37). The FEN1 structure-specific nuclease removes the displaced flap and the PCNA protein stimulates these reactions (38), acting as a scaffold protein in this alternative pathway in a way similar to that of XRCC1 in the main pathway. Another replication factor, DNA ligase I (LIG1) then completes this longer patch form of repair.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0751"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FEN1) actsIn cat(p(HGNC:FEN1))",
              "summary_text": "Here we show that the endonucleases Dna2 and Fen1 act sequentially to facilitate the complete removal of the primer RNA.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Jul 26 412(6845) 456-61",
                "id": "11473323"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FEN1) actsIn cat(p(HGNC:FEN1))",
              "summary_text": "Remarkably, acetylation of the Fen1 C terminus by p300 significantly reduced Fen1's DNA binding and nuclease activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jun 7(6) 1221-31",
                "id": "11430825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:FEN1) actsIn cat(p(HGNC:FEN1))",
              "summary_text": "we have isolated heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), which forms a direct complex with FEN-1 and stimulates its enzymatic activities.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2003 Dec 30 42(51) 15045-52",
                "id": "14690413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATRIP)",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:ATR))",
        "directed": false,
        "label": "p(HGNC:ATRIP) directlyIncreases kin(p(HGNC:ATR))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a18",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATRIP) directlyIncreases kin(p(HGNC:ATR))",
              "summary_text": "Activation and recruitment of these kinases to DNA lesions occurs through direct interactions with the specificity factors NBS1 (for ATM), ATRIP (for ATR) and Ku80 (for DNA-PK)16,17.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PKMYT1))",
        "relation": "directlyIncreases",
        "target": "p(EGID:5424,pmod(P,Y,15))",
        "directed": false,
        "label": "kin(p(HGNC:PKMYT1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a19",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PKMYT1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "The Myt1 protein kinase functions to negatively regulate Cdc2-cyclin B complexes by phosphorylating Cdc2 on threonine 14 and tyrosine 15.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jul 19(7) 5113-23",
                "id": "10373560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:PKMYT1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "Inhibitory phosphorylation of adjacent threonine and tyrosine residues (T14/Y15 in CDK1) is mediated by dualspecificity kinases (such as WEE1 and MYT1). This inhibition is relieved when the CDC25 phosphatases (CDC25A,CDC25B and CDC25C) dephosphorylate these residues, which triggers entry into mitosis",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2001 Dec 1(3) 222-31",
                "id": "11902577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:PKMYT1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "When Myt1 lysates were combined together with Cdc2 and cyclin B1-containing lysates, a dramatic reduction in Cdc2 kinase activation was also observed (Fig. 1 B). Furthermore, Myt1 lysates inhibited both Cdc2-A14 and Cdc2-F15 activation, indicating that Myt1 can phosphorylate either Thr14 or Tyr15inhibitory sites in Cdc2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 29 272(35) 22300-6",
                "id": "9268380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GADD45A)",
        "relation": "directlyDecreases",
        "target": "kin(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(HGNC:GADD45A) directlyDecreases kin(p(HGNC:POLD1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a1a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:GADD45A) directlyDecreases kin(p(HGNC:POLD1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:POLE2))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "directed": false,
        "label": "cat(p(HGNC:POLE2)) increases bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a1b",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:POLE2)) increases bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
              "summary_text": "After a 24- to 32-residue oligonucleotide is released, the gap is filled in by PCNA-dependent POL epsilon or delta and sealed by a DNA ligase, presumably LIG1.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:SIRT1))",
        "relation": "decreases",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "cat(p(HGNC:SIRT1)) decreases tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a1c",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:SIRT1)) decreases tscript(p(HGNC:TP73))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Arsenic)",
        "relation": "decreases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "a(SCHEM:Arsenic) decreases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a1d",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Arsenic) decreases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": " arsenic inhibits NER",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2008 Jul 47(7) 508-18",
                "id": "18085531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CDKN1A,pmod(P,T,145))",
        "relation": "directlyDecreases",
        "target": "deg(p(HGNC:CDKN1A))",
        "directed": false,
        "label": "p(HGNC:CDKN1A,pmod(P,T,145)) directlyDecreases deg(p(HGNC:CDKN1A))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a1e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CDKN1A,pmod(P,T,145)) directlyDecreases deg(p(HGNC:CDKN1A))",
              "summary_text": "As shown in Fig. 3C, phosphorylation on Thr145 site can increase the steady-state level of transfected p21 as does Thr145Asp/Ser146Asp (DD). On the other hand, Ser146Asp (S/D) mutants showed no stabilizing effect compared with WT p21.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2007 Sep 5(9) 909-22",
                "id": "17855660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDKN1A,pmod(P,T,145)) directlyDecreases deg(p(HGNC:CDKN1A))",
              "summary_text": "ZIP kinase phosphorylates p21(WAF1) at Thr145. Transfected ZIPK can promote the phosphorylation of p21(WAF1) at Thr145 in vivo and can increase the half-life of p21(WAF1)",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Mar 12 337(1) 115-28",
                "id": "15001356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CDKN1A,pmod(P,T,145)) directlyDecreases deg(p(HGNC:CDKN1A))",
              "summary_text": "Using a p21 expression vector encoding an alanine substitution at Thr145, the half-life of the protein was nearly identical in the absence or in the presence of transfected ZIP kinase (Figure 7(C) versus (D)).",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Mar 12 337(1) 115-28",
                "id": "15001356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CDKN1A)",
        "relation": "hasModification",
        "target": "p(HGNC:CDKN1A,pmod(P,T,145))",
        "directed": false,
        "label": "p(HGNC:CDKN1A) hasModification p(HGNC:CDKN1A,pmod(P,T,145))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a1f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CDKN1A) hasModification p(HGNC:CDKN1A,pmod(P,T,145))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PARP2)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:PARP2))",
        "directed": false,
        "label": "p(HGNC:PARP2) actsIn cat(p(HGNC:PARP2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a20",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PARP2) actsIn cat(p(HGNC:PARP2))",
              "summary_text": "The DNA damage-dependent poly(ADP-ribose) polymerase-2 (PARP-2) is, together with PARP-1, an active player of the base excision repair process, thus defining its key role in genome surveillance and protection.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(4) 1595-607",
                "id": "14749375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PARP2) actsIn cat(p(HGNC:PARP2))",
              "summary_text": "caspase-8 is relocated into the nucleus of apoptotic neurons, where it cleaves PARP-2 Activity assays confirm that cleavage of PARP-2 results in inactivation of its poly(ADP-ribosylation) property, proportional to the efficiency of the cleavage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 13 277(37) 34217-22",
                "id": "12065591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:SRC))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP73,pmod(P,Y,28))",
        "directed": false,
        "label": "kin(p(HGNC:SRC)) directlyIncreases p(HGNC:TP73,pmod(P,Y,28))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a21",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:SRC)) directlyIncreases p(HGNC:TP73,pmod(P,Y,28))",
              "summary_text": "Co-expression of p73 with Hck or c-Src in mammalian cells resulted in tyrosine phosphorylation of p73. Using site directed mutational analysis, we determined that Tyr-28 was the major site of phosphorylation by Hck and c-Src, unlike c-Abl which phosphorylates Tyr-99. ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Mol Biol 2007 8 45",
                "id": "17535448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:E2F1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:ATM)",
        "directed": false,
        "label": "tscript(p(HGNC:E2F1)) directlyIncreases p(HGNC:ATM)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a22",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:E2F1)) directlyIncreases p(HGNC:ATM)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"PPP1R Family\")",
        "relation": "actsIn",
        "target": "phos(p(SFAM:\"PPP1R Family\"))",
        "directed": false,
        "label": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a23",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Next, we used FRAP to verify the existence of nuclear fluxes, and consequent nuclear shuttling of HDAC4 in unstimulated fibers under resting control conditions without pharmacological suppression of nuclear efflux by leptomycin B. The mean initial rate of recovery of nuclear fluorescence, determined by linear fit to the fluorescence during the first 30 min after photobleaching in each of six nuclei in six fibers, was 0.89 +/- 0.15%/min. Subsequently, 120 min after photobleaching, leptomycin B was added to the same fibers and the mean rate of increase in nuclear fluorescence in the same fibers in the presence of leptomycin B was found to be 1.08 +/- 0.18%/min. Thus the initial rate of HDAC4 fluorescence recovery in nuclei after near complete photobleaching was very similar to the rate of increase of nuclear fluorescence in the presence of leptomycin B, which is consistent with a resting nuclear influx (and efflux) equal to the rate of net nuclear influx seen in the presence of leptomycin B. HDAC4 movements in resting fibers in the presence of protein kinase inhibitors The CaMK inhibitor KN-62 completely blocked the net nuclear to cytoplasmic translocation of HDAC4-GFP in response to electrical stimulation (10-Hz trains; Fig. 2 C). Thus, we also explored the possible role of CaMK in the dynamic shuttling of HDAC4-GFP in resting fibers. During a 1-h period of exposure of unstimulated fibers to KN-62 (5 microM), the HDAC4- GFP fluorescence in the nucleus and in the cytoplasm were both stable, without any significant change (Fig. 8 C). This unexpected finding points out that although CaMK, inhibited by KN-62, played an essential role in calcium-triggered translocation of HDAC4-GFP out of nuclei during muscle activity (Figs. 1 and 2), any HDAC4 phosphorylation required for shuttling of HDAC4-GFP out of nuclei in unstimulated resting fibers was not mediated by CaMK, but may be mediated by another kinase. To examine whether or not other protein kinases might affect the distribution of HDAC4-GFP in resting fibers, the broad-spectrum protein kinase inhibitor staurosporine was added to the same fibers that had been previously treated with KN-62 for 1 h. As shown in Fig. 8 C, staurosporine increased the fluorescence signal in the nucleus without affecting cytoplasmic fluorescence in the same unstimulated fibers that did not respond to KN-62. This finding demonstrates that there is one or more unidentified (non-CaMK) protein kinase controlling the shuttling of HDAC4-GFP in unstimulated fibers, whereas CaMK is activated and responsible for the Ca2+ dependent increase in nuclear to cytoplasmic translocation of HDAC4 in stimulated fibers. Collectively, it seems that there are two different parallel biochemical pathways mediating HDAC4 phosphorylation before efflux from the nucleus, one that is activity and CaMK dependent and another that is activity and CaMK independent.  Phosphatases mediating HDAC4 nuclear influx Next, we tested the role of phosphatases in HDAC4 shuttling in resting fibers. Over a 60-min period of treatment with 1 microM calyculin A (a PP1 and PP2A phosphatase inhibitor that does not affect PP2B; Ishihara et al., 1989), the nuclear HDAC4-GFP fluorescence decreased linearly with a mean net export rate of -0.71 +/- 0.07%/min (Fig. 9 A, 13 nuclei from 5 fibers). This rate is a measure of the net efflux with the calyculin A-sensitive endogenous phosphatases (PP1 and 2A) inhibited in the absence of muscle fiber activity and the resulting Ca2+ dependent stimulation of kinases. Before addition of calyculin A, nuclear HDAC4 was constant, indicating that nuclear influx and efflux of HDAC4 were equal. The observed rate of efflux thus corresponds to the rate of PP1- and/or 2A-dependent HDAC4 influx into resting fibers. This rate is very similar to the rate of influx (0.88%/min) in the presence of leptomycin B, indicating that almost all of the influx of HDAC4 into nuclei during shut...",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 Mar 14 168(6) 887-97",
                "id": "15767461"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0759"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "In the present study, we demonstrate that PP-1 can dephosphorylate p53 at Ser-15 and Ser-37 through co-immunoprecipitation, in vitro and in vivo dephosphorylation assays, overexpression and silence of the gene encoding the catalytic subunit for PP-1. We further show that mutations mimicking constitutive dephosphorylation or phosphorylation of p53 at these sites attenuate or enhance its transcriptional activity, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 May 18 25(21) 3006-22",
                "id": "16501611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0758"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Figure 2. Signaling from Rho to the CytoskeletonThe pathways from Rho to the formation of stress fibers are described in the text. Direct activating signals are presented by solid arrows. Inhibitory signals are depicted as red bars. Double-lined arrows and bars represent the net result of a signaling pathway. Abbreviations used: LIMK, LIM kinase; MLC-P, phosphorylated myosin II regulatory light chain; MLC phosphatase, myosin light chain phosphatase.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Jan 23 116(2) 167-79",
                "id": "14744429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0757"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Transient overexpression of FLAG-alpha 4 resulted in increased dephosphorylation of elongation factor 2, but had no effect on phosphorylation of either p70S6 kinase or PHAS-I (eIF4E-BP). This gene encodes a member of the GTP-binding translation elongation factor family. This protein is an essential factor for protein synthesis. It promotes the GTP-dependent translocation of the nascent protein chain from the A-site to the P-site of the ribosome. This protein is completely inactivated by EF-2 kinase phosporylation.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1999 Aug 10 38(32) 10371-6",
                "id": "10441131"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0756"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "TIMAP is a prenylated endothelial cell protein with a domain structure that predicts it to be a protein phosphatase-1 (PP-1) regulatory subunit. We found that TIMAP interacts with the 37/67 kDa laminin receptor (LAMR1) in yeast two-hybrid assays. In endothelial cells, endogenous TIMAP and LAMR1 co-immunoprecipitated and co-localized at the plasma membrane. TIMAP amino acids 261-290, representing the fourth ankyrin repeat of TIMAP, are necessary and sufficient for the interaction. In MDCK cells, lacking endogenous TIMAP, overexpression of full-length TIMAP, but not TIMAP deleted in the fourth ankyrin domain, allowed co-immunoprecipitation with LAMR1. PP-1 co-precipitated with overexpressed and endogenous TIMAP in MDCK and endothelial cells, respectively. In MDCK cells, PP-1 associated with LAMR1 in the presence, but not in the absence, of TIMAP. LAMR1 was a substrate for PP-1 in vitro, and in MDCK cells its phosphorylation was abrogated by expression of full-length TIMAP but not by TIMAP deficient in the fourth ankyrin domain. Hence, TIMAP targets PP-1 to LAMR1, and LAMR1 is a TIMAP-dependent PP-1 substrate.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Dec 23 338(3) 1327-34",
                "id": "16263087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0755"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": " In vitro dephosphorylation assay showed that PP1 dephosphorylated ultraviolet C (UVC)-induced phospho-ser15 of p53, and that OA treatment inhibited it. One of the PP1 regulators, growth arrest and DNA damage 34 (GADD34), disturbed PP1 binding with p53, interfered with the dephosphorylation of p53 and increased the amount of phospho-p53 after UVC-treatment. This report provides the first evidence that PP1, but not PP2A, dephosphorylates phospho-serine 15 of p53.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Jun 4 567(2-3) 171-4",
                "id": "15178317"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0754"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "While Aurora-A is required for centrosome separation in animals (147), the unique yeast Aurora kinase does not appear to subserve this function, as a conditional loss-of-function mutation of this enzyme did not affect spindle pole body separation (356). Like Aurora- B, Aurora-A interacts with PP1, and this interaction peaks at mitosis. A mechanism of regulation of Aurora-A by PP1 that is similar to that of Aurora-B (269) is suggested by the observation that PP1 dephosphorylates and thereby inactivates Aurora-A in vitro. Interestingly, PP1 is also an in vitro substrate for Aurora-A, and this phosphorylation results in the inactivation of the phosphatase.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2004 Jan 84(1) 1-39",
                "id": "14715909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0753"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Next, we used FRAP to verify the existence of nuclear fluxes, and consequent nuclear shuttling of HDAC4 in unstimulated fibers under resting control conditions without pharmacological suppression of nuclear efflux by leptomycin B. The mean initial rate of recovery of nuclear fluorescence, determined by linear fit to the fluorescence during the first 30 min after photobleaching in each of six nuclei in six fibers, was 0.89 +/- 0.15%/min. Subsequently, 120 min after photobleaching, leptomycin B was added to the same fibers and the mean rate of increase in nuclear fluorescence in the same fibers in the presence of leptomycin B was found to be 1.08 +/- 0.18%/min. Thus the initial rate of HDAC4 fluorescence recovery in nuclei after near complete photobleaching was very similar to the rate of increase of nuclear fluorescence in the presence of leptomycin B, which is consistent with a resting nuclear influx (and efflux) equal to the rate of net nuclear influx seen in the presence of leptomycin B. HDAC4 movements in resting fibers in the presence of protein kinase inhibitors The CaMK inhibitor KN-62 completely blocked the net nuclear to cytoplasmic translocation of HDAC4-GFP in response to electrical stimulation (10-Hz trains; Fig. 2 C). Thus, we also explored the possible role of CaMK in the dynamic shuttling of HDAC4-GFP in resting fibers. During a 1-h period of exposure of unstimulated fibers to KN-62 (5 microM), the HDAC4- GFP fluorescence in the nucleus and in the cytoplasm were both stable, without any significant change (Fig. 8 C). This unexpected finding points out that although CaMK, inhibited by KN-62, played an essential role in calcium-triggered translocation of HDAC4-GFP out of nuclei during muscle activity (Figs. 1 and 2), any HDAC4 phosphorylation required for shuttling of HDAC4-GFP out of nuclei in unstimulated resting fibers was not mediated by CaMK, but may be mediated by another kinase. To examine whether or not other protein kinases might affect the distribution of HDAC4-GFP in resting fibers, the broad-spectrum protein kinase inhibitor staurosporine was added to the same fibers that had been previously treated with KN-62 for 1 h. As shown in Fig. 8 C, staurosporine increased the fluorescence signal in the nucleus without affecting cytoplasmic fluorescence in the same unstimulated fibers that did not respond to KN-62. This finding demonstrates that there is one or more unidentified (non-CaMK) protein kinase controlling the shuttling of HDAC4-GFP in unstimulated fibers, whereas CaMK is activated and responsible for the Ca2+ dependent increase in nuclear to cytoplasmic translocation of HDAC4 in stimulated fibers. Collectively, it seems that there are two different parallel biochemical pathways mediating HDAC4 phosphorylation before efflux from the nucleus, one that is activity and CaMK dependent and another that is activity and CaMK independent.  Phosphatases mediating HDAC4 nuclear influx Next, we tested the role of phosphatases in HDAC4 shuttling in resting fibers. Over a 60-min period of treatment with 1 microM calyculin A (a PP1 and PP2A phosphatase inhibitor that does not affect PP2B; Ishihara et al., 1989), the nuclear HDAC4-GFP fluorescence decreased linearly with a mean net export rate of -0.71 +/- 0.07%/min (Fig. 9 A, 13 nuclei from 5 fibers). This rate is a measure of the net efflux with the calyculin A-sensitive endogenous phosphatases (PP1 and 2A) inhibited in the absence of muscle fiber activity and the resulting Ca2+ dependent stimulation of kinases. Before addition of calyculin A, nuclear HDAC4 was constant, indicating that nuclear influx and efflux of HDAC4 were equal. The observed rate of efflux thus corresponds to the rate of PP1- and/or 2A-dependent HDAC4 influx into resting fibers. This rate is very similar to the rate of influx (0.88%/min) in the presence of leptomycin B, indicating that almost all of the influx of HDAC4 into nuclei during shut...",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 Mar 14 168(6) 887-97",
                "id": "15767461"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0752"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "We conclude that RhoA/ROCK play a critical role in maintenance of spontaneous tone in the IAS SMC via inhibition of myosin light chain phosphatase",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2007 Jun 292(6) G1747-56",
                "id": "17379756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe030b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "the apparent phosphorylation level is diminished to an undetectable level due to the constitutive action of type 1 protein phosphatas",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 3 274(49) 34932-9",
                "id": "10574968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe030a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Loss of PP1 function by phosphorylation decreases levels of the cyclin-dependent kinase inhibitor p27Kip1, which in turn facilitates cell cycle progression [34].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0309"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Dephosphorylation and inactivation of activated CaMKI/IV can be catalyzed in vitro by PP1, PP2A, calcineurin (CaN), and the CaMK phosphatase, but the relevant phosphatase(s) in vivo is still unclear (6, 7). CaMKI is ubiquitously expressed, whereas CaMKIV has a more limited distribution, although both enzymes are strongly expressed in the brain.  ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 2975-8",
                "id": "11096122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0308"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "This [association] allows NEk2 to phosphorylate and inactivate PP1, and the coordination of  the two enzymes in turn controls their common substrate, the centrosomal protein cNAP-1, which is also found in this complex.",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2000 Nov 7 2000(57) PE1",
                "id": "11752618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0307"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "hSNF5/INI1 binds GADD34 and stimulates the bound PP1 phosphatase activity",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 May 23(10) 3477-86",
                "id": "12724406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0306"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "We conclude that ILK may activate smooth-muscle contraction both directly, via phosphorylation of myosin, and indirectly, via phosphorylation and activation of CPI-17 and PHI-1, leading to inhibition of MLCP.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Oct 15 367(Pt 2) 517-24",
                "id": "12144526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0305"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "In the present study, we demonstrate that PP-1 can dephosphorylate p53 at Ser-15 and Ser-37 through co-immunoprecipitation, in vitro and in vivo dephosphorylation assays, overexpression and silence of the gene encoding the catalytic subunit for PP-1. We further show that mutations mimicking constitutive dephosphorylation or phosphorylation of p53 at these sites attenuate or enhance its transcriptional activity, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 May 18 25(21) 3006-22",
                "id": "16501611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0304"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "The regulation of CaMKIIalpha by dephosphorylation by protein phosphatase 1 (PP1) has been demonstrated.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res 2006 Apr 12 1082(1) 1-10",
                "id": "16516168"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0303"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "okadaic acid (OA), which specifically inhibits the serine threonine protein phosphatases 1 and 2A.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2000 Mar 57(3) 610-8",
                "id": "10692503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0302"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Zipper-interacting protein kinase (ZIPK) regulates Ca(2 )-independent phosphorylation of both smooth muscle (to regulate contraction) and non-muscle myosin (to regulate non-apoptotic cell death) through either phosphorylation and inhibition of myosin phosphatase, the myosin phosphatase inhibitor CPI17, or direct phosphorylation of myosin light chain.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Feb 16 282(7) 4884-93",
                "id": "17158456"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0301"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "In contrast, selective inhibition of protein phosphatase 1 with tautomycin inhibited pRB phosphatase activity and maintained pRB in a highly phosphorylated state. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31917-24",
                "id": "10542219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0300"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "now describe a novel PKC (protein kinase C)-dependent PP1 inhibitor, namely GBPI (gut and brain phosphatase inhibitor). ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Jan 1 377(Pt 1) 171-81",
                "id": "12974676"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Here, we report discovery of a new inhibitor protein called PHI-1 that is specific for type-1 protein phosphatase (PP1).",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1999 Dec 21 38(51) 16952-7",
                "id": "10606530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Differential display analysis of mRNA derived from hypoxic epithelia revealed a specific and time-dependent repression of protein phosphatase 1 (PP1), a serine phosphatase important in CREB dephosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 12091-6",
                "id": "11035795"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "Phosphorylation of both Thr695 and Thr850 by Rho-kinase inhibited activity of the type 1 phosphatase catalytic subunit.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Dec 5 579(29) 6611-5",
                "id": "16297917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02fc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "In smooth muscle the majority of MP activity is due to PP1c (5), and this finding was extended to include skeletal and cardiac muscle. Three genes encode PP1c: alpha, gamma, and delta (also called beta). Five PP1c isoforms are expressed, where 1/2 and 1/2 are generated by alternative splicing (1).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 3 279(36) 37211-4",
                "id": "15136561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02fb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "In addition, protein phosphatase-1 was identified as a major enzyme that is responsible for dephosphorylation of MARCKS.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2002 Jun 15 115(Pt 12) 2465-73",
                "id": "12045217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"PPP1R Family\") actsIn phos(p(SFAM:\"PPP1R Family\"))",
              "summary_text": "We conclude (i) that PP2A negatively regulates the Ras/MAP kinase pathway by binding to Shc, inhibiting tyrosine phosphorylation;",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(7) 2375-87",
                "id": "11884620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe02f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:XRCC1))",
        "relation": "increases",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "cat(p(HGNC:XRCC1)) increases bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a24",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:XRCC1)) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe075a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "cat(p(HGNC:XRCC1)) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "XRCC1, which is required for efficient DNA single-strand break (SSB) repair",
              "citation": {
                "type": "PubMed",
                "name": "DNA Repair (Amst) 2011 Aug 12",
                "id": "21840775"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe030c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"AKT Family\"))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CDKN1A,pmod(P,T,145))",
        "directed": false,
        "label": "kin(p(SFAM:\"AKT Family\")) directlyIncreases p(HGNC:CDKN1A,pmod(P,T,145))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a25",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"AKT Family\")) directlyIncreases p(HGNC:CDKN1A,pmod(P,T,145))",
              "summary_text": "Whereas the function of CKIs as tumour suppressors is well characterized in the nucleus, they also seem to function in the cytoplasm,where they regulate cytoskeletal functions. This occurs through the modulation of the Rho signalling pathway. This cytoplasmic function could be oncogenic, as inhibition of the Rho pathway can result in increased migratory capacity. Phosphorylation of p21 on Thr145 by protein kinase B (PKB)/Akt48 or Pim1 inhibits the nuclear localization of p21. In the cytoplasm, p21 can protect the cell from apoptosis, as well as bind and inhibit the Rho kinases ROCK1 and -2 to modulate actin cytoskeleton organization46,47.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Dec 4(12) 948-55",
                "id": "15573116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe075b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA1)",
        "relation": "hasModification",
        "target": "p(HGNC:BRCA1,pmod(P,S,1524))",
        "directed": false,
        "label": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1524))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a26",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1524))",
              "summary_text": "Alcohol metabolism in human cells causes DNA damage and activates the Fanconi anemia-breast cancer susceptibility (FA-BRCA) DNA damage response network.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21919919"
              },
              "metadata": {
                "created_by": "mgvelez96",
                "id": "55775d252f9e24174cfe07f1"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1524))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe030d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PLK1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP73,pmod(P,T,27))",
        "directed": false,
        "label": "kin(p(HGNC:PLK1)) directlyIncreases p(HGNC:TP73,pmod(P,T,27))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a27",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PLK1)) directlyIncreases p(HGNC:TP73,pmod(P,T,27))",
              "summary_text": "Here, we present novel findings that show TAp73 can interact and co-localise, with Polo-Like Kinase 1 (PLK1) and that TAp73 is phosphorylated by this kinase on Threonine-27 (Thr-27) within the TA domain. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2008 May 1 7(9) 1214-23",
                "id": "18418051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe030f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:PLK1)) directlyIncreases p(HGNC:TP73,pmod(P,T,27))",
              "summary_text": "In this study, we have found that Plk1 (polo-like kinase 1) associates with p73, phosphorylates p73 at Thr-27, and thereby inhibits its pro-apoptotic activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Mar 28 283(13) 8555-63",
                "id": "18174154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe030e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RHOA)",
        "relation": "actsIn",
        "target": "gtp(p(HGNC:RHOA))",
        "directed": false,
        "label": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a28",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Both RhoGDI and D4GDI (hereafter referred to collectively as GDIs) are cytosolic and form 1:1 complexes with Rho family GTPases, although several Rho family members have been reported to not effectively bind to GDIs (Table 1). First, they inhibit the dissociation of GDP from Rho proteins, maintaining the GTPase in an inactive form and preventing GTPase activation by GEFs (Box 1). Second, they are able to interact with the GTP-bound form of the Rho GTPase to inhibit GTP hydrolysis, blocking both intrinsic and GAP-catalyzed GTPase activity and preventing interactions with effector targets.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2005 Jul 15(7) 356-63",
                "id": "15921909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe077c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "A G protein-coupled chemoattractant receptor (R) activates PI3K isoforms, which converts PtdIns(4,5)P2 to PtdIns(3,4,5)P3. PI3K activation itself would lead only to a transient increase in PtdIns(3,4,5)P3 followed by a decrease in this lipid product as a result of depletion of the upstream phosphoinositide substrates, such as PtdIns(4,5)P2. Hence, PtdIns(3,4,5)P3 at the leading edge or front of the cell stimulates its own accumulation through the activation of one or more Rho GTPases (Rac, cdc42 and/or Rho), which in turn activate PI3K and increase PtdIns(3,4,5)P3 formation. ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2004 Feb 25(2) 67-74",
                "id": "15102365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe077b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Interestingly, IMC-C225 pretreatment was accompanied by EGFR phosphorylation, as detected using an anti-phosphorylated tyrosine antibody (PY99), which correlated with phosphorylation of Vav2 guanine nucleotide exchange factor and activation of RhoA GTPase irrespective of EGFR level, and Vav2 interacted with EGFR only in IMC-C225-treated cells.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2008 Oct 1 14(19) 6161-70",
                "id": "18829495"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe077a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "LipoxinA4 rapidly stimulates macrophages to phagocytose apoptotic neutrophils, induces RhoA- and Rac-dependent cytoskeleton re-organization of macrophages and inhibits macrophage CXCL8 release, supporting macrophage-mediated resolution of inflammation. In turn,as a result of engulfment of apoptotic neutrophils, macrophages themselves become a primary source of lipoxins  ",
              "citation": {
                "type": "PubMed",
                "name": "Front Immunol 2011 2 65",
                "id": "22566854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0779"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "inhibition of Rho prevents both thrombin- and histamine-induced increases in endothelial permeability and decreases in transendothelial resistance. Dominant-negative RhoA and a Rho kinase inhibitor, Y-27632, not only inhibit stress fibre assembly and contractility but also prevent thrombin- and histamine-induced disassembly of adherens and tight junctions in endothelial cells, providing an explanation for their effects on permeability.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Apr 114(Pt 7) 1343-55",
                "id": "11257000"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0778"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Ox-LDL induced rapid RhoA and Rac1 activation as well as MT1-MMP activity in cultured human aortic ECs.....the present study provides evidence that the LOX-1-MT1-MMP axis plays a crucial role in RhoA and Rac1 activation signalling pathways in ox-LDL stimulation......Fluorescent immunostaining revealed the colocalization of LOX-1 and MT1-MMP, and the formation of a complex of LOX-1 with MT1-MMP was detected by immunoprecipitation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2009 Oct 1 84(1) 127-36",
                "id": "19487339"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0777"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "By using SHP-2 substrate-trapping mutants, we identified p190-B RhoGAP as a SHP-2 substrate. When dephosphorylated, p190-B RhoGAP has been shown to stimulate the activation of RhoA. During myogenesis, p190-B RhoGAP was tyrosyl dephosphorylated concomitant with the stimulation of SHP-2's phosphatase activity. These observations strongly suggest that SHP-2 dephosphorylates p190-B RhoGAP, leading to the activation of RhoA.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(12) 5340-52",
                "id": "15169898"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0776"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "myofibroblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "(Jubilant) Pretreatment with C3 transferase exoenzyme, an inhibitor of Rho small GTP binding proteins (Rho A, B and C) inhibited the bradykinin induced NFkB activity. Treatment with calpain I or PDTC completely inhibited the DNA binding activity of NFkB. Transfection of cell with dominant negative RhoA-T19N inhibited the bradykinin induced NFkB activity. A dominant-negative form of RhoA (T19N) inhibited BK-stimulated reporter gene expression in a dose-dependent and kappaB-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Mar 15 160(6) 3038-45",
                "id": "9510209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0775"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "M-RIP binds directly to the myosin binding subunit of myosin phosphatase in vivo in vascular smooth muscle cells by an interaction between coiled-coil and leucine zipper domains in the two proteins. An adjacent domain of M-RIP directly binds RhoA in a nucleotide-independent manner. M-RIP copurifies with RhoA and Rho kinase, colocalizes on actin stress fibers with RhoA and MBS, and is associated with Rho kinase activity in vascular smooth muscle cells. M-RIP can assemble a complex containing both RhoA and MBS, suggesting that M-RIP may play a role in myosin phosphatase regulation by RhoA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 19 278(51) 51484-93",
                "id": "14506264"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0774"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "desmocollin 3 and Dsg3 are the main desmosomal cadherins displayed at the cell surface of keratinocytes (Green and Gaudry, 2000; Dusek et al., 2007). Similar to E-cadherin, they are stabilized following RhoA activation (Waschke et al., 2006), Dsg3-associated plakoglobin becomes tyrosine phosphorylated in a Src-family kinase-dependent manner (Calautti et al., 1998) and PI3K (p85) associates with the Dsg3/plakoglobin complex (SID Meeting abstract; Schulze et al., 2007).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0773"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We also employed double-strand (ds) RNA mediated interference (RNAi) (Elbashir et al., 2001) to deplete endogenous Daam1 protein. The ds RNAi oligo for Daam1 reduces the protein level of Daam1, but not of RhoA, ?-catenin (Figure 3C) or Dvl2 (not shown). Importantly, the RNAi oligo inhibits RhoA activation by Wnt-1, Fz, or Dvl, but not by Ephexin (Figure 3C). A control ds RNAi oligo has no effect on Daam1 or RhoA protein level or RhoA activation (Figure 3C). Thus, Daam1 is essential for Wnt/Fz/Dvl activation of RhoA. AN ACTIVATED DAAM1 INDUCES RHO ACTIVATION IN A RHO-GEF-DEPENDENT MANNER Previous studies suggest that deletion of the amino terminal domain results in constitutive activation of FH proteins by releasing an intramolecular inhibition (Watanabe et al. 1999; Tominaga et al. 2000 and Westendorf 2001). C-Daam1 thus may represent an activated form of Daam1. Indeed, while the full length Daam1 is inactive, C-Daam1 overexpression causes activation of RhoA, but not of Rac or Cdc42 (Figure 3D). C-Daam1 activation of RhoA is not affected by ?PDZ-Dvl (Figure 3A), which inhibits RhoA activation by Fz or Dvl (Figure 1F), further demonstrating that Daam1 functions downstream of Dvl in Rho activation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Dec 28 107(7) 843-54",
                "id": "11779461"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0772"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Shh activity in ECs is mediated by Rho, rather than through the \\\"classic\\\" Shh signaling pathway, which involves the Gli transcription factors. The Rho dependence of Shh-induced EC angiogenic activity was documented both in vitro, with dominant-negative RhoA and Rho kinase (ROCK) constructs, and in vivo, with the ROCK inhibitor Y27632 in the mouse corneal angiogenesis model. Finally, experiments performed in MMP-9- and OPN-knockout mice confirmed the roles of the ROCK downstream targets MMP-9 and OPN in Shh-induced angiogenesis. ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2010 Sep 49(3) 490-8",
                "id": "20478312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0771"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We then tested whether the canonical TGF-beta receptor/Smad pathway mediates regulation of the above effectors and actin reorganization. Adenoviruses expressing constitutively activated TGF-beta type I receptor led to robust actin reorganization and Rho activation, whereas the constitutively activated TGF-beta type I receptor with mutated Smad docking sites (L45 loop) did not affect either actin organization or Rho activity. In line with this, ectopic expression of the inhibitory Smad7 inhibited TGF-beta1-induced Rho activation and cytoskeletal reorganization. Our data define a novel pathway emanating from the TGF-beta type I receptor and leading to regulation of actin assembly, via the kinase LIMK2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11448-57",
                "id": "15647284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0770"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Transcriptional profiling of the cellular transformation induced by Rho subfamily GTPases. We took advantage of the oncogenic properties of the constitutively active versions (Q63L mutants) of Rho subfamily proteins when overexpressed in rodent fibroblasts (Schuebel et al., 1998). Based on this property, we transfected NIH3T3 cells with plasmids encoding the indicated versions of Rho subfamily proteins to obtain foci of transformed cells. Selected foci were picked, pooled, and used for the subsequent microarray experiments. GENSTRUCT R-PIPELINE ANALYSIS of GSE5913 on 6/11/2010 by SE. Cutoffs used for curation by AV: Fold change 1.8, adjusted p-value .001, abundance 250 (values were adjusted to restrict # of statements to ~300)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jan 8",
                "id": "17213802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe076f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "LSC (also known as ARHGEF1) is a haematopoietic cell-restricted GEF for RHOA, which interacts with G protein-coupled receptor (GPCR)-associated Galpha12 and Galpha13 proteins (Fig. 5). In addition to its DH domain with GEF activity, LSC has a regulator of G protein signalling (RGS) domain, which binds to Galpha proteins and increases their intrinsic GTPase activity, thereby turning off GPCR signalling. So LSC seems to carry out two functions. First, it transduces GPCR signals from Galpha12 and Galpha13 proteins to activate RHOA and second, it attenuates other Galpha12- or Galpha13-coupled GPCR signals. In LSC-deficient mice, the number of B cells is decreased as are T cell-dependent antibody responses to protein antigens owing to a cell-intrinsic requirement for LSC in B cells27, 28. Further analysis has shown that LSC-deficient marginal zone B cells migrate more effectively in response to sphingosine 1-phosphate (S1P) in vitro, which might be due to the loss of LSC-mediated inhibition of signalling from Galpha12/13-coupled S1P receptors. By contrast, LSC-deficient marginal zone B cells have a defect in their ability to detach from ICAM1 and they do not migrate to the follicles following LPS stimulation in vivo. The defects in migration to the follicles might reflect a requirement for LSC-mediated RHOA activation in the disengagement of integrin binding at the trailing edge of the migrating B cell28. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 Sep 9(9) 630-44",
                "id": "19696767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe076e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The myosin phosphatase (MP) composed of the catalytic subunit of type 1 protein phosphatase and myosin phosphatase target subunit isoform 1 (MYPT1) was identified as the major serine/threonine phosphatase component in the platelet-cytoskeleton fraction. MYPT1 was phosphorylated by cytoskeletal kinase(s), but the identity of the kinase(s) and the effect of phosphorylation were not established. Incubation of platelet-cytoskeletal fraction with MgATP or MgATP[S] (magnesium adenosine 5'-[gamma-thio]triphosphate) caused a decrease in the 20 kDa light-chain of smooth-muscle myosin (MLC20) phosphatase and phosphorylase phosphatase activities. MYPT1 contains a phosphorylation site, Thr-695, involved in the inhibition of MP in a RhoA/Rho kinase-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Jul 1 365(Pt 1) 79-87",
                "id": "11931630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe076d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "we found that DLC-1 had robust activity on RhoA in vitro. Furthermore, DLC-1 also had strong GAP activity on both RhoB and RhoC (Fig. 1B - D).....we introduced a missense mutation in the conserved arginine-718 residue critical for RhoGAP catalytic activity [38]. We found that DLC-1(R718E) was completely impaired in stimulating the intrinsic hydrolysis activity of GTP-loaded RhoA, RhoB, and RhoC in vitro (Fig. 1B - D).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2008 May 47(5) 326-37",
                "id": "17932950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe076c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "MAb200 was injected into H460 cells along with purified activated RhoA mutant, RhoAV14 (Ridley and Hall, 1992), and cell behaviour was examined for 2 - 3 days. About 35% of injected cells underwent apoptosis in the duration of the experiment, that is a twofold reduction in the number of cell deaths compared to that obtained after injection of mAb200 alone.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Aug 26 18(34) 4884-9",
                "id": "10490822"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe076b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We report here that, surprisingly, Rho signaling suppresses downstream gene expression events associated with differentiation. Similar inhibitory effects are exerted by a specific Rho effector, CRIK (Citron kinase), which is selectively down-modulated with differentiation, thereby allowing the normal process to occur.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Aug 9 102(32) 11313-8",
                "id": "16061799"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe076a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Angiotensin II (Ang II) participates in the pathogenesis of cardiovascular diseases. In hypertension, Ang II via AT1 receptors induces vascular structural changes, including cell hypertrophy, accumulation of extracellular matrix (ECM) proteins, and induction of profibrotic growth factors, such as connective tissue growth factor (CTGF).3 This growth factor also mediates cell proliferation/apoptosis, migration, cellular adhesion, wound healing, and angiogenesis.4 CTGF overexpression has been found in human atherosclerotic and myocardial lesions as well as in the aorta of Ang IIinfused rats, associated with ECM accumulation. In VSMCs, CTGF acts as a downstream mediator of Ang IIinduced fibrosis. The AT1 are G-coupled receptors that activate several intracellular signaling systems, such as protein kinases (MAPK and Rho kinase [ROCK]), small G proteins, including Ras, Rac1 and RhoA, transcription factors (AP-1, Smads), and redox process, which regulate several Ang IImediated responses.  In VSMCs, statins inhibited Ang II-induced Rho membrane localization and activation. In these cells Ang II regulated CTGF via RhoA/Rho kinase activation, as shown by inhibition of Rho with C3 exoenzyme, RhoA dominant-negative overexpression, and Rho kinase inhibition. ",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2007 Aug 50(2) 377-83",
                "id": "17592071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0769"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We show that functional RhoA is required for LPA-, serum-, and AIF4--induced transcriptional activation by SRF and that tw~ other Rho family GTPases, Racl and CDC42Hs, can also potentiate SRF activity.......NIH 3T3 cells were transfected with CAT reporter genes controlled by either two copies of the wild-type c-los SRE, or its derivative SRE.L, which cannot bind TCF, together with expression plasmids producing the activated small GTPases Ras.R12, RhoA.V14, Rac1.V12, or CDC42Hs.......The serum response element (SRE) is a regulatory sequence found in many growth factor-regulated promoters (reviewed by Treisman, 1990). The SRE binds the ubiquitous transcription factor SRF (serum response factor; Norman et al., 1988), which is required for its activity. V12. Coexpression of each of the proteins activated the wild-type SRE in the absence of growth factor stimulation, with an efficiency approaching that of serum stimulation in the case of CDC42Hs (Figure 3A, left).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1995 Jun 30 81(7) 1159-70",
                "id": "7600583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0768"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase (Cdc) 42, regulate cytoskeletal organization during the cell cycle and also mediate Ras-induced activation of Raf, especially C-Raf.134-136 These GTPases do not directly bind to Raf but, instead, signal by activating downstream kinases. Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase (PAK).134-136",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0767"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "these findings indicate that HTS and LPA consecutively activate FAK/paxillin and RhoA/Rho-kinase, and the phosphorylation of FAK/paxillin is located downstream of the RhoA/Rho-kinase cascade in HUVECs. Previous studies have also suggested the sequential activation of these intracellular signals. For instance, microinjection of RhoA or the activation of endogenous RhoA with LPA or bombesin induced the activation of FAK/paxillin",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2004 Jul 15 558(Pt 2) 479-88",
                "id": "15155793"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0766"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "RhoA and Rac1 proteins were efficiently expressed in a cell line of human bronchial epithelial cells (16HBE) by adenovirus-based gene transfer. We found that both constitutively active RhoA and dominant negative RhoA inhibited wound healing, suggesting that both activation and inhibition of RhoA interfere with normal wound healing. Overexpression of wild-type Rac1 induced upregulation of RhoA, disrupted intercellular junctions, and inhibited wound closure. Dominant negative Rac1 also inhibited wound closure. Inhibition of the downstream effector of RhoA, Rho-kinase, with Y-27632 suppressed actin stress fibers and focal adhesion formation, increased Rac1 activity, and stimulated wound closure.RhoA and Rac1 are both required for efficient wound closure of airway epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Dec 287(6) L1134-44",
                "id": "15298851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0765"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Chloride channels, like Na+ channels, are more frequently activated by cytochalasin and inactivated by increasing actin cross linking, but again, there are exceptions to a simple interpretation, since F-actin itself can also activate some Cl channel activity.  In several cases where the effects of cytochalasin have been compared with those of nocodazole or colchicine, microtubule disruption has not been found to affect Na+, K+, or Cl channels. However, disruption of microtubules has been reported to enhance the activity of both Ca2+ (73, 218) and Cl (92, 109) channels in some cases.  An intriguing hypothesis for how disruption of actin may activate K+ channels is by release of protein kinase A (PKA) bound to the actin (175). In this model, the regulation depends not only on a link of actin to the receptor, but on changing localization of a cytoskeleton-bound signaling kinase, as discussed in section IIB.  Some Ca2+ channels are inactivated by cytochalasin, and the effect is blocked by phalloidin. However, stretch-activated Ca2+ influx can be activated by cytochalasin and inhibited by F-actin. Moreover, there are several reports of microtubule disruption also altering Ca2+ channel activity (73, 218), with a strong enhancement in one case that was not achieved by cytochalasin. A scenario derived from Reference 78 for how actin filaments may affect Ca2+ influx resulting from mechanical stresses is shown in Figure 2. In this model, application of a mechanical stress at the plasma membrane of a resting cell causes deformation of channels in the plasma membrane that results in Ca2+ influx. In these cells, a sustained mechanical stress leads to assembly of two distinct structures: contractile elements containing actin filaments that create an opposing force and an elastic network that resists subsequent application of the external stress. As the stress is transmitted to the newly formed three-dimensional cytoskeleton, it is directed away from the plasma membrane, and the deformation of membrane elements near the site of force is now insufficient to activate Ca2+ influx.   One context in which mechanical effects on the cytoskeleton regulate ion fluxes is volume regulation after osmotic stress. Although the elastic modulus of the cytoskeleton is probably too low (1,000-10,000 Pa in some cell types and lower in others) to prevent volume changes caused by osmotic imbalance (10,000 Pa/mosM), its presence as an elastic element provides the cell with a countering tension and a memory of the undeformed state, at least for the time that the cross-linked cytoskeleton remains intact. It is not surprising, therefore, that the cytoskeleton affects ion transport in volume regulation (33, 43, 92, 129, 193). Among the clearest evidence for a mechanical function comes from the finding that melanoma cells containing approximately normal amounts of cytoskeletal filaments and ion channels, but lacking the cross-linking protein ABP280 that provides rigidity to the cell cortex, fail to volume regulate under hypotonic conditions. Transfection of ABP280 to these cells restores this capacity (33).  Whether the effects of the cytoskeleton on ion channel activity are a direct mechanical effect or an indirect effect due to such changes as regulation of kinases sequestered at the cytoskeleton remains a controversial issue. There are reports that the cytoskeleton has no effect on channel activity and reports that ion conductance through channels within a lipid bilayer can be altered by bilayer dilation in the absence of any internal network (162). On the other hand, there are intriguing hypotheses that actin filaments and microtubules could directly transmit ion fluxes because of their polyelectrolyte nature and the presence of a condensed counterion cloud (133). Although such effects appear plausible from a physical-chemical perspective, demonstrating their importance in biological ion signaling remains a chal...",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 1998 Jul 78(3) 763-81",
                "id": "9674694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0764"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "p27 binds to RhoA and prevents the interaction of RhoA with its activators the guanine-nucleotide exchange factors. Fibroblasts lacking p27 have impaired migration. CIP1 binds to and inhibits Rho kinases (ROCK1 and -2) - downstream effectors of Rho. p57 (KIP2) binds to and targets LIM domain-containing protein kinase (LIMK) to the nucleus, sequestering it in a compartment where it cannot regulate the actin cytoskeleton.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Dec 4(12) 948-55",
                "id": "15573116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0763"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "(332) Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Vaillant N, Gadeau AP, Desgranges C, Scalbert E, Chardin P, Pacaud P, and Loirand G. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 278: H1751 H1761, 2000.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2003 Oct 83(4) 1325-58",
                "id": "14506307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0762"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "This comparative study presents detailed kinetic data on specificity, activity, and regulation of the catalytic DH domains of four GEFs, namely p115, p190, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG). We demonstrate that (i) these GEFs are specific guanine nucleotide exchange factors for the Rho isoforms (RhoA, RhoB, and RhoC) ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 May 20 286(20) 18202-12",
                "id": "21454492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0761"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "One novel target of RhoA was protein-tyrosine phosphatase 1B (PTP1B), which catalyzes dephosphorylation of key signaling molecules in response to activation of diverse pathways. Subsequent analysis demonstrated that RhoA enhances post-translational modification of PTP1B, inactivates phosphotyrosine phosphatase activity, and up-regulates tyrosine phosphorylation of p130Cas, a key mediator of focal adhesion turnover and cell migration. Thus, protein profiling reveals a novel role for PTP1B as a mediator of RhoA-dependent phosphorylation of p130Cas.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Proteomics 2006 Aug 5(8) 1359-67",
                "id": "16644720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0760"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "VASP-induced F-actin accumulation and SRF activation require both functional Rho and its effector mDia, and conversely, mDia-mediated SRF activation is critically dependent on functional VASP. VASP and mDia also associate physically in vivo. These findings show that VASP and mDia function cooperatively downstream of Rho to control F-actin assembly and SRF activity.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Jun 16 22(12) 3050-61",
                "id": "12805219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe075f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Gel electrophoretic analysis demonstrated that 1,10-phenanthroline almost totally abolished the labeling of methylated proteins in kidney intracellular membranes. Immunoblotting analysis showed that one of the two major peaks of (3)H-methylated proteins in intracellular membranes comigrated with the small G proteins Ras, Cdc42, RhoA, and Rab1.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Aug 11 261(3) 790-7",
                "id": "10441503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe075e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Figure 2. Signaling from Rho to the CytoskeletonThe pathways from Rho to the formation of stress fibers are described in the text. Direct activating signals are presented by solid arrows. Inhibitory signals are depicted as red bars. Double-lined arrows and bars represent the net result of a signaling pathway. Abbreviations used: LIMK, LIM kinase; MLC-P, phosphorylated myosin II regulatory light chain; MLC phosphatase, myosin light chain phosphatase.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Jan 23 116(2) 167-79",
                "id": "14744429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe075d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "C3 transferase exoenzyme, an inhibitor of Rho, abolished BK-induced NF-kappaB activation at 10 microg/ml and significantly inhibited BK-stimulated IL-1beta synthesis at 5 microg/ml. A dominant-negative form of RhoA (T19N) inhibited BK-stimulated reporter gene expression in a dose-dependent and kappaB-dependent manner. These results demonstrate that BK stimulates NF-kappaB activation and IL-1beta synthesis in A549 cells, and that RhoA is both necessary and sufficient to mediate this effect.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Mar 15 160(6) 3038-45",
                "id": "9510209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe075c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Because KLF2 induces RhoA activity (Figure 2C) and Rho is known to induce actin stress fiber formation through Rho kinase,44 we tested whether KLF2-mediated shear fiber formation is dependent on Rho kinase (Figure 5B).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 Mar 25 115(12) 2533-42",
                "id": "20032497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Our most recent works show that pertussis toxin-sensitive G proteins and Gbetagamma subunits are required for Flt-1-mediated down-regulation of human umbilical vein endothelial cell (HUVEC) proliferation and that Gq/11 proteins are required for KDR-mediated RhoA activation and HUVEC migration.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 6 278(23) 20738-45",
                "id": "12670961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Induction of DNA DSBs stimulates the activation of the MAPK p38 in a RhoA-dependent manner; and this is required to delay cell death in response to toxin treatment or ?-irradiation (Guerra et al., 2008a).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2011 Aug 15 124(Pt 16) 2735-42",
                "id": "21807938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The Dbl-homology domains of Bcr and Abr were active in stimulating GTP binding to CDC42Hs, RhoA, Rac1, and Rac2",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1995 Oct 24 92(22) 10282-6",
                "id": "7479768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Dishevelled-dependent WNT/PCP signals are transduced to the RHOA signaling cascade through Formin homology proteins DAAM1 and DAAM2, and to the JNK signaling cascade through MAPKKKs and MAPKK4/7",
              "citation": {
                "type": "PubMed",
                "name": "Oncol Rep 2005 Dec 14(6) 1583-8",
                "id": "16273260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "RHOA / Phospholipase D1 signaling has been demonstrated to mediate the anti- ischemic effect of A3ARs",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Drug Discov 2006 Mar 5(3) 247-64",
                "id": "16518376"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Herein, we demonstrate that RhoA, Rac1, and Cdc42 promote the expression of cyclooxygenase-2 (COX-2) at the transcriptional level. Rho GTPases induce the expression of COX-2 in NIH3T3, HT29, DLD-1, and MDCK cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Jul 14(7) 3041-54",
                "id": "12857884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "These results suggest that simvastatin may inhibit Rho activity possibly by inhibiting its prenylation and thereby induce SR-BI expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Nov 15 181(10) 7332-40",
                "id": "18981156"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "This effect is mediated, at least in part, by a decrease in TTF-1 activity, since transient or stable expression of RhoA QL results in a reduction in the activity of the wild-type Tg promoter as well as an artificial promoter the activation of which depends exclusively on TTF-1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Jan 16(1) 33-44",
                "id": "11773437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Tyr31/118-phosphorylated paxillin serves as a template for the localized suppression of RhoA activity",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Nov 25 159(4) 673-83",
                "id": "12446743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "FAK-mediated RhoA activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 20 281(3) 1587-98",
                "id": "16298995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "In this study, we report that stimulation of TLR2 in human epithelial and monocytic cells leads to rapid and transient activation of RhoA. RhoA cooperated with the canonical I-kappaB kinase-mediated pathway that induces the release of NF-kappaB, in regulating the trans activation of the NF-kappaB subunit p65/RelA by affecting Ser(311) phosphorylation, and subsequent cytokine production.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jul 1 173(1) 507-14",
                "id": "15210811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Tenascin-C suppresses Rho activation Ariadne: We find that the change in actin organization  occurs because RhoA activation is completely suppressed by tenascin-C.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Aug 21 150(4) 913-20",
                "id": "10953015"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The atypical protein kinase C (PKC) isoform PKCzeta, which is downstream of PI3K, was activated in cells expressing active RhoA. In addition, expression of constitutively activated PKCzeta in TRAMP cells enhanced proliferation and p70S6 kinase phosphorylation, whereas the inhibition of PKCzeta activation resulted in activation of Akt and enhanced cell survival. Thus, the effects of RhoA on TRAMP cell proliferation and apoptosis may be mediated by PKCzeta.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 May 1 62(9) 2630-6",
                "id": "11980660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The subsequent activation of Rac and Rho leads to the formation of focal complexes and focal adhesions, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 27 276(30) 28300-8",
                "id": "11382766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "p160ROCK, a serine/threonine protein kinase, is a direct RhoA target mediating RhoA-induced assembly of focal adhesions and stress fibers.",
              "citation": {
                "type": "PubMed",
                "name": "J Hepatol 2000 May 32(5) 762-70",
                "id": "10845663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2001 Oct 12(10) 3282-94",
                "id": "11598209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "As indicated in Fig. 2, the purified p115RhoGEF activates GDP/GTP exchange on GST-tagged RhoA ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29420-34",
                "id": "12748184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Aug 1 117(Pt 17) 3735-48",
                "id": "15252113"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe039f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Indeed, mouse Dishevelled-2 (Dvl2) activates RhoA and Rac but not Cdc42 (Figure 1A).",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Dec 28 107(7) 843-54",
                "id": "11779461"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe039e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Overexpression of MAGI-3 stimulated LPA-induced RhoA activation, whereas silencing of MAGI-3 by siRNA resulted in a small but statistically significant decrease in RhoA activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Feb 19(2) 261-8",
                "id": "16904289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe039d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Thrombin activated Rho A and extracellular signal-regulated kinase (ERK)1 and ERK2.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Sep 28 89(7) 583-90",
                "id": "11577023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe039c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "RhoA-SRF activation of the skeletal a-actin promoter occurs through an integrin-dependent pathway (68). Overexpression of either b1D- or b1Asubunits can enhance RhoA activation of skeletal a-actin and, conversely, a dominant negative mutant of b1-integrin inhibits RhoA activation (68).",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2000 Jan 88(1) 337-43",
                "id": "10642399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe039b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Moreover, RhoA also stimulates the autoregulatable murine SRF gene promoter in myoblasts, and the expression level of SRF is reduced in myoblasts overexpressing N19-RhoA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Nov 13 273(46) 30287-94",
                "id": "9804789"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe039a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "p160ROCK, a serine/threonine protein kinase, is a direct RhoA target mediating RhoA-induced assembly of focal adhesions and stress fibers.",
              "citation": {
                "type": "PubMed",
                "name": "J Hepatol 2000 May 32(5) 762-70",
                "id": "10845663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0399"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Here, we show that stimulation of the Rho signalling pathway induces translocation of the transcriptional LIM-only coactivator FHL2 to the nucleus and subsequent activation of FHL2- and androgen receptor-dependent genes.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Feb 15 21(4) 736-48",
                "id": "11847121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0398"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Treatment of MVHO cells with keratinocyte growth factor (KGF) for 1 h upon isolation reduced RhoA activity and restored attachment to control levels",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Sep 293(3) L769-78",
                "id": "17601798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0397"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "RhoA signaling regulates the activity of the transcription factor SRF (serum response factor) during muscle differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2004 Dec 22 16(6) 867-80",
                "id": "15610731"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0396"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Here we identified Rnd3/RhoE, a GTPase-deficient Rho family member and RhoA antagonist,",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2005 Apr 15 305(1) 74-82",
                "id": "15777789"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0395"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Here, using a site- and phosphorylation state-specific antibody, we found that the expression of dominant active RhoA in COS7 cells induced moesin phosphorylation and the formation of microvilli-like structures at apical membranes where the Thr558-phosphorylated moesin accumulated, whereas the expression of dominant negative Rho-kinase inhibited both of these processes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Dec 25 273(52) 34663-6",
                "id": "9856983"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0394"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "# Ariadne: We show that although RhoA, RhoB,  and RhoC are equally effective in stimulating actin stress fiber formation and  focal complex assembly in NIH 3T3 cells, RhoA and RhoB are capable of  transforming cells whereas RhoC induces cell migration. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44617-25",
                "id": "12939257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0393"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Monc-1 (A) and C3H10T1/2 (B) cells were treated with TGF-beta (5 ng/ml) for various times as indicated. Cell lysates were prepared, and GTP-bound RhoA was enriched by absorbing cell lysates to GST-RBD beads and measured by Western blotting using RhoA antibody. Total RhoA and {alpha}-tubulin in cell lysates were detected by Western blotting as controls.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 20 281(3) 1765-70",
                "id": "16317010"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0392"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "neural crest"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 May 16 304(4) 714-9",
                "id": "12727213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0391"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "A Mirk promoter construct was activated when C2C12 myoblasts were switched from growth to differentiation medium and was also activated by the Rho family members RhoA, Cdc42, and to a lesser degree Rac1, but not by MyoD or Myf5",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41347-54",
                "id": "12902328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0390"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Endothelin 1 and phenylephrine (both hypertrophic agonists) induced rapid activation of endogenous Rac1, and endothelin 1 also promoted significant activation of RhoA.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(4) 1173-84",
                "id": "11158304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe038f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "the chemokine Mig, a ligand for CXCR3, activates the small GTPases RhoA and Rac1, induces a reorganization of the actin cytoskeleton, and triggers cell chemotaxis and modulation of integrin VLA-5- and VLA-4-dependent cell adhesion to fibronectin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 45098-105",
                "id": "11571298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe038e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Jul 15 169(2) 1007-13",
                "id": "12097408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe038d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Contactin-1-specific RNA interference resulted in loss of metastatic and invasive capacity in both in vitro and in vivo models. This loss was overturned by constitutive expression of the active form of RhoA. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Mar 1 66(5) 2553-61",
                "id": "16510572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe038c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "# Ariadne: LyGDI/D4 has been reported to interact with RhoA, Cdc42Hs  and Rac1, but not with Ras and Rap (Adra et al. , 1993 ; Scherle et al. , 1993  ). [Binding]",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Nov 2 17(21) 6241-9",
                "id": "9799233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe038b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "As expected, from the pharmacological data presented in Fig. 3C and 4A, the proinvasive activity of the Wnt-2 CM was alleviated by stable expression of the dominant negative form of the small GTPase RhoA, the T19N-RhoA mutant, in HCT8/S11 cells (40), as shown in Fig. 4C.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Jan 19(1) 144-6",
                "id": "15507471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe038a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "stimulation of Erk by alpha6beta4 was suppressed by dominant-negative Shc, Ras and RhoA",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 May 1 16(9) 2365-75",
                "id": "9171350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0389"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Ephrin-A stimulation of EphA receptors modulates the activity of ephexin leading to RhoA activation, Cdc42 and Rac1 inhibition, and cell morphology changes.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Apr 20 105(2) 233-44",
                "id": "11336673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0388"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "it has been reported that Rac1 inhibits RhoA activity in a number of cell systems (Rottner et al., 1999; Sander et al., 1999)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2009 Mar 20(6) 1715-27",
                "id": "19158396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0387"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Supplementary table 2: List of significantly changed genes by overexpressing RHOA in human mammary epithelial cells (p < 0.01)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Jan 15 69(2) 483-91",
                "id": "19147561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0386"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Pre-incubation of serumstarved HUVEC cells with either 0.5 microM KAAD-cyclopamine or 100 ng/ml PTX prevented activation of RhoA by Shh (Fig. 2A), indicating that both tubulogenesis and RhoA activation by Shh involve SMO and Gi proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2010 Feb 1 9(3) 570-79",
                "id": "20081366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0385"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "This indicated that DEF6 acts upstream of the Rho GTPases resulting in the activation of the Cdc42, Rac1, and RhoA signaling pathways. In vitro, DEF6 specifically interacted with Rac1, Rac2, Cdc42, and RhoA, suggesting a direct role for DEF6 in the activation of Rho GTPases",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 Apr 1 294(2) 335-44",
                "id": "15023524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0384"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "First, we determined that RhoG was regulated by guanine nucleotide exchange factors that also activate Rac and/or Cdc42. Vav2 (which activates RhoA, Rac1, and Cdc42) and to a lesser degree Dbs (which activates RhoA and Cdc42) activated RhoG in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47810-7",
                "id": "12376551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0383"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Strikingly, a 10- to 50-fold overexpression of cortactin led to a progressive increase in RhoA activation, up to a maximum of approximately 2.5-fold (Fig. 8d).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Nov 30(21) 5057-70",
                "id": "20805359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0382"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "However, the molecular mechanism by which KDR mediates EC migration is not clear yet. Here we show for the first time that activation of RhoA and Rac1 is fully and partially required for KDR-mediated human umbilical vein endothelial cell (HUVEC) migration, respectively, and that CDC42, however, is not involved.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46791-8",
                "id": "12244099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0381"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "When cells were stimulated with LXA4 (10?9 mol/L) or the two analogues (10?11 mol/L) for 15 minutes, a threefold increase in membrane-associated RhoA, an index of Rho activation, 27 was observed, whereas 15-(S)-HETE was without effect (Figure 5)",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2002 Jun 160(6) 2275-83",
                "id": "12057930"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0380"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2000 Aug 11(8) 2513-28",
                "id": "10930450"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe037f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "in Fig. 7A, STAT3 KO cells were unresponsive to the active RhoA-, Rac1-, or Cdc42-stimulated cyclin D1 transcription in a luciferase-based reporter assay, whereas in WT- or STAT3-reconstituted cells, the cyclin D1 luciferase activity was significantly up-regulated by all three GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 17275-85",
                "id": "15705584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe037e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Moreover, geldanamycin inhibited the VEGF-induced activation of the small GTPase RhoA, which resulted in an inhibition of phosphorylation of FAK on site Tyr(407). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 10 279(37) 39175-85",
                "id": "15247219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe037d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "NET1 is a guanine nucleotide exchange factor for RhoA NET1 is important for the increase of Rho activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 4 276(18) 15362-8",
                "id": "11278519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe037c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "high glucose concentration activated Rho",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Feb 24(2) 276-81",
                "id": "14670931"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe037b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "FAK also complexes through proline-rich motifs in the C-terminal domain with the SH3 domains of the adaptors, p130cas and paxillin, and a Rho GTPase-activating protein, GRAF. Indeed, p130cas and paxillin are phosphorylated by the FAK/Src complex, enabling the recruitment of even more proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe037a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Using the yeast two hybrid system and overlay assays we identified a putative rholrac effector, citron, which interacts with the GTP-bound forms of rho and rac1, but not with cdc42.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1995 Dec 18 377(2) 243-8",
                "id": "8543060"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0379"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We show here that PtdIns, PtdIns4P, PtdIns3,4P2, PtdIns4,5P2 and PtdInsP3 enhance not only the C3-dependent ADP-ribosylation, but also the GDP/GTP exchange in the RhoA component of the prenylated RhoA/Rho-GDI complex.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1999 Jun 262(3) 879-89",
                "id": "10411652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0378"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Finally, in a nude mouse model, intratumoral injections of anti-RhoA siRNA (100 microl at 85 nM) every 3 days for 20 days almost totally inhibited the growth and angiogenesis of xenografted MDA-MB-231 tumors.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Ther 2005 Feb 11(2) 267-74",
                "id": "15668138"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0377"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Matrigel invasion assay using the ovarian cancer cell line, SKOV3, showed that up-regulation and activation after treatment with lysophosphatidic acid was associated with enhanced invasion of the cancer cells. This increase in invasiveness was suppressed by the addition of C3, a specific inhibitor of Rho.",
              "citation": {
                "type": "PubMed",
                "name": "Lab Invest 2003 Jun 83(6) 861-70",
                "id": "12808121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0376"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "BeWo cells expressing constitutively active RhoA showed enhanced protein levels of not only HIF-1alpha but also vascular endothelial growth factor (VEGF) and glucose transporter 1, which are target gene products of HIF-1alpha",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Endocrinol Metab 2005 Mar 90(3) 1712-9",
                "id": "15598682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0375"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "trophoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "These results demonstrate that activin B promotes epithelial wound closure in vivo through the RhoA-Rock-JNK-cJun signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(9) e25143",
                "id": "21949871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0374"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "HGF promoted epithelial spreading and RhoA GTPase activation in a time-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2004 Oct 287(4) G886-98",
                "id": "15191880"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0373"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "from full text - Figure 1 ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9",
                "id": "16484682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0372"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "ARAP3 causes a Rho GAP-dependent decrease in active RhoA and Rac1 in vivo. ARAP3 stimulated a marked decrease in active RhoA levels in cells.ARAP3 showed GAP activity towards RhoA in vitro (our results) (Krugmann et al., 2002Go), and when overexpressed, inhibited actin stress fibre formation in PAE (Krugmann et al., 2002Go) and NIH3T3 cells ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Dec 1 117(Pt 25) 6071-84",
                "id": "15546919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0371"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1999 Jun 103(11) 1561-70",
                "id": "10359565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0370"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "pitavastatin, a novel HMG Co-A reductase inhibitor, was found to inhibit the expression of apoB48 receptor via inhibition of RhoA. In fact, pretreatment of THP-1 macrophage significantly reduced RLP-induced foam cell formation...",
              "citation": {
                "type": "PubMed",
                "name": "J Atheroscler Thromb 2005 12(2) 73-6",
                "id": "15942116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe036f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Monc-1 (A) and C3H10T1/2 (B) cells were treated with TGF-beta (5 ng/ml) for various times as indicated. Cell lysates were prepared, and GTP-bound RhoA was enriched by absorbing cell lysates to GST-RBD beads and measured by Western blotting using RhoA antibody. Total RhoA and {alpha}-tubulin in cell lysates were detected by Western blotting as controls.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 20 281(3) 1765-70",
                "id": "16317010"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe036e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "RhoA GTPase was reduced after pitavastatin treatment. Interestingly, an inhibitor of RhoA GTPase, but not that of the ERK1/2 pathway, attenuated MCP-1-dependent adhesion of THP-1 cells to HUVEC",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2004 Jul 30 75(11) 1333-41",
                "id": "15234191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe036d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "RhoA, RhoB, and RhoC all markedly stimulated inositol phosphate accumulation in PLC-epsilon-expressing cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41253-8",
                "id": "12900402"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe036c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Feb 18 156(4) 737-50",
                "id": "11839767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe036b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Treatment of cells with an inhibitor of protein kinase C, GF109203X, and azaserine, an inhibitor of the hexosamine pathway, suppressed high glucose-induced Rho activation.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Feb 24(2) 276-81",
                "id": "14670931"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe036a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Expression of p27deltaNLS in MCF7 breast cancer cells down-regulated RhoA and increased motility, survival, and Akt levels without an effect on cell cycle distribution.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Feb 15 66(4) 2162-72",
                "id": "16489017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0369"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "DLC2 encodes a unique RhoGTPase-activating protein (RhoGAP) specific for small RhoGTPases, RhoA, and Cdc42.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Oct 18 102(42) 15207-12",
                "id": "16217026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0368"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Here, we provide evidence that Rho GTPases modulate Stat5a, a transcription factor of the family of signal transducers and activators of transcription. RhoA triggers tyrosine phosphorylation (Y696) of Stat5a via a JAK2-dependent mechanism and promotes DNA-binding activity of Stat5a.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Jan 14(1) 40-53",
                "id": "12529425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0367"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1998 Jul 9(7) 1891-902",
                "id": "9658178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0366"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Interestingly, agLDL strongly increased the membrane (active) form of RhoA (agLDL: by 2.67-fold vs nLDL: by 1.50-fold) and simvastatin completely prevented agLDL induced RhoA activation (Fig. 2B).",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2007 Jan 1 73(1) 208-16",
                "id": "17141748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0365"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "First, we found that p116Rip activated the GTPase activity of RhoA in vitro and that p116Rip overexpression in cells consistently diminished the epidermal growth factor-induced increase in GTP-bound RhoA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 11 280(6) 4983-91",
                "id": "15545284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0364"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Interference with Rho or Pyk2 inhibited cofilin inactivation and the migratory speed of DCs, but did not affect chemotaxis.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Apr 1 174(7) 4070-80",
                "id": "15778365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0363"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Conversely, overexpression of LINGO-1 leads to activation of RhoA ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2005 Jun 8(6) 745-51",
                "id": "15895088"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0362"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Gef10 activates RhoA-C, but not Rac1 or Cdc42",
              "citation": {
                "type": "PubMed",
                "name": "Naunyn Schmiedebergs Arch Pharmacol 2006 Aug 373(5) 333-41",
                "id": "16896804"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0361"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "This results in a net increase in active Rho, and increased stress fibers and focal adhesions.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 May 1 295(2) 488-96",
                "id": "15093746"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0360"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "RhoA, which induces the formation of stress fibers, can activate SRFmediated gene expression",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Aug 23",
                "id": "16928770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe035f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The regulation of Net1 activity is poorly understood. PAK1-dependent phosphorylation of Net1 on Ser152 and Ser153 inhibits its GEF activity and abolishes Net1-dependent RhoA activation and stress fiber induction [15].",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2008 3(5) e2254",
                "id": "18509476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe035e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "gether, these data demonstrate that Rho GTPases regulate lymphocyte polarization and chemokine-induced migration, and underscore the key role of Cdc42 in lymphocyte directional migration.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 1999 Nov 29(11) 3609-20",
                "id": "10556816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe035d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "VEGF failed to induce RhoA activation in HUVECs transfected with ECT2-specific siRNAs or KLEIP-specific siRNAs (Figure 6B and 6C)",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Apr 27 100(8) 1155-63",
                "id": "17395875"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe035c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "28,29We have recently shown that IGF-Imediated MM cell migration is PKC and RhoA dependent",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Sep 1 106(5) 1786-93",
                "id": "15886323"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe035b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "# Ariadne: During the course of our studies, Bustelo and colleagues ( 18 ) showed that Vav2 was an activator of RhoA, RhoB, and RhoG but not Rac1 or Cdc42 in vitro . [Regulation] Vav and Vav2 are members of the Dbl family of proteins that act as guanine nucleotide exchange factors (GEFs) for Rho family proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10141-9",
                "id": "10744696"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe035a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The activity of RhoA, when normalized to its total levels, was also decreased by ~40% in synchronized cortactin knockdown cells while there was no alteration in the activity of Cdc42 or Rac (Fig. 8c).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Nov 30(21) 5057-70",
                "id": "20805359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0359"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Head and Neck Neoplasms",
                "cell": "squamous cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Moreover, ECT2 T412A, but not phosphomimic T412D, displayed a diminished accumulation of GTP-bound RhoA compared with WT ECT2, suggesting that phosphorylation of Thr-412 is critical for the catalytic activity of ECT2. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Feb 9 25(6) 827-37",
                "id": "16247472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0358"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "(Fig. 1) The PCP pathway activates Dvl, small G proteins (Rho or Rac), and Rho kinase or JNK, resulting in regulation of the cytoskeleton, cell migration, and cell polarity.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2006 Feb 28 38(1) 1-10",
                "id": "16520547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0357"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "MgcRacGAP, a GTPase-activating protein, associates during cytokinesis with ECT2, a guanine nucleotide exchange factor for RhoA, and the localization of ECT2 to both the central spindle and the contractile ring depends on MgcRacGAP. Knockdown of ECT2 phenocopies that of MgcRacGAP.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Sep 13 102(37) 13158-63",
                "id": "16129829"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0356"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The dissociation of [3H]GDP from RhoA was stimulated dose-dependently by Sf9 cell lysates containing the CDEP peptide. CDEP is a novel GEF for Rho family GTPases with the transforming activity.",
              "citation": {
                "type": "PubMed",
                "name": "Osteoarthritis Cartilage 2001 9 Suppl A S64-8",
                "id": "11680691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0355"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Our most recent works show that pertussis toxin-sensitive G proteins and Gbetagamma subunits are required for Flt-1-mediated down-regulation of human umbilical vein endothelial cell (HUVEC) proliferation and that Gq/11 proteins are required for KDR-mediated RhoA activation and HUVEC migration.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 6 278(23) 20738-45",
                "id": "12670961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0354"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We observed that although RhoB appeared dispensable for HUVEC viability, RhoB was required for endothelial cell migration, sprouting, and capillary morphogenesis. We also observed that siRNA-mediated depletion of RhoB in HUVEC resulted in increased RhoA activation in response to VEGF stimulation",
              "citation": {
                "type": "PubMed",
                "name": "Vasc Cell 2012 4 1",
                "id": "22316440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0353"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The small G protein RhoA and its GDP/GTP exchange factors (GEFs) Net and Dbl can transform NIH 3T3 fibroblasts, dependent on the activity of the RhoA effector kinase ROCK.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2000 Sep 1 19(17) 4565-76",
                "id": "10970850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0352"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "These early stages paralleled collagen I activation of Src kinase and GTPase Rho through beta1 integrins.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Mar 18(3) 457-68",
                "id": "15003991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0351"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Mar 1 15(5) 535-53",
                "id": "11238375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0350"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Using the yeast two-hybrid system, we identified an interaction between PAR-1 cytoplasmic tail and the brain isoform of creatine kinase, a key ATP-generating enzyme that regulates ATP within subcellular compartments. The interaction was confirmed in vitro and in vivo. Reducing creatine kinase levels or its ATP-generating potential inhibited PAR-1-mediated cellular shape changes as well as a PAR-1 signaling pathway involving the activation of RhoA",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 12062-7",
                "id": "11050237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe034f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "As shown in Fig. 3A, RhoA activity increased 5.7-fold at 15 min after bFGF stimulation, with peak activation at 30 min and remained high for 60 min.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(8) e12228",
                "id": "20808927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe034e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "In fibroblasts, Rho function is required for activation of PKD catalytic activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 1 281(35) 25089-96",
                "id": "16772297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe034d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Aug 15 102(4) 1490-8",
                "id": "12714496"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe034c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2003 Oct 285(4) G704-13",
                "id": "12816757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe034b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "These data suggest a model whereby rapamycin inhibits endothelial cell migration through an increase in p27Kip1 protein, which in turn inhibits RhoA activation, blocking the cytoskeletal reorganization required for cell migration.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Apr 16 285(16) 11991-7",
                "id": "20097763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe034a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "RhoA also has been reported to down-regulate both p21cip1 and p27 and to stimulate cyclin D1 accumulation in various settings (20, 52, 58). However, the downstream targets of RhoA that link it with the cell-cycle machinery remain elusive.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 18 279(25) 26323-30",
                "id": "15096506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0349"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "exogenous H2O2 treatment during normoxia mimicked the effects of hypoxia on RhoA, further supporting a role for ROS.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Jul 1 120(Pt 13) 2214-22",
                "id": "17550967"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0348"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "After 1 min exposure to thrombin RhoA activity was enhanced 3.760.3-fold (P,0.0001, n = 7), while Rac1 activity was reduced to 76610% of control (P = 0.0256, n = 5).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(8) e23448",
                "id": "21858121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0347"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "When expressed in cells, XPLN activates RhoA and RhoB, but not RhoC, and stimulates the assembly of stress fibers and focal adhesions in a Rho kinase-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 42964-72",
                "id": "12221096"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0346"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We further demonstrate that a fraction of RhoA resides in the nucleus, and can also be found in a GTP-bound active form and that Net1 plays a role in the activation of nuclear RhoA. In addition, we show that ionizing radiation (IR) specifically promotes the activation of the nuclear pool of RhoA in a Net1-dependent manner, while the cytoplasmic activity remains unchanged. ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(2) e17380",
                "id": "21390328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0345"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Inhibitor studies show that these processes are dependent on RhoA",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Jul 15 17(14) 4075-85",
                "id": "9670022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0344"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Plexin-B1 has recently been shown to mediate activation of RhoA through a stable interaction with the Rho guanine nucleotide exchange factors PDZ-RhoGEF and LARG. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Jun 21 165(6) 869-80",
                "id": "15210733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0343"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Structure function analysis revealed that Nogo-A protein contains at least two active domains, NiG and Nogo-66, with diverse effects on neurite outgrowth and cell spreading. We now provide evidence that these inhibitory domains mediate their effects via an antagonistic regulation of the small GTPases RhoA and Rac1, resulting in activation of RhoA and suppression of Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2002 Dec 1 22(23) 10368-76",
                "id": "12451136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0342"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The activation and targeting of both RhoA and Ras to the ER further confirmed the action of Nox4 on the ER, as these GTPases function upstream and downstream of Nox4, respectively.Thus, RhoA, Nox4, and Ras appear to signal on the ER surface to mediate the Tat-dependent ER stress response.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Jul 30(14) 3553-68",
                "id": "20457808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0341"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Integrin activation in ECs by either attachment to ECM or mechanical shearing causes a 2-phase change in RhoA activity. EC attachment to ECM initially causes a decrease in RhoA activity, which has been linked to an activation of either FAK or Src, resulting in tyrosine phosphorylation and activation of p190 Rho GTPase? activating protein.61,62",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2002 Nov 1 91(9) 769-75",
                "id": "12411390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0340"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We show that endogenous Gem down-regulates the level of active RhoA and actin stress fibers. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Apr 18(4) 1242-52",
                "id": "17267693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe033f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "In vitro the GAP domain activates RhoA, Rac1, and Cdc42 GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36885-91",
                "id": "10967100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe033e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "GTPases of the RHOA subfamily have an important role in the regulation of integrin- mediated adhesion. Transgenic expression of constitutively active V14RHOA results in increased adhesion of both thymocytes and T cells through beta1 and beta2 integrins, whereas expression of C3 transferase, which inhibits RHOA, RHOB and RHOC, causes decreased adhesion105. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Immunol 2009 Sep 9(9) 630-44",
                "id": "19696767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe033d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "RhoGDI inhibits RhoA",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Dec 29 281(52) 40379-88",
                "id": "17074770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe033c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "DLC-1 protein was a GTPase-activating protein specific for RhoA and Cdc42.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Nov 15 63(22) 7646-51",
                "id": "14633684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe033b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2004 Jan 15 67(2) 303-13",
                "id": "14698043"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe033a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Blockade of RhoA/ROCK signaling by pharmacological inhibitors of RhoA (Clostridium botulinum C3 exoenzyme) or ROCK (Y-27632, 10 micromol/l, 1 h) markedly attenuated stretch-induced FAK and ERK1/2 phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2005 Oct 289(4) H1488-96",
                "id": "15923313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0339"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Expression of constitutively active form of RhoA (RhoACAT) was capable of inducing NF-kB activity in the absence of thrombin challenge, and depletion of cofilin-1 inhibited this response (Fig. 6).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 31 284(31) 21047-56",
                "id": "19483084"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0338"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "This physical interaction is mediated by their PDZ domains and a PDZ-binding motif found only in Plexins of the B family. In addition, we show that ligand-induced dimerization of Plexin B is sufficient to stimulate endogenous RhoA potently and to induce the reorganization of the cytoskeleton.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 43115-20",
                "id": "12183458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0337"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2003 Mar 63(3) 714-21",
                "id": "12606782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0336"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We consistently observe a transient decrease of cellular RhoA-GTP levels upon plexin activation in adherent cells. One of the main effectors of RhoA downregulation is p190, a ubiquitously expressed GTPase activating protein (GAP).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2005 Oct 15 118(Pt 20) 4689-700",
                "id": "16188938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0335"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "(ResnetDB) However, the results clearly demonstrated that activation of RhoA and its downstream signaling were essential for the induction of CTGF gene expression by nocodazole or colchicine.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44305-11",
                "id": "12951326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0334"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "# Pubmed:gene: XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 42964-72",
                "id": "12221096"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0333"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 30 274(31) 21926-31",
                "id": "10419514"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0332"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "FAK regulates focal adhesion turnover via a RhoA-dependent pathway ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Oct 13(10) 3601-13",
                "id": "12388760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0331"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "we show that a basic motif within the p120ctn Arm repeat domain known to be required for the inhibition of RhoA is also required for binding to microtubules. We therefore propose that binding of p120ctn to microtubules is inversely related to its ability to regulate Rho GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 20 279(8) 6588-94",
                "id": "14660598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0330"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Furthermore, inhibition of the VEGFR abolishes RhoA activation by IL-8/CXCL8, and gap formation, s",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Dec 18(12) 5014-23",
                "id": "17928406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe032f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We show here the transient activation of the small GTPase Rac, followed by a rise in reactive oxygen species (ROS), as necessary early steps in a signal transduction cascade that lead to NFkappaB activation and collagenase-1 (CL-1)/matrix metalloproteinase-1 production after integrin-mediated cell shape changes.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 357-68",
                "id": "12119354"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe032e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Thrombin stimulates MAP kinase and NF-kappaB pathways through Rho.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2008 Jul 18 372(1) 216-20",
                "id": "18474218"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe032d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Table 2 Summary of genes regulated by H-Ras V12, RhoA QL, Rac1 QL and Cdc42 QL [activated forms]",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 May 1 22(17) 2689-97",
                "id": "12730683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe032c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "HA binding to CD44 is directly involved in LARG-mediated RhoA activation in HSC-3 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 19 281(20) 14026-40",
                "id": "16565089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe032b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Head and Neck Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Of note, simvastatin, a 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor, blocked the development of cigarette smoke-induced emphysema (183), probably through the inhibition of RhoA (224).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe032a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "dominant negative Rho-family GTPase (RhoA, Rac1, and Cdc42) and an expression vector encoding a mutated c-jun (TAM67) partially blocked the LPA-induced uPAR expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2008 Feb 4",
                "id": "18247343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0329"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Rnd2-bound Pragmin significantly stimulates RhoA activity and induces cell contraction through RhoA and the Rho-kinase pathway in HeLa cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 14 281(15) 10355-64",
                "id": "16481321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0328"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "These data indicate a novel mechanism for Ang II-induced NF-kappaB activation in VSMCs, mediated by RhoA-induced phospho-Ser536 RelA formation, IL-6 expression, and vascular inflammation.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2006 Sep 29 99(7) 723-30",
                "id": "16960103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0327"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "These cellular events are regulated by the small GTPase Rho, and in the absence of syndecan-4 ligation, cellular levels of GTP-bound Rho are decreased implicating syndecan-4 in the regulation of the small GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 47172-6",
                "id": "15371457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0326"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6531-7",
                "id": "11641777"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0325"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "inactivation of RhoA with C3-exoenzyme or treatment with ROK inhibitors strongly inhibited myocardin mRNA expression in retinoic acid-treated A404 cells",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2006 Feb 17 98(3) 378-85",
                "id": "16397143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0324"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Under these circumstances activated RhoA is reported to prevent the expression of the CKI p21Cip1, a major mediator of RAS- or RAF-induced cell cycle arrest in mouse fibroblasts (43).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10868-81",
                "id": "15572689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0323"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Rnd1 is a recently discovered small GTP binding protein, related to RhoA, that inhibits RhoA-mediated stress fiber formation (283) and Ca2 sensitization of smooth muscle (229).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2003 Oct 83(4) 1325-58",
                "id": "14506307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0322"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Activated Rho induces tyrosine phosphorylation of beta and gamma catenin and p120ctn through a Fyn/Src-dependent mechanism",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jan 7 156(1) 137-48",
                "id": "11777936"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0321"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Herein, we demonstrate that RhoA, Rac1, and Cdc42 promote the expression of cyclooxygenase-2 (COX-2) at the transcriptional level. Rho GTPases induce the expression of COX-2 in NIH3T3, HT29, DLD-1, and MDCK cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Jul 14(7) 3041-54",
                "id": "12857884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0320"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Here we report that p63RhoGEF, a recently identified RhoA-specific guanine nucleotide exchange factor, enhances the Rho-dependent gene transcription induced by agonist-stimulated G(q/11)-coupled receptors (M3-cholinoceptor, histamine H1 receptor) or GTPase-deficient mutants of G alpha(q) and G alpha11.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11134-9",
                "id": "15632174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe031f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Stimulation with those CCR6 ligands leads to calcium mobilization and elevated active RhoA, phosphorylated myosin light chain, and F-actin accumulation. HBD2 and CCL20 were unable to stimulate migration in the presence of either Rho-kinase or phosphoinositide 3-kinase inhibitors or an intracellular calcium chelator.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Apr 10 284(15) 10034-45",
                "id": "19233848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe031e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "This effect is PAR1 specific and is mediated by RhoA and Rho kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2006 Jun 116(6) 1606-14",
                "id": "16710477"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe031d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Lis1 haploinsufficiency is shown here to also result in reduced filamentous actin at the leading edge of migrating neurons, associated with upregulation of RhoA and downregulation of Rac1 and Cdc42 activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Sep 24 23(25) 8673-81",
                "id": "14507966"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe031c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "In neuroblastoma cells, GEFT promotes the active GTP-bound state of Rac1, Cdc42, and RhoA and increases neurite outgrowth primarily via Rac1. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 45824-32",
                "id": "15322108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe031b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "We demonstrate that vascular endothelial growth factor-A (VEGF) rapidly induces RhoA activation in endothelial cells (ECs).",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2010 Sep 24(9) 3186-95",
                "id": "20400538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe031a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Embryonic Pancreatic Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Mar 13(3) 902-14",
                "id": "11907271"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0319"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Together, our findings indicate that NT-stimulated IL-8 expression is mediated via a Rho-dependent NF-kappaB-mediated pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Jun 284(6) C1397-404",
                "id": "12584113"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0318"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Pitx2a expression resulted in activation of the Rho GTPases Rac1 and RhoA",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Feb 13(2) 683-97",
                "id": "11854422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0317"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Aug 1 64(15) 5291-300",
                "id": "15289335"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0316"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "The full-length Ly-GDI cDNA encodes a 27-kDa protein which binds to RhoA and inhibits GDP dissociation from RhoA. Stimulation of T lymphocytes with phorbol ester leads to phosphorylation of Ly-GDI, suggesting an involvement of Ly-GDI in lymphocyte activation pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Aug 15 90(16) 7568-72",
                "id": "8356058"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0315"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "cyclin D1(-/-) cells showed increased Rho GTP and ROCKII activity",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Jun 26(11) 4240-56",
                "id": "16705174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0314"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "PDZ RhoGEF, which, together with LARG and p115RhoGEF, links the G(12/13) family of heterotrimeric G proteins to Rho activation, binds through its C-terminal region to the serine-threonine kinase p21-activated kinase 4 (PAK4), an effector for Cdc42. This interaction results in the phosphorylation of PDZ RhoGEF and abolishes its ability to mediate the accumulation of Rho-GTP by Galpha13.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 13 279(7) 6182-9",
                "id": "14625312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0313"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Reorganization of the actin cytoskeleton in response to growth factor signaling, such as transforming growth factor beta (TGF-beta), controls cell adhesion, motility, and growth of diverse cell types. In Swiss3T3 fibroblasts, a widely used model for studies of actin reorganization, TGF-beta1 induced rapid actin polymerization into stress fibers and concomitantly activated RhoA and RhoB small GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11448-57",
                "id": "15647284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0312"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 4 274(23) 16377-86",
                "id": "10347197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0311"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOA) actsIn gtp(p(HGNC:RHOA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Aug 15 62(16) 4829-35",
                "id": "12183443"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0310"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC5))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 3'-to lesion\")",
        "directed": false,
        "label": "cat(p(HGNC:ERCC5)) increases bp(GOBP:\"nucleotide-excision repair, DNA incision, 3'-to lesion\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a29",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC5)) increases bp(GOBP:\"nucleotide-excision repair, DNA incision, 3'-to lesion\")",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe077d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FANCD2)",
        "relation": "hasModification",
        "target": "p(HGNC:FANCD2,pmod(P,S,222))",
        "directed": false,
        "label": "p(HGNC:FANCD2) hasModification p(HGNC:FANCD2,pmod(P,S,222))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a2a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FANCD2) hasModification p(HGNC:FANCD2,pmod(P,S,222))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FANCD2)",
        "relation": "hasModification",
        "target": "p(HGNC:FANCD2,pmod(P,T,691))",
        "directed": false,
        "label": "p(HGNC:FANCD2) hasModification p(HGNC:FANCD2,pmod(P,T,691))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a2b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FANCD2) hasModification p(HGNC:FANCD2,pmod(P,T,691))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "deg(p(HGNC:CDKN1A))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:CDKN1A)",
        "directed": false,
        "label": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a2c",
          "evidences": [
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "ZIP kinase phosphorylates p21(WAF1) at Thr145. Transfected ZIPK can promote the phosphorylation of p21(WAF1) at Thr145 in vivo and can increase the half-life of p21(WAF1)",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Mar 12 337(1) 115-28",
                "id": "15001356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "Cdc42/Rac1 signaling pathway activates proteasomal degradation of p21(CIP1).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jul 22(13) 4587-97",
                "id": "12052868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "TNF-alpha-induced apoptosis in LNCaP cells was accompanied by caspase-dependent proteolysis of p21/WAF1 and Rb, which was significantly attenuated in LN-56.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Apr 6 19(15) 1959-68",
                "id": "10773886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "These results implicate galectin-8 as a modulator of cellular growth through up-regulation of p21. This process involves activation of JNK, which enhances the synthesis of p21, combined with the activation of PKB, which inhibits p21 degradation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 13 280(19) 19105-14",
                "id": "15753078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "As shown in Fig. 3C, phosphorylation on Thr145 site can increase the steady-state level of transfected p21 as does Thr145Asp/Ser146Asp (DD). On the other hand, Ser146Asp (S/D) mutants showed no stabilizing effect compared with WT p21.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2007 Sep 5(9) 909-22",
                "id": "17855660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "SKP2 targets negative regulators of the cell cycle such as p27, p21 and p57 for degradation, and thereby promotes cell cycle progression during S and G2 phases. SKP2 is upregulated in many human cancers.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2006 May 6(5) 369-81",
                "id": "16633365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "Skp2 and its cofactor Cks1 are the substrate-targeting subunits of the SCF(Skp2-Cks1) (Skp1/Cul1/F-box protein) ubiquitin ligase complex that regulates entry into S phase by inducing the degradation of the cyclin-dependent kinase inhibitors p21 and p27",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2004 Mar 11 428(6979) 190-3",
                "id": "15014502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "Using the proteasome-specific inhibitors, MG132 and lactacystin, we show that the p53, the cdk inhibitors p21 and p27, and cyclin A are degraded by the ubiquitin-proteasome pathway in human osteosarcoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jun 11 318(4) 868-72",
                "id": "15147952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "The described role of Skp2 in inducing the ubiquitinylation and degradation of the tumor suppressor p27,and more recently of p21, p57 and p130, indicates that Skp2 may be the product of a proto-oncogene an inverse relationship between Skp2 and p27 protein levels was found in human lymphomas, breast carcinomas epithelial dysplasias, colorectal carcinomas, oral squamous cell carcinomas small cell lung cancers gastric carcinomas and prostate cancers",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Mar 15 23(11) 2037-49",
                "id": "15021891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "Using a p21 expression vector encoding an alanine substitution at Thr145, the half-life of the protein was nearly identical in the absence or in the presence of transfected ZIP kinase (Figure 7(C) versus (D)).",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Mar 12 337(1) 115-28",
                "id": "15001356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "UV and IR both target p21 protein for degradation immediately after DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2008 Aug 15 7(16) 2535-43",
                "id": "18719376"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "These data show that GSK-3beta is activated by UV irradiation through the ATR signaling pathway and phosphorylates p21 at ser-114 for its degradation by the proteasome. # p21 = CDKN1A",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Apr 27(8) 3187-98",
                "id": "17283049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "p53RFP is involved in ubiquitination and degradation of p21, a p53 downstream protein promoting growth arrest and antagonizing apoptosis,",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2006 Feb 6 580(3) 940-7",
                "id": "16427630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "p38 alpha and JNK1 phosphorylated p21 in vivo, and both p38 alpha and JNK1 phosphorylated p21 at Ser(130) in vitro.Peptide mapping demonstrated that both TGF-beta 1 and p38 alpha induced phosphorylation of p21 at Ser(130) in vivo, and mutation of Ser(130) to alanine rendered p21 less stable than wild-type p21. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29792-802",
                "id": "12058028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "Its expression was negatively correlated to that of p21(WAF1) protein; p53RFP is likely to play a role in the regulation of this protein, probably through interaction with, and ubiquitination of, p21(WAF1).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jul 10 22(28) 4449-58",
                "id": "12853982"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "GSK-3 triggers p21(Cip1) degradation. In contrast, stimulation of AKT increases p21(Cip1) via inhibitory phosphorylation of GSK-3.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 9684-9",
                "id": "11779850"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:CDKN1A)) directlyDecreases p(HGNC:CDKN1A)",
              "summary_text": "Therefore, MDM2 mutants without amino acids 251-260 (but not without other amino acids of the acidic domain of MDM2) lose the ability to promote the C8 binding and subsequent degradation of p21Waf1 (Fig. 4E).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jun 11 285(24) 18407-14",
                "id": "20308078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAD52)",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "p(HGNC:RAD52) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a2d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAD52) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "The RAD52 epistasis group of proteins, including Rad51, Rad52, and Rad54, plays an important role in the homologous recombination repair of double strand breaks",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 13 277(50) 48944-8",
                "id": "12379650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PRKDC)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:PRKDC))",
        "directed": false,
        "label": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a2e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": " Here, using solid-phase protein sequencing, MS and phosphospecific antibodies, we have identified seven in vitro autophosphorylation sites in DNA-PKcs. Six of these sites (Thr2609, Ser2612, Thr2620, Ser2624, Thr2638 and Thr2647) are clustered in a region of 38 amino acids in the central region of the protein. Five of these sites (Thr2609, Ser2612, Thr2638, Thr2647 and Ser3205) are conserved between six vertebrate species. Moreover, we show that DNA-PKcs is phosphorylated in vivo at Thr2609, Ser2612, Thr2638 and Thr2647",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Nov 15 368(Pt 1) 243-51",
                "id": "12186630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0780"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "3-Phosphoinositide- dependent protein kinase (PDK) 1 has been identified as a primary kinase that will phosphorylate Akt at Thr308. Kinases that activate Ser473 are known as PDK2, which include mitogen-activated protein kinase (MAPK)-activated protein kinase (PK)-2, integrin-linked kinase, p38 MAPK, PKCa, PKCbII, rictor-mTOR complex (mTORC2), double-stranded DNA-dependent PK, autophosphorylation, and ataxia telangiectasia- mutated gene product (Brazil et al., 2004; Manning and Cantley, 2007).",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2009 Dec 17(6) 800-10",
                "id": "20059950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe077f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "We assessed DNA-PK activity by first immunopurifying it and then taking equal immunoreactive amounts (Fig. S10) to determine its ability to phosphorylate a p53 substrate peptide under various conditions (Fig. 4A)....No significant activity was seen in control experiments using capture beads without antiserum, whereas a basal activity (100%) was evident in resting cells. This was increased ~2- to 3-fold upon challenge of cells with either forskolin or PMT-cAMP.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Sep 2 105(35) 12791-6",
                "id": "18728186"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe077e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Active DNAPKcs autophosphorylate themselves as well as several other targets, including the Ku subunits, p53, H2AX, Artemis, XRCC4, and WRN (Collis et al, 2005).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "translation. Small-molecule inhibitors and inhibitory peptides/proteins and antibody fragments inhibit DNA-PK function by binding to specific regions of the protein complex. Ultimately, such inhibition prevents either the formation of the DNA-PK trimer, or an impaired DNA-PK molecule, which is inefficient at repairing DNA DSBs, ultimately resulting in increased chromosomal abnormalities and eventual mitotic cell death",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Feb 3 24(6) 949-61",
                "id": "15592499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Activation and recruitment of these kinases to DNA lesions occurs through direct interactions with the specificity factors NBS1 (for ATM), ATRIP (for ATR) and Ku80 (for DNA-PK)16,17.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "In vitro, DNA-PK phosphorylated PKB on Ser-473, resulting in a approximately 10-fold enhancement of PKB activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 24 279(39) 41189-96",
                "id": "15262962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "# Ariadne: We present evidence that transcription of the extracellular matrix gene laminin alpha 4 (Lama4) is regulated by DNA-PK in a radiation-independent manner. [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "Radiat Res 2001 Aug 156(2) 167-76",
                "id": "11448237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03df"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "DNA repair enzymes (MGMT, DNA-PK, Ku70, Ku80, and ERCC-1)  (DNA-PK = PRKDC, Ku70 = XRCC6, Ku80 = XRCC5)",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2007 Jul 102(2) 522-38",
                "id": "17596214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Feb 15 97(4) 1584-8",
                "id": "10677503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03dd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": " the kinase activity of DNA-PK (protein kinase) complexes, which leads to increased phosphorylation of p53 on Ser-15 and Ser-37",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29940-7",
                "id": "12756247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "In other studies, at 6 and 12 h after UVB irradiation, we observed a moderate serine 139 phosphorylation of H2A.X (Fig. 6D), which is shown to be one of the substrates of DNA-PK as well as ATM/ATR (37).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20375-83",
                "id": "15792956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "DNA-PK showed the same preference for phosphorylation of threonine 68 (see Supplementary Information).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Oct 2(10) 762-5",
                "id": "11025670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Because RPA2 phosphorylation kinetics are distinct from those of the S phase checkpoint, we propose that DNA-PK and ATM cooperate to phosphorylate RPA after DNA damage to redirect the functions of the protein from DNA replication to DNA repair.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Dec 1 61(23) 8554-63",
                "id": "11731442"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "<s18> KARP1 stimulates DNA-PK activity and may function in complex with DNA-PK and Ku (Mysung et al., 1997; Myung et al., 1998) (also see P50).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1995 Feb 16 10(4) 789-93",
                "id": "7862459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "We also show that Lyn phosphorylates DNA-PKcs but not Ku in vitro. The interaction between Lyn and DNA-PKcs inhibits DNA-PKcs activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 2 273(40) 25654-8",
                "id": "9748231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 3 279(36) 37282-90",
                "id": "15194694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Therefore, this result suggests that DNA-PK may negatively regulate the transcriptional level of thisgene in M059K cells upon UV damage (50 J/m2), associated with celltoxicity.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Seq 1999 10(3) 195-8",
                "id": "10647823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Here we report the ionizing radiation (IR)-induced autophosphorylation of DNA-PKcs at a novel site, serine 2056, the phosphorylation of which is required for the repair of DSBs by NHEJ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 15 280(15) 14709-15",
                "id": "15677476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Initiation of these checkpoints is dependent on the transient recruitment of the MRE11/RAD50/NBS1 (MRN) complex at DSB sites, followed by the recruitment/activation of ataxiatelangiectasia mutated (ATM) a member of the family of phosphoinositide-3-kinase-related kinases (PIKKs) (Su, 2006). In addition, two other PIKKs, DNA-dependent protein kinase (DNAPK) and ATR (ATM and Rad3 related), are also activated and involved in the response to DSBs.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Heterodimers of the 70 and 80 kDa Ku autoantigens (Ku70 and Ku80) activate the DNA-dependent protein kinase (DNA-PK)",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Nov 17 16(22) 6874-85",
                "id": "9362500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2001 2 12",
                "id": "11483158"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Oct 5 268(28) 21147-54",
                "id": "8407951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Akt can be phosphorylated and activated by DNA-dependent protein kinase following DNA damage (Bozulic et al., 2008).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2010 May 28 38(4) 524-38",
                "id": "20513428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6056-64",
                "id": "16880517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "In addition, wortmannin, a DNA-dependent protein kinase (DNA-PK) inhibitor, decreased the level of hHR21(SP) mRNA, indicating that DNA-PK might be involved in the regulation of hHR21(SP).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 Mar 281(5) 1106-12",
                "id": "11243849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "Ku binding allowed the recruitment of the homeodomain to DNA ends and dramatically enhanced the phosphorylation of homeodomain-containing proteins by DNA-PK. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 18 276(20) 16848-56",
                "id": "11279128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "We also show that NF90, NF45, and eIF-2 beta are substrates for DNA-PK in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 23 273(4) 2136-45",
                "id": "9442054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "We show that DNA-PK phosphorylates and activates c-Abl in vitro. Cells deficient in DNA-PK are defective in c-Abl activation induced by ionizing radiation. In a potential feedback mechanism, c-Abl phosphorylates DNA-PK, but not Ku, in vitro. Phosphorylation of DNA-PK by c-Abl inhibits the ability of DNA-PK to form a complex with DNA. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 Apr 17 386(6626) 732-5",
                "id": "9109492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "9295339;9139719;14872059",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) actsIn kin(p(HGNC:PRKDC))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Feb 28 272(9) 5647-58",
                "id": "9038175"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"double-stranded DNA break\")",
        "relation": "increases",
        "target": "kin(p(HGNC:PRKDC))",
        "directed": false,
        "label": "a(SCHEM:\"double-stranded DNA break\") increases kin(p(HGNC:PRKDC))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a2f",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"double-stranded DNA break\") increases kin(p(HGNC:PRKDC))",
              "summary_text": "Initiation of these checkpoints is dependent on the transient recruitment of the MRE11/RAD50/NBS1 (MRN) complex at DSB sites, followed by the recruitment/activation of ataxiatelangiectasia mutated (ATM) a member of the family of phosphoinositide-3-kinase-related kinases (PIKKs) (Su, 2006). In addition, two other PIKKs, DNA-dependent protein kinase (DNAPK) and ATR (ATM and Rad3 related), are also activated and involved in the response to DSBs.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0781"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"double-stranded DNA break\") increases kin(p(HGNC:PRKDC))",
              "summary_text": "It has been proposed that DNA-PK is a molecular sensor for DNA damage that enhances the signal via phosphorylation of many downstream targets. The crucial role of DNA-PK in the repair of DSBs is highlighted by the hypersensitivity of DNA-PK(-/-) mice to IR and the high levels of unrepaired DSBs after genotoxic insult.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Feb 3 24(6) 949-61",
                "id": "15592499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"double-stranded DNA break\") increases kin(p(HGNC:PRKDC))",
              "summary_text": "The Src-like protein-tyrosine kinase Lyn is activated by ionizing radiation and certain other DNA-damaging agents, whereas the DNA-dependent protein kinase (DNA-PK), consisting of the catalytic subunits (DNA-PKcs) and Ku DNA-binding components, requires DNA double-stranded breaks for activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 2 273(40) 25654-8",
                "id": "9748231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"double-stranded DNA break\")",
        "relation": "increases",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "a(SCHEM:\"double-stranded DNA break\") increases kin(p(HGNC:ATM))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a30",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"double-stranded DNA break\") increases kin(p(HGNC:ATM))",
              "summary_text": "Initiation of these checkpoints is dependent on the transient recruitment of the MRE11/RAD50/NBS1 (MRN) complex at DSB sites, followed by the recruitment/activation of ataxiatelangiectasia mutated (ATM) a member of the family of phosphoinositide-3-kinase-related kinases (PIKKs) (Su, 2006). In addition, two other PIKKs, DNA-dependent protein kinase (DNAPK) and ATR (ATM and Rad3 related), are also activated and involved in the response to DSBs.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0782"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "a(SCHEM:\"double-stranded DNA break\") increases kin(p(HGNC:ATM))",
              "summary_text": "We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA molecules. Inactive ATM dimers were activated in vitro with DNA in the presence of MRN",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Apr 22 308(5721) 551-4",
                "id": "15790808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"double-stranded DNA break\")",
        "relation": "increases",
        "target": "p(HGNC:H2AFX,pmod(P,S,140))",
        "directed": false,
        "label": "a(SCHEM:\"double-stranded DNA break\") increases p(HGNC:H2AFX,pmod(P,S,140))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a31",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"double-stranded DNA break\") increases p(HGNC:H2AFX,pmod(P,S,140))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:Nickel)",
        "relation": "decreases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "a(SCHEM:Nickel) decreases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a32",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:Nickel) decreases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "Taken together, our results indicate that the nucleotide excision repair pathway is affected in general by water-soluble and particulate nickel compounds and provide further evidence that DNA repair inhibition may be one predominant mechanism in nickel-induced carcinogenicity ... from full text, A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2002 Jan 23(1) 47-53",
                "id": "11756222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ABL1)",
        "relation": "hasModification",
        "target": "p(HGNC:ABL1,pmod(P,S,446))",
        "directed": false,
        "label": "p(HGNC:ABL1) hasModification p(HGNC:ABL1,pmod(P,S,446))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a33",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ABL1) hasModification p(HGNC:ABL1,pmod(P,S,446))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FANCD2)",
        "relation": "hasModification",
        "target": "p(HGNC:FANCD2,pmod(P,S,1257))",
        "directed": false,
        "label": "p(HGNC:FANCD2) hasModification p(HGNC:FANCD2,pmod(P,S,1257))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a34",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FANCD2) hasModification p(HGNC:FANCD2,pmod(P,S,1257))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP73,pmod(P,T,27))",
        "relation": "directlyDecreases",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "p(HGNC:TP73,pmod(P,T,27)) directlyDecreases tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a35",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP73,pmod(P,T,27)) directlyDecreases tscript(p(HGNC:TP73))",
              "summary_text": "In this study, we have found that Plk1 (polo-like kinase 1) associates with p73, phosphorylates p73 at Thr-27, and thereby inhibits its pro-apoptotic activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Mar 28 283(13) 8555-63",
                "id": "18174154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CDK2))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:TP63)",
        "directed": false,
        "label": "kin(p(HGNC:CDK2)) directlyDecreases p(HGNC:TP63)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a36",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CDK2)) directlyDecreases p(HGNC:TP63)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BRCA1)",
        "relation": "hasModification",
        "target": "p(HGNC:BRCA1,pmod(P,S,1457))",
        "directed": false,
        "label": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1457))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a37",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BRCA1) hasModification p(HGNC:BRCA1,pmod(P,S,1457))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATM)",
        "relation": "increases",
        "target": "p(HGNC:BRCA1)",
        "directed": false,
        "label": "p(HGNC:ATM) increases p(HGNC:BRCA1)",
        "metadata": {
          "casual": true,
          "createdBy": "ndiaz",
          "edgeId": "55775d252f9e24174cfe0a38",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:ATM)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a39",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "There is evidence that FANCD2,like BRCA1, participates in the events that are triggered by DNA damage during S and G2 phases and that lead to cell-cycle arrest. As well as modifying BRCA1, the ATM protein kinase can phosphorylate FANCD2 on several residues, including serine 222, following exposure to ionizing radiation77. Ser222 phosphorylation is required for the intra-S-phase arrest and is, in turn, dependent on the protein kinase NBS1, which is a component of the trimeric MRE11-RAD50-NBS1 complex78. FANCD2 can also be phosphorylated in an ATM-independent manner by the ATR kinase79,which signals an intra-S-phase arrest that is triggered by ultraviolet radiation or DNA-crosslinking agents46.Here, too, FANCD2 phosphorylation depends on NBS1, which is required to fully enforce the S-phase checkpoint. The participation of FANCD2 in ionizingradiation- activated checkpoint responses through phosphorylation on Ser222 seems to be independent78 of its mono-ubiquitylation on Lys561, which promotes the translocation of FANCD2 to damage-induced nuclear foci that contain BRCA1 and RAD51, and that are presumed sites of DNA repair. Similarly, FANCD2 foci do not require ATR-dependent phosphorylation79.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0795"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We observed that in response to DNA damage, ATM phosphorylated COP1 on Ser387 and stimulated a rapid autodegradation mechanism. Ionizing radiation triggered an ATM-dependent movement of COP1 from the nucleus to the cytoplasm, and ATM-dependent phosphorylation of COP1 on Ser387 was both necessary and sufficient to disrupt the COP1-p53 complex and subsequently to abrogate the ubiquitination and degradation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2006 Aug 25 313(5790) 1122-6",
                "id": "16931761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0794"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation of the ATM kinase and its downstream effectors, such as histone H2AX, were impaired in the myc null cell line HO15.19, compared to the myc positive TGR-1 and HOmyc3 cells. Nuclear foci formation of the Nijmegen Breakage Syndrome (Nbs) 1 protein, essential for efficient ATM activation, was also reduced in absence of myc",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(1) e8924",
                "id": "20111719"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0793"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNAPK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0792"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "preincubation of cells with the hydroxyl radical scavenger, N-acetylcysteine, significantly attenuated the doxorubicin-mediated phosphorylation and accumulation of p53, p53-DNA binding, and the phosphorylation of H2AX, Nbs1, SMC1, Chk1, and Chk2, suggesting that hydroxyl radicals contribute to the doxorubicin-induced activation of ATM-dependent pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 17 279(51) 53272-81",
                "id": "15489221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0791"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0790"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Abrogation of cyclin G enhances p53 accumulation and phosphorylation of p53 at the Ser-15 residue, resulting in cell cycle arrest. Ectopically expressed cyclin G significantly reduces the steady-state levels of p53 as well as that of phosphorylated p53 at Ser-15 after DNA damage in normal human dermal fibroblasts containing normal ATM. However, cyclin G does not cause similar reductions in p53 levels in ATM-mutated cells. We also show that translocation of cyclin G to the nucleus requires functional ATM.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jul 8 23(31) 5405-8",
                "id": "15077171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe078f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Our results show that despite the presence of higher than normal levels of DNA-PK kinase activity, c-Abl fails to become activated after IR exposure in ATM-deficient cells. Conversely, normal activation of both ATM and c-Abl occurs in DNA-PKcs-deficient cells, indicating that ATM but not DNA-PK is required for activation of Abl in response to IR treatment.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 29 275(39) 30163-8",
                "id": "10906134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe078e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "3-Phosphoinositide- dependent protein kinase (PDK) 1 has been identified as a primary kinase that will phosphorylate Akt at Thr308. Kinases that activate Ser473 are known as PDK2, which include mitogen-activated protein kinase (MAPK)-activated protein kinase (PK)-2, integrin-linked kinase, p38 MAPK, PKCa, PKCbII, rictor-mTOR complex (mTORC2), double-stranded DNA-dependent PK, autophosphorylation, and ataxia telangiectasia- mutated gene product (Brazil et al., 2004; Manning and Cantley, 2007).",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2009 Dec 17(6) 800-10",
                "id": "20059950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe078d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "KAP-1 is phosphorylated in an ATM-dependent manner on Ser 824. KAP-1 is phosphorylated exclusively at the damage sites, from which phosphorylated KAP-1 spreads rapidly throughout the chromatin. Ablation of the phosphorylation site of KAP-1 leads to loss of DSB-induced chromatin decondensation and renders the cells hypersensitive to DSB-inducing agents. Knocking down KAP-1, or mimicking a constitutive phosphorylation of this protein, leads to constitutive chromatin relaxation. These results suggest that chromatin relaxation is a fundamental pathway in the DNA-damage response and identify its primary mediators.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2006 Aug 8(8) 870-6",
                "id": "16862143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe078c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": " In the presence of CPT, topo I forms a covalent intermediate with the 3'-phosphate end of the broken DNA strand (5) . This single-strand nick lesion is believed to convert into an irreversible double-strand break after it encounters the replication fork machinery in S phase. This unusual form of DNA damage induces a signaling cascade that is propagated by ATM-family kinases in human cells (6) , which phosphorylate numerous targets involved in transcription, DNA repair, cell cycle arrest, and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Mar 15 64(6) 2096-104",
                "id": "15026349"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe078b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - To study the effects of SOCS1 in normal cells, we infected the human diploid fibroblast strain IMR90 with a retroviral vector encoding SOCS1 or a control vector. Expression of SOCS1 inhibited cell growth (Figure 3A) and induced senescence, characterized by senescence-associated ?-galactosidase staining (Figure S3A) and the accumulation of PML bodies (Figure S3B). In addition, SOCS1 induced high levels of p53 and its target, p21; a reduction in Rb phosphorylation; and the inhibition of E2F target genes such as Mcm6 (Figure 3B). Intriguingly, during SOCS1-induced senescence, the increase in p53 levels was accompanied with serine 15 phosphorylation of p53 (Figure 3B) and activation of the DNA damage-regulated kinases ATM and Chk2 (Figure 3C). Staining of SOCS1-expressing cells with an antibody against ?H2AX revealed numerous DNA damage foci (Figure S3C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2009 Dec 11 36(5) 754-67",
                "id": "20005840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe078a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway  for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-DCdk4 from phosphorylating Rb  unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 46,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0789"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show that, upon DNA damage, RASSF1A is phosphorylated by ATM on Ser131 and is involved in the activation of both MST2 and LATS1, leading to the stabilization of p73....As shown previously, expression of RASSF1A  enhances the stability of p73 [7], but this stabilization was further enhanced when combined with DNA damage (Figure 4C, left). In agreement with a role for the ATM phosphorylation site in pathway signaling, RASSF1A-S131A blocked the stabilization of p73 in response to cisplatin-mediated DNA damage (Figure 4C, right).",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2009 Dec 15 19(23) 2020-5",
                "id": "19962312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0788"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "we show that ATM interacts with BRCA1, and this association is enhanced by radiation. We also demonstrate that BRCA1 is a substrate of ATM kinase in vitro and in vivo. Using phospho-specific antibodies against serines 1387, 1423, and 1457 of BRCA1, we demonstrate radiation-induced, ATM-dependent phosphorylation of BRCA1 at these sites ... from full text, A-T lymphoblastoid cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 15 60(12) 3299-304",
                "id": "10866324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0787"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Figure 3 Nbs1 modulates ATMactivation after low doses of IR. Human NBS-Tert cells expressing different Nbs1 mutant forms and the cells infected with empty vector were irradiated with 2Gy and lysed at the indicated times (5 min to 8 h) after irradiation. Phosphorylation of S1981 of ATMand S966 of SMC1 and the total level of SMC1 were examined by immunoblotting as described in Figure 1",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 15 23(17) 3122-7",
                "id": "15048089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0786"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "To study the expression of CDX transcription factors, we used qRT-PCR to measure the expression level of CDX1 (MIM 600746) and CDX2 (MIM 600297) in lymphoblastoid cells from noncarriers, AT carriers, and AT patients. Results showed that the CDX1 level is similar in individuals with different ATM genotypes (data not shown); however, the CDX2 level is significantly higher in AT carriers and AT patients compared to noncarriers (Figure 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Hum Genet 2008 Aug 83(2) 243-53",
                "id": "18674748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0785"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "immune cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "<s8> Human RPA2 can be phosphorylated at several Ser/Thr sites within the N-terminal 33 amino acids (Henricksen et al., 1996). At least five phosphorylation states have been resolved (Zernik-Kobak et al., 1997). In unirradiated cells, RPA2 is phosphorylated primarily at Ser23 and Ser29 (Dutta and Stillman, 1992; Pan and Hurwitz, 1993). DNA damage by UV, IR, camptothecin, or etoposide induces phosphorylation of additional sites (Zernik-Kobak et al., 1997; Shao et al., 1999). These hyperphosphorylations are attributable to DNA-PK (Shao et al., 1999) and independently to ATM (Gately et al., 1998). <s12>  ATM (or an ATM-associated kinase other than DNA-PK or ATM-related protein) hyperphosphorylates RPA2 on serine and threonine residues in response to DNA damage; the reaction is dependent on both ssDNA and linear dsDNA (Gately et al., 1998). <s13> DNA damage-induced hyperphosphorylation of RPA2 prevents the binding of RPA to p53 (Abramova et al., 1997).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0784"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The main downstream targets (of BRCA1) identified so far are p53-responsive genes, including p21 and BcIX13. BRCA1 binds to BRCA2, p53, RAD51 and many other proteins involved in cell cycling and DNA-damage response14,15 (Fig. 2a). The involvement of BRCA1 in response to DNA damage is supported by extensive data, including evidence that BRCA1 is phosphorylated by the ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) proteins in response to DNA damage16,17, that cells without functional BRCA1 do not arrest in G2 after DNA damage and are deficient in transcription-coupled repair18,19, and that BRCA1 is part of the RAD50-MRE11-p95 complex, an essential component of recombination- mediated repair of DNA double-stranded breaks20.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2001 May 7(5) 552-6",
                "id": "11329055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0783"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In this report, we utilized small interfering RNA to deplete BRCA1 and BARD1 to demonstrate that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated/ATM and Rad3-related)-mediated phosphorylation of p53(Ser-15) following IR- and UV radiation-induced DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31251-8",
                "id": "15159397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0452"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2003 Jan 33(1) 80-4",
                "id": "12447371"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0451"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 31 274(53) 37538-43",
                "id": "10608806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0450"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show that doses of gamma-radiation (IR) as low as 0.25 Gy, which generate vast numbers of SSBs but only a few DSBs per cell (<8), promptly activate ATM kinase and induce the phosphorylation of the ATM substrates p53-Ser15, Nbs1-Ser343 and Chk2-Thr68. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Oct 7 23(46) 7691-700",
                "id": "15361830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe044f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "ATM had intrinsic protein kinase activity and phosphorylated p53 on serine-15 in a manganese-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Sep 11 281(5383) 1677-9",
                "id": "9733515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe044e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39527-33",
                "id": "12890678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe044d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Following exposure to ionizing radiation (IR), the BRCA1-c-Abl complex is disrupted in an ATM-dependent manner, which correlates temporally with ATM-dependent phosphorylation of BRCA1 and ATM-dependent enhancement of the tyrosine kinase activity of c-Abl. In vivo, BRCA1 is phosphorylated at tyrosine residues in an ATM-dependent, radiation-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4020-32",
                "id": "12024016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe044c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2002 May 17 109(4) 459-72",
                "id": "12086603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe044b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 17 275(11) 7803-10",
                "id": "10713094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe044a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0449"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In cultured cardiac myocytes, doxorubicin induced oxidative stress, DNA damage, ATM activation, and p53 induction. ...Doxorubicin treatment in vivo also induced oxidative stress, DNA damage, ATM activation, and p53 accumulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2009 Nov 47(5) 698-705",
                "id": "19660469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0448"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We and others have recently shown that a cluster of repeated consensus ATM phosphorylation sites in MDC1 is crucial for the recruitment of BRCA1 and 53BP1 to IRIF, but not for NBS1 focus formation. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2008 Aug 9(8) 795-801",
                "id": "18583988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0447"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 23 276(12) 8898-903",
                "id": "11114307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0446"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 23 276(12) 8898-903",
                "id": "11114307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0445"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "C-terminal domain harbors three known phosphorylation sites (S325, T366 and S428), the latter two of which are targeted by ATM (ataxia telangiectasia mutated), and protein kinase A (PKA), ribosomal protein S6 kinase 90 kDa or protein kinase C z, respectively (Collins et al., 2000; Xie et al., 2006; Sapkota et al. 2002a, b).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Nov 24 27(55) 6908-19",
                "id": "19029933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0444"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Figure 6. ATF2 Is Important for IR-Induced Activation of ATM and Chk2 (A) ATF2 is important for activation of ATM. U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 May 27 18(5) 577-87",
                "id": "15916964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0443"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The immunoprecipitated ATM efficiently phosphorylated recombinant H2AXin vitro (Fig. 3  c, lane 1).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 42462-7",
                "id": "11571274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0442"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Apr 6 404(6778) 613-7",
                "id": "10766245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0441"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Apr 2 304(5667) 93-6",
                "id": "15064416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0440"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": " Here we describe the FA protein FANCI, identified as an ATM/ATR kinase substrate required for resistance to mitomycin C.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Apr 20 129(2) 289-301",
                "id": "17412408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe043f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Furthermore, inhibition of ATM/ATR kinases abolishes both induction of Rad51 and phosphorylation of p53 and reduced the level of apoptosis induced by coexpression of oncogenes and ARF (Pauklin et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe043e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Mar 21(5) 1719-29",
                "id": "11238909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe043d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6056-64",
                "id": "16880517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe043c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Aug 15 62(16) 4588-91",
                "id": "12183412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe043b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Here, we observe that UVA, unlike UVC, triggers ATM kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 1 277(5) 3124-31",
                "id": "11723137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe043a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "9295339;9139719;14872059",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0439"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation on Chk1(Ser-345), Chk2(Thr-68), and p53(Ser-15)following oxidative damage by IR involved both ATM and ATR. phosphorylation on Chk1, Chk2, and p53 was found to be ATM-dependent, whereas ATR also contributed to Chk1 phosphorylation ... from full text, A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1186-92",
                "id": "15533933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0438"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Sep 12 97(19) 10389-94",
                "id": "10973490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0437"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "TRF2 represses ATM, whereas POT1 prevents activation of ATR. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2007 Aug 30 448(7157) 1068-71",
                "id": "17687332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0436"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Dec 2(12) 893-8",
                "id": "11146653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0435"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Moreover, induction of both apoptosis and p53 phosphorylation by E2F1 is abolished by caffeine; this is an inhibitor of the ATM and ATR kinases [33], supporting the notion that E2F1 uses the ATM signaling pathway to induce p53 and CHK2 phosphorylation and thereby apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0434"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Figure 2 Comparison of gene expression (induction fold) obtained from microarray data and real-time RT-PCR analysis for 11 genes selected from the set of Atm-dependent, putatively NF-kB-mediated responding genes",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Mar 9 25(10) 1584-92",
                "id": "16314843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0433"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "immune cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Evasion from apoptosis is a hallmark of cancer, and recent success using targeted therapeutics underscores the importance of identifying anti-apoptotic survival pathways. Here we utilize RNA interference (RNAi) to systematically screen the kinase and phosphatase component of the human genome.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Jun 7(6) 591-600",
                "id": "15864305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0432"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In the cells exposed to CS, there is strong and rather uniform IF revealing the presence of activated ATM throughout the nucleus (Fig. 7C).",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2007 8 26",
                "id": "17594478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0431"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Thr383 (Fig. 5C) or Thr387 (data not shown). This suggests that ATM phosphorylation of Thr68 is required for the subsequent phosphorylation of Thr383 and Thr387 in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 30537-41",
                "id": "11390408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0430"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) kinases regulate cell cycle checkpoints by phosphorylating multiple substrates including the CHK1 and -2 protein kinases and p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 26 278(39) 37139-45",
                "id": "12847089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe042f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The serine/threonine protein kinase ATM signals to cell cycle and DNA repair components by phosphorylating downstream targets such as p53, CHK2, NBS1, and BRCA1.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Dec 15 64(24) 9152-9",
                "id": "15604286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe042e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Apr 20 101(16) 5898-903",
                "id": "15073328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe042d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Exposure of ES cells to genotoxins caused an ATM-dependent nuclear accumulation of Abl but not Abl muNLS. ES cells expressing Abl muNLS exhibited delayed Bax activation, reduced cytochrome c release and decreased caspase-9 activity in response to DNA damage. These results provide a genetic proof that Abl nuclear entry contributes to DNA damage-induced activation of the intrinsic apoptotic pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2007 Jun 14(6) 1139-48",
                "id": "17363963"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe042c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Here, we pinpoint a single ATM-phosphorylated residue in 53BP1--Ser25--that is required for binding of 53BP1 to hPTIP",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(16) 5312-22",
                "id": "17690115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe042b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe042a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 42462-7",
                "id": "11571274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0429"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show here that E2F-1 elevates ATM promoter activity and induces an increase in ATM mRNA and protein levels. This is accompanied by an E2F-induced increase in p53 phosphorylation ... ATM activates the tumor suppressor p53",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jan 16 22(2) 161-7",
                "id": "12527885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0428"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Reconstitution of the AT cells with wild-type ATM increases TonEBP/OREBP transactivating activity both at 300 and 500 mosmol/kg, but the inactive mutant, ATM S1981A, does not (Fig. 3E). We conclude that ATM regulates transactivating activity of TonEBP/OREBP.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Jun 8 101(23) 8809-14",
                "id": "15173573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0427"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Jul 15 15(14) 1833-44",
                "id": "11459832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0426"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Jul 13 406(6792) 210-5",
                "id": "10910365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0425"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 41656-60",
                "id": "11514540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0424"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Immunoprecipitates of ATM collected from IGF-1-stimulated cells also caused the phosphorylation of the AMPK-alpha subunit in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Nov 19 324(3) 986-92",
                "id": "15485651"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0423"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "these kinases phosphorylate CDC25C, the molecule that is responsible for activating CDK1",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0422"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39527-33",
                "id": "12890678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0421"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "As shown in Figure 3A, exposure to CSE induced activation of ATM, p53, and pRb, a marked increase in p53 and p21, and a mild increase in p16 accumulation.  ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Dec 35(6) 681-8",
                "id": "16840774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0420"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "heterogeneous nuclear ribonucleoprotein K (hnRNP K) as being rapidly induced by DNA damage in a manner that requires the DNA-damage signaling kinases ATM or ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Dec 16 123(6) 1065-78",
                "id": "16360036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe041f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Nov 11 18(47) 6411-8",
                "id": "10597242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe041e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The essential elements of this checkpoint are ATM/ATR kinases that indirectly lead to the phosphorylation and inhibition of the mitosis-promoting factor (Cdc2/cyclin B1).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Nov 13 22(51) 8283-92",
                "id": "14614452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe041d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "When ATM and ATR are recruited to sites of damage, they target many substrates, including checkpoint kinase-2 (CHK2) and CHK1, respectively (FIG. 2; BOX 2).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe041c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - S395 of Mdm2 is phosphorylated in vitro by ATM",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 May 1 15(9) 1067-77",
                "id": "11331603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe041b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Interestingly, oxidative stress induced the translocation of PP2A-C, an ATM inhibitor, into caveolar membranes, away from ATM, and promoted the interaction between PP2A-C and caveolin- 1 (supplemental Fig. 2, A and B, respectively).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Feb 27 284(9) 5462-6",
                "id": "19103597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe041a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "caffeine, a widely used inhibitor to ATM/ATR",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jun 15 184(12) 6901-9",
                "id": "20488792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0419"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation of ATM/ATR substrates and H2AX in VSMCs increased with disease severity in vivo (Figure 1A), reaching 70% to 90% of intimal VSMCs in advanced disease.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Sep 26 103(7) 717-25",
                "id": "18723444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0418"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show that oxidation of ATM directly induces ATM activation in the absence of DNA DSBs and the MRN complex.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2010 Oct 22 330(6003) 517-21",
                "id": "20966255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0417"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jun 23 95(13) 7664-9",
                "id": "9636207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0416"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 2006 Feb 24 311(5764) 1141-6",
                "id": "16497931"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0415"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hum Genet 105(1-2) 17-27",
                "id": "10480350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0414"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We have demonstrated that ionizing radiation-associated DNA double-strand breaks (DSBs) induce phosphorylation of at least Ser-56 and Ser-101 residues on Sp1 in an ATM-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Oct 20(10) 1795-803",
                "id": "18619531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0413"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 13 276(15) 11783-90",
                "id": "11278277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0412"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation of histone H2AX on serine 139 and p53 on serine 15 in Parp-1 knockout (Parp-1(-/-)) mouse embryonic fibroblasts (MEF) was significantly induced by NCS treatment compared with MEF derived from wild-type (Parp-1(+/+)) mouse.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jun 25 319(2) 596-602",
                "id": "15178448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0411"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Consistent with a role of ATM in the phosphorylation of Chk2, Thr68 phosphorylation and Chk2 activation were not detected in ATM-deficient FT169A cells after IR, while Chk2 was phosphorylated and activated in the isogenic, wild-type ATM-reconstituted YZ5 cells ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 47755-8",
                "id": "11668173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0410"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 Nov 1 59(21) 5456-60",
                "id": "10554017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe040f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We also discovered that the phosphorylation of NBS1 by ATM is required for the phosphorylation of SMC1, establishing the role of NBS1 as an adaptor in the ATM/NBS1/SMC1 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2002 Mar 1 16(5) 571-82",
                "id": "11877377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe040e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In vitro substrates included the translation repressor PHAS-I and the p53 protein. ATM phosphorylated p53 in vitro on a single residue, serine-15, which is phosphorylated in vivo in response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Sep 11 281(5383) 1674-7",
                "id": "9733514"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe040d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In vitro kinase assay indicated that ATM phosphorylates IKK-alpha at Ser-473. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Feb 14 27(8) 1183-8",
                "id": "17700524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe040c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Wild-typeATMincreases TonEBP/OREBP transcriptional activity both at 300 and 500 mosmol/kg, whereas ATMS1981A does not (Fig. 3D).....anti-ATM antibody coimmunoprecipitates TonEBP/OREBP and ATM both at 300 and 500 mosmol/kg (Fig. 4A Lower).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Jun 8 101(23) 8809-14",
                "id": "15173573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe040b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Nov 1 60(21) 5934-6",
                "id": "11085506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe040a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": ". ATM-phosphorylated p300 in vitro and in vivo, in response to DNA damage. Phosphorylation of p300 proteins was observed upon gamma-irradiation in ATM(+) cells but not ATM(-) cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jul 9 397(4) 637-43",
                "id": "20471956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0409"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Substitution of threonine 68 by alanine in the full-length kinase-dead Chk2 dramatically reduced but did not abolish the ATM phosphorylation of Chk2/Cds1 in vitro (Fig. 4B; threonine 68 accounts for approximately 70% of the total phosphorylation).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0408"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "IR-inducible phosphorylation of threonine 691 and serine 717 is also dependent on ATM and is more strongly impaired when both ATM and ATR are knocked down",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Sep 26(18) 7005-15",
                "id": "16943440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0407"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": " These observations indicate that ATM-mediated phosphorylation of S1189 is required for BRCA1 functions in the modulation of DNA damage response and in the suppression of tumor formation by regulating p53 and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Dec 15 69(24) 9291-300",
                "id": "19996295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0406"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Activation of ATM induces Sp1 phosphorylation with kinetics similar to H2AX; inhibition of ATM activity blocks Sp1 phosphorylation; depletion of Sp1 sensitizes cells to DNA damage and increases the frequency of double strand breaks. We have identified serine 101 as a critical site phosphorylated by ATM;",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2007 Dec 5(12) 1319-30",
                "id": "18171990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0405"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 30 278(22) 19579-82",
                "id": "12697768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0404"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 5296-302",
                "id": "11076947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0403"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "ATM phosphorylates Nbs1 on Ser343",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Dec 15 63(24) 8586-91",
                "id": "14695167"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0402"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "However, no such activation was found in A-T cells indicating that caffeine inhibited the ATM-dependent Chk2/Cds1 activation (Fig. 3A, lanes 6 and 8).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0401"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Sep 3 154(5) 913-23",
                "id": "11535615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0400"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "ATM-mediated phosphorylation of p53 stabilizes this tumor suppressor protein by reducing constitutive interactions with MDM2, which usually promotes the degradation of p53 (Figure 1) (Giaccia and Kastan, 1998; Chin et al., 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In other studies, at 6 and 12 h after UVB irradiation, we observed a moderate serine 139 phosphorylation of H2A.X (Fig. 6D), which is shown to be one of the substrates of DNA-PK as well as ATM/ATR (37).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20375-83",
                "id": "15792956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA molecules. Inactive ATM dimers were activated in vitro with DNA in the presence of MRN",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Apr 22 308(5721) 551-4",
                "id": "15790808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Thus, stimuli that activate these kinases, including exposure to pro-inflammatory cytokines, UV irradiation, DNA damage or change in ROS, are among the classic inducers of ATF2 transcriptional activity (van Dam et al., 1995).ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Fig 2 and 3 - ATM kinase activates c-Abl kinase.  Serine-465 of c-Abl is required for tyrosine kinase activation by ionizing radiation and ATM.  3T3 cells",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 May 29 387(6632) 516-9",
                "id": "9168116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Depletion of ATM also decreased NF-kB reporter activity to roughly the same level as p38MAPK inhibition (Figure 5E, Po0.001). Although increased concentrations of SB203580 had no additional effect on NF-kB reporter output (data not shown), the combined treatment of SB203580 and ATM depletion had a synergistic effect, lowering NF-kB transcriptional activity to PRE control levels (Figure 5E, SBshATM).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2011 Apr 20 30(8) 1536-48",
                "id": "21399611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Dec 1 368(Pt 2) 507-16",
                "id": "12234250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We therefore conclude that threonine 68 is the preferred site of phosphorylation in vitro and that other sites (possibly a combination of several) are phosphorylated at lower stoichiometry.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Oct 2(10) 762-5",
                "id": "11025670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 3 276(31) 29282-91",
                "id": "11375976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Further analysis on the impact of MCT-1 in DNA damage signaling cascades revealed that autophosphorylation of ATM (Ser1981) and phosphorylation of NBS1 (Ser343) mediated by ATM kinase were induced approximately twofold, while phospho-H2AX (Ser136) has more than a 10-fold induction (Figure 2c).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jul 21 24(31) 4956-64",
                "id": "15897892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "ATM is one of the major kinases that phosphorylate p53 at Ser15 after IR and that ATM also phosphorylates and activates Chk2 after IR, which then phosphorylates p53 at Ser20",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Jan 28(1) 448-56",
                "id": "17967874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Jan 18 97(2) 889-94",
                "id": "10639175"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 11 276(19) 16580-6",
                "id": "11278446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Silencing of ATR or ATM and inhibition of ATM activity by KU-55933 blocked Chk1 activation and RRM2 up-regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 3 284(27) 18085-95",
                "id": "19416980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "the ATM cDNA expression vector pMAT1 (16) was transiently transfected into Atm?/? spontaneously immortalized fibroblasts. The ectopic expression of ATM in the transfected cells resulted in restoration of H2AX phosphorylation upon irradiation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 42462-7",
                "id": "11571274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Here we show that efficient damage-induced degradation of human Hdmx depends on functional ATM and at least three sites on the Hdmx that are phosphorylated in response to DSBs. One of these sites, S403, is a direct ATM target. Accordingly, each of these sites is important for Hdm2-mediated ubiquitination of Hdmx after DSB induction",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Apr 5 102(14) 5056-61",
                "id": "15788536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Nov 5 286(5442) 1162-6",
                "id": "10550055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The ATM (23) and ATR (24) protein kinases play key roles in p53 activation in response to IR and UV, respectively. Bulky chemical adducts have also been shown to induce stabilization and nuclear accumulation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Feb 24(2) 225-34",
                "id": "12584171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe03ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MDM2)",
        "relation": "directlyIncreases",
        "target": "deg(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:MDM2) directlyIncreases deg(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a3a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MDM2) directlyIncreases deg(p(HGNC:TP53))",
              "summary_text": "In vitro, nuclear p14arf stabilizes nuclear p53 nuclear p14arf binds Hdm2 to block Hdm2-dependent nucleocytoplasmic shuttling of p53, which is required before cytoplasmic degradation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2004 6(5) R571-85",
                "id": "15318938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0455"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MDM2) directlyIncreases deg(p(HGNC:TP53))",
              "summary_text": "In concert with these results, Lyn reverses Mdm2-mediated degradation of p53 and increases p53-dependent apoptosis. Our findings support a previously undefined role for nuclear Lyn in both activation and Mdm2-mediated regulation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 1(6) 703-8",
                "id": "12642697"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0454"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MDM2) directlyIncreases deg(p(HGNC:TP53))",
              "summary_text": "MDM2 functions as an E3 ubiquitin ligase to degrade p53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Dec 1(14) 993-1000",
                "id": "14707282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0453"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATF2)",
        "relation": "hasModification",
        "target": "p(HGNC:ATF2,pmod(P,S,498))",
        "directed": false,
        "label": "p(HGNC:ATF2) hasModification p(HGNC:ATF2,pmod(P,S,498))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a3b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATF2) hasModification p(HGNC:ATF2,pmod(P,S,498))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0456"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BRCA2),p(HGNC:FANCD2))",
        "relation": "hasComponent",
        "target": "p(HGNC:BRCA2)",
        "directed": false,
        "label": "complex(p(HGNC:BRCA2),p(HGNC:FANCD2)) hasComponent p(HGNC:BRCA2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a3c",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BRCA2),p(HGNC:FANCD2)) hasComponent p(HGNC:BRCA2)",
              "summary_text": "FANCD2 interacts with BRCA2.",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2004 Jun 15 13(12) 1241-8",
                "id": "15115758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0809"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:BRCA2),p(HGNC:FANCD2))",
        "relation": "hasComponent",
        "target": "p(HGNC:FANCD2)",
        "directed": false,
        "label": "complex(p(HGNC:BRCA2),p(HGNC:FANCD2)) hasComponent p(HGNC:FANCD2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a3d",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:BRCA2),p(HGNC:FANCD2)) hasComponent p(HGNC:FANCD2)",
              "summary_text": "FANCD2 interacts with BRCA2.",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2004 Jun 15 13(12) 1241-8",
                "id": "15115758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0457"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:SFN)",
        "relation": "increases",
        "target": "p(HGNC:TP53)",
        "directed": false,
        "label": "p(HGNC:SFN) increases p(HGNC:TP53)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a3e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:SFN) increases p(HGNC:TP53)",
              "summary_text": "We found that 14-3-3 sigma interacted with p53 in response to the DNA-damaging agent adriamycin. Importantly, 14-3-3 sigma expression led to stabilized expression of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Oct 23(20) 7096-107",
                "id": "14517281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0458"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:SFN)",
        "relation": "decreases",
        "target": "p(HGNC:MDM2)",
        "directed": false,
        "label": "p(HGNC:SFN) decreases p(HGNC:MDM2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a3f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:SFN) decreases p(HGNC:MDM2)",
              "summary_text": "In studying the molecular mechanism of this increased stabilization of p53, we found that 14-3-3 sigma antagonized the biological functions of Mdm2 by blocking Mdm2-mediated p53 ubiquitination and nuclear export. In addition, we found that 14-3-3 sigma facilitated the oligomerization of p53 and enhanced p53's transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Oct 23(20) 7096-107",
                "id": "14517281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0459"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ERCC6)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:ERCC6))",
        "directed": false,
        "label": "p(HGNC:ERCC6) actsIn cat(p(HGNC:ERCC6))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a40",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ERCC6) actsIn cat(p(HGNC:ERCC6))",
              "summary_text": "The known nucleotide excision repair (NER) defects of xeroderma pigmentosum (XP) and Cockayne syndrome (CS) cells can be exploited to analyze mechanisms of repair of UV-induced cyclobutane pyrimidine dimers (CPDs) at nucleotide (nt.) resolution. The two gene products of the CS complementation groups (CSA and CSB) have been implicated in the preferential repair of the transcribed strand of human genes. ",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 1998 May 25 400(1-2) 143-51",
                "id": "9685618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0796"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ERCC6) actsIn cat(p(HGNC:ERCC6))",
              "summary_text": "We find that CSB is present at sites of activated PARP-1 after oxidative stress, identify CSB as a new substrate of PARP-1, and demonstrate that poly(ADP-ribosyl)ation of CSB inhibits its DNA-dependent ATPase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Sep 25(17) 7625-36",
                "id": "16107709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe045b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ERCC6) actsIn cat(p(HGNC:ERCC6))",
              "summary_text": "In transcription-coupled NER (TC-NER), blockage of transcribing RNA Polymerase II (RNA-Pol II) on the damaged DNA template is thought to initiate the repair reaction in a process that requires, in addition to TFIIH, XPA, XPG, and ERCC1-XPF, the TCR-specific proteins CSB and CSA [9] (Figure 2). ",
              "citation": {
                "type": "PubMed",
                "name": "J Nucleic Acids 2010 2010",
                "id": "20725631"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe045a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:XRCC1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:XRCC1))",
        "directed": false,
        "label": "p(HGNC:XRCC1) actsIn cat(p(HGNC:XRCC1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a41",
          "evidences": [
            {
              "bel_statement": "p(HGNC:XRCC1) actsIn cat(p(HGNC:XRCC1))",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe045e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:XRCC1) actsIn cat(p(HGNC:XRCC1))",
              "summary_text": "XRCC1 can bind by itself to DNA nicks (Mani et al., 2004), but this ability is facilitated and accelerated via its interaction with PARP-1 and also PARP-2 (Schreiber et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe045d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:XRCC1) actsIn cat(p(HGNC:XRCC1))",
              "summary_text": "XRCC1, which is required for efficient DNA single-strand break (SSB) repair",
              "citation": {
                "type": "PubMed",
                "name": "DNA Repair (Amst) 2011 Aug 12",
                "id": "21840775"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe045c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NET1,pmod(P,S,152))",
        "relation": "decreases",
        "target": "cat(p(HGNC:NET1))",
        "directed": false,
        "label": "p(HGNC:NET1,pmod(P,S,152)) decreases cat(p(HGNC:NET1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a42",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NET1,pmod(P,S,152)) decreases cat(p(HGNC:NET1))",
              "summary_text": "The regulation of Net1 activity is poorly understood. PAK1-dependent phosphorylation of Net1 on Ser152 and Ser153 inhibits its GEF activity and abolishes Net1-dependent RhoA activation and stress fiber induction [15].",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2008 3(5) e2254",
                "id": "18509476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe045f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:RNF8),p(HGNC:MDC1))",
        "relation": "increases",
        "target": "p(HGNC:BRCA1)",
        "directed": false,
        "label": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) increases p(HGNC:BRCA1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a43",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) increases p(HGNC:BRCA1)",
              "summary_text": "We show that RNF8, a RING-finger ubiquitin ligase, rapidly assembles at DSBs via interaction of its FHA domain with the phosphorylated adaptor protein MDC1. This is accompanied by an increase in DSB-associated ubiquitylations and followed by accumulation of 53BP1 and BRCA1 repair proteins ... from full text, U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Nov 30 131(5) 887-900",
                "id": "18001824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0797"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) increases p(HGNC:BRCA1)",
              "summary_text": "Recent evidence suggests that RNF8 binds to MDC1 and ubiquitylates phosphorylated H2AX. These events facilitate the recruitment of factors (such as BRCA1 and 53BP1) that are required for DNA repair and checkpoint signalling, probably through a ubiquitin-ligase cascade98?100,102 (FIG. 2). (primary sources used as in statements)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0460"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:RNF8),p(HGNC:MDC1))",
        "relation": "hasComponent",
        "target": "p(HGNC:MDC1)",
        "directed": false,
        "label": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) hasComponent p(HGNC:MDC1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a44",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) hasComponent p(HGNC:MDC1)",
              "summary_text": "Recent evidence suggests that RNF8 binds to MDC1 and ubiquitylates phosphorylated H2AX. These events facilitate the recruitment of factors (such as BRCA1 and 53BP1) that are required for DNA repair and checkpoint signalling, probably through a ubiquitin-ligase cascade98?100,102 (FIG. 2). (primary sources used as in statements)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0799"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) hasComponent p(HGNC:MDC1)",
              "summary_text": "We show that RNF8, a RING-finger ubiquitin ligase, rapidly assembles at DSBs via interaction of its FHA domain with the phosphorylated adaptor protein MDC1. This is accompanied by an increase in DSB-associated ubiquitylations and followed by accumulation of 53BP1 and BRCA1 repair proteins ... from full text, U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Nov 30 131(5) 887-900",
                "id": "18001824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0798"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:RNF8),p(HGNC:MDC1))",
        "relation": "hasComponent",
        "target": "p(HGNC:RNF8)",
        "directed": false,
        "label": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) hasComponent p(HGNC:RNF8)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a45",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) hasComponent p(HGNC:RNF8)",
              "summary_text": "We show that RNF8, a RING-finger ubiquitin ligase, rapidly assembles at DSBs via interaction of its FHA domain with the phosphorylated adaptor protein MDC1. This is accompanied by an increase in DSB-associated ubiquitylations and followed by accumulation of 53BP1 and BRCA1 repair proteins ... from full text, U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Nov 30 131(5) 887-900",
                "id": "18001824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe079b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) hasComponent p(HGNC:RNF8)",
              "summary_text": "Recent evidence suggests that RNF8 binds to MDC1 and ubiquitylates phosphorylated H2AX. These events facilitate the recruitment of factors (such as BRCA1 and 53BP1) that are required for DNA repair and checkpoint signalling, probably through a ubiquitin-ligase cascade98?100,102 (FIG. 2). (primary sources used as in statements)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe079a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:RNF8),p(HGNC:MDC1))",
        "relation": "increases",
        "target": "p(HGNC:TP53BP1)",
        "directed": false,
        "label": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) increases p(HGNC:TP53BP1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a46",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:RNF8),p(HGNC:MDC1)) increases p(HGNC:TP53BP1)",
              "summary_text": "We show that RNF8, a RING-finger ubiquitin ligase, rapidly assembles at DSBs via interaction of its FHA domain with the phosphorylated adaptor protein MDC1. This is accompanied by an increase in DSB-associated ubiquitylations and followed by accumulation of 53BP1 and BRCA1 repair proteins ... from full text, U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Nov 30 131(5) 887-900",
                "id": "18001824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe079c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TP53)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a47",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Fractionation of HeLa nuclear extracts and biochemical analyses indicate that this kinase is distinct from the DNA-dependent protein kinase (DNA-PK) and corresponds to the human cell cycle checkpoint protein ATR. Immunoprecipitation studies of recombinant ATR reveal that catalytic activity of this polypeptide is required for DNA-stimulated phosphorylation of p53 on serine-15.  These data suggest that ATR may function upstream of p53 in a signal transduction cascade initiated upon DNA damage and provide a biochemical assay system for ATR activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jul 8 18(27) 3989-95",
                "id": "10435622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The p53 TSG serves as a major cellular barrier against cancer development by way of apoptosis induction. P53 gene mutations and/or protein accumulation are the most common genetic changes in human tumors [88,  89]. The p53 gene is frequently inactivated by loss of heterozygosity (LOH), missense mutations and frameshift deletions, and in addition to the loss of wild-type p53, a high percentage of tumor cells accumulate mutant P53 protein isoforms [12,  88]. Whilst wild-type P53 functions as a tumor-suppressor, tumor-associated P53 proteins acquire novel functions enabling them to regulate gene expression and promote a large spectrum of cancer phenotypes [88]. P53 gene mutations are more frequent in intestinal than in diffuse type tumors, and alterations have been reported to occur at the premalignant stages of dysplasia and IM. Thus, p53 mutations have a crucial and early role in gastric carcinogenesis of the intestinal type; an immunohistochemical and genetic analysis revealed that early tumors with the poorest prognosis (i.e. that deeply penetrated the submucosa), showed the highest frequency of both p53 gene mutation and of nonmutated protein accumulation. However, p53 mutations and nuclear accumulation are late events in diffuse-type GC [89]. P53 belongs to a small family of sequence-specific nuclear transcription factors, to which p63 and p73 also belong [90]. P53 and P73 share structural and functional similarities; both are potent tumor suppressors with different isoforms that accumulate in response to DNA damage and have altered functions which often oppose those of the wild-type. Isoforms of P73 can inhibit both p53 and p73, thus assisting in tumor progression in contrast to the wild-type role of tumor suppression. In the absence of functional p53, p73 can be responsible for regulating the cell cycle, promoting apoptotic cell death in tumor cells and regulating the response of tumor cells to drugs; however, the regulatory mechanisms of the pro-apoptotic activity of p73 are distinct from those used by p53. The complexity of p73?s activity results in contradiction in its role as an important member of the p53 TSG family, thus further investigations are needed to fully verify its role in cancer [90,  91]. The Puma protein (p53-upregulated modulator of apoptosis) belongs to the BH3-only group of proteins along with Bcl-2. It is a potent mediator of the p53 apoptotic response that dimerizes with other BH3-only proteins resulting in release of cytochrome C from the mitochondria and induction of apoptosis by the activation of caspases 3 and 9 [84]. However, Puma expression is transactivated by p53 and p73 and its expression is increased in gastric carcinomas whilst remaining absent in normal gastric mucosa, suggesting it may have a potential oncogenic role and could possibly be used as a diagnostic marker [92].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Genomics 2007 Sep 8(6) 379-97",
                "id": "19412438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "As an approach to understanding how mammals regulate H(2)O(2) toxicity, intracellular concentration to prevent its we analyzed the genome-wide mRNA profile changes of human cells after treatment with a non-toxic H(2)O(2) concentration. We identified a large and essentially late H(2)O(2) response of induced and repressed genes that unexpectedly comprise few or no antioxidants but mostly apoptosis and cell cycle control activities. The requirement of the p53 regulator for regulating about a third of this H(2)O(2) stimulon and the lack of an associated enhancement of total cellular H(2)O(2) scavenging activity further suggest that H(2)O(2) elicits a stress antiproliferative/repair response that does not increase antioxidant defenses. We conclude that mammalian antioxidant defenses are constitutive, a finding that contrasts with the oxidant-inducibility of such defenses in microorganisms. This finding might be important in understanding the role of H(2)O(2) as a key signaling molecule in mammals.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31157-63",
                "id": "15155764"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The p300/CBP-mediated acetylation of p53 significantly potentiates p53-mediated transactivation and growth inhibition. MDM2 inhibits the acetylation of p53 by p300/CBP through a mechanism that requires a stable p53-MDM2 interaction and that is sensitive to the deacetylase inhibitor, TSA. MDMX is an MDM2-like protein that shares with MDM2 the ability to interact with p53 and, in turn, inhibit p53-mediated transcription. It was therefore of interest to determine if MDMX could also inhibit the acetylation of p53 by p300/CBP. We demonstrate that MDMX dramatically inhibits the acetylation of p53 induced by both endogenous and ectopically expressed p300/CBP. We also demonstrate that the p53-binding domain of MDMX is required for the MDMX-mediated inhibition of p53 acetylation. Our results indicate that MDMX shares with MDM2 the ability to regulate a potentially important post-translational modification of p53. These results may have important biologic implications with respect to the MDMX-mediated regulation of p53 activity during development.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2002 Jul 21(7) 519-25",
                "id": "12162806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "To investigate the p53 signaling pathway, we looked for genes whose expression was significantly induced or suppressed by induction of wild-type p53 protein, and identified seven. DNA sequence analyses revealed that the two genes that were upregulated encoded isozyme 6 of aldehyde dehydrogenase (ALDH6) and subunit I of cytochrome c oxidase (COI). The five genes that were downregulated encoded protein-tyrosine kinase (Syk), high mobility group chromosomal protein 17 (HMG-17), transferrin receptor, human alpha-tubulin, and sds22-like protein",
              "citation": {
                "type": "PubMed",
                "name": "Oncol Res 1999 11(6) 281-5",
                "id": "10691030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Gas2 is a caspase-3 substrate that plays a role in regulating microfilament and cell shape changes during apoptosis. Here we provide evidence that overexpression of Gas2 efficiently increases cell susceptibility to apoptosis following UV irradiation, etoposide and methyl methanesulfonate treatments, and that these effects are dependent on increased p53 stability and transcription activity.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jun 1 20(11) 2702-14",
                "id": "11387205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Among 31 genes analyzed, we observed down-regulation in response to IR of the mRNA levels of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51. A similar reduction in the expression levels of these genes occurred when irradiated cells were released from confluence and allowed to proliferate. This was not observed in cells in which p53 function was defective ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1998 Nov 9(11) 887-96",
                "id": "9831241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": ". In this report, we show that BCCIP, a BRCA2 and CDKN1A-interacting protein, is required for the transactivation activity of wild type p53. In p53 wild type cells, BCCIP knock down by RNA interference diminishes the transactivation activity of p53 without reducing the p53 protein level, inhibits the binding of p53 to the promoters of p53 target genes p21 and HDM2,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 19 282(3) 1570-6",
                "id": "17135243"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In this study, we describe the application of the same strategy for the identification of p300 acetyltransferase-mediated acetylation sites on p53. Consistent with the previous finding, lysines 370, 372, 373, 381, and 382 were detected by this modified selected ion tracing method as the target sites of p300 in vitro. Moreover, two novel acetylation sites, Lys-292 and Lys-305, were also found.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 25568-76",
                "id": "12724314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "two examples of coherent gene responses are the TGF-b and Jun/Fos clusters. Four genes in the TGF-b pathway appear in the NE quadrant of the GEM (Fig. 5) Citation  and in the b cluster (Figs. 3Citation , 4Citation , and 6Citation ): PLAB (spots 59 and 62); KIAA0888 (spot 60); and MAD6 (spot 61). The up-regulation of these genes was p53 dependent.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jun 1 63(11) 2782-93",
                "id": "12782583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Furthermore, we found that Opn expression was upregulated by DNA damage-induced Tp53 activity and by adenovirus-mediated transfer of the human TP53 gene. In addition, a luciferase assay showed that the Opn gene has a functional Tp53-responsive element in its promoter region, and a chromatin immunoprecipitation assay confirmed interaction between the Opn promoter and Tp53 protein in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Chromosomes Cancer 2002 Mar 33(3) 270-8",
                "id": "11807984"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53, a known transcriptional activator of PTEN. However, we confirmed that the binding of the p53 protein to p53 binding site-oligo of PTEN promoter is decreased in HBx-transfected liver cells by electrophoretic mobility shift analysis and, in addition, that HBx disrupts p53-mediated PTEN transcription, as evidenced by a PTEN promoter assay.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 1 63(13) 3453-8",
                "id": "12839924"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Mutations in the tumor suppressor gene p53 also protect tumor cells against apoptosis and increase tumor angiogenic activity. Both advantages may be overcome by antiangiogenic therapy. Tumor cells with p53 mutations may become resistant to apoptosis [55], and thus decrease their response to cytotoxic chemotherapy. In mice, p53 mutations may also decrease the response of cancer cells to antiangiogenic therapies [56]. Wild-type p53 normally suppresses tumor angiogenesis by up-regulating thrombospondin-1 [57], inducing degradation of HIF-1-alpha [58], suppressing transcription of VEGF [59] and down-regulating bFGF-binding protein expression [60].",
              "citation": {
                "type": "PubMed",
                "name": "Semin Cancer Biol 2003 Apr 13(2) 159-67",
                "id": "12654259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "This increase is not observed in the aromatic hydrocarbon receptor (AhR)-defective TAOc1BP(r)c1 and the AhR nuclear translocator (Arnt)-defective BP(r)c1 variants, demonstrating that the induction of mdr1 by 3-MC requires AhR.Arnt. We show that the mdr1 promoter (-1165 to +84) is able to activate the expression of a reporter gene in response to 3-MC in Hepa-1c1c7 but not in BP(r)c1 cells. Deletion analysis indicated that the region from -245 to -141 contains cis-acting sequences mediating the induction, including a potential p53 binding sequence. 3-MC treatment of the cells increased the levels of p53 and induced p53 binding to the mdr1 promoter in an AhR.Arnt-dependent manner. Mutations in the p53 binding site abrogated induction of mdr1 by 3-MC, indicating that p53 binding to the mdr1 promoter is essential for the induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 4819-27",
                "id": "11096091"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Genes from table 1 that are marked to show that they were also up regulated in Human H1299 cells.  The list contains genes from LTR6 cells that showed over threefold induction [in response to a temperature induction of p53 in LTR7 cells upon shifting from 37 degrees to 32 degrees - BCD] in at least three time points compared to M1 cells at 2 h at 32 degrees C. The ratios of gene expression at di?erent time points (2, 6, 9 and 12 h at 328C) are shown.   [ Note that this experiment compares cells shifted to 32 degrees C for up to 12 hours to a control that is shifted to 32 degrees for only 2 hours - BCD ]",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Jun 7 20(26) 3449-55",
                "id": "11423996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Through direct cloning of p53 binding sequences from human genomic DNA, we have isolated a novel gene, designated p53AIP1 (p53-regulated Apoptosis-Inducing Protein 1), whose expression is inducible by wild-type p53. Ectopically expressed p53AIP1, which is localized within mitochondria, leads to apoptotic cell death through dissipation of mitochondrial A(psi)m. We have found that upon severe DNA damage, Ser-46 on p53 is phosphorylated and apoptosis is induced. In addition, substitution of Ser-46 inhibits the ability of p53 to induce apoptosis and selectively blocks expression of p53AIP1. Our results suggest that p53AIP1 is likely to play an important role in mediating p53-dependent apoptosis, and phosphorylation of Ser-46 regulates the transcriptional activation of this apoptosis-inducing gene.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2000 Sep 15 102(6) 849-62",
                "id": "11030628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Specifically, we show that myosin VI is induced by p53 and DNA damage in a p53-dependent manner. We found that p53 directly binds to, and activates, the promoter of the myosin VI gene. We also show that the intracellular localization of myosin VI is substantially altered by p53 and DNA damage in a p53-dependent manner such that the pool of myosin VI in endocytic vesicles, membrane ruffles, and cytosol migrates to the Golgi complex, perinuclear membrane, and nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Mar 26(6) 2175-86",
                "id": "16507995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In this study we used adenovirus vector-mediated transduction of either the p53 gene (rAd-p53) or the p21(WAF1/CIP1) gene (rAd-p21) to mimic both p53-dependent and -independent up-regulation of p21(WAF1/CIP1) within a human ovarian cancer cell line, 2774, and the derivative cell lines, 2774qw1 and 2774qw2. We observed that rAd-p53 can induce apoptosis in both 2774 and 2774qw1 cells but not in 2774qw2 cells. Surprisingly, overexpression of p21(WAF1/CIP1) also triggered apoptosis within these two cell lines. Quantitative reverse transcription-PCR analysis revealed that the differential expression of BAX, BCL2, and caspase 3 genes, specific in rAd-p53-induced apoptotic cells, was not altered in rAd-p21-induced apoptotic cells, suggesting p21(WAF1/CIP1)-induced apoptosis through a pathway distinguishable from p53-induced apoptosis. Expression analysis of 2774qw1 cells infected with rAd-p21 on 60,000 cDNA microarrays identified 159 genes in response to p21(WAF1/CIP1) expression in at least one time point with 2.5-fold change as a cutoff. Integration of the data with the parallel microarray experiments with rAd-p53 infection allowed us to extract 66 genes downstream of both p53 and p21(WAF1/CIP1) and 93 genes in response to p21(WAF1/CIP1) expression in a p53-independent pathway. The genes in the former set may play a dual role in both p53-dependent and p53-independent pathways, and the genes in the latter set gave a mechanistic molecular explanation for p53-independent p21(WAF1/CIP1)-induced apoptosis. Furthermore, promoter sequence analysis suggested that transcription factor E2F family is partially responsible for the differential expression of genes following p21(WAF1/CIP1). This study has profound significance toward understanding the role of p21(WAF1/CIP1) in p53-independent apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36329-37",
                "id": "12138103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Screening for Omi proteolytic substrates from 40 proteins  has revealed that only 4 proteins alpha casein, beta casein,  hyaluronidase, and glycoprotein alpha1 acid are cleavable by Omi (Gray et al. 2000Go). None of the four Omi substrates, however, has been reported to be involved in apoptosis. p53-mediated Omi up-regulation correlates with c-IAP1 cleavage in etoposide- induced cell death. This c-IAP1 cleavage, as well as the respective apoptotic cell death, can be inhibited by a serine protease inhibitor, indicating that Omi may cleave c-IAP1",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jun 15 17(12) 1487-96",
                "id": "12815069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway  for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-DCdk4 from phosphorylating Rb  unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 46,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Supplemental Table I.  Probe sets altered by nutlin-3a treatment.  From results: Of ?40,000 human transcripts represented on the chip, 143 genes (166 probe sets) were found differentially expressed in HCT116 cells treated with nutlin-3a (Fig. 1D and Table 1, which is published as supporting information on the PNAS web site). The list included multiple genes previously shown to be affected by p53 activation (19?21), including 32 transcripts reported as directly regulated by p53. Changes in the expression of many genes may reflect the altered cell-cycle distribution in cells that arrest predominantly in G1 and G2 phases as a result of p53 activation (12). With the exception of a few genes that were marginally down-regulated in HCT116 cells, the inactive enantiomer did not significantly change the gene expression profile of both cell lines. Taken together, the data in Fig. 1 indicate that nutlin-3a is a highly selective MDM2 antagonist and p53 inducer. *Differential expression was determined as 3-fold altered in HCT116 treated with nutlin-3a vs. vehicle and P < 0.05, and no change (<1.5-fold change) in the H1299 cells or HCT116 treated with nutlin-3b. **Expression vaules are the average of three replicates of Affymetrix MAS5 signal intensities scaled to the median of the experiment.  P value calculations are a simple t test P value of the null hypothesis of no difference between nutlin-3a treated samples vs. DMSO-treated samples.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Feb 7 103(6) 1888-93",
                "id": "16443686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "To confirm that SCO2 transcription is directly transactivated by p53, we used human colon cancer DLD1 cell lines with either inducible wild-type (WT) or mutant (MUT) p53 for expression studies (18). SCO2 mRNA expression increased within 3 to 18 hours of induced WT p53 expression but was not affected by mutant p53 (Fig. 2A and fig. S2). We also measured the mRNA expression level of SCO1, another COX assembly factor. SCO1 mRNA expression remained unchanged with induced p53 expression, serving as a negative control and demonstrating the specificity of the observed SCO2 mRNA increase (Fig. 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Science 2006 Jun 16 312(5780) 1650-3",
                "id": "16728594"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Figure 5. Regulation of the core cell-death machinery by E2F-1 and the p53 family. E2F-1 can regulate apoptosis in many ways. It can induce cell death by stabilizing the levels of p53 through activating the ARF tumor suppressor, which suppresses Mdm2, a negative regulator of p53. The p53 protein regulates the transcription of several celldeath genes including BH3-only proteins, proapoptotic Bcl-2 protein Bax and the caspase-9 adaptor Apaf-1. In cells lacking p53, E2F-1 can act through p73, a member of p53 family that activates some of the same target genes as p53. E2F-1 can also directly regulate the transcription of several different caspases and suppress cell survival pathways by suppressing Mcl-1 expression or by inhibiting NFkB-mediated antiapoptotic signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Biochem Sci 2004 Apr 29(4) 193-9",
                "id": "15082313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "There is strong evidence that selenium protects against certain human cancers, but the underlying mechanism is unknown. Glutathione peroxidase (GPX1) and thioredoxin reductase (TR), the most abundant antioxidant selenium-containing proteins in mammals, have been implicated in this protection. We analyzed the expression of TR and GPX1 in the following model cancer systems: (1) liver tumors in TGFalpha/c-myc transgenic mice; (2) human prostate cell lines from normal and cancer tissues; and (3) p53-induced apoptosis in a human colon cancer cell line. TR was induced while GPX1 was repressed in malignancies relative to controls in transgenic mice and prostate cell lines. In the colon cell line, p53 expression resulted in elevated GPX1, but repressed TR. The data indicate that TR and GPX1 are regulated in a contrasting manner in the cancer systems tested and reveal the p53-dependent regulation of selenoprotein expression. The data suggest that additional studies on selenoprotein regulation in different cancers are required to evaluate future implementation of selenium as a dietary supplement in individuals at risk for developing certain cancers.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1998 Oct 20 251(2) 488-93",
                "id": "9792801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The transcriptional program regulated by the tumor suppressor p53 was analysed using oligonucleotide microarrays. A human lung cancer cell line that expresses the temperature sensitive murine p53 was utilized to quantitate mRNA levels of various genes at different time points after shifting the temperature to 32 degrees C. Inhibition of protein synthesis by cycloheximide (CHX) was used to distinguish between primary and secondary target genes regulated by p53. In the absence of CHX, 259 and 125 genes were up or down-regulated respectively; only 38 and 24 of these genes were up and down-regulated by p53 also in the presence of CHX and are considered primary targets in this cell line. (Data from Table 1 Primary target genes upregulated by p53)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Apr 26 20(18) 2225-34",
                "id": "11402317"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Employing the highly tractable primary murine embryonic fibroblast (MEF) system we show that cellular transformation is not an inevitable consequence of NPM-ALK activity but is combated by p53 and Rb. Activation of p53 and/or Rb by NPM-ALK triggers a potent proliferative block with features reminiscent of senescence. While loss of p53 alone is sufficient to circumvent NPM-ALK-induced senescence and permit cellular transformation, sole loss of Rb permits continued proliferation but not transformation due to p53-imposed restraints. Furthermore, NPM-ALK attenuates p53 activity in an Rb and MDM2 dependent manner but this activity is not sufficient to bypass senescence. ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(3) e17854",
                "id": "21423761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "the oncogenic effects of Notch include phosphatidylinositol 3-kinase (PI3K) activation and induction of ERBB2 and NF-?B2 expression. The mechanism by which PI3K is activated by NOTCH1-IC is not known, but the induction of ERBB2 and NF-?B2 - the promoters of which contain CSL-binding sites - is  almost certainly mediated  by the transactivation function of NOTCH1-IC. PI3K signalling confers resistance to anoikis 80,81 and p53-mediated apoptosis 82, whereas ERBB2 stimulates proliferation and growth of cells.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 756-67",
                "id": "14570040"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Microarray studies performed with an NIH 3T3 cell line engineered to express an inducible Arf gene identified numerous p19Arf-responsive genes that were temporally regulated in either a p53-dependent or -independent manner (33). Among these, the Hzf gene (gene identifier 7305176) encoding a previously described \\\"hematopoietic zinc finger\\\" (Hzf) protein (23) was rapidly induced with kinetics similar to that of the bona fide p53-regulated target gene, Mdm2. The failure of exogenously expressed p19Arf to increase Hzf mRNA levels in p53-null MEFs indicated that Hzf expression is p53 dependent.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Jan 26(2) 502-12",
                "id": "16382142"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Also members of the selectin family, in particular P-selectin and E-selectin, which promotes adhesion of leukocytes to cytokine-activated vascular endothelium, have been shown to play a role in angiogenesis (134). E-selectin was found to induce endothelial migration and tube formation in vitro and angiogenesis in vivo (167). However, little is known about the mechanism of action of these molecules and mice deficient in both E-selectin and P-selectin are viable and fertile (139).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2001 Feb 1 61(3) 253-70",
                "id": "11172729"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The tumor suppressor protein, p53 is a transcription factor that not only activates expression of genes containing the p53 binding site but also can repress the expression of some genes lacking this binding site. Previous studies have shown that overexpression of wild-type p53 leads to apoptosis and cell cycle arrest. DNA damage, such as that caused by UV irradiation, results in p53 stabilization and nuclear localization that subsequently induces apoptosis. Recently, the level of calreticulin (CRT) has been correlated with the rate of apoptosis. Therefore, the aim of this study was to investigate the role of CRT in the regulation of apoptosis via modulating p53 function and expression. Here we show a significant decrease in both basal and DNA damage induced p53 functions in the CRT-deficient cells (crt-/-). This study is the first to demonstrate that CRT function is required for the stability and localization of the p53 protein. By using immuonocytochemical techniques, we showed that observed changes in p53 in the crt-/- cells are due to the nuclear accumulation of Mdm2 (murine double minute gene). These results, lead us to conclude that CRT regulates p53 function by affecting its rate of degradation and nuclear localization.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2004 Apr 15(4) 1862-70",
                "id": "14767071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "DNA damage-induced acetylation of p53 protein leads to its activation and either growth arrest or apoptosis. We show here that the protein product of the gene hSIR2(SIRT1), the human homolog of the S. cerevisiae Sir2 protein known to be involved in cell aging and in the response to DNA damage, binds and deacetylates the p53 protein with a specificity for its C-terminal Lys382 residue, modification of which has been implicated in the activation of p53 as a transcription factor. Expression of wild-type hSir2 in human cells reduces the transcriptional activity of p53. In contrast, expression of a catalytically inactive hSir2 protein potentiates p53-dependent apoptosis and radiosensitivity. We propose that hSir2 is involved in the regulation of p53 function via deacetylation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Oct 19 107(2) 149-59",
                "id": "11672523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The mechanisms for \\\"gain-of-function\\\" phenotypes produced by mutant p53s such as enhanced proliferation, resistance to transforming growth factor-beta-mediated growth suppression, and increased tumorigenesis are not known. One theory is that these phenotypes are caused by novel transcriptional regulatory events acquired by mutant p53s. Another explanation is that these effects are a result of an imbalance of functions caused by the retention of some of the wild-type transcriptional regulatory events in the context of a loss of other counterbalancing activities. An analysis of the ability of DNA-binding domain mutants A138P and R175H, and wild-type p53 to regulate the expression levels of 6.9 x 10(3) genes revealed that the mutants retained only wild-type protein. A138P p53 exhibited mostly retained wild-type regulatory activities and few acquired novel events. However, R175H p53 possessed an approximately equal number of wild-type regulatory events and novel activities. This is the first report that, after examination of the regulation of a large unfocused set of genes, provides data indicating that remaining wild-type transcriptional regulatory functions existing in the absence of counterbalancing activities as well as acquired novel events both contribute to the gain-of-function phenotypes produced by mutant p53s. However, mutant p53s are likely to be distinct in terms of the extent to which each mechanism contributes to their gain-of-function phenotypes.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Nov 15 64(22) 8199-207",
                "id": "15548685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Using this cellular model for presence or absence of the transcription factor p53 and transactivated genes, the Suppression Subtractive Hybridization (SSH) technique permitted the isolation of 17 mRNA candidates (GIPs-Genes induced by p53), whose expression appears to be p53-dependent. Identity has been established for nine of the 17 isolated candidates. These are HGFL/MSP, Zap-70, APOBEC2, Ponsin/SH3P12/CAP/FLAF2, CDCrel2b/H5/Pnutl2, IgG, lats 2, cytokeratin 15 and PIG-3 (quinone oxidoreductase)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Aug 17 19(35) 3978-87",
                "id": "10962554"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Transfected cells had increased protein expression of p21, Fas, and MDM2 at the wild-type p53 conformation at 32.5 degrees C, but not in the mutant p53 form at 37 degrees C.  To definitively determine whether the Fas signal transduction pathway and the function of the pathway are dependent on p53 status, we have established stable transfectants of p53 mutant 143Ala in two human cancer cell lines: H1299 (lung cancer line) and PC-3 (prostate cancer line), the native state of which contains null p53 status and can grow at 37 degrees C and 32.5 degrees C.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Apr 1 63(7) 1527-33",
                "id": "12670900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In these experiments p53??223Leu was as active as wild-type p53 in transactivation of the reporter construct, whereas p53??274Phe had no detectable activity (Fig. 4b). Coexpression of p53??274Phe inhibited transactivation by p53??223Leu, thus correlating with the above-described effects of this mutant on growth-inhibitory activity of p53??223Leu. The lack of detectable transactivation activity of p53??274Phe suggests that the toxicity of this protein to 10(1) cells is mediated not through p21.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jun 1 63(11) 2905-12",
                "id": "12782597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Through isolation and analysis of the SIVA promoter, we have identified response elements for both p53 and E2F1. Like p53, E2F1 is another tumor suppressor gene involved in the regulation of apoptosis, including neuronal injury models. We have identified E2F consensus sites in the promoter region, whereas p53 recognition sequences were found in intron1. Sequence analysis has shown that these consensus sites are also conserved between mouse and human SIVA genes. Electrophoretic mobility shift assays reveal that both transcription factors are capable of binding to putative consensus sites, and luciferase reporter assays reveal that E2F1 and p53 can activate transcription from the SIVA promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28706-14",
                "id": "15105421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The list contains genes from LTR6 cells that showed over threefold induction [in response to a temperature induction of p53 in LTR7 cells upon shifting from 37 degrees to 32 degrees - BCD] in at least three time points compared to M1 cells at 2 h at 32 degrees C. The ratios of gene expression at di?erent time points (2, 6, 9 and 12 h at 328C) are shown. [ Note that this experiment compares cells shifted to 32 degrees C for up to 12 hours to a control that is shifted to 32 degrees for only 2 hours - BCD ]",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Jun 7 20(26) 3449-55",
                "id": "11423996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07aa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Upregulation of p53 was associated with an accumulation of angiotensinogen and AT(1) and enhanced production of angiotensin II.  Bax quantity also increased. Myocyte death by apoptosis directly correlated with glucose and angiotensin II levels. In conclusion, these in vitro results support the notion that hyperglycemia with diabetes promotes myocyte apoptosis mediated by activation of p53 and effector responses involving the local renin-angiotensin system.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Oct 50(10) 2363-75",
                "id": "11574421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "the rise in Gklf mRNA level precedes that in p21(WAF1/Cip1), suggesting that GKLF may be involved in the induction of p21(WAF1/Cip1). Indeed, GKLF activates p21(WAF1/Cip1) through a specific Sp1-like cis-element in the p21(WAF1/Cip1) proximal promoter GKLF is an essential mediator of p53 in the transcriptional induction of p21(WAF1/Cip1) Potential mechanisms by which p53 activates the p21(WAF1/Cip1) promoter include a physical interaction between p53 and GKLF and the transcriptional induction of Gklf by p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 16 275(24) 18391-8",
                "id": "10749849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The inactivation of the p53 gene in a large proportion of human cancers has inspired an intense search for the encoded protein's physiological and biological properties. Expression of p53 induces either a stable growth arrest or programmed cell death (apoptosis). In human colorectal cancers, the growth arrest is dependent on the transcriptional induction of the protein p21WAF1/CIP1 , but the mechanisms underlying the development of p53-dependent apoptosis are largely unknown. As the most well documented biochemical property of p53 is its ability to activate transcription of genes, we examined in detail the transcripts induced by p53 expression before the onset of apoptosis. Of 7,202 transcripts identified, only 14 (0.19%) were found to be markedly increased in p53-expressing cells compared with control cells. Strikingly, many of these genes were predicted to encode proteins that could generate or respond to oxidative stress, including one that is implicated in apoptosis in plant meristems. These observations stimulated additional biochemical and pharmacological experiments suggesting that p53 results in apoptosis through a three-step process: (1) the transcriptional induction of redox-related genes; (2) the formation of reactive oxygen species; and (3) the oxidative degradation of mitochondrial components, culminating in cell death.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 Sep 18 389(6648) 300-5",
                "id": "9305847"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Western blot analysis revealed that introduction of E6 effectively reduced the level of p53 protein and also markedly reduced the expression of p21, its target protein (Figure 1D). Treatment of mock-infected VSMCs with Ang II significantly increased the number of SA -gal positive cells (Figure 1E). In contrast, the effect of Ang II on senescence was reduced in E6-infected VSMCs.",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2006 Aug 29 114(9) 953-60",
                "id": "16908765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The p53 tumour suppressor is a short-lived protein that is maintained at low levels in normal cells by Mdm2-mediated ubiquitination and subsequent proteolysis. Stabilization of p53 is crucial for its tumour suppressor function. However, the precise mechanism by which ubiquitinated p53 levels are regulated in vivo is not completely understood. By mass spectrometry of affinity-purified p53-associated factors, we have identified herpesvirus-associated ubiquitin-specific protease (HAUSP) as a novel p53-interacting protein. HAUSP strongly stabilizes p53 even in the presence of excess Mdm2, and also induces p53-dependent cell growth repression and apoptosis. Significantly, HAUSP has an intrinsic enzymatic activity that specifically deubiquitinates p53 both in vitro and in vivo. In contrast, expression of a catalytically inactive point mutant of HAUSP in cells increases the levels of p53 ubiquitination and destabilizes p53. These findings reveal an important mechanism by which p53 can be stabilized by direct deubiquitination and also imply that HAUSP might function as a tumour suppressor in vivo through the stabilization of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Apr 11 416(6881) 648-53",
                "id": "11923872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Pretreatment with an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1), NU1025, nearly doubled the DNA damage produced by 5 microM 3MI, implying that PARP1, which among other activities, functions to repair single-strand breaks in DNA, repaired at least some of the 3MI-induced DNA fragmentation. A key cellular response to DNA damage, phosphorylation, and nuclear localization of p53 was seen at subtoxic levels of 3MI exposure ... from Fig 6, TP53 P@S20",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2009 Nov 112(1) 59-67",
                "id": "19700606"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We originally discovered the serum and glucocorticoid inducible protein kinase, SGK, as a novel protein kinase that is under acute transcriptional control by serum and glucocorticoids. although, the direct stimulus regulation of SGK promoter activity has been established only for glucocorticoids, p53 tumor suppressor protein, hyperosmotic stress and follicle stimulating hormone.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2003 13(1) 1-12",
                "id": "12649597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we show that genotoxic stress promotes the p53-dependent up-regulation of the homologous miRNAs miR-192 and miR-215. Like miR-34a, activation of miR-192/215 induces cell cycle arrest, suggesting that multiple miRNA families operate in the p53 network. Furthermore, we define a downstream gene expression signature for miR-192/215 expression, which includes a number of transcripts that regulate G(1) and G(2) checkpoints. Of these transcripts, 18 transcripts are direct targets of miR-192/215, and the observed cell cycle arrest likely results from a cooperative effect among the modulations of these genes by the miRNAs. miR-192 and miR-215 generate a gene expression signature that is enriched for regulators of cell cycle progression. Microarray profiling of miR-192 and miR-215regulated transcripts. HCT116 DICERex5 cells were transfected with luciferase siRNA (Luc siRNA) or miR-192 or miR-215 synthetic duplexes. RNA was isolated at 10 and 24 h following transfection and was compared with RNA isolated from mock-transfected cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Dec 15 68(24) 10105-12",
                "id": "19074876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We also show that the p53 activation of the Apaf-1 luciferase construct can be enhanced by the putative tumor suppressor gene product, Zac-1, a transcription factor that has previously been shown to inhibit cell proliferation. Furthermore, we demonstrate that Zac-1 is a possible direct target of p53 since the sequence upstream to the first coding exon of Zac-1 contains a p53 recognition site and the luciferase construct containing this region is activated by p53",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Feb 28 21(10) 1469-76",
                "id": "11896574"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The WAF1, Cyclin G and muscle creatine kinase (MCK) genes, all contain multiple copies of the consensus p53-binding element within their regulatory regions. Our results provide evidence for a model by which high level transcriptional activation of promoters with multiple p53 response elements is achieved.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Jan 15 16(2) 283-92",
                "id": "9464547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we report the identification of a new direct p53 target, Ptprv (or ESP), encoding a transmembrane tyrosine phosphatase. Ptprv transcription is dramatically and preferentially increased in cultured cells undergoing p53-dependent cell cycle arrest, but not in cells undergoing p53-mediated apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Sep 7 24(17) 3093-103",
                "id": "16107883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe079f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "After establishing the role of p53 in cardiomyocyte apoptosis, we examined whether or not p53 activation was dependent on p38alpha MAPK, inhibition of which was essential in cytoprotection by E2.4 In order to block endogenous p38alpha MAPK, we expressed dominant negative p38alphaDN, via adenovirus infection, carrying a TGY180182 ? AGF mutation in the phosphorylation site of the kinase.9 This mutant prevents hypoxia-induced activation of endogenous p38alpha MAPK.4 We predicted that inactivating p38alpha MAPK would diminish the subsequent phosphorylation and activation of p53. Accordingly, little p-p53(S15) was observed in the presence of p38alphaDN during H/R, corrected for modest change in total p53 protein concentration (Figure 2). Similarly, the use of a chemical inhibitor of p38alpha MAPK, SB203580 (SB), also attenuated p-p53(S15). Although SB inhibits both p38alpha and p38beta MAPKs, the latter is not activated by H/R stress alone, whereas the former is significantly up-regulated by the same stimulus.4 Therefore, SB is likely to inhibit p38alpha MAPK to a much greater degree than p38beta in H/R. Overall, these results indicate that H/R-induced p53 depends on p38alpha MAPK. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2011 Jan 1 89(1) 119-28",
                "id": "20724307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe079e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras ... Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression ... from full text, oncogenic ras is HRAS G12V and TP53 is phosphorylated at S37 ... human primary BJ fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Jan 26 128(2) 295-308",
                "id": "17254968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe079d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": " Addition of nutlin restored doxorubicin-induced p53 protein and transcriptional activity in senescent cells to the levels in early passage cells",
              "citation": {
                "type": "PubMed",
                "name": "Aging (Albany NY) 2009 Oct 1(10) 845-54",
                "id": "20157557"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0640"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "These data suggest that the fgf1 gene is a repressed target of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Aug 1",
                "id": "16091747"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe063f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The study described here demonstrates that the expression of the POLD1 gene  mRNA is repressed by wild-type p53 in response to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 29729-39",
                "id": "11375983"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe063e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 appears to exert its inhibition of human AR by disrupting its amino- to carboxyl-terminal (N-to-C) interaction, which is thought to be responsible for the homodimerization of this receptor",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 19 276(42) 38472-9",
                "id": "11504717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe063d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Deletion of p53in HCT116 human colon carcinoma cells and primary mouse astrocytes resulted in a 6-fold increase of DNA cytosine methyltransferase 1 (Dnmt1) mRNA and protein, suggesting relief of p53-mediated Dnmt1repression. ...implying that p53 controls Dnmt1transcription through direct DNA binding.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Oct 15 63(20) 6579-82",
                "id": "14583449"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe063c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Unexpectedly, MUC2 expression was also induced in human osteosarcoma cells,  U-2OS and Saos-2, by exogenous p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 13 277(50) 48270-5",
                "id": "12374798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe063b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We further found that BubR1 transcription is largely controlled by p53. In early-passage p53(-/-) cells, BubR1 expression is low",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 May 25(10) 4046-61",
                "id": "15870277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe063a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We showed that DDR1 is a direct p53 transcriptional target, and that DNA damage induced a p53-dependent DDR1 response associated with activation of its tyrosine kinase.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Mar 17 22(6) 1289-301",
                "id": "12628922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0639"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The activation of tumor suppressor p53 induces apoptosis or cell cycle arrest depending on the state and type of cell, but it is not fully understood how these different responses are regulated.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4952-62",
                "id": "17024184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0638"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 alone is sufficient to induce the caspase-8 promoter even in p53-deficient Hep3B hepatoma cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 25 278(30) 27593-604",
                "id": "12748179"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0637"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "CARM1 and p300 cooperate with BRCA1 and p53 to induce expression of the critical cell cycle and proliferation regulator p21(WAF1/CIP1) in response to DNA damage.  ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2011 Jan 15 25(2) 176-88",
                "id": "21245169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0636"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "These results suggest that Bach1 is a negative regulator of the p53-mediated senescence program in response to oxidative stress, although Bach1 could be either parallel or upstream to p53 in this process.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Struct Mol Biol 2008 Dec 15(12) 1246-54",
                "id": "19011633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0635"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "embryonic tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "LNCaP and LN-56 were injected s.c. in nude mice and tumors were identified in all LN-56, but not LNCaP, bearing mice indicating that p53 plays an important role in growth control of prostatic neoplasms.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Apr 6 19(15) 1959-68",
                "id": "10773886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0634"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Moreover, Rac1 and Cdc42Hs extinction in normal cells activates endogenous p53.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 May 11 19(20) 2377-85",
                "id": "10828879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0633"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Figure 2. p53DINP1 Is a Direct-Target Gene of p53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 85-94",
                "id": "11511362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0632"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "from full text - Figure 4.  SOCS1 Stimulates the Transcriptional Activity of p53 and Figure 5.  SOCS1 Directly Interacts with p53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2009 Dec 11 36(5) 754-67",
                "id": "20005840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0631"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Senescent fibroblasts exhibited enhanced expression of phosphorylated and acetylated p53, and cyclin-dependent kinase inhibitor, p21. Together, these results demonstrated that knockdown of endogenous MBP-1 is involved in cellular senescence of HFF through p53-p21 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS ONE 2008 3(10) e3384",
                "id": "18852884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0630"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": " In addition to the repair role of Ape1, it also functions as a major redox-signaling factor to reduce and activate transcription factors such as AP1, p53, HIF-1alpha, and others that control the expression of genes important for cell survival and cancer promotion and progression.  ",
              "citation": {
                "type": "PubMed",
                "name": "Stem Cells 2009 Jun 27(6) 1455-62",
                "id": "19492297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe062f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "H460 cells overexpressing p53 showed slight decrease in Il-6 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Feb 1 62(3) 932-40",
                "id": "11830554"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe062e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1998 Aug 1 58(15) 3231-6",
                "id": "9699647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe062d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "These results suggest that Bach1 impedes p53-mediated transactivation by binding to a subset of target genes along with p53 and by recruiting Hdac1.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Struct Mol Biol 2008 Dec 15(12) 1246-54",
                "id": "19011633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe062c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Both ING1 and p53 were able to suppress AFP transcription and cause p21 induction; hSIR2, a negative regulator of the p53 protein, showed the opposite effects on the AFP promoter and, like HDAC1, repressed p21 promoter activity",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Sep 15 63(18) 5785-92",
                "id": "14522900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe062b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "miR-29 miRNAs failed to induce cell death in HCT116p53KD, but they were effective in the parental HCT116 line. We observed similar results when p53 was knocked down in MCF-7 cells by transient transfection of siRNA against p53 (Supplementary Fig. 6d). Thus, our data indicate that miR-29 miRNAs induce apoptosis through p53 activation.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Struct Mol Biol 2009 Jan 16(1) 23-9",
                "id": "19079265"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe062a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "The Prostate 2006 Sep 15;66(13):1455-62",
                "id": "16741917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0629"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5718-31",
                "id": "10409760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0628"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Figure 2. Binding and transactivation of the CYFIP2 promoter by p53",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2007 Jan 1 6(1) 95-103",
                "id": "17245118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0627"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53-dependent induction of BOK and NOXA genes,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28367-74",
                "id": "15102863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0626"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Our data show that IRF1 and p53 suppress the CDK2  promoter through distinct mechanisms, whereas both proteins function as  positive regulators of the CDK inhibitor protein p21 through their cognate  sites ( 7 , 55 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 18 278(29) 26589-96",
                "id": "12732645"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0625"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In this report, we describe robust induction of heat shock protein 27 (hsp27) in prostate cancer cells (DU145, LNCaP, PC3) following wild-type p53 expression from an adenoviral p53 expression vector (AdWTp53)",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2000 Oct 15 88(2) 191-4",
                "id": "11004667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0624"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In this report, we show that p53-inducible RING-finger protein (p53RFP), a p53-inducible E3 ubiquitin ligase, induces p53-dependent but caspase-independent apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2006 Feb 6 580(3) 940-7",
                "id": "16427630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0623"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Conversely, MUC1 attenuates activation of Bax transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2005 Feb 7(2) 167-78",
                "id": "15710329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0622"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Consistent with this finding, we report that p53 physically associates in vivo with HDACs. This interaction is not direct but, rather, is mediated by the corepressor mSin3a. Both wild-type p53 and mSin3a, but not mutant p53, can be found bound to the Map4 promoter at times when this promoter preferentially associates with deacetylated histones in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Oct 1 13(19) 2490-501",
                "id": "10521394"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0621"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "from full text Table 1 p53 mutants able to discriminate between di?????erent p53 responsive elements",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Jun 14 20(27) 3573-9",
                "id": "11429705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0620"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "overexpression of two genes (M17S2 and cathepsin B) resulted in down-regulation of p53 activity in mammalian cells",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Mar 9 101(10) 3456-61",
                "id": "14990790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe061f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 Aug 1 59(15) 3663-70",
                "id": "10446979"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe061e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "It  has been reported that S100B inhibits phosphorylation of p53 by direct interaction and not by influencing the kinase activity ( 36 ) and that S100C inhibits actin-activated myosin ATPase in the same way",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 7 277(23) 21103-9",
                "id": "11927578"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe061d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Cdca4 (Hepp) was originally identified as a gene expressed specifically in hematopoietic progenitor cells as opposed to hematopoietic stem cells. More recently, it has been shown to stimulate p53 activity and also lead to p53-independent growth inhibition when overexpressed.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2006 Mar 16",
                "id": "16546331"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe061c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Proceedings of the National Academy of Sciences of the United States of America 2003 Jul 8;100(14):8424-9",
                "id": "12826609"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe061b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "14-3-3sigma is a candidate tumour suppressor gene transactivated by p53 in response to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Pathol 2004 Mar 202(3) 274-85",
                "id": "14991892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe061a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1995 Nov 16 11(10) 2175-8",
                "id": "7478539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0619"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "These results were anticipated from  the work of others (10 , 11) , who demonstrated that stathmin was repressed by  wild-type p53 protein",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Dec 1 62(23) 6864-9",
                "id": "12460900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0618"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1997 Mar 11(3) 312-29",
                "id": "9058378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0617"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "FIP200 significantly induced p21 promoter activity in MCF-7 cells and this response was abolished upon deletion of p53 binding sites within p21 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Aug 1 65(15) 6676-84",
                "id": "16061648"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0616"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We here demonstrate that ICBP90 expression is down-regulated by the p53/p21Cip1/WAF1-dependent DNA damage checkpoint signals.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2004 Feb 9(2) 131-42",
                "id": "15009091"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0615"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Similar to SUV39H1, EHMT1 also inhibited p53 activity in an MDM2-dependent manner (Figure 7B). ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2010 Aug 4 29(15) 2538-52",
                "id": "20588255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0614"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From full text:  \\\"p21 expression was positively regulated by p53\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 Jun 15 59(12) 2957-64",
                "id": "10383161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0613"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "When S100B expression was inhibited in C8146As by siRNA (siRNAS100B), wt p53 mRNA levels were unchanged, but p53 protein, phosphorylated p53, and p53 gene products (i.e. p21, PIDD) were increased.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jun 29",
                "id": "20587415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0612"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We found that MDMX binds to the casein kinase 1 alpha isoform (CK1alpha) and is phosphorylated by CK1alpha. Expression of CK1alpha stimulates the ability of MDMX to bind to p53 and inhibit p53 transcriptional function. Regulation of MDMX-p53 interaction requires CK1alpha binding to the central region of MDMX and phosphorylation of MDMX on serine 289. Inhibition of CK1alpha expression by isoform-specific small interfering RNA (siRNA) activates p53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Aug 25(15) 6509-20",
                "id": "16024788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0611"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "JAZ associates with p53 to stimulate its transcriptional activity in p53-expressing cells, but not in p53-null cells unless complemented with p53. JAZ functions to mediate G1 cell-cycle arrest followed by apoptosis in a p53-dependent mechanism",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2006 Dec 15 108(13) 4136-45",
                "id": "16931621"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0610"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hematopoietic",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Furthermore, p53 binds regions of the S100B promoter, one of which matches the 20-nucleotide p53-binding consensus DNA sequence perfectly. Therefore, when p53 levels increase, it contributes to its own demise by up-regulating the transcription of S100B as part of a negative feedback loop.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 6 279(32) 34071-7",
                "id": "15178678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe060f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "malignant melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From Cell Signaling Technologies Pathway Maps for p38 and JNK signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2001 Apr 81(2) 807-69",
                "id": "11274345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe060e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "S100B(beta beta) was found to interact with the tumor suppressor protein, p53, and inhibit its PKC-dependent phosphorylation and tetramer formation [Baudier, J., Delphin, C., Grunwald, D., Khochbin, S., and Lawrence, J. J. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 11627-11631]",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1998 Feb 17 37(7) 1951-60",
                "id": "9485322"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe060d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "However, treatment with ADR or cisplatin is accompanied by a significant increase and redistribution of RAD6 to DNA, and RAD6, RAD18, PCNA, phosphohistone H3, as well as p53 proteins are all found in the DNA fractions.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 15 23(17) 3097-106",
                "id": "14981545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe060c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we show that wild-type p53 represses survivin expression at both mRNA and protein levels. Transient transfection analyses revealed that the expression of wild-type p53, but not mutant p53, was associated with strong repression of the survivin promoter in various cell types ... from full text, ovarian cancer cells and A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Apr 18 21(17) 2613-22",
                "id": "11965534"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe060b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "expression of a dominant negative IkappaBalpha (IkappaBalphaM) inhibited NF-kappaB-dependent p53 activation and apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 25 279(26) 27549-59",
                "id": "15102862"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe060a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The acrolein-induced increase in FasL expression was significantly inhibited by pifithrin-alpha, suggesting that this response was mediated by p53 (Fig. 2E).",
              "citation": {
                "type": "PubMed",
                "name": "Can J Physiol Pharmacol 2010 Mar 88(3) 353-68",
                "id": "20393600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0609"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here, we demonstrate that the transcription factor Yin Yang 1 (YY1) interacts with p53 and inhibits its transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Aug 17 101(33) 12165-70",
                "id": "15295102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0608"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The PCNA gene is induced by p53",
              "citation": {
                "type": "PubMed",
                "name": "Int J Radiat Biol 2001 Oct 77(10) 1007-21",
                "id": "11682006"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0607"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Chloride intracellular channel (CLIC)4 is a p53- and tumor necrosis factor alpha (TNFalpha)-regulated chloride channel protein",
              "citation": {
                "type": "PubMed",
                "name": "J Investig Dermatol Symp Proc. 2005 Nov;10(2):105-9",
                "id": "16358817"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0606"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53-responsive genes such as GADD45, TOP2A, and p21",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Mar 15 63(6) 1382-8",
                "id": "12649203"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0605"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "BCL6 overrides the senescence response downstream of p53 through a process that requires induction of cyclin D1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2002 Mar 15 16(6) 681-6",
                "id": "11914273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0604"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Collectively, we conclude that p53 directly regulates the DcR2 gene expression via an intronic p53BS.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Oct 15 65(20) 9169-75",
                "id": "16230375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0603"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53-inducible TSAP6 ...TSAP6 could augment Myt1 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Mar 4 100(5) 2284-9",
                "id": "12606722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0602"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Gel shift and supershift assays demonstrate binding of p53 and NFkappaB to their corresponding sites in vitro. CAT-reporter gene assays show transactivation of the human p22/PRG1 promoter by p53 in Hep3B cells stably transfected with a temperature-sensitive mutant p53, but not in p53-deficient Hep3B cells.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1998 Oct 2 436(2) 139-43",
                "id": "9781666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0601"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "39. Mercer J, Figg N, Stoneman V, Braganza D, Bennett MR (2005) Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res 96:667674 ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2008 Jul 86(7) 761-70",
                "id": "18385967"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0600"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "histone methyltransferase SETD2 could selectively regulate the transcription of subset genes via cooperation with the transcription factor p53",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Sep 20(9) 1671-8",
                "id": "18585004"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We found that BRCA1 when subjected to forced expression acts synergistically with wild-type p53, resulting in irreversible growth arrest  n particular, we found that BRCA1 expression attenuated p53-mediated cell death in response to gamma-irradiation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jun 12 22(24) 3749-58",
                "id": "12802282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05fe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "wild-type p53 represses the translation of CDK4",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1995 Jan 15 9(2) 204-17",
                "id": "7851794"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Transfection of the p53 gene with an alanine mutation at the Ser(315) site into Saos-2 cells gave rise to a form of p53 protein with a substantially reduced specific activity as a transcription factor",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 4699-708",
                "id": "11078726"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "coexpression of oncogenic ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone and produced an irreversible cell cycle arrest that displayed features of cellular senescence",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 May 22(10) 3497-508",
                "id": "11971980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Overexpression of hEcd increases the levels of p53 and enhances p53 target gene transcription whereas hEcd knockdown has the opposite effects on p53 levels and target gene expression",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Jul 15 66(14) 7167-75",
                "id": "16849563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "High levels of p53 have been reported in atherosclerotic lesions [141], especially in senescent cells in which p53 induces the expression of ICAM1 [142].",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Atherosclerosis",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We found that integrin alphav inactivated p53",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Nov 22 167(4) 745-56",
                "id": "15557124"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 31 281(13) 8600-6",
                "id": "16443602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Adenovirus-mediated p53 transfection induced a high level of DDR mRNA in SAOS2 human osteosarcoma cells. These results indicate that DDR is up-regulated by the p53 protein.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1996 Dec 2 398(2-3) 165-9",
                "id": "8977099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "under hypoxic conditions, p53 is stabilized to a form that blocks transcription but then requires further modification by phosphorylation to cause apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Jan 2(1) 38-47",
                "id": "11902584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In studying the molecular mechanism of this increased stabilization of p53, we found that 14-3-3 sigma antagonized the biological functions of Mdm2 by blocking Mdm2-mediated p53 ubiquitination and nuclear export. In addition, we found that 14-3-3 sigma facilitated the oligomerization of p53 and enhanced p53's transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Oct 23(20) 7096-107",
                "id": "14517281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer research 1999 Sep 1;59(17):4165-9",
                "id": "10485447"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table I - Target genes modulated by p73 and p53",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 43359-68",
                "id": "12213815"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "transcription of the DRAL gene can be stimulated by p53",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Oct 30 151(3) 495-506",
                "id": "11062252"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Figure 3 showing mutations with loss of Transactivation activity",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mutat 2007 Jun 28(6) 622-9",
                "id": "17311302"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Strikingly, cotransfection of either the murine or human wild type p53, but not a mutant p53, repressed the dexamethasone-stimulated transactivation of reporter plasmids containing either the sgkGRE or a consensus GRE.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1997 Mar 11(3) 312-29",
                "id": "9058378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ef"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The human AK1 gene contains several consensus p53 binding sites and we report that p53-dependent induction of the alternative AK1beta transcript also occurs in human cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Oct 21 18(43) 5879-88",
                "id": "10557075"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Likewise, early onset of senescence and activation of the p53/p21 signaling pathway have been detected in EPCs from patients with diabetes.59",
              "citation": {
                "type": "PubMed",
                "name": "Nat Clin Pract Cardiovasc Med 2008 Oct 5(10) 637-48",
                "id": "18762784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "endothelial progenitor cell"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In addition, we found that SCN3B levels are upregulated in human cancer cell lines by DNA damaging agents, as well as by overexpression of p53, but not significantly by p63 or p73.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Oct 14 23(47) 7791-8",
                "id": "15334053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "E2FBP1/DRIL1 expression is activated by p53  and is also induced following DNA damage in a manner dependent on endogenous  p53.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Apr 1(6) 438-44",
                "id": "12692263"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Nuclear PTEN, independent of its phosphatase activity, leads to p53-mediated G(1) growth arrest, cell death, and reduction of reactive oxygen species production. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 May 28(10) 3281-9",
                "id": "18332125"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Experiments involving transient transfection, mobility shift assay, and site-directed mutagenesis demonstrated that p53 specifically binds and transactivates the M-PGAM promoter. The p53-related proteins p51A and p73L also transactivated M-PGAM.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 May 10(5) 295-306",
                "id": "10359011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Nov 15 165(10) 5884-90",
                "id": "11067949"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Finally, IR induction of the human GADD45 gene, an induction that is also defective in AT cells, was dependent on wild-type p53 function. Wild-type but not mutant p53 bound strongly to a conserved element in the GADD45 gene, and a p53-containing nuclear factor, which bound this element, was detected in extracts from irradiated cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1992 Nov 13 71(4) 587-97",
                "id": "1423616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1992 Apr 11 20(7) 1539-45",
                "id": "1579447"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "That hypothesis is consistent with the presence of a functional p53-response element within the promoter region of the mouse SIP gene and confirmed by the induction of SIP mRNA expression in mouse embryo fibroblasts upon activation of a p53-dependent pathway by transfection with rasV12 or rasV12/E1A",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Cell Biol 2002 May 81(5) 294-301",
                "id": "12067065"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "By contrast, serum- and glucocorticoid-inducible kinase 1 (SGK1) was significantly induced in a p53-dependent manner after DNA damage, and this induction was through extracellular signal-regulated kinase 1/2-mediated posttranslational regulation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Sep 28 101(39) 14057-62",
                "id": "15383658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "This report demonstrates that Gadd45, a p53-responsive stress protein, can facilitate topoisomerase relaxing and cleavage activity in the presence of core histones.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Mar 19(3) 1673-85",
                "id": "10022855"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 Oct 10(10) 677-83",
                "id": "10547071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Cotransfection of Saos-2 (os-teosarcoma-derived cells) and RD (rhabdomyosarcoma-derived cells) cells with IGF-I-R promoter constructs driving luciferase reporter genes and with wild-type p53 expression vectors suppressed promoter activity in a dose-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1996 Aug 6 93(16) 8318-23",
                "id": "8710868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "the expression of p21, the most prominent p53-regulative gene, was markedly upregulated (APOPTOSIS RELATED GENES)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 12 23(6) 1300-7",
                "id": "14676844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Jan 3(1) 17-22",
                "id": "12559172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Furthermore, Skp2 overexpression inhibited UV-C-induced mRNA expression of a p53 target gene, p21WAF1 (Figure 3I).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2010 May 28 38(4) 524-38",
                "id": "20513428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Maspin gene expression can be upregulated by the tumor suppressor p53.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 Apr 20 114(4) 555-62",
                "id": "15578720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Our results demonstrated that wt p53 acts as a negative regulator of MRP gene transcription, at least in part by diminishing the effect of a powerful transcription activator Sp1",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1998 Dec 15 58(24) 5762-9",
                "id": "9865734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "IL-8, for example, has been shown to be pro-oncogenic, such as releasing BCL-2, but also suppresses oncogenes, such as p53, hence minimizing apoptosis while inducing cell transformation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2008 Dec 1 5(8) 842-7",
                "id": "19017739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32137-44",
                "id": "10542249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05da"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 15 277(7) 5484-9",
                "id": "11729185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Transcriptional target genes of p53 include the cyclin-dependent kinase (CDK) inhibitor p21, the proapoptotic genes BAX and APAF1, and the E3 ubiquitin ligase MDM2 (Vousden and Lu, 2002; Riley et al., 2008).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2011 Jun 30 30(26) 2901-11",
                "id": "21383691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Nov 10 95(23) 13869-74",
                "id": "9811893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "from full text - Fig 1 - p21 induction by IFI16 inhibition is wild-type p53-dependent. p53-null Saos-2 cells were transiently transfected with p53 or empty vector (pcDNA3). At the time of transfection with p53, cells were also transfected with control siRNA or IFI16 siRNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 40899-904",
                "id": "12925527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 Jun 15 59(12) 2829-33",
                "id": "10383141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Adenovirus-mediated high dose p53 overexpression induced Peg3/Pw1 mRNA expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 4 277(1) 623-9",
                "id": "11679586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "activation of p53 by DNA damage results in enhanced Cdc6 destruction by the anaphase-promoting complex.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Aug 25(16) 6937-47",
                "id": "16055707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The (dominant negative) mutant p53 genes also increased IL-6 gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 1999 Jun 42(6) 1088-92",
                "id": "10366100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "synovium"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We concluded that H7 inhibits constitutive C-terminal phosphorylation of p53, which regulates its turnover in unstressed cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 24 276(34) 31819-24",
                "id": "11431470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Constitutive activation of Akt promotes senescence-like arrest of cell growth via a p53/p21-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 Apr 3(4) 449-51",
                "id": "15004530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "PRPK phosphorylates serine-15 residue of p53 and enhances transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 May 26 344(1) 377-85",
                "id": "16600182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Ad-p53 was able to inhibit TNF-induced MnSOD mRNA expression in MCF7/Adr cells",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2000 Jan 1 85(1) 93-7",
                "id": "10585590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Aug 20 274(34) 24297-307",
                "id": "10446206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "total p53 protein levels increased after BPDE treatment (Figure 6A). Consistent with increased p53 protein levels, we detected increased p53-driven luciferase reporter activity at 4 h, which verified that endogenous p53 was activated (Figure 6B).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2331-40",
                "id": "16774943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We have identified a close relative of ribonucleotide reductase, recently named p53R2, as a p53-inducible gene, and show that this gene is activated by several stress signals that activate a p53 response, including DNA damaging agents and p14(ARF).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Aug 31 19(37) 4283-9",
                "id": "10980602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Forced up-regulation of proline oxidase induced the formation of reactive oxygen species and mediated apoptosis in the 786-0 renal cell carcinoma cell line. A proline oxidase antisense vector repressed p53-induced up-regulation of proline oxidase, release of cytochrome c from mitochondria, and apoptosis in 786-0 renal carcinoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 14 278(11) 9784-9",
                "id": "12514185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jun 23 95(13) 7664-9",
                "id": "9636207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Furthermore, evidence is provided that increased Cdk5 activity increases p53 transcriptional activity significantly, suggesting that p53 is modulated in situ by Cdk5. This is the first demonstration that p53 is a substrate of Cdk5, and that Cdk5 can modulate p53 levels and activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2002 Apr 81(2) 307-13",
                "id": "12064478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "K10.5/LANA-2. K10.5 expresses LANA-2, which inhibits p53-mediated transactivation and apoptosis but is expressed latently only in B cells, not KS tissue",
              "citation": {
                "type": "PubMed",
                "name": "Microbiol Mol Biol Rev 2003 Jun 67(2) 175-212, table of contents",
                "id": "12794189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "AK1beta,was specifically induced upon activation of wt p53 in Val5 cells",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Oct 21 18(43) 5879-88",
                "id": "10557075"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The ATM (23) and ATR (24) protein kinases play key roles in p53 activation in response to IR and UV, respectively. Bulky chemical adducts have also been shown to induce stabilization and nuclear accumulation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Feb 24(2) 225-34",
                "id": "12584171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The p53-induced transactivation of the S100A2 promoter was enhanced by etoposide and blocked by a dominant negative p53 mutant.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Feb 26 445(2-3) 265-8",
                "id": "10094469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In this report, we utilized small interfering RNA to deplete BRCA1 and BARD1 to demonstrate that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated/ATM and Rad3-related)-mediated phosphorylation of p53(Ser-15) following IR- and UV radiation-induced DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31251-8",
                "id": "15159397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "novel p53 target gene Snk/Plk2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Aug 23(16) 5556-71",
                "id": "12897130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Knockdown of Foxo3a expression inhibited the starvation-induced increase in SIRT1 expression.  Stimulation of SIRT1 transcription by Foxo3a was mediated through two p53 binding sites present in the SIRT1 promoter, and a nutrient-sensitive physical interaction was observed between Foxo3a and p53.  SIRT1 expression was not induced in starved p53-deficient mice.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Dec 17 306(5704) 2105-8",
                "id": "15604409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Several direct targets of p53 were increased in Cr(VI) transformed cells, including CYFIP2, Perp, and RNF144B, which were known to mediate p53-dependent apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(3) e17982",
                "id": "21437242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "during apoptosis, p53 activates transcription of PAC1",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Apr 3 422(6931) 527-31",
                "id": "12673251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 also contributes to the G2/M checkpoint through its transactivation of p21 and 14-3-3. P21 effectively blocks the phosphorylation of CDC2, initiating the onset of the G2/M cell-cycle arrest. 14-3-3 sequesters CDC25C in the cytoplasm and promotes the activation ofWee1, a tyrosine kinase that negatively regulates CDC2, thus blocking entry into mitosis.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we found that MORC3 (microrchidia3)-ATPase activated p53 and induced cellular senescence in normal human and mouse fibroblasts but not p53-/- fibroblasts. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 May 18(5) 1701-9",
                "id": "17332504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table 1 Substrates of DNA-PK",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Feb 3 24(6) 949-61",
                "id": "15592499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Phosphorylation of serine 15 increases the transcriptional activity of p53 (ref. 22).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Oct 2(10) 762-5",
                "id": "11025670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "As expected, the transcriptional activity of p53 was strongly activated by cotransfection with ING1b. We found that the transcriptional activities of p73? and p63? were also enhanced by ING1b, albeit not as robust as p53.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Oct 23 553(3) 277-85",
                "id": "14572637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": " This study identifies the anti-apoptotic survivin gene as a p53-repressed gene. Notably, Survivin repression by p53 is shown to be distinct from p53-dependent growth arrest. Chromatin immunoprecipitations indicate that p53 binds the survivin promoter in vivo ... from full text, H1299, MCF-7, and SAOS-2 cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 1 277(5) 3247-57",
                "id": "11714700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In a series of New England and Swedish patients, we find that 14/24 (58%) of invasive squamous cell carcinomas of the skin contain mutations in the p53 tumor suppressor gene",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1991 Nov 15 88(22) 10124-8",
                "id": "1946433"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Within the cell, the apoptosis-inducing tumor suppressor, p53, can also induce IGFBP-3 expression",
              "citation": {
                "type": "PubMed",
                "name": "Microsc Res Tech 2002 Oct 1 59(1) 12-22",
                "id": "12242693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 14 276(37) 35037-41",
                "id": "11454863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "# Jubilant: PERP is a direct target of 53, involved in p53-dependent apoptosis. High level PERP expression correlated with the induction of cell death, with 21 percent of cells undergoing apoptosis by 16 hours. Accumulation of high levels of PERP gene expression is dependent on p53, E1A and DNA damage which are all essential for E1A-induced apoptosis in mouse endothelial fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Mar 15 14(6) 704-18",
                "id": "10733530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 appeared to up-regulate caspase-6 mRNA expression in a variety of human cancer cell lines (Fig. 1D). ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jul 9 99(14) 9492-7",
                "id": "12089322"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1996 Mar 19 93(6) 2442-7",
                "id": "8637893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Simultaneous depletion of p53 rescued this phenotype, enabling PTEN-depleted cells to continue proliferating.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Jan 27(2) 662-77",
                "id": "17060456"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "MKP1 mRNA and protein levels were increased upon p53 activation in several well defined p53-regulated cell systems.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41059-68",
                "id": "12890671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Integrin avb3 is expressed in high quantities on angiogenic endothelial cells (Brooks et al., 1994a), where it suppresses the activity of p53 and the p53-inducible cell-cycle inhibitor p21WAF1/CIP1 and increases the Bcl-2:Bax ratio, with a consequent antiapoptotic effect (Stromblad et al., 1996).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Feb 15 18(4) 882-92",
                "id": "10022831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "we have identified a signal transduction pathway that is activated by NGF; proceeds through NOS, p53, and p21(WAF1) to block cell proliferation;",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Sep 19 272(38) 24002-7",
                "id": "9295352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05af"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Mdm2 is a negative regulator of p53, ultimately causing p53 degradation by the proteasome, whereas p53 transcriptionally upregulates Mdm2. ARF inhibits Mdm2 function. MYC activation leads to increased ARF expression (Zindy et al., 1998), resulting in increased p53 protein.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The ARF tumor suppressor is widely regarded as an upstream activator of p53-dependent growth arrest and apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Nov 24(21) 9327-38",
                "id": "15485902"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ad"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Breast cancer research and treatment 2007 Apr;102(2):157-72",
                "id": "17039268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We have identified a p53-inducible gene named TIGAR (TP53-induced glycolysis and apoptosis regulator). TIGAR expression lowered fructose-2,6-bisphosphate levels in cells, resulting in an inhibition of glycolysis and an overall decrease in intracellular reactive oxygen species (ROS) levels.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2006 Jul 14 126(1) 107-20",
                "id": "16839880"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "osteosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Finally, miR-34a itself is a transcriptional target of p53",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Sep 9 105(36) 13421-6",
                "id": "18755897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table 1 Transcription factors activated by OxLDL",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The tumor suppressor  protein p53 has been reported to induce TR2 expression in colon and lung cancer  cells (28 , 29) .",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Mar 1 63(5) 1122-9",
                "id": "12615731"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": " We confirmed this hypothesis by showing that p53-dependent signaling through c-jun N-terminal kinase (JNK) led to increased cJun-Ser63 phosphorylation and that inhibition of JNK-mediated cJun activation using p53- or JNK-specific inhibitors significantly reduced IL gene expression and subsequent production of IL8.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2010 Jun 31(6) 1149-57",
                "id": "20382639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We show here that upon UV irradiation p53 activates transcription of the human mismatch repair gene MSH2.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 Dec 1 59(23) 5882-6",
                "id": "10606228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "colon epithelium",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In some cell types, increased HIF-1 can induce apoptosis for example, through the stabilization of p53 (REF. 75) or through transactivation of BNIP3, which encodes a pro-apoptotic BCL2 family member.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 721-32",
                "id": "13130303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "we found that expression of the Reprimo gene was significantly increased in normal uteri of p53(wt/wt) mice",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jun 1 62(11) 3024-9",
                "id": "12036908"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "DNA damage elicited by gamma-irradiation induces WAF1/CIP1 in normal human and mouse fibroblasts but does not affect WAF1/CIP1 expression in p53-deficient cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1994 Jul 1 54(13) 3391-5",
                "id": "8012956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Reprimo, in which induction in cells exposed to X-irradiation is dependent on p53 expression, has been isolated. Ectopic p53 expression results in the induction of its mRNA. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 28 275(30) 22627-30",
                "id": "10930422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Specifically, we showed that DEC1 is induced by the p53 family and DNA damage in a p53-dependent manner. We also found that the p53 family proteins bind to, and activate, the promoter of the DEC1 gene",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Feb 1 283(5) 2896-905",
                "id": "18025081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2004 Sep 30 431(7008) 525-6",
                "id": "15457249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe05a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cell biology and toxicology 2005 Mar;21(2):115-25",
                "id": "16142585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe059f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Recent studies revealed that phosphorylation of p53 on Ser(46) was associated with induction of p53AIP1 expression, resulting in the commitment of the cell fate into apoptotic cell death.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 3 281(9) 5734-40",
                "id": "16377624"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe059e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Wild-type p53, but not mutant p53, strongly stimulated sgk promoter activity in both mammary epithelial cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 May 24 271(21) 12414-22",
                "id": "8647846"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe059d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Fractalkine mediated the MEK-1 and G alpha i-dependent but phosphatidylinositol-3-kinase-independent activation of extracellular signal-regulated kinase-MAPK. Fractalkine activated NF-kappa B and p53 resulting in interleukin 8 and fractalkine mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2002 Jan 122(1) 166-77",
                "id": "11781291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe059c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "CBP and P/CAF enhanced the ability of p53 to activate expression of the endogenous p21(cip1/waf1) gene,",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1997 Sep 1 57(17) 3693-6",
                "id": "9288775"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe059b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Using cDNA microarray technology, we found that cyclin K mRNA was dramatically increased in U373MG, a glioblastoma cell line deficient in wild-type p53, in the presence of exogenous p53.",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 4(3) 268-74",
                "id": "11988847"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe059a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "glioblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 could down-regulate PTPA promoter activity in a dose-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 7 275(27) 20488-95",
                "id": "10787423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0599"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "together to form a ternary complex. We show that, when overexpressed, L23 inhibits HDM2-induced p53 polyubiquitination and degradation and causes a p53-dependent cell cycle arrest.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Sep 24(17) 7669-80",
                "id": "15314174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0598"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Rather, the metabolite BPDE  elevated p53, which in turn inhibited BRCA-1 promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jan 1 62(1) 113-21",
                "id": "11782367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0597"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Mutation of p53 Ser(58) (equivalent to human p53 Ser(46)) abrogates transcription of these genes",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Jan 1 69(1) 219-26",
                "id": "19118006"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0596"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Gynecologic oncology 2005 Oct;99(1):58-64",
                "id": "16043214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0595"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "TAF(II)31-mediated p53 stabilization results in activation of p53-mediated transcriptional activity and leads to p53-dependent growth arrest in fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13852-7",
                "id": "11278372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0594"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "PIG7/LITAF transcription is induced by p53",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2004 Aug 20 111(2) 218-23",
                "id": "15197774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0593"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Interestingly, alpha-synuclein also diminishes both p53 expression and transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 27 277(52) 50980-4",
                "id": "12397073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0592"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Oct 21(20) 6768-81",
                "id": "11564862"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0591"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "(Title: Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.) Ablating p53 expression in Notch3 knockdown (KD) cells largely abolished their enhanced doxorubicin sensitivity; and Notch3 KD in p53(-/-) Hep3B cells failed to influence their response to doxorubicin. ",
              "citation": {
                "type": "PubMed",
                "name": "J Hepatol 2009 May 50(5) 969-79",
                "id": "19304334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0590"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of liver",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here, we have identified EphA2 as a target gene of the p53 family, that is, p53, p73, and p63.  We found that EphA2 expression resulted in an increase in apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6503-15",
                "id": "11641774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe058f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Beta-interferon switched on p53 in two steps. First, it induced the acetylation of p53 at lysine 320 and its dephosphorylation at serine 392 but not p53 activity. Later on, it triggered a DNA signaling pathway, the phosphorylation of p53 at serine 15 and its transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2006 Apr 17(4) 1583-92",
                "id": "16436515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe058e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In other models of oxidant stress, JNK-mediated phosphorylation of Ser-15 has been associated with the stabilization and enhanced transcriptional activity of p53. We treated primary rat alveolar type II cells with SP600125 as described above and measured the phosphorylation of p53 at Ser-15 4 h later (Fig. 7F). Treatment with SP600125 prevented the PM2.5-induced phosphorylation of p53 at Ser-15.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 23 284(4) 2176-86",
                "id": "19033436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe058d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table 2. Genes whose expression was down-regulated upon endogenous p53 inactivation",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jun 1 65(11) 4530-43",
                "id": "15930270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe058c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In the present study, we have demonstrated that DR4 is a p53 target gene and is regulated by p53 through a functional intronic p53 binding site (p53BS) ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Aug 1 64(15) 5078-83",
                "id": "15289308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe058b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The expression of BMP-2, BMP-4 and BMP-7 were modulated in a p53 dependent fashion. ",
              "citation": {
                "type": "PubMed",
                "name": "J Orthop Res 2005 Nov 23(6) 1345-53",
                "id": "15994055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe058a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Wild-type p53 protein has been shown to induce TSP-1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Virchows Arch 2003 Jun 442(6) 563-8",
                "id": "12719977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0589"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Tumor suppressor p53 is a  regulator of bcl-2 and bax gene expression in vitro and in vivo .",
              "citation": {
                "type": "PubMed",
                "name": "Cancer research 2003 May 1;63(9):2228-33",
                "id": "12727844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0588"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Wt p53 but not p21(WAF-1) induced dramatic apoptosis in these prostate cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 May 2 21(19) 3082-8",
                "id": "12082540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0587"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Exp Biol Med (Maywood) 2001 Jul 226(7) 692-700",
                "id": "11444106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0586"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "DNA damage elicited by gamma-irradiation induces WAF1/CIP1 in normal human and mouse fibroblasts but does not affect WAF1/CIP1 expression in p53-deficient cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1994 Jul 1 54(13) 3391-5",
                "id": "8012956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0585"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Forced expression of MKP5, a JNK phosphatase, in JNK kinase-expressing cells decreased T81 phosphorylation while reducing p53 transcriptional activity and p53-mediated apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(8) 2743-54",
                "id": "11283254"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0584"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The STAG1 gene was one of the transcripts showing higher expression levels in cells infected with Ad-p53-121F as opposed to Ad-wtp53",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Oct 7 23(46) 7621-7",
                "id": "15361841"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0583"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "As shown in Figure 3A, exposure to CSE induced activation of ATM, p53, and pRb, a marked increase in p53 and p21, and a mild increase in p16 accumulation.  ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Dec 35(6) 681-8",
                "id": "16840774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0582"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53-dependent up-regulation of manganese superoxide dismutase (MnSOD) and glutathione peroxidase 1 (GPx)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Apr 1 64(7) 2350-6",
                "id": "15059885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0581"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 is a strong suppressor of caveolin-1 transcription",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jun 19 22(25) 3888-900",
                "id": "12813462"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0580"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Adenocarcinoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "we show that the cytosolic accumulation of beta catenin is disrupted by ectopic overexpression of Dkk-3 in OS cells. Dkk-3 and dominant-negative LRP5 appear to down-regulate beta catenin nuclear translocation in OS cells, suggesting that these molecules can exert Wnt- modulating activities Dkk-3 can induce a redistribution of beta catenin to the cell membrane. Dkk-1 has been identified recently as a direct target of p53 in response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Apr 15 64(8) 2734-9",
                "id": "15087387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe057f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The tumor necrosis factor stimulated gene 6, TSG-6, seems to be under the control of p53 and is only and specifically induced upon PALA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2000 Dec 21(12) 2203-10",
                "id": "11133809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe057e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 1999 Nov 1 19(21) 9654-62",
                "id": "10531467"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe057d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "SOM caused up-regulation of p53, Bcl-2, Fas and caspase-8 activities, and down-regulation of iNOS expression and NO production",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2001 Sep 15 101(1-3) 43-9",
                "id": "11495678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe057c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Ad5CMV-p53 treatment resulted in substantial growth inhibition, induction of apoptosis and up-regulation of Fas receptor as well as Fas ligand mRNA expression in LNCaP, DU145 and PC3 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Prostate 2000 Dec 1 45(4) 341-9",
                "id": "11102960"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe057b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Co-exposure to C75 and Taxol induced a remarkable nuclear accumulation of activated p38 mitogen-activated protein kinase (p38 MAPK), which was accompanied by a synergistic nuclear accumulation of the p53 tumor-suppressor protein that was phosphorylated at Ser46, a p38 MAPK-regulated pro-apoptotic modification of p53",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 May 20 115(1) 19-35",
                "id": "15657900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe057a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We define CD200 as a p53-target gene and identify both p53- and caspase-dependent pathways that control CD200 expression during apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Apr 1 103(7) 2691-8",
                "id": "14644999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0579"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "after the induction of p53 transcriptional activity by cell treatment with Dox.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Jul 16(7) 1577-89",
                "id": "12089352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0578"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Nuclear competition for limiting amounts of CBP provides a novel mechanism for altering the balance between the expression of NF-kappaB-dependent proliferation or survival genes and p53-dependent genes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jan 22 274(4) 1879-82",
                "id": "9890939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0577"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We report here that p53 and Zac induce expression of the PAC1-R gene",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 1999 Jun 8 69(2) 290-4",
                "id": "10366751"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0576"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "These two BH3-only proteins interact with BCL2 survival proteins to induce mitochondriadependent cell death. In addition, p53 also induces the expression of other components of the apoptotic or deathreceptor signaling such as apoptotic peptidase activating factor 1 (APAF1), caspase 6 or FAS.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2007 Jan 13(1) 4-11",
                "id": "17118707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0575"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2003 Aug 5;42(30):9022-7",
                "id": "12885235"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0574"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "repressed by TP53",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Apr 15 14(8) 981-93",
                "id": "10783169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0573"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We show here that E2F-1 elevates ATM promoter activity and induces an increase in ATM mRNA and protein levels. This is accompanied by an E2F-induced increase in p53 phosphorylation ... ATM activates the tumor suppressor p53",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jan 16 22(2) 161-7",
                "id": "12527885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0572"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "this site confers p53-dependent transcriptional activity to the p22/PRG1 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 May 14 16(19) 2479-87",
                "id": "9627114"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0571"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.",
              "citation": {
                "type": "PubMed",
                "name": "J Hepatol 2011 Jan 54(1) 164-72",
                "id": "20961644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0570"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Thus, inactivation of p53 by E6 or short-hairpin RNA (shRNA) resulted in reduced Notch1 expression at the transcription level, and a p53-responsive element could be identified in the Notch1 promoter. The expression of E6, p53 shRNA, or Notch1 shRNA suppressed both spontaneous keratinocyte differentiation in culture and its induction upon DNA damage. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 May 27(10) 3732-42",
                "id": "17353266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe056f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "K9/vIRF-1 and K10.5/K10.6/vIRF-3. In addition to the latently expressed vIRFs discussed above, KSHV encodes two other homologs of these proteins (Fig. 1). vIRF-1, encoded by K9, transforms cells in culture, is tumorigenic in nude mice, and inhibits apoptosis induced by Sendai virus infection, IFN-{alpha}, IFN-, TNF-{alpha}, TCR/CD3 cross-linking, and p53",
              "citation": {
                "type": "PubMed",
                "name": "Microbiol Mol Biol Rev 2003 Jun 67(2) 175-212, table of contents",
                "id": "12794189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe056e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 overexpression significantly and reproducibly activated the Type II hexokinase promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Sep 5 272(36) 22776-80",
                "id": "9278438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe056d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We identified IFI16 as a BRCA1-associated protein involved in p53-mediated apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Dec 4 22(55) 8931-8",
                "id": "14654789"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe056c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "FIGURE 1.  Nutlin-3a activates p53 signaling and induces senescence phenotype in apoptosis-resistant H460 cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2009 Sep 7(9) 1497-509",
                "id": "19737973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe056b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "One of these is the p53-inducible protein DRAL/FHL2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 37045-53",
                "id": "12145280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe056a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "c-met gene is also a target of p53 gene regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Feb 5 274(6) 3565-72",
                "id": "9920903"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0569"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "shutdown of BCCIP expression by RNA interference reduces p21 levels and...the regulation of p21 expression by BCCIP is dependent on p53, and BCCIP regulates p53 transcription activity. p53 is a critical transcriptional activator for p21 expression",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 Nov 3(11) 1457-62",
                "id": "15539944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0568"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We show that ets-1 and p53 associate physically in vitro and in vivo and that their interaction, rather than a direct binding of p53 to the TXSA promoter, is required for transcriptional repression of TXSA by wild-type p53.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Oct 30 22(49) 7716-27",
                "id": "14586398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0567"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we report that the enhanced sensitivity of HCT116/p21(-/-) cells to chemotherapeutic drug-induced apoptosis correlates with an increased expression of p53 and a modification of their Bax/Bcl-2 ratio in favor of the pro-apoptotic protein Bax.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 37949-54",
                "id": "12151395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0566"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Gadd45, but not MyD118, was induced by activating wild type (wt) p53 function",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1996 Jun 20 12(12) 2579-94",
                "id": "8700517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0565"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Mdm2 and mdmx prevent ASPP1 and ASPP2 from stimulating the apoptotic function of p53 by binding and inhibiting the transcriptional activity of p53. Importantly, mdm2 and mdmx can prevent the stimulatory effects of ASPP1 and ASPP2 without targeting p53 for degradation",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 May 26 24(23) 3836-41",
                "id": "15782125"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0564"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "L23 interacted with MDM2, forming a complex independent of the 80S ribosome and polysome. The interaction of L23 with MDM2 was enhanced by treatment with actinomycin D but not by gamma-irradiation, leading to p53 activation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Sep 24(17) 7654-68",
                "id": "15314173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0563"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Upregulated in p53-",
              "citation": {
                "type": "PubMed",
                "name": "Development 2006 Jan 133(2) 363-9",
                "id": "16368933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0562"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neural Stem Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "iASPP is an evolutionarily conserved inhibitor of p53; inhibition of iASPP by RNA-mediated interference or antisense RNA in C. elegans or human cells, respectively, induces p53-dependent apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2003 Feb 33(2) 162-7",
                "id": "12524540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0561"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Mutation of p53 Ser(58) (equivalent to human p53 Ser(46)) abrogates transcription of these genes",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Jan 1 69(1) 219-26",
                "id": "19118006"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0560"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Irradiation of wild-type mice, but not p53-/- mice, led to markedly increased levels of miRNA34b in the spleen (Figure 2B).",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2007 Aug 7 17(15) 1298-307",
                "id": "17656095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe055f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "TGF-B has also been shown to regulate the function of p53, with decreased TGF-B signaling resulting in decreased radiation-induced activation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Mar 20 23(9) 2078-93",
                "id": "15774796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe055e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "It has been reported that maspin is expressed in normal human mammary epithelial cells but is downregulated during cancer progression, and that p53 could induce maspin expression by transcriptional activation.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2002 Aug 1 100(4) 452-5",
                "id": "12115529"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe055d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Proline oxidase (POX), localized on inner mitochondrial membranes, is encoded by a p53-induced gene and metabolically participates in p53-induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Aug 26(8) 1335-42",
                "id": "15817612"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe055c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "from full text - The activation of p53 by nutlin-3a was confirmed by immunoblot analysis that showed stabilization of p53, increased p53 phosphorylation at Ser18, and increased levels of the p53 downstream targets MDM2 and p21 ( Fig. 1D).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Aug 1 67(15) 7350-7",
                "id": "17671205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe055b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "we analyzed p53 promoter activity by reporter assay system. Contrary to enhanced binding activity, the transcriptional activity was attenuated in a TNFalpha concentration-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2002 Sep 10(3) 269-75",
                "id": "12165799"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe055a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We also demonstrated that PC4 can stimulate p53- and p53Delta30-mediated transactivation from a p53-responsive promoter. Furthermore, PC4 enhances p53- and p53Delta30-dependent apoptosis by inducing bax (a p53-targeted proapoptotic gene) gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Mar 24(5) 2052-62",
                "id": "14966284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0559"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From full text:  Expression of Fbxw7 was shown to be up-regulated by p53, and a potential p53 binding site is present in exon 1b of human FBXW7 [18]. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Nov 10 350(1) 114-9",
                "id": "16989775"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0558"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53-mediated activation of the Bax promoter",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2002 Nov 15 30(22) 4872-80",
                "id": "12433990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0557"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "\\\"Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 29 23(20) 3580-8",
                "id": "15116093"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0556"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We have identified a p53-inducible gene named TIGAR (TP53-induced glycolysis and apoptosis regulator). TIGAR expression lowered fructose-2,6-bisphosphate levels in cells, resulting in an inhibition of glycolysis and an overall decrease in intracellular reactive oxygen species (ROS) levels.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2006 Jul 14 126(1) 107-20",
                "id": "16839880"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0555"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Furthermore, by coimmunoprecipitaton and cotransfection assays, we found that PTEN physically binds p53 in vitro as well as in vivo. Binding of PTEN to p53 attenuated MDM2-mediated p53 inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Oct 1 63(19) 6357-62",
                "id": "14559824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0554"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "acute lymphoblastic leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": " In this report, we show that Dnmt3a interacts with p53 directly and represses p53-mediated transactivation of the p21 gene ... from full text, MEFs",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2005 Oct 4(10) 1138-43",
                "id": "16131836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0553"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The role of p53 in controlling the G2 checkpoint, in part by repressing cyclin B1 transcription, has been well established.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 2002 Oct 31 508(1-2) 49-58",
                "id": "12379461"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0552"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In this context, SIRT1-deficient cells fail to normally upregulate either the p19(ARF) senescence regulator or its downstream target p53.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Metab 2005 Jul 2(1) 67-76",
                "id": "16054100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0551"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Glut-1-mediated MMP-2 expression involved the binding of the transcription factor p53 but not Ets-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Natl Cancer Inst 2002 Jul 17 94(14) 1080-91",
                "id": "12122099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0550"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "miRNAs exhibiting a 3-fold or greater change in expression upon drug treatment in the p53WT cells and less than a 2-fold change in expression in the p53/ cells were chosen for further study. Seven upregulated miRNAs satisfied these criteria and showed the expected expression pattern by northern blotting with adriamycin-induced accumulation specifically in p53WT cells (miR-23a, miR-26a, miR-34a, miR-30c, miR-103, miR-107, and miR-182;",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2007 Jun 8 26(5) 745-52",
                "id": "17540599"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe054f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Lisanti  and colleagues (Razani et al. , 2000 ) have demonstrated that caveolin-1 gene  transcription is induced by p53.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Jul 13(7) 2502-17",
                "id": "12134086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe054e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p73 belongs to a family of transcription factors, including p53 and p63, that mediate response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2007 Jan 1095 315-24",
                "id": "17404044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe054d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The suppression of STK15 oncogenic activity by p53 might be explained in part by the finding that p53 inhibited STK15 kinase activity via direct interaction with the latter's Aurora box.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Sep 2 21(17) 4491-9",
                "id": "12198151"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe054c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In the present study, we demonstrated that COX-2 inhibits genotoxic stress-induced apoptosis by using an adenoviral COX-2 overexpression system. In addition, we found that COX-2 regulates the transcription function of p53 as evidenced by suppression of p53 target gene induction by COX-2 cotransfection. Furthermore, COX-2 interacted with p53 in vitro and in vivo, which was inhibited by the treatment with NS-398.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Mar 25 328(4) 1107-12",
                "id": "15707991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe054b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Treatment with the RR inhibitor hydroxyurea has been shown to cause a p53-dependent G0/G1 arrest (31). Similarly, knockdown of TFRC1 may render RR inactive by depriving cells of adequate intracellular iron, thus depleting deoxyribonucleotide pools and activating p53.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Mar 26(6) 2373-86",
                "id": "16508012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe054a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Follow-up studies on one gene, RAI3, suggested that p53 interacts with the promoter of RAI3 and repressed its expression at the onset of apoptosis. The expression of RAI3 is elevated in most tumor cell lines expressing mutant p53, whereas RAI3 mRNA is relatively repressed in the tumor cell lines expressing wild-type p53",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 1 280(13) 12935-43",
                "id": "15659406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0549"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 induce p21 which alleviates block of p300 by Cdk2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13505-8",
                "id": "11279224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0548"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "FHL2 increased the p53-dependent transcriptional activation",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jan 27 339(4) 1056-62",
                "id": "16343438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0547"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We show that Slug is transcriptionally induced by p53 upon irradiation and then protects the damaged cell from apoptosis by directly repressing p53-mediated transcription of puma, a key BH3-only antagonist of the antiapoptotic Bcl-2 proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Nov 18 123(4) 641-53",
                "id": "16286009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0546"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "As a result of alpha4 deletion, multiple proapoptotic genes were transcribed.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Oct 22 306(5696) 695-8",
                "id": "15499020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0545"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "we present evidence that ASC can function as an adaptor molecule for Bax and regulate a p53-Bax mitochondrial pathway of apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2004 Feb 6(2) 121-8",
                "id": "14730312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0544"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we demonstrate that ICAM-1 induction represents a new cellular response to p53 activation",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Apr 1 22(7) 1567-78",
                "id": "12660163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0543"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "delta Np63 alpha and p53 can bind the p21 and 14-3-3 sigma promoters in vitro and in vivo, with decreased binding of p63 to these promoters during HEK differentiation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Apr 23(7) 2264-76",
                "id": "12640112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0542"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "E1B 19K expression permitted efficient transcriptional activation of the p21/WAF-1/cip-1 mRNA by p53, consistent with maintenance of the growth arrest function of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Feb 15(2) 1060-70",
                "id": "7823921"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0541"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We and others have recently identified hAda3 (human homologue of yeast alteration/deficiency in activation 3) as a p53-interacting protein and enhancer of p53 activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Mar 23 282(12) 8812-20",
                "id": "17272277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0540"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Zhonghua Xue Ye Xue Za Zhi 2003 Dec 24(12) 640-3",
                "id": "14761612"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe053f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Compound mutant cells also show increased levels of p53 and induction of Noxa, a death effector p53 target gene, suggesting that cell death is potentially mediated by reactive oxygen species activation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 28 278(48) 48021-9",
                "id": "12968018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe053e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53-dependent induction of p21Cip1/Waf1 RNA expression, in response to DNA damage, was not altered by RASSF1A (Fig. 3C).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Mar 1 69(5) 1748-57",
                "id": "19223555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe053d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "- Ariadne: Moreover, these data support the fact that the endogenous expression of UNC5B, provoked by p53, is sufficient to inhibit in vitro cell transformation. [Regulation] - Ariadne: We took advantage of the recent observation that p53 transactivates the UNC5B gene ( 20 ). [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Apr 1 100(7) 4173-8",
                "id": "12655055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe053c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "exogenous BAFF and APRIL up-regulate c-Myc, an inducer of cell proliferation; down-regulate p53, an inhibitor of cell proliferation; and increase Bcl-6, an inhibitor of B cell differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Mar 1 172(5) 3268-79",
                "id": "14978135"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe053b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 strongly activated the rat CKM promoter",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Dec 14(12) 8483-92",
                "id": "7969181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe053a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "implicating recruitment of HDAC by PML-RAR as the mechanism underlying p53 inhibition",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Mar 10 23(5) 1144-54",
                "id": "14976551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0539"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "That hypothesis is consistent with the presence of a functional p53-response element within the promoter region of the mouse SIP gene and confirmed by the induction of SIP mRNA expression in mouse embryo fibroblasts upon activation of a p53-dependent pathway by transfection with rasV12 or rasV12/E1A",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Cell Biol 2002 May 81(5) 294-301",
                "id": "12067065"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0538"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "expression of ID2, a common target of BMP7 and p53 (41-44), was weakly inhibited by stable p53 knockdown, its expression was abrogated by lack of both BMP7 and p53.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Oct 1 67(19) 9117-24",
                "id": "17909016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0537"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Overexpression of p53 into SAOS-2 cells significantly decreased the pAPCP promoter activity. p53 binds to the pAPCP promoter at the P1+2 sites whose binding affinity is similar to the p21P promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 25 276(21) 18193-9",
                "id": "11279192"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0536"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we find that suppression of TRX1 expression via shRNA rapidly induces premature senescence in young human skin fibroblasts through upregulation of the p53/p21(Cip1/Waf1) and p16(INK4a) tumor suppressor pathways",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Feb 12 392(3) 363-8",
                "id": "20074557"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0535"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Rather, p53 expression stimulates the serine/threonine kinase ribosomal S6 kinase 1 (RSK1),",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 18 279(25) 26115-25",
                "id": "15073170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0534"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "null mutations for Brca2 result in early mouse embryonic lethality and impaired HR (Ludwig et al, 1997; Suzuki et al, 1997; Moynahan et al, 2001). Furthermore, loss of Brca2 in murine cells resulted in increased genomic instability and activation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0533"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Ferritin increases the transcriptional activity of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Nov 20 389(3) 399-404",
                "id": "19716362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0532"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Using colon carcinoma cells that express a temperature-sensitive variant of p53 and undergo p53-dependent apoptosis after UV irradiation, we found that the number of p53-induced genes Table 3. The size of genes induced at the permissive temperature",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Apr 27 101(17) 6582-6",
                "id": "15087501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0531"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "BMC biotechnology 2003 Jul 23;3:11",
                "id": "12877750"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0530"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The suppressed genes include mainly cell cycle regulators like cyclin B1, cyclin H and kinases like c-abl, CLK1 and others.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2000 Mar 17 470(1) 77-82",
                "id": "10722849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe052f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The Dkk-1 promoter contains a p53-responsive element and the expression of Dkk-1 is induced by p53 (Wang et al., 2000 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2003 Jul 1 116(Pt 13) 2627-34",
                "id": "12775774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe052e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In addition, treatment of cells with the PKC activator phorbol ester stimulated the ubiquitination of p53 and reduced its ability to accumulate after stress. H7 did not induce the phosphorylation of human p53 on Ser-15 (Ser-18 in mouse protein), a modification that occurs in response to DNA damage and leads to the release of MDM2 and to transactivation by p53",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 24 276(34) 31819-24",
                "id": "11431470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe052d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We have previously shown that after DNA-damage, the p52 NF-kB subunit can function cooperatively with the p53 tumor suppressor to both repress and induce Skp2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2010 Dec 15 9(24) 4795-804",
                "id": "21131783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe052c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "However, some drug effects seem of questionable selectivity (nonspecific depression of contractility in the fresh aorta, Fig. 2 ; a certain stimulatory effect of MG-132 that seemed to counteract the expected inhibitions of cytokine-induced increase of B1R mRNA, Fig. 3 B ; the theoretical accumulation of p53 when proteasome is blocked, a situation that may be significant as p53 inhibits B1R gene promoter activity, Ref. 49 ).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2002 Jul 283(1) H227-37",
                "id": "12063295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe052b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "These results suggest that the lowered viability in MEFPERK-/- and MEFGCN2-/- cells was due to the upregulated apoptosis, which was mediated by p53 signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 2010 Jan 12(1) 61-8",
                "id": "20072654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe052a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Inhibition of CABC1 expression by transfection with antisense oligonucleotide significantly reduced the apoptotic response induced by wild-type p53",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Mar 1 62(5) 1246-50",
                "id": "11888884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0529"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In conclusion, MDM-2 overexpression can block UV-induced cell cycle arrest and apoptosis by inhibiting P53 transcriptional activity. Furthermore, increased expression of MDM-2 in OsACL cells following UV irradiation appears to be related to P53-independent mechanisms",
              "citation": {
                "type": "PubMed",
                "name": "Tumour Biol 24(3) 130-9",
                "id": "14610316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0528"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "osteosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Substitution of Thr-55 with an alanine residue (T55A) stabilizes p53 and impairs the ability of TAF1 to induce G1 progression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2004 Mar 26 13(6) 867-78",
                "id": "15053879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0527"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Expression of PRG3 was induced by the activation of endogenous p53 and it contains a p53-responsive element.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 Jul 31 524(1-3) 163-71",
                "id": "12135761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0526"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "cell cycle arrest by AMPK involves accumulation of the tumour suppressor protein p53 by phosphorylation of its Ser-15 residue (Ser-18 in mice), and the accumulated p53 protein upregulates one of the CDKIs, p21CIP protein by a transcriptional mechanism",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2006 Jul 1 574(Pt 1) 63-71",
                "id": "16613876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0525"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Thr18 residue phosphorylation, in the transactivation domain of p53, has been implicated in both disruption of p53-Mdm2 interaction and p300 coactivator recruitment, which acetylates the p53 carboxy terminus. This leads to a decrease in p53 degradation and its subsequent stabilization and to an increase in p53-dependent transactivation activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(23) 10366-80",
                "id": "15542844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0524"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Gynecol Oncol 1999 Jul 74(1) 53-60",
                "id": "10385551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0523"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The proapoptotic activity of BARD1 involves binding to and elevations of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Dec 8(6) 1255-66",
                "id": "11779501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0522"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "the central module is the interplay between p53 and the Mdm2 protein, which inactivates p53 and targets it for rapid proteolysis.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Nov 973 374-83",
                "id": "12485897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0521"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53-mediated regulation of mPTP might be suppressed by inhibition of GSK-3b activity. Activation of p53 by GSK-3b enhances its functional activity and translocation to the nucleus and mitochondria.52",
              "citation": {
                "type": "PubMed",
                "name": "Circ J 2009 Jul 73(7) 1184-92",
                "id": "19506320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0520"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Expression of TauT was decreased after activation of p53",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39266-73",
                "id": "12163498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe051f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "KChAP increases p53 levels and stimulates phosphorylation of p53 residue serine 15.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 17 277(20) 17852-62",
                "id": "11877452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe051e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "When the cells were pretreated with anti?miR-29, p53 activity was lower than in the control oligonucleotide?treated cells (Fig. 3c)...the increased level of p53 protein in response to etoposide treatment was suppressed (Supplementary Fig. 7b). ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Struct Mol Biol 2009 Jan 16(1) 23-9",
                "id": "19079265"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe051d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "One of the few p53- induced genes that inhibits autophagy is TIGAR, a fructose-2,6-bisphosphatase that stimulates the pentose phosphate shunt and helps to lower intracellular ROS (Bensaad et al., 2009).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2010 Oct 22 40(2) 280-93",
                "id": "20965422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe051c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Conversely, the p53 tumor suppressor protein represses the human topo II gene through the basal transcriptional machinery ( 40 ) or via an inverted CCAAT box at position -68 ( 41 ).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2001 Dec 1(2) 121-31",
                "id": "12467229"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe051b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22330-7",
                "id": "11950834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe051a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "CONCLUSION: Ectogenetic p53 promotes mRNA expression of Wnt signaling pathway inhibitor sFRP in Hep3B cells.",
              "citation": {
                "type": "PubMed",
                "name": "Di Yi Jun Yi Da Xue Xue Bao 2004 Apr 24(4) 453-5",
                "id": "15090324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0519"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "AMF1 binds to p53 and stimulates p53-dependent transcription. AMF1 also modulates the p53 transactivation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Sep 21(17) 5913-24",
                "id": "11486030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0518"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Transcriptional activity of p53, as measured via mdm2 promoter-driven luciferase, exhibited a substantial increase in DeltaMEKK1-expressing cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Sep 1 95(18) 10541-6",
                "id": "9724739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0517"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here, we identified FDXR as a target gene of the p53 family, that is, p53, p63, and p73. We found that FDXR can be induced by DNA damage in cells in a p53-dependent manner and by a mutated form of p53 that is competent in inducing apoptosis. In addition, we identified a p53 response element located within the FDXR promoter that is responsive to wild-type p53, p63alpha, p63gamma, p73alpha, and p73beta.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 17 21(47) 7195-204",
                "id": "12370809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0516"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 is required for the post-irradiation rise in KU70 levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 3 275(9) 6651-6",
                "id": "10692474"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0515"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "we uncovered a p53-binding site in its promoter, which indicated that WTH3 could be regulated by the p53 gene. The resulting data revealed that (1) the WTH3 promoter was upregulated by the p53 transgene in diverse host cells; (2) there was a correlation between WTH3 expression levels and p53 gene status in a cell line panel; (3) a WTH3 promoter region was directly targeted by the p53 protein in vitro and in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2007 May 21 96(10) 1579-86",
                "id": "17426708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0514"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Together with the mouse models discussed above, it can be concluded that permanent activation of p53, either by loss of Mdm2 regulation or by constitutive DNA instability, is deleterious, exhausts the renewal capacity of tissues, and results in premature aging ( Fig. 1, far left  )",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Aug 1 68(15) 6031-4",
                "id": "18676821"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0513"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 accumulation resulted in a gradual and dramatic loss of MGMT mRNA, protein, and enzyme activity, whose levels were undetectable by day 3 of induction. The loss of MGMT protein was, however, not due to its degradation because the ubiquitin-promoted in vitro degradation of MGMT, which mediates the cellular disposal of the repair protein, was not altered by p53.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2001 May 7(5) 1398-409",
                "id": "11350911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0512"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Jul 27(7) 1323-33",
                "id": "16531451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0511"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "JNK1 associates with p53 in vivo, with or without activation, confirming that JNK1 is indeed a p53 kinase. Interestingly, activated JNK2 and JNK3 also phosphorylate serine 34 of mouse p53. Furthermore, JNK2 and JNK3 also associate with p53 in vivo, indicating that not only JNK1, but also JNK2 and JNK3 are p53 N-terminal serine 34 kinases",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Nov 6 15(19) 2277-87",
                "id": "9393873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0510"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The expression of ASPP is frequently downregulated in human breast carcinomas expressing wild-type p53 but not mutant p53. Therefore, ASPP regulate the tumor suppression function of p53 in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Oct 8(4) 781-94",
                "id": "11684014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe050f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Increased protein tyrosine phosphatase activity as well as mRNA levels of PTPbeta2 and PTPepsilon could be observed by wildtype p53 overexpression.",
              "citation": {
                "type": "PubMed",
                "name": "Leukemia 2000 Jul 14(7) 1292-300",
                "id": "10914555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe050e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "CTCF induces expression of the gene encoding p19Arf, which sequesters the p53 inhibitor MDM2, resulting in activation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Jun 15 2004(237) pe25",
                "id": "15199223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe050d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "BRCA1 has been shown to act as a transcriptional coactivator and increase the p53- dependent transcription from P21 and BAX promoters (47). DNAdamaging agents trigger a transient induction of p53, and this gene has been strongly implicated in DNA damage repair",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Sep 15 60(18) 4993-5001",
                "id": "11016617"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe050c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Gynecologic oncology 1998 Jul;70(1):17-22",
                "id": "9698467"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe050b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "This activation of the p53 pathway leads to the elevation of p21 mRNA expression, which can be considered an indicator of p53 activity,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 20571-5",
                "id": "14985341"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe050a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "The Journal of biological chemistry 1999 Dec 3;274(49):34924-31",
                "id": "10574967"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0509"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "binding to IFI16 resulted in its transcriptional activation as shown by an increase in the activity of a reporter gene driven by p53-responsive sequences derived from the p21(WAF1) promoter, along with an increase in the p21 mRNA and protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2005 May 77(5) 820-9",
                "id": "15728246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0508"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Expression of SEI-1, SEI-2 or SEI-3 strongly stimulates p53-dependent gene activation in HeLa and U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2005 Aug 10(8) 851-60",
                "id": "16098148"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0507"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 May 1 64(9) 3022-9",
                "id": "15126337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0506"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "the silencing of astrin induce a p53-dependent apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 May 5 343(2) 428-34",
                "id": "16546135"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0505"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Treatment of p53 induces 3-4 fold upregulation of TRAIL-R2 and Fas mRNA but not upon induction of p53-R175H.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Feb 1 20(5) 571-80",
                "id": "11313989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0504"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Activation of the tumour suppressor protein p53 rapidly inhibits protein synthesis. This is associated with dephosphorylation and cleavage of initiation factor eIF4GI and the eIF4E-binding protein 4E-BP1.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2007 Mar 14(3) 576-85",
                "id": "16990847"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0503"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "brain-specific angiogenesis inhibitor 1, brain-specific endogenous angiogenesis inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Jun 3(6) 401-10",
                "id": "12778130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0502"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We identified REDD1 as a novel transcriptional target of p53 induced following DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Nov 10(5) 995-1005",
                "id": "12453409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0501"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "endogenous wild type (wt) p53 at a physiological level in MCF-7 breast carcinoma cells triggered a rapid downregulation of hTERT mRNA expression",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Oct 26 19(45) 5123-33",
                "id": "11064449"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0500"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We have shown above that the MCG10 gene is induced by p53 and DNA damage (Fig. 1 ).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Aug 20(15) 5602-18",
                "id": "10891498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53RFP appears to represent the second known example, the first being MDM2, of an E3 ubiquitin ligase as a p53 target.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jul 10 22(28) 4449-58",
                "id": "12853982"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Levels of Cox-2 protein and mRNA were markedly suppressed by wt p53 but not by mutant p53. Electrophoretic mobility shift assay revealed that p53 competed with TATA-binding protein for binding to mouse Cox-2 or human Cox-2 promoter extending from -50 to +52 base pairs. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Apr 16 274(16) 10911-5",
                "id": "10196169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In co-transfection studies wild-type, but not mutant, p53 down-regulated transcription of an ecNOS promoter-luciferase reporter gene construct.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 31 274(53) 37679-84",
                "id": "10608825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Mutations in the Drg1/RTP/Rit42 gene are commonly identified in hereditary neuropathies of the motor and sensory systems. This gene was also identified as a p53 target",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 10 279(37) 38597-602",
                "id": "15247272"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 May 1 273(18) 10972-8",
                "id": "9556576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Recently, Ang II was reported to induce the premature senescence of human VSMCs via the p53/p21-dependent pathway.74",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Sublethal exposure of IMR-90 hTERT cells to H2O2 resulted in a time dependent increase of ATF-2 and p53 DNA binding activity (Fig. 2). The presence of 20 ?M SB203580 prevented the increased DNA binding activity of ATF-2 and p53",
              "citation": {
                "type": "PubMed",
                "name": "Biogerontology 2009 Jun 10(3) 291-8",
                "id": "19082758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In search of the molecular link between ER stress and the mitochondrial apoptotic pathway, we have discovered that in MEFs, ER stress selectively activates BH3-only proteins PUMA and NOXA at the transcript level through the tumor suppressor gene p53. In p53(-/-) MEFs, ER stress-induced apoptosis is partially suppressed.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 17 281(11) 7260-70",
                "id": "16407291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Like I kappa B alpha, HSCO inhibited NF-kappa B activity and abrogated p53-induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2002 Oct 2(4) 335-46",
                "id": "12398897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We show here that p53 also suppresses the transcription of a presenilin-1 promoter-chloramphenicol acetyltransferase reporter synthetic gene in transient infection assays in neuroblastoma (SK-N-SH) and hepatoma (HepG2) cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 10 275(45) 34938-45",
                "id": "10942770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Depletion of endogenous KAP1 expression by RNAi stimulates p53 transcriptional activity, sensitizes p53 response to DNA damage, and increases apoptosis. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Sep 21 24(18) 3279-90",
                "id": "16107876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The results suggest that p53R2-dependent DNA synthesis plays a pivotal role in cell survival by repairing damaged DNA in the nucleus and that dysfunction of this pathway might result in activation of p53-dependent apoptosis to eliminate dangerous cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Nov 15 61(22) 8256-62",
                "id": "11719458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "With regard to Maspin, ATF-2 and p53 directly bind to different sites in the Maspin promoter to independently activate its transcription. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Feb 14 27(8) 1045-54",
                "id": "17700520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Thus, the activation of p53 might constitute a negative feedback loop against excess fat accumulation in adipocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 25395-400",
                "id": "12734185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table 3. Alteration of Gene Expression Specially Associated with p53 and H-ras Status in Skin Tumorigenesis upregulated",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2005 Oct 3(10) 563-74",
                "id": "16254190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04f0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we have shown that L5 also activates p53. Consequently, L5 enhanced p53 transcriptional activity and induced p53-dependent G1 cell cycle arrest.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 44475-82",
                "id": "15308643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The intrinsic transcriptional activity of p53 was up-regulated by a transient transfection of PRPK to COS-7 cells. PRPK was shown to bind to p53 and to phosphorylate p53 at Ser-15.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 23 276(47) 44003-11",
                "id": "11546806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Biochemical and biophysical research communications 2005 May 27;331(1):295-302",
                "id": "15845392"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The tumor suppressor p53 down-regulates expression of cdc25C as part of G2/M checkpoint control.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2002 May 1 30(9) 1967-76",
                "id": "11972334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Investigation of the human genomic PTEN locus revealed a p53 binding element directly upstream of the PTEN gene. Deletion and mutation analyses showed that this element is necessary for inducible transactivation of PTEN by p53. induction of p53 in primary and tumor cell lines with wild-type p53 increased PTEN mRNA levels.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Aug 8(2) 317-25",
                "id": "11545734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04eb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In p53-competent cells, Ckap2 does not induce tetraploidy but activates p53-mediated cell cycle arrest and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Aug 1 65(15) 6685-91",
                "id": "16061649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We demonstrate that Skp2 forms a complex with p300 through the CH1 and the CH3 domains of p300 to which p53 is thought to bind and antagonizes the interaction between p300 and p53 in cells and in vitro. As Skp2 antagonizes the interaction between p300 and p53, Skp2 suppresses p300-mediated acetylation of p53 and the transactivation ability of p53. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2008 Feb 1 29(2) 217-31",
                "id": "18243116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In the present study, we demonstrate that PP-1 can dephosphorylate p53 at Ser-15 and Ser-37 through co-immunoprecipitation, in vitro and in vivo dephosphorylation assays, overexpression and silence of the gene encoding the catalytic subunit for PP-1. We further show that mutations mimicking constitutive dephosphorylation or phosphorylation of p53 at these sites attenuate or enhance its transcriptional activity, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 May 18 25(21) 3006-22",
                "id": "16501611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We demonstrate that the Bfl-1 protein suppresses apoptosis induced by the p53 tumor suppressor protein in a manner similar to other Bcl-2 family members such as Bcl-2, Bcl-xL and EBV-BHRF1",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1996 Sep 1 56(17) 3879-82",
                "id": "8752150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we show that p53 is phosphorylated by the mitotic kinase Aurora-A at serine 215. Unlike most identified phosphorylation sites of p53 that positively associate with p53 function (Brooks, C. L., and Gu, W. (2003) Curr. Opin. Cell Biol. 15, 164-171), the phosphorylation of p53 by Aurora-A at Ser-215 abrogates p53 DNA binding and transactivation activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 52175-82",
                "id": "15469940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "our results imply that cyclin G is transcriptionally activated by p53 or p73, and, in turn, cyclin G negatively regulates the stabilization of p53 family proteins",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Mar 20 22(11) 1678-87",
                "id": "12642871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Jul 23 17(3) 347-56",
                "id": "9690516"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The p53 can induce expression of many death effectors and may contribute to the induction of both death-receptor (FAS and DR5) and mitochondrial (APAF1 and BAX) apoptotic pathways [38-43].",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Agents Med Chem 2009 Sep 1",
                "id": "19663788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "5LO stabilizes p53 through phosphorylation at Ser15 and increases expression of the p53-transcriptional target p21. This is achieved by regulating ROS production. Indeed, ROS are increased in 5LO-arrested cells",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Jan 12 24(1) 170-9",
                "id": "15616590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Changes in expression affected not only known p53 target genes, but also several unexpected genes such as Expi (Wdnm1), Cyp1b1, Gelsolin, Ramp2 and class I MHC genes.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Sep 12 21(41) 6366-76",
                "id": "12214277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "mRTVP-1, a novel p53 target gene RTVP-1 mRNA was induced in multiple cancer cell lines by adenovirus-mediated delivery of p53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 May 22(10) 3345-57",
                "id": "11971968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "from full text - MdmX blocks p53 transactivation and degradation ...MdmX is capable of associating with p53 ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Feb 20(3) 1001-7",
                "id": "10629057"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Initially, the interaction of MIF with p53 was shown by Hudson et al. [60] in 1999. They demonstrated that MIF treatment was able to overcome p53 activity and inhibited its transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncology 2008 75(3-4) 127-33",
                "id": "18791328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04de"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Analysis of the human securin promoter reveals that DNA-binding sites for Sp1 and NF-Y are both required for activation of securin expression; however, only the NF-Y site is essential for the suppression by p53. Our study indicates that securin is a p53 target gene and may play a role in p53-mediated cellular response to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 3 278(1) 462-70",
                "id": "12403781"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 also modulates the levels of microRNAs (miRNAs). Specifically, p53 can induce expression of microRNA-34a (miR-34a) in cultured cells as well as in irradiated mice, by binding to a perfect p53 binding site located within the gene that gives rise to miR-34a. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2007 Jun 8 26(5) 731-43",
                "id": "17540598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "TP53INP1 mediates phosphorylation of p53 on serine 46 (S46). ASPP-1 and ASPP-2 modulate the cellular apoptotic threshold by direct interaction with p53, thereby enhancing the DNA binding and trans-activation function of p53 on the promoters of pro-apoptotic genes in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Analysis of these data also suggested that p53 activity is negatively regulated by AR activation even though p53 RNA was unchanged.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 9 279(2) 1310-22",
                "id": "14576152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04da"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "As shown in Figure 1B, TRAIL mRNA was upregulated by p53-induction as compared to the GFP expressing Ad.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2008 Dec 7(12) 2034-8",
                "id": "19106633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "that TUCAN/CARDINAL associates with DRAL, a p53-responsive gene implicated in induction of apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 Jun 19 521(1-3) 165-9",
                "id": "12067710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Using cDNA-microarray technology, we found that the expression of DUSP5 mRNA was dramatically increased by exogenous p53 in U373MG, a p53-mutant glioblastoma cell line.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Aug 28 22(36) 5586-91",
                "id": "12944906"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "glioblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1997 Dec 15 57(24) 5584-9",
                "id": "9407971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Upregulation of IGF-1 in myocytes was associated with a protein-to-protein interaction between Mdm2 and p53, which attenuated p53 transcriptional activity for bax, Aogen, and AT1 receptor. Similarly, the amount of Bax, Aogen, and AT1 receptor proteins in these cells decreased",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1999 Apr 16 84(7) 752-62",
                "id": "10205143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "expression of the DFNA5 gene was strongly induced by exogenous and endogenous p53",
              "citation": {
                "type": "PubMed",
                "name": "J Hum Genet 2006 51(8) 652-64",
                "id": "16897187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Most strikingly, upon cell cycle arrest resulting from genotoxic stress and p53 activation, TFII-I is ubiquitinated and targeted for proteasomal degradation in a p53- and ATM (ataxia telangiectasia mutated)-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Dec 25(24) 10940-52",
                "id": "16314517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 20 275(42) 32543-51",
                "id": "10931825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The life span of normal human VSMCs can be extended by inactivation of p53 or pRB alone, although inactivation of both p53 and pRB is more efficient and is required for full immortalisation [23,24].",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2006 Oct 1 72(1) 9-17",
                "id": "16824498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "HCCR-2 probably represents a new oncogene that is related to tumorigenesis, functioning as a negative regulator of the p53 tumor suppressor.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jul 24 22(30) 4679-89",
                "id": "12879013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04d0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The Mts1 binding to p53 interferes with the DNA binding activity of p53 in vitro and reporter gene transactivation in vivo, and this has a regulatory function.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 22 276(25) 22699-708",
                "id": "11278647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "PTEN enhances p53 transactivation, a relationship that requires the interaction between PTEN and p53 and is PTEN phosphatase independent.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Jan 15 66(2) 736-42",
                "id": "16424003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The p53 tumor suppressor is activated in the cellular response to stress.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 1(6) 703-8",
                "id": "12642697"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Several of these gene products, including FAS, TRAILR3, PHLDA3, LRDD, and IER3 are previously implicated in the apoptotic death receptor pathway, while others including SESN1, FDXR, PLK3, and DDIT4 are known mediators of reactive oxygen species generation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Sep 8 24(40) 6090-100",
                "id": "15940259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Dexamethasone, antioxidants, and tumor-suppressor protein p53 suppress COX-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Ann Clin Lab Sci 2000 Jan 30(1) 3-21",
                "id": "10678579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Overexpression of wild-type hHR23A inhibits the p53 transcriptional activity and results in a decreased steady-state protein level of cellular p53.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jan 1 61(1) 64-70",
                "id": "11196199"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 1999 Feb 19 84(1) 80-5",
                "id": "9988237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We report here that expression of endogenous sodium channel subunit beta 3 (SCN3B) is upregulated in mouse embryonic fibroblasts by DNA damage in a p53-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Oct 14 23(47) 7791-8",
                "id": "15334053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In the present study, we demonstrate that PP-1 can dephosphorylate p53 at Ser-15 and Ser-37 through co-immunoprecipitation, in vitro and in vivo dephosphorylation assays, overexpression and silence of the gene encoding the catalytic subunit for PP-1. We further show that mutations mimicking constitutive dephosphorylation or phosphorylation of p53 at these sites attenuate or enhance its transcriptional activity, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 May 18 25(21) 3006-22",
                "id": "16501611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p38MAPK inhibition markedly reduced the secretion of most SASP factors, constitutive p38MAPK activation was sufficient to induce an SASP, and p53 restrained p38MAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2011 Apr 20 30(8) 1536-48",
                "id": "21399611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Our previous work demonstrated that the overexpression of HOXA5 in MCF7 cells resulted in cell death through a p53-dependent apoptotic pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(2) 924-35",
                "id": "14701762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table 1. Alteration of Gene Expression Specially Associated with p53 Status in Skin Tumorigenesis #[JL] TP53 dominant negative",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2005 Oct 3(10) 563-74",
                "id": "16254190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Our study suggests that wt p53 functions as a transcriptional repressor of topo II alpha gene expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Jan 17(1) 389-97",
                "id": "8972219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we show that induction of p53 causes an activation of NF-kappaB that correlates with the ability of p53 to induce apoptosis. Inhibition or loss of NF-kappaB activity abrogated p53-induced apoptosis, indicating that NF-kappaB is essential in p53-mediated cell death",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Apr 20 404(6780) 892-7",
                "id": "10786798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "KAI1/CD82 has been shown to be a metastasis suppressor for several human cancers, and a recent study revealed that wild-type tumor suppressor p53 can directly activate KAI1/CD82 gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jan 15 61(2) 673-8",
                "id": "11212267"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "FIG. 1. IRF-1 stimulates p53 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Nov 24(22) 10083-98",
                "id": "15509808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Elevation of mTHTR-1 expression was found in DNA damage-induced normal mouse embryonic fibroblast cells, but not in p53(-/-) mouse embryonic fibroblast cells, suggesting that mTHTR-1 induction was p53-dependent.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 5 276(40) 37186-93",
                "id": "11481326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04bf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "up-regulated by p53 (CNKN1A, TGF, and EPHA2, middle panel), and down-regulated by p53 (PTTG1, RAD21, and CDKN3, lower panel)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 21183-92",
                "id": "15016801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 22 280(16) 16030-7",
                "id": "15703170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Two reports have implicated p53 in PRL transcriptional control but in opposing roles with respect to PRL-1 and PRL-3. Daoud et al. (28), using cDNA microarrays, found the presence of p53 correlated with decreased expression of PRL-1 when comparing wild-type p53 HCT 116 colorectal cancer cells and an isogenic p53 knockout counterpart.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2005 Nov 4(11) 1653-61",
                "id": "16275986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Consistently,  MAD1 promoter activity diminished in a dose-dependent manner when induced by  p53, indicating that p53 repressed MAD1 at a transcriptional level.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 26 278(39) 37439-50",
                "id": "12876282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table 1 Transcription factors activated by OxLDL",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "This increase was nearly completely inhibited in Wi38 cells stably expressing a short hairpin RNA (shRNA) targeting p53 [21].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2007 Aug 7 17(15) 1298-307",
                "id": "17656095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In addition to effects on metabolism, LKB1 has also been suggested to possess a variety of potentially tumor-suppressive functions such as inhibition of mammalian target of rapamycin, regulation of cell polarity, inhibition of the cell cycle, and activation of p53 (4).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 May 15 68(10) 3562-5",
                "id": "18483235"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Twist expression bypassed p53-induced growth arrest. These effects correlated with an ability of Twist to interfere with activation of a p53-dependent reporter and to impair induction of p53 target genes in response to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Sep 1 13(17) 2207-17",
                "id": "10485844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we demonstrate that homeodomain-interacting protein kinase-2 (HIPK2), a member of a novel family of nuclear serine/threonine kinases, binds to and activates p53 by directly phosphorylating it at Ser 46",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jan 4(1) 11-9",
                "id": "11780126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "CSPG2 is validated as being directly transactivated by p53",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Nov 26 99(24) 15632-7",
                "id": "12438652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "[PR]",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2000 Feb 24 268(3) 921-7",
                "id": "10679306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We further showed that the novel p53 target genes are transcriptionally regulated by p53. The binding of p53 to promoters of target genes correlated with increased transcript levels of these genes in cells with functional p53.  # novel TP53 genes are named in full text \\\"C12orf5, GPX1, PLK3, and PRKAB1 possess p53-responsive elements.\\\" ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Sep 1 65(17) 7666-73",
                "id": "16140933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Our data show a significant transcriptional activation of E2F-1 in primary rat hepatocytes incubated with TGF-beta1, as well as a 5-fold increase in p53 and a 2-fold decrease in its inhibitor, Mdm-2 (p < 0.05).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 48831-8",
                "id": "14514686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We also show that LRBA promoter activity and endogenous LRBA mRNA levels are reduced by p53 and increased by E2F1, indicating that mutations in the tumor suppressors p53 and Rb could contribute to the deregulation of LRBA",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 May 20 23(23) 4089-97",
                "id": "15064745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here, we report that Synoviolin targets tumor suppressor gene p53 for ubiquitination. Synoviolin sequestrated and metabolized p53 in the cytoplasm and negatively regulated its cellular level and biological functions, including transcription, cell cycle regulation and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2007 Jan 10 26(1) 113-22",
                "id": "17170702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Endogenous p53 is also phosphorylated in Thr18 by VRK2B, promoting its stabilization and transcriptional activation in A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "FEBS J 2006 Jun 273(11) 2487-504",
                "id": "16704422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Similar to overexpression of oncogenic H-ras in the normal human fibroblast, overexpression of IRF3 in human fibroblast BJ cells was shown to decrease cell growth and increase senescence-associated beta-galactosidase activity by activating a p53 tumor suppressor",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2006 Oct 28 242(2) 215-21",
                "id": "16513254"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In this study, we demonstrate that p53 directly inhibits expression of the T cell growth factor (IL-2) in activated T cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Dec 15 169(12) 6767-78",
                "id": "12471108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Overexpression of tumor protein p53-induced nuclear protein 1 (TP53INP1) induces G1 cell cycle arrest and increases p53-mediated apoptosis. TP53INP1-positive rate decreases with the progression of gastric cancer.",
              "citation": {
                "type": "PubMed",
                "name": "World J Gastroenterol 2006 Feb 7 12(5) 691-6",
                "id": "16521180"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 12 279(46) 47455-63",
                "id": "15345715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Upon DNA damage, the amino terminus of p53 is phosphorylated at a number of serine residues including S20, a site that is particularly important in regulating stability and function of the protein.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 289-300",
                "id": "10673501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table 3. Expression analysis of steady-state total mRNA transcripts in HCT-116 (wt-p53) and HCT-116 (null-p53) cells",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2006 Apr 1 12(7 Pt 1) 2014-24",
                "id": "16609010"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "E(2) inhibited resveratrol-induced, p53-directed transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2004 Jul 5 91(1) 178-85",
                "id": "15188005"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We then used these lines to define the genes whose expression was altered after DNA damage induced by ionizing radiation. Transcriptome analyses revealed a consistent up-regulation of polo-like kinase 1 (PLK1) as well as other genes controlling the G(2)/M transition in the cells whose TP53 genes were inactivated compared with those with WT TP53 genes. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2009 Mar 10 106(10) 3964-9",
                "id": "19225112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The p53 gene was frequently mutated or inactivated in all types of human lung cancer.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1989 Oct 27 246(4929) 491-4",
                "id": "2554494"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "wild-type (wt) p53 upregulated the expression of Nm23-H1 at protein and mRNA levels in MCF-7 ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2003 Apr 36(4) 204-14",
                "id": "12669312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Overexpression of p53 by transfection in U2OS and A549 cells increased Ipaf mRNA levels. The Ipaf promoter was activated by normal p53 but not by His(273) mutant of p53. A functional p53-binding site was identified in the Ipaf promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jan 20 24(4) 627-36",
                "id": "15580302"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Senescence is an irreversible form of G1 arrest that requires the p19ARF/p53 and p16INK4a/pRB pathways and may suppress tumorigenesis in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Sep 21 24(18) 3301-12",
                "id": "16107878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table 1 Transcription factors activated by OxLDL",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Jan 15 46(2) 127-37",
                "id": "18996472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The level of Bcl-xL protein increased approximately 2 fold after Ad-p53 infection in PC3 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2001 Jan 15 91(2) 159-66",
                "id": "11146439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We demonstrate that the Bfl-1 protein suppresses apoptosis induced by the p53 tumor suppressor protein in a manner similar to other Bcl-2 family members such as Bcl-2, Bcl-xL and EBV-BHRF1",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1996 Sep 1 56(17) 3879-82",
                "id": "8752150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe04a0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The inhibition of forkhead activity by SIRT1 parallels the effect of this deacetylase on the tumor suppressor p53.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Feb 20 116(4) 551-63",
                "id": "14980222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe049f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here, we show that the mechanism by which PML induces a permanent cell cycle exit and activates p53 and senescence involves a recruitment of E2F transcription factors bound to their promoters and the retinoblastoma (Rb) proteins to PML nuclear bodies enriched in heterochromatin proteins and protein phosphatase 1.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2011 Jan 1 25(1) 41-50",
                "id": "21205865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe049e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer research 2004 Nov 15;64(22):8381-8",
                "id": "15548708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe049d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Tumor suppressor p53 represses transcription of RECQ4 helicase",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Mar 3 24(10) 1738-48",
                "id": "15674334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe049c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "overexpression of TRF2 in p53 P/P MEFs resulted in upregulation of p21 (Fig 1D). In addition, reduction of BrdU incorporation, induction of p21 level and increased number of SA-beta-gal-positive senescent cells were also observed when oncogenic H-Ras was overexpressed in p53 P/P MEFs (Fig 1A?C). ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2007 May 8(5) 497-503",
                "id": "17396137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe049b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "embryonic tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "the present study indicates that survivin should accelerate tumorigenesis by inhibiting the anti-proliferative effect of p53 tumor suppressor that is activated by aurora B in normal and glioblastoma cells containing intact p53.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Nov 4 336(4) 1164-71",
                "id": "16171786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe049a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "VSMC proliferation and migration are also critical events in atherosclerosis and vascular-intervention-induced restenosis. TZDs inhibit both these changes in the VSMCs and neointimal thickening after vascular injury [3134]. Furthermore, TZDs induce apoptosis of VSMCs via p53 and Gadd45 [35, 36].",
              "citation": {
                "type": "PubMed",
                "name": "PPAR Res 2010 2010",
                "id": "20814542"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0499"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The tumor suppressor  protein p53 has been reported to induce TR2 expression in colon and lung cancer  cells (28 , 29) .",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Mar 1 63(5) 1122-9",
                "id": "12615731"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0498"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Together, our data demonstrate a role for Zac as a transcription factor in addition to its role as coactivator for nuclear receptors and p53",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Feb 23(3) 988-1003",
                "id": "12529403"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0497"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Table 6 P53 APOPTOSIS RESPONSIVE GENES THAT ENCODE DAVPI-LIKE PROTEINS",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2(4) 406-15",
                "id": "14508115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0496"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We also showed that the expression of KIAA0101 was regulated tightly by the p53-p21 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Mar 15 67(6) 2568-76",
                "id": "17363575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0495"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "AP2-alpha interacts directly with p53. AP2-alpha augments p53-mediated transactivation of p53 regulated genes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 45028-33",
                "id": "12226108"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0494"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Here we show that NPM interacts directly with the tumour suppressor p53, regulates the increase in stability and transcriptional activation of p53 after different types of stress, and induces p53-dependent premature senescence on overexpression in diploid fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jul 4(7) 529-33",
                "id": "12080348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0493"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Tetracycline-regulated IFI16 also induced apoptosis when coexpressed with p53 in p53-deficient EJ cells subjected to IR, suggesting that IFI16 is involved in p53-mediated transmission of apoptosis signaling.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 7 279(19) 20339-44",
                "id": "14990579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0492"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Further studies reveal that PML can selectively suppress AR transactivation and PML protein expression positively correlates with increased p21 protein level and enhances p53 transcription ability in CWR22R cells",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jan 30 314(1) 69-75",
                "id": "14715247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0491"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "ASPP2 and its RVXF-containing homolog ASPP1 also bind to p53 and thereby specifically stimulate the transactivation of proapoptotic genes by p53 (310), but addition of PP1 dissociated p53 from the COOH-terminal half of ASPP2 (163), leaving the function of the PP1-ASSP interaction unknown.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2004 Jan 84(1) 1-39",
                "id": "14715909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0490"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We present evidence that ellipticine can restore the transactivation function of several transfected p53 mutants (175 H, 248W, 249S, 273 H, 281G), resulting in the induction of p53-responsive genes (p21(WAF1),MDM2) and activation of a p53-responsive luciferase reporter. Ellipticine also activates mutant p53 function in tumor cells expressing endogenous 194F, 233L, 241F, and 273C mutants. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jul 17 22(29) 4478-87",
                "id": "12881704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe048f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Ectopic c- MYC expression leads to stabilization of the tumor suppressor gene product p53 and activation of p53's proapoptotic activity",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2003 Jun 3(3) 163-75",
                "id": "12769686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe048e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 27 277(52) 50980-4",
                "id": "12397073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe048d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Figure 2. p53 directly binds to its consensus-binding site found in the first intron of RPS27L gene",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Apr 26 26(19) 2707-16",
                "id": "17057733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe048c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 can exhibit transcriptional activity to induce p21waf-1/sdi-1 expression, which inhibits D-type cyclins to prevent cyclin-dependent kinase (CDK) from phosphorylating the retinoblastoma protein p110Rb to p112Rb.",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe048b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In diabetic WTM, p53 was increased in myocytes, and this activation of p53 was characterized by upregulation of Bax, angiotensinogen, Ang type 1 (AT(1)) receptors, and Ang II.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Jun 50(6) 1414-24",
                "id": "11375343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe048a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53-induced Noxa and Puma",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Oct 15 17(20) 2481-95",
                "id": "14561771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0489"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Furthermore, loss of TERT or bFGF markedly increases a p53 activity and DNA-damage sensitivity in HFFS, HeLa and U87MG cells.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2010 Aug 31 42(8) 574-82",
                "id": "20628269"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0488"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Rat lung tissues expression and phosphorylation of p53 was significantly increased after exposure of CS.",
              "citation": {
                "type": "PubMed",
                "name": "Chem Biol Interact 2005 Jun 30 155(1-2) 31-42",
                "id": "15970277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0487"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis.  Here, we report that p53 activates Bad transcription and expression through binding to a short conserved sequence located approximately 6.6 kb upstream of the translation start point.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Dec 26(23) 9071-82",
                "id": "17000778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0486"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Significantly, the PTTG1-induced senescence is p53-dependent and telomerase-independent, which is distinctively different from that of replicative senescence.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 May 7",
                "id": "20452981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0485"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We also found that both NAP1 and TAF1 could similarly induce p53 activity (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Dec 20(23) 8933-43",
                "id": "11073993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0484"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Transfection of MDA-MB-453 cells with p53 and cdc25c construct activated the transcription of the reporter construct containing the p53 response elements of the cdc25c gene as demonstrated by luciferase assay.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 19 274(47) 33747-56",
                "id": "10559267"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0483"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "expression of p21 was upregulated and expressions of cdc2, cyclin B2 and protein regulator of cytokinesis 1 (PRC1) were suppressed by overexpression of the wt p53",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res Treat 2003 Jul 80(1) 23-37",
                "id": "12889596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0482"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "H(2)O(2) increased mesangial cell apoptosis, predominantly through p53 activation by acetylation",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2006 Jun 15 40(12) 2175-82",
                "id": "16785031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0481"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In summary, the results presented in this article state that chaperone activity of Hsp90 is important for the transcriptional activity of genotypically wild-type p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 19 279(47) 48836-45",
                "id": "15358769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0480"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 activation was accompanied by a two- to threefold transcriptional induction of the p53-responsive genes Mdm2 and Puma (which encodes a BH3-only proapoptotic Bcl-2 family member).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Apr 26(7) 2661-74",
                "id": "16537910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe047f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "inhibition of APE/Ref-1 accelerated p53 protein turnover, resulting in a decrease in p53 levels and activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jun 2 24(24) 3853-63",
                "id": "15824742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe047e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "it has been recently shown that ATM is critical for p53 activation and the induction of apoptosis in response to c-MYC, suggesting that, in at least some cases, the ARF and ATM pathways cooperate with c-MYC to activate p53 and promote apoptosis (Figure 1a; Pusapati et al., 2006).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe047d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Aug 3(8) 895-902",
                "id": "15299072"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe047c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Actinomycin D, but not cycloheximide, inhibited the p53 dependent DDA3 induction, suggesting that the activation is through transcriptional regulation and does not require de novo protein synthesis.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Dec 16 18(54) 7765-74",
                "id": "10618717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe047b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Transient transfection experiments showed that wild-type mouse p53 severely repressed the rat CKB promoter in HeLa",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Dec 14(12) 8483-92",
                "id": "7969181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe047a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 17 278(3) 2066-71",
                "id": "12427754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0479"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Angiotensin II has been reported to induce premature senescence of human VSMCs in vitro via the p53/p21-dependent pathway.33",
              "citation": {
                "type": "PubMed",
                "name": "Nat Clin Pract Cardiovasc Med 2008 Oct 5(10) 637-48",
                "id": "18762784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0478"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "from full text - p53 functions as an efficient repressor of BIRC5 transcription, through occupancy of a binding site in the BIRC5 promoter (41)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Jan 8(1) 61-70",
                "id": "18075512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0477"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "SUMO-1 might be important for the full biological activity of p53",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 May 5 275(18) 13321-9",
                "id": "10788439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0476"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Furthermore, PRMT5 depletion triggers p53-dependent apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2008 Dec 10(12) 1431-9",
                "id": "19011621"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0475"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "The interaction of MDM2 with p53 inhibits p53 transcriptional activity and targets p53 for ubiquitin-dependent degradation. The ability of MDM2 to inhibit p53 functions is antagonized by the ARF oncosuppressor protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 25 277(4) 2674-81",
                "id": "11714701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0474"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "HIPK2 is activated by ultraviolet (UV) radiation and selectively phosphorylates p53 at Ser 46 ... Accordingly, the kinase function of HIPK2 mediates the increased expression of p53 target genes",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Jan 4(1) 1-10",
                "id": "11740489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0473"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "<s7> The binding of RPA to p53 inhibits the binding of RPA to ssDNA (Dutta et al., 1993) and the binding of p53 to its promoter sites (Miller et al., 1997).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0472"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "report that p53 can directly upregulate expression of Bnip3L, a cell death inducer.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2004 Dec 6(6) 597-609",
                "id": "15607964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0471"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "In cultured cardiac myocytes, doxorubicin induced oxidative stress, DNA damage, ATM activation, and p53 induction. ...Doxorubicin treatment in vivo also induced oxidative stress, DNA damage, ATM activation, and p53 accumulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2009 Nov 47(5) 698-705",
                "id": "19660469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0470"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "wild-type p53 was found to repress expression of the survivin gene by binding to the survivin promoter ... from Fig 3, rat fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res Treat 2004 Sep 87(1) 23-31",
                "id": "15377848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe046f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "p53 binding site in the promoter of the GPX gene. This site bound to purified p53 as well as p53 in nuclear extract activated by etoposide.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Apr 23 274(17) 12061-6",
                "id": "10207030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe046e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "tumor suppressor p53 normally inhibits Sirt1 expression by binding to two sites in the promoter region of the Sirt1 gene (Figure 5). In response to nutrient deprivation, FoxO releases p53-dependent repression of the Sirt1 gene, thereby allowing the upregulation of Sirt1 expression... (Nemoto et al., 2004).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2276-88",
                "id": "18391970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe046d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "MIF forms a complex with p53 and suppresses p53-induced transcription (26).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Nov 21 283(47) 32669-79",
                "id": "18815136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe046c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "RNA interference and inducible gene expression approaches suggest that NDRG1 is necessary but not sufficient for p53-mediated caspase activation and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 19 279(47) 48930-40",
                "id": "15377670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe046b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "a feedback loop exists through which ARF levels are negatively regulated by p53. Significantly, ARF expression is positively regulated by members of the E2F family of transcription factors",
              "citation": {
                "type": "PubMed",
                "name": "Prog Cell Cycle Res 2000 4 71-81",
                "id": "10740816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe046a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Apr 1 61(7) 2816-21",
                "id": "11306450"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0469"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Transfection assays using p53 mutants further demonstrated that the p53-induced increase in ER alpha gene transcription was not dependent on the ability of p53 to bind to DNA but on its ability to interact with other proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Endocrinol 2004 Mar 180(3) 497-504",
                "id": "15012604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0468"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "phosphorylation by the kinase complex enhances p53 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Feb 7(2) 283-92",
                "id": "11239457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0467"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Cyclin A1 but not cyclin A2 was upregulated in etoposide-treated tumor cells undergoing p53-dependent apoptosis and mitotic catastrophe. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2006 Jun 63(12) 1425-39",
                "id": "16799873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0466"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "We show here that the tumor suppressor p53 transcriptionally upregulates the CCN3 gene.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2008 May 1 7(9) 1254-61",
                "id": "18418052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0465"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Moreover, Rac1 and Cdc42Hs extinction in normal cells activates endogenous p53.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 May 11 19(20) 2377-85",
                "id": "10828879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0464"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Conversely, introduction of wild-type p53 into undifferentiated thyroid carcinoma cell line induced reexpression of TPO gene ( 52 ).",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Dec 141(12) 4373-82",
                "id": "11108245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0463"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of thyroid gland",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Nov 16(11) 6009-19",
                "id": "8887630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0462"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:TP53) actsIn tscript(p(HGNC:TP53))",
              "summary_text": "(3) capsaicin induces apoptosis by stabilization of p53 through JNK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2007 Apr 1773(4) 565-76",
                "id": "17292493"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0461"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKDC))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:H2AFX,pmod(P,S,140))",
        "directed": false,
        "label": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a48",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:H2AFX,pmod(P,S,140))",
              "summary_text": "The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6056-64",
                "id": "16880517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKDC))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:PRKDC,pmod(P,T,2638))",
        "directed": false,
        "label": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,T,2638))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a49",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,T,2638))",
              "summary_text": " Here, using solid-phase protein sequencing, MS and phosphospecific antibodies, we have identified seven in vitro autophosphorylation sites in DNA-PKcs. Six of these sites (Thr2609, Ser2612, Thr2620, Ser2624, Thr2638 and Thr2647) are clustered in a region of 38 amino acids in the central region of the protein. Five of these sites (Thr2609, Ser2612, Thr2638, Thr2647 and Ser3205) are conserved between six vertebrate species. Moreover, we show that DNA-PKcs is phosphorylated in vivo at Thr2609, Ser2612, Thr2638 and Thr2647",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Nov 15 368(Pt 1) 243-51",
                "id": "12186630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,T,2638))",
              "summary_text": "12186630;15302935;15677476;15258142",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0641"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKDC))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:PRKDC,pmod(P,S,2612))",
        "directed": false,
        "label": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,S,2612))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a4a",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,S,2612))",
              "summary_text": " Here, using solid-phase protein sequencing, MS and phosphospecific antibodies, we have identified seven in vitro autophosphorylation sites in DNA-PKcs. Six of these sites (Thr2609, Ser2612, Thr2620, Ser2624, Thr2638 and Thr2647) are clustered in a region of 38 amino acids in the central region of the protein. Five of these sites (Thr2609, Ser2612, Thr2638, Thr2647 and Ser3205) are conserved between six vertebrate species. Moreover, we show that DNA-PKcs is phosphorylated in vivo at Thr2609, Ser2612, Thr2638 and Thr2647",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Nov 15 368(Pt 1) 243-51",
                "id": "12186630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,S,2612))",
              "summary_text": "12186630;15302935;15677476;15258142",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0642"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKDC))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP53,pmod(P,S,37))",
        "directed": false,
        "label": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:TP53,pmod(P,S,37))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a4b",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:TP53,pmod(P,S,37))",
              "summary_text": "<p6> DNA-PK phosphorylates P53 at Ser15 and Ser37 dependent on DNA double-strand ends",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0644"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:TP53,pmod(P,S,37))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2001 2 12",
                "id": "11483158"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0643"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKDC))",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "kin(p(HGNC:PRKDC)) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a4c",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "DNA-dependent protein kinase (DNA-PK), consisting of Ku and DNA-PKcs subunits, is the key component of the non-homologous end-joining (NHEJ) pathway of DNA double strand break (DSB) repair",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 15 280(15) 14709-15",
                "id": "15677476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0645"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKDC))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP53,pmod(P,S,15))",
        "directed": false,
        "label": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a4d",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "11875057;10446957",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0647"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "<p6> DNA-PK phosphorylates P53 at Ser15 and Ser37 dependent on DNA double-strand ends",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0646"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKDC))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:PRKDC,pmod(P,T,2609))",
        "directed": false,
        "label": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,T,2609))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a4e",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,T,2609))",
              "summary_text": " Here, using solid-phase protein sequencing, MS and phosphospecific antibodies, we have identified seven in vitro autophosphorylation sites in DNA-PKcs. Six of these sites (Thr2609, Ser2612, Thr2620, Ser2624, Thr2638 and Thr2647) are clustered in a region of 38 amino acids in the central region of the protein. Five of these sites (Thr2609, Ser2612, Thr2638, Thr2647 and Ser3205) are conserved between six vertebrate species. Moreover, we show that DNA-PKcs is phosphorylated in vivo at Thr2609, Ser2612, Thr2638 and Thr2647",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Nov 15 368(Pt 1) 243-51",
                "id": "12186630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,T,2609))",
              "summary_text": "12186630;15302935;15677476;15258142",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0648"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKDC))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:PRKDC,pmod(P,T,2647))",
        "directed": false,
        "label": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,T,2647))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a4f",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,T,2647))",
              "summary_text": " Here, using solid-phase protein sequencing, MS and phosphospecific antibodies, we have identified seven in vitro autophosphorylation sites in DNA-PKcs. Six of these sites (Thr2609, Ser2612, Thr2620, Ser2624, Thr2638 and Thr2647) are clustered in a region of 38 amino acids in the central region of the protein. Five of these sites (Thr2609, Ser2612, Thr2638, Thr2647 and Ser3205) are conserved between six vertebrate species. Moreover, we show that DNA-PKcs is phosphorylated in vivo at Thr2609, Ser2612, Thr2638 and Thr2647",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Nov 15 368(Pt 1) 243-51",
                "id": "12186630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,T,2647))",
              "summary_text": "12186630;15302935;15677476;15258142",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0649"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:PRKDC))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:PRKDC,pmod(P,S,2056))",
        "directed": false,
        "label": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,S,2056))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a50",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:PRKDC)) directlyIncreases p(HGNC:PRKDC,pmod(P,S,2056))",
              "summary_text": "Here we report the ionizing radiation (IR)-induced autophosphorylation of DNA-PKcs at a novel site, serine 2056, the phosphorylation of which is required for the repair of DSBs by NHEJ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 15 280(15) 14709-15",
                "id": "15677476"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe064a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:POLD1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(HGNC:POLD1) actsIn kin(p(HGNC:POLD1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a51",
          "evidences": [
            {
              "bel_statement": "p(HGNC:POLD1) actsIn kin(p(HGNC:POLD1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe064b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:POLE))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "directed": false,
        "label": "cat(p(HGNC:POLE)) increases bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a52",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:POLE)) increases bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
              "summary_text": "After a 24- to 32-residue oligonucleotide is released, the gap is filled in by PCNA-dependent POL epsilon or delta and sealed by a DNA ligase, presumably LIG1.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe064c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:POLE))",
        "relation": "increases",
        "target": "bp(GOBP:\"single strand break repair\")",
        "directed": false,
        "label": "cat(p(HGNC:POLE)) increases bp(GOBP:\"single strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a53",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:POLE)) increases bp(GOBP:\"single strand break repair\")",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe064d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:ERCC8))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "cat(p(HGNC:ERCC8)) increases bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a54",
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:ERCC8)) increases bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "The known nucleotide excision repair (NER) defects of xeroderma pigmentosum (XP) and Cockayne syndrome (CS) cells can be exploited to analyze mechanisms of repair of UV-induced cyclobutane pyrimidine dimers (CPDs) at nucleotide (nt.) resolution. The two gene products of the CS complementation groups (CSA and CSB) have been implicated in the preferential repair of the transcribed strand of human genes. ",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 1998 May 25 400(1-2) 143-51",
                "id": "9685618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe064e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RHOB)",
        "relation": "actsIn",
        "target": "gtp(p(HGNC:RHOB))",
        "directed": false,
        "label": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a55",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Knockout mouse studies have established that the transformation-selective death program triggered by farnesyltransferase inhibitor (FTI) requires a gain-of-function in the stress-regulated small GTPase RhoB. In support of the concept of RhoB as a negative regulator of Ras signaling pathways, the most strongly downregulated gene scored was farnesyl pyrophosphate synthetase, the enzyme that produces the substrate used by FT to farnesylate Ras proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2(3) 273-80",
                "id": "12878865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "we found that DLC-1 had robust activity on RhoA in vitro. Furthermore, DLC-1 also had strong GAP activity on both RhoB and RhoC (Fig. 1B - D).....we introduced a missense mutation in the conserved arginine-718 residue critical for RhoGAP catalytic activity [38]. We found that DLC-1(R718E) was completely impaired in stimulating the intrinsic hydrolysis activity of GTP-loaded RhoA, RhoB, and RhoC in vitro (Fig. 1B - D).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2008 May 47(5) 326-37",
                "id": "17932950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Transcriptional profiling of the cellular transformation induced by Rho subfamily GTPases. We took advantage of the oncogenic properties of the constitutively active versions (Q63L mutants) of Rho subfamily proteins when overexpressed in rodent fibroblasts (Schuebel et al., 1998). Based on this property, we transfected NIH3T3 cells with plasmids encoding the indicated versions of Rho subfamily proteins to obtain foci of transformed cells. Selected foci were picked, pooled, and used for the subsequent microarray experiments. GENSTRUCT R-PIPELINE ANALYSIS of GSE5913 on 6/11/2010 by SE. Cutoffs used for curation by AV: Fold change 1.7, adjusted p-value .01, abundance 250 (values were adjusted to restrict # of statements to ~300) ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jan 8",
                "id": "17213802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "However, ectopic expression of RhoB, but not the closely related family member RhoA, resulted in a 5-fold decrease of T beta R-II promoter activity. Furthermore, ectopic expression of RhoB, but not RhoA, resulted in a significant decrease of T beta R-II protein expression and resistance of tumor cells to TGF-beta-mediated cell growth inhibition. Consequently, transcription assays using an AP1 reporter showed that AP1-mediated transcription is down-regulated by RhoB. Altogether, these results identify a mechanism by which RhoB antagonizes TGF-beta action through transcriptional down-regulation of AP1 in T beta R-II promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 8 277(10) 8500-7",
                "id": "11741970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase (Cdc) 42, regulate cytoskeletal organization during the cell cycle and also mediate Ras-induced activation of Raf, especially C-Raf.134-136 These GTPases do not directly bind to Raf but, instead, signal by activating downstream kinases. Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase (PAK).134-136",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6531-7",
                "id": "11641777"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe066b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "# Ariadne: Furthermore, SEK WT overexpression enhanced JNK stimulation induced by  activated RhoA, RhoB, RhoC, Cdc42, and MEKK (Fig. 4 ). [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Oct 18 271(42) 25731-4",
                "id": "8824197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe066a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "# Pubmed:gene: XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 42964-72",
                "id": "12221096"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0669"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Transient overexpression of wild type RhoB but not its dominant negative mutant RhoB-N19 antagonizes TGF-beta-mediated transcriptional activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Apr 17 273(16) 9921-6",
                "id": "9545335"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0668"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Further mechanistic studies showed that miR-21 targets RhoB, as revealed by a decrease in RhoB expression and activity in miR-21 overexpressing cells. RhoB silencing impairs endothelial cell migration and tubulogenesis, thus providing a possible mechanism for miR-21 to inhibit angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(2) e16979",
                "id": "21347332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0667"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "# Ariadne: During the course of our studies, Bustelo and colleagues ( 18 ) showed that Vav2 was an activator of RhoA, RhoB, and RhoG but not Rac1 or Cdc42 in vitro . [Regulation] Vav and Vav2 are members of the Dbl family of proteins that act as guanine nucleotide exchange factors (GEFs) for Rho family proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10141-9",
                "id": "10744696"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0666"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Transfection of PC12 cells with constitutively active RhoB increased MLC phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 Oct 15 300(1) 35-42",
                "id": "15383312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0665"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "We found JNK to be downstream of RhoB activation and that suppression of RhoB activity, either by reducing RhoB protein levels directly or reducing the amount of stimulating GEFs, Ect2 and Net1, was sufficient to inhibit JNK phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(2) e17108",
                "id": "21373644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0664"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "We report here that the activated GTP-bound form of RhoB is increased rapidly within 5 min of exposure to UVB, and then RhoB  protein levels increased concomitantly with EGF receptor (EGFR) activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 43257-63",
                "id": "16278215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0663"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "RhoB is a small GTPase that regulates actin organization and vesicle transport. It is required for signalling apoptosis in transformed cells that are exposed to farnesyltransferase inhibitors, DNA-damaging agents or taxol.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2001 Nov 1(2) 162-8",
                "id": "11905808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0662"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "When expressed in cells, XPLN activates RhoA and RhoB, but not RhoC, and stimulates the assembly of stress fibers and focal adhesions in a Rho kinase-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 42964-72",
                "id": "12221096"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0661"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "RhoA, RhoB, and RhoC all markedly stimulated inositol phosphate accumulation in PLC-epsilon-expressing cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41253-8",
                "id": "12900402"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0660"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "This comparative study presents detailed kinetic data on specificity, activity, and regulation of the catalytic DH domains of four GEFs, namely p115, p190, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG). We demonstrate that (i) these GEFs are specific guanine nucleotide exchange factors for the Rho isoforms (RhoA, RhoB, and RhoC) ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 May 20 286(20) 18202-12",
                "id": "21454492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe065f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Aug 15 102(4) 1490-8",
                "id": "12714496"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe065e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "# Ariadne: This indicates that  RhoB represses NF-kappaB activation by inhibiting dissociation and subsequent  degradation of IkappaBalpha. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 3115-22",
                "id": "11062238"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe065d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "# Ariadne: RhoB also has cell cycle inhibitory roles and is upregulated during stress responses ( 14 , 15 ) and by the inhibitory growth factor transforming growth factor beta ( 12 ). [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Aug 20(16) 6095-104",
                "id": "10913191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe065c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "This results in a net increase in active Rho, and increased stress fibers and focal adhesions.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 May 1 295(2) 488-96",
                "id": "15093746"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe065b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Reorganization of the actin cytoskeleton in response to growth factor signaling, such as transforming growth factor beta (TGF-beta), controls cell adhesion, motility, and growth of diverse cell types. In Swiss3T3 fibroblasts, a widely used model for studies of actin reorganization, TGF-beta1 induced rapid actin polymerization into stress fibers and concomitantly activated RhoA and RhoB small GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11448-57",
                "id": "15647284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe065a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "# Ariadne: We show that although RhoA, RhoB,  and RhoC are equally effective in stimulating actin stress fiber formation and  focal complex assembly in NIH 3T3 cells, RhoA and RhoB are capable of  transforming cells whereas RhoC induces cell migration. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44617-25",
                "id": "12939257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0659"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Interference with Rho or Pyk2 inhibited cofilin inactivation and the migratory speed of DCs, but did not affect chemotaxis.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Apr 1 174(7) 4070-80",
                "id": "15778365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0658"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Furthermore, RhoB, but not RhoA, inhibits colony formation and proliferation and induces anoikis in A-549 cells and Ras-transformed NIH3T3 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 5 23(5) 1136-45",
                "id": "14647415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0657"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "We also provide evidence for the importance of the downregulation of RhoB in oncogenesis by demonstrating that RhoB antagonizes Ras/PI3K/Akt malignancy.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(12) 5565-76",
                "id": "15169915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0656"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "RhoB is a small GTP-binding protein that is involved in apoptotic signal transduction.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jan 13 24(3) 502-11",
                "id": "15543229"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0655"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Reorganization of the actin cytoskeleton in response to growth factor signaling, such as transforming growth factor beta (TGF-beta), controls cell adhesion, motility, and growth of diverse cell types. In Swiss3T3 fibroblasts, a widely used model for studies of actin reorganization, TGF-beta1 induced rapid actin polymerization into stress fibers and concomitantly activated RhoA and RhoB small GTPases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 25 280(12) 11448-57",
                "id": "15647284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0654"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "# Ariadne: RhoB inhibits anchorage-dependent growth and induces apoptosis in Panc-1 cells. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 16 275(24) 17974-8",
                "id": "10770919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0653"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Gef10 activates RhoA-C, but not Rac1 or Cdc42",
              "citation": {
                "type": "PubMed",
                "name": "Naunyn Schmiedebergs Arch Pharmacol 2006 Aug 373(5) 333-41",
                "id": "16896804"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0652"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Moreover, pharmaceutical means to deplete RhoB in neonatal rats is associated with apoptosis in the sprouting endothelial cells of newly forming vessels. Similarly, acute depletion of RhoB by antisense or dominant-negative strategies in primary endothelial cell culture models led to apoptosis and failures in tube formation. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Nov 1 17(21) 2721-32",
                "id": "14597666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0651"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Although recent evidence supports a tumor-suppressive role for the GTPase RhoB, little is known about its regulation by signal transduction pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(12) 5565-76",
                "id": "15169915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0650"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RHOB) actsIn gtp(p(HGNC:RHOB))",
              "summary_text": "Using the yeast two hybrid system and overlay assays we identified a putative rholrac effector, citron, which interacts with the GTP-bound forms of rho and rac1, but not with cdc42.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1995 Dec 18 377(2) 243-8",
                "id": "8543060"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe064f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PNKP)",
        "relation": "actsIn",
        "target": "phos(p(HGNC:PNKP))",
        "directed": false,
        "label": "p(HGNC:PNKP) actsIn phos(p(HGNC:PNKP))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a56",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PNKP) actsIn phos(p(HGNC:PNKP))",
              "summary_text": "Human polynucleotide kinase/phosphatase (PNKP) is a dual specificity 5'-DNA kinase/3'-DNA phosphatase, with roles in base excision repair, DNA single-strand break repair and non-homologous end joining (NHEJ)",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2011 Aug 8",
                "id": "21824916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe066c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAD51)",
        "relation": "hasModification",
        "target": "p(HGNC:RAD51,pmod(P,Y,54))",
        "directed": false,
        "label": "p(HGNC:RAD51) hasModification p(HGNC:RAD51,pmod(P,Y,54))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a57",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAD51) hasModification p(HGNC:RAD51,pmod(P,Y,54))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe066d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PRKDC)",
        "relation": "hasModification",
        "target": "p(HGNC:PRKDC,pmod(P,S,2056))",
        "directed": false,
        "label": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,S,2056))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a58",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,S,2056))",
              "summary_text": "Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "21083655"
              },
              "metadata": {
                "created_by": "mgvelez96",
                "id": "55775d252f9e24174cfe0817"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,S,2056))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe066e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ABL1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:RAD52,pmod(P,Y,104))",
        "directed": false,
        "label": "kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:RAD52,pmod(P,Y,104))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a59",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:RAD52,pmod(P,Y,104))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Feb 13 336(2) 307-11",
                "id": "14757045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe066f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ABL1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:RAD51,pmod(P,Y,315))",
        "directed": false,
        "label": "kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:RAD51,pmod(P,Y,315))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a5a",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:RAD51,pmod(P,Y,315))",
              "summary_text": "11684015;10212258",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0671"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:RAD51,pmod(P,Y,315))",
              "summary_text": "Rad51 is a key element of recombinational DNA repair and its activity is regulated by phosphorylation of the tyrosine residue at position 315 by cAbl kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Jun 11 339(4) 797-804",
                "id": "15165851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0670"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ABL1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:RAD51,pmod(P,Y,54))",
        "directed": false,
        "label": "kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:RAD51,pmod(P,Y,54))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a5b",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ABL1)) directlyIncreases p(HGNC:RAD51,pmod(P,Y,54))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Feb 13 273(7) 3799-802",
                "id": "9461559"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0672"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1))",
        "relation": "increases",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 5'-to lesion\")",
        "directed": false,
        "label": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) increases bp(GOBP:\"nucleotide-excision repair, DNA incision, 5'-to lesion\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a5c",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) increases bp(GOBP:\"nucleotide-excision repair, DNA incision, 5'-to lesion\")",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1))",
        "relation": "hasComponent",
        "target": "p(HGNC:ERCC4)",
        "directed": false,
        "label": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC4)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a5d",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC4)",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC4)",
              "summary_text": "<N6> The XPF C-terminal region (residues 814, 905) binds to the C-terminal region of ERCC1 (residues 224-297) (de Laat et al., 1998b).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0676"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC4)",
              "summary_text": "Once the incision complex consisting of XPC-hHR23B, TFIIH, and XPG (as well as RPA) has been constituted, the complex is completed by the association of ERCC1-XPF requiring XPA. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 213-24",
                "id": "11511374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0675"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC4)",
              "summary_text": "in vitro; in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1994 May 24 91(11) 5017-21",
                "id": "8197175"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0674"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC4)",
              "summary_text": "Formation of this open complex creates specific sites for cutting on the 3' side by the XPG nuclease and then on the  5' side by the ERCC1-XPF nuclease.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0673"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1))",
        "relation": "hasComponent",
        "target": "p(HGNC:ERCC1)",
        "directed": false,
        "label": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a5e",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC1)",
              "summary_text": "nucleotide excision repair (NER); a number of proteins involved in DNA repair are termed XPA to XPG depending on which one is defective in a particular complementation group of XP and include: (i) proteins involved in the recognition of (6-4) photoproducts (XPE) and of a broad range of lesions such as pyrimidine dimers (XPA); (ii) proteins that are DNA helicases and integral parts of the general transcription factor TFIIH functioning in both transcription and repair (XPB, XPD); (iii) endonucleases that perform the two incisions, the XPG incising six nucleotides (nt) to the 3' side from a photodimer and the ERCC1-XPF protein complex incising 22 nt to the 5' side of the lesion; and (iv) single-strand DNA-binding proteins (XPC). ",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 16(2) 693-708",
                "id": "8687116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC1)",
              "summary_text": "Once the incision complex consisting of XPC-hHR23B, TFIIH, and XPG (as well as RPA) has been constituted, the complex is completed by the association of ERCC1-XPF requiring XPA. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 213-24",
                "id": "11511374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe067a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC1)",
              "summary_text": "in vitro; in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1994 May 24 91(11) 5017-21",
                "id": "8197175"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0679"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC1)",
              "summary_text": "Formation of this open complex creates specific sites for cutting on the 3' side by the XPG nuclease and then on the  5' side by the ERCC1-XPF nuclease.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0678"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ERCC4),p(HGNC:ERCC1)) hasComponent p(HGNC:ERCC1)",
              "summary_text": "<N6> The XPF C-terminal region (residues 814, 905) binds to the C-terminal region of ERCC1 (residues 224-297) (de Laat et al., 1998b).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0677"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CHEK2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP53,pmod(P,S,20))",
        "directed": false,
        "label": "kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:TP53,pmod(P,S,20))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a5f",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:TP53,pmod(P,S,20))",
              "summary_text": "Two peptides derived from the DNA-binding domain of p53 bind to CHK2 and stimulate phosphorylation of full-length p53 at Thr 18 and Ser 20, thus identifying CHK2-docking sites. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2003 Aug 4(8) 787-92",
                "id": "12897801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe067c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:TP53,pmod(P,S,20))",
              "summary_text": "12111733;10801407;15489221;15254178",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe067b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CHEK2))",
        "relation": "increases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "kin(p(HGNC:CHEK2)) increases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a60",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CHEK2)) increases tscript(p(HGNC:TP53))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway  for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-DCdk4 from phosphorylating Rb  unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 46,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:CHEK2)) increases tscript(p(HGNC:TP53))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNAPK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe067d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CHEK2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP53,pmod(P,T,18))",
        "directed": false,
        "label": "kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:TP53,pmod(P,T,18))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a61",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:TP53,pmod(P,T,18))",
              "summary_text": "Two peptides derived from the DNA-binding domain of p53 bind to CHK2 and stimulate phosphorylation of full-length p53 at Thr 18 and Ser 20, thus identifying CHK2-docking sites. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2003 Aug 4(8) 787-92",
                "id": "12897801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe067e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CHEK2))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK2,pmod(P,T,68))",
        "directed": false,
        "label": "kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a62",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CHEK2)) directlyIncreases p(HGNC:CHEK2,pmod(P,T,68))",
              "summary_text": "10973490;11901158;12493754",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe067f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CHEK2))",
        "relation": "increases",
        "target": "p(HGNC:TP53,pmod(P,S,15))",
        "directed": false,
        "label": "kin(p(HGNC:CHEK2)) increases p(HGNC:TP53,pmod(P,S,15))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a63",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CHEK2)) increases p(HGNC:TP53,pmod(P,S,15))",
              "summary_text": "The respective kinetics of p53-Ser15 phosphorylation versus ATM and Chk2 activation suggest that in response to DNA damage by TPT or MXT, Chk2 rather than ATM mediates p53 phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2008 Oct 7(19) 3048-55",
                "id": "18802408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0680"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATF2)",
        "relation": "hasModification",
        "target": "p(HGNC:ATF2,pmod(P,S,490))",
        "directed": false,
        "label": "p(HGNC:ATF2) hasModification p(HGNC:ATF2,pmod(P,S,490))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a64",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATF2) hasModification p(HGNC:ATF2,pmod(P,S,490))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0681"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:H2AFX,pmod(P,S,140))",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair\")",
        "directed": false,
        "label": "p(HGNC:H2AFX,pmod(P,S,140)) increases bp(GOBP:\"double-strand break repair\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a65",
          "evidences": [
            {
              "bel_statement": "p(HGNC:H2AFX,pmod(P,S,140)) increases bp(GOBP:\"double-strand break repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0682"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:H2AFX,pmod(P,S,140))",
        "relation": "increases",
        "target": "complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
        "directed": false,
        "label": "p(HGNC:H2AFX,pmod(P,S,140)) increases complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a66",
          "evidences": [
            {
              "bel_statement": "p(HGNC:H2AFX,pmod(P,S,140)) increases complex(p(HGNC:MRE11A),p(HGNC:RAD50),p(HGNC:NBN))",
              "summary_text": "phosphorylated H2AX recruits 53BP1, BRCA1, MDC1 and the MRE11-RAD50-NBS1 complex to the site of DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0683"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:H2AFX)",
        "relation": "hasModification",
        "target": "p(HGNC:H2AFX,pmod(P,S,140))",
        "directed": false,
        "label": "p(HGNC:H2AFX) hasModification p(HGNC:H2AFX,pmod(P,S,140))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a67",
          "evidences": [
            {
              "bel_statement": "p(HGNC:H2AFX) hasModification p(HGNC:H2AFX,pmod(P,S,140))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0684"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:WEE1))",
        "relation": "directlyIncreases",
        "target": "p(EGID:5424,pmod(P,Y,15))",
        "directed": false,
        "label": "kin(p(HGNC:WEE1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a68",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:WEE1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "Fig. (1). Regulation of CDK1 by phosphorylation in the S phase. Cyclin B dimerizes with CDK1, and this complex is phosphorylated by CDK activity (CAK on Threonine161). wee1 and mik1 phosphorylate tyrosine15 and threonine14, which inactivates the complex. The G2/M transition cdc25 phosphatase dephosphorylates tyrosine15 and threonine14, but phosphorylation of threonine161 is retained, resulting in an active CDK1. Upon the completion of M phase, cyclin B is ubiquitinated and targeted for degradation. (reproduced with permission [64])",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:WEE1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "<C16> Cdk1 is phosphorylated at Tyr15 by Wee1 and at Thr14 by Myt1 (Liu et al., 1997, and references therein). Phosphorylations of Cdks are facilitated by Cyclin binding and stabilize the Cyclin:Cdk complex (Jackman and Pines, 1997). Human Myt1 phosphorylates and inactivates Cdk1 associated with cyclins A and B but does not phosphorylate Cdk2 or Cdk4 complexes (Booher et al., 1997) (unlike wee1, which can phosphorylate both Cdk1 and Cdk2). Myt1 is membrane bound to endoplasmic reticulum and Golgi complex. Phosphorylation of Thr14 and Tyr15 occurs when the cycB:Cdk1 complex assembles in the cytoplasm (Pines and Hunter, 1994). Wee1, however, is in the nucleus; hence another kinase may be operating in the cytoplasm (Matsuura and Wang, 1996). Thr14 phosphorylation precedes Tyr15 phosphorylation (Liu et al., 1997).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:WEE1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "Inhibitory phosphorylation of adjacent threonine and tyrosine residues (T14/Y15 in CDK1) is mediated by dualspecificity kinases (such as WEE1 and MYT1). This inhibition is relieved when the CDC25 phosphatases (CDC25A,CDC25B and CDC25C) dephosphorylate these residues, which triggers entry into mitosis",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2001 Dec 1(3) 222-31",
                "id": "11902577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0688"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:WEE1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "96108162;7743995;15592455;16083285;15964826",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0687"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:WEE1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "Antibody depletion experiments demonstrate that WEE1 accounts for most of the activity that phosphorylates CDC2 on Tyr15 in an in vitro assay of HeLa cell lysates ... inhibitory tyrosine phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 May 15 14(10) 2166-75",
                "id": "7774574"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0686"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:WEE1)) directlyIncreases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "from full text - As shown in Fig.1 A, addition of Wee1 lysates effectively inhibited Cdc2cyclin B1 kinase activation. The Wee1 inhibitory activity was dependent on the presence of the Tyr15 residue in Cdc2, since both Cdc2-F15 (Tyr15 replaced with phenylalanine) and Cdc2-AF (Thr14 and Tyr15 replaced with alanine and phenylalanine) proteins complexed to cyclin B1 retained full activity in the presence of Wee1 lysates. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 29 272(35) 22300-6",
                "id": "9268380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0685"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1)",
        "relation": "hasModification",
        "target": "p(HGNC:RASSF1,pmod(P,S,131))",
        "directed": false,
        "label": "p(HGNC:RASSF1) hasModification p(HGNC:RASSF1,pmod(P,S,131))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a69",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1) hasModification p(HGNC:RASSF1,pmod(P,S,131))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0689"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1,pmod(P,S,131))",
        "relation": "increases",
        "target": "p(HGNC:TP73)",
        "directed": false,
        "label": "p(HGNC:RASSF1,pmod(P,S,131)) increases p(HGNC:TP73)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a6a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1,pmod(P,S,131)) increases p(HGNC:TP73)",
              "summary_text": "We show that, upon DNA damage, RASSF1A is phosphorylated by ATM on Ser131 and is involved in the activation of both MST2 and LATS1, leading to the stabilization of p73....As shown previously, expression of RASSF1A  enhances the stability of p73 [7], but this stabilization was further enhanced when combined with DNA damage (Figure 4C, left). In agreement with a role for the ATM phosphorylation site in pathway signaling, RASSF1A-S131A blocked the stabilization of p73 in response to cisplatin-mediated DNA damage (Figure 4C, right).",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2009 Dec 15 19(23) 2020-5",
                "id": "19962312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:LIG1)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:LIG1))",
        "directed": false,
        "label": "p(HGNC:LIG1) actsIn cat(p(HGNC:LIG1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a6b",
          "evidences": [
            {
              "bel_statement": "p(HGNC:LIG1) actsIn cat(p(HGNC:LIG1))",
              "summary_text": "DNA strand displacement may instead occur, involving either POL b or a larger polymerase such as POL d, for filling-in of gaps a few nucleotides long (37). The FEN1 structure-specific nuclease removes the displaced flap and the PCNA protein stimulates these reactions (38), acting as a scaffold protein in this alternative pathway in a way similar to that of XRCC1 in the main pathway. Another replication factor, DNA ligase I (LIG1) then completes this longer patch form of repair.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:LIG1) actsIn cat(p(HGNC:LIG1))",
              "summary_text": "<r8> PCNA binds DNA ligase I; the complex may function to join Okazaki fragments during DNA replication (Levin et al.,1997).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe068d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:LIG1) actsIn cat(p(HGNC:LIG1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 1 277(44) 41715-24",
                "id": "12200445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe068c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:LIG1) actsIn cat(p(HGNC:LIG1))",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe068b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:LIG1) actsIn cat(p(HGNC:LIG1))",
              "summary_text": " Since MRN complex is involved in the repair of double-stranded DNA breaks by homologous recombination at stalled replication forks our data support the notion that DNA ligase I participates in homology dependent pathways that deal with replication-associated lesions generated when replication fork encounters DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Aug 15 8(16) 2600-7",
                "id": "19597347"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe068a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1)",
        "relation": "decreases",
        "target": "p(HGNC:CCND1)",
        "directed": false,
        "label": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a6c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "summary_text": "RNA interference-mediated downregulation of endogenous RASSF1A expression in human epithelial cells results in abnormal accumulation of cyclin D1 protein",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4309-18",
                "id": "12024041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0690"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "summary_text": "The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe068f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "summary_text": "As shown in Fig. 1B, the exogenous expression of RASSF1A inhibited the phosphorylation of c-Jun and reduced the expression of Cyclin D1.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe068e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1)",
        "relation": "decreases",
        "target": "tscript(p(HGNC:ATF2))",
        "directed": false,
        "label": "p(HGNC:RASSF1) decreases tscript(p(HGNC:ATF2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a6d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1) decreases tscript(p(HGNC:ATF2))",
              "summary_text": "JNK phosphorylation was inhibited in cells stably expressing RASSF1A, and the phosphorylation inhibition of JNK substrates, such as c-Jun and ATF-2, was then accompanied (Fig. 2D).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0691"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1)",
        "relation": "decreases",
        "target": "p(HGNC:MDM2)",
        "directed": false,
        "label": "p(HGNC:RASSF1) decreases p(HGNC:MDM2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a6e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:MDM2)",
              "summary_text": "Importantly, RASSF1A associates with MDM2 and death-domain-associated protein (DAXX) in the nucleus, thereby disrupting the interactions between MDM2, DAXX, and the deubiquitinase, HAUSP, and enhancing the self-ubiquitin ligase activity of MDM2. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Jul 9 27(13) 1863-74",
                "id": "18566590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0692"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(EGID:5424,pmod(P,Y,15))",
        "relation": "directlyDecreases",
        "target": "kin(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(EGID:5424,pmod(P,Y,15)) directlyDecreases kin(p(HGNC:POLD1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a6f",
          "evidences": [
            {
              "bel_statement": "p(EGID:5424,pmod(P,Y,15)) directlyDecreases kin(p(HGNC:POLD1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0693"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:WRN)",
        "relation": "hasModification",
        "target": "p(HGNC:WRN,pmod(P,S,1292))",
        "directed": false,
        "label": "p(HGNC:WRN) hasModification p(HGNC:WRN,pmod(P,S,1292))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a70",
          "evidences": [
            {
              "bel_statement": "p(HGNC:WRN) hasModification p(HGNC:WRN,pmod(P,S,1292))",
              "summary_text": "Recruitment of HRDC domain of WRN and BLM to the sites of DNA damage induced by mitomycin C and methyl methanesulfonate.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22657828"
              },
              "metadata": {
                "created_by": "mgvelez96",
                "id": "55775d252f9e24174cfe0818"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WRN) hasModification p(HGNC:WRN,pmod(P,S,1292))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0694"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "relation": "increases",
        "target": "kin(p(HGNC:ATR))",
        "directed": false,
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATR))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a71",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATR))",
              "summary_text": "activation of the G2 checkpoint begins with the detection of DNA damage by the sensory molecules ATM and ATR",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0698"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATR))",
              "summary_text": "Phosphorylation on Chk1(Ser-345), Chk2(Thr-68), and p53(Ser-15)following oxidative damage by IR involved both ATM and ATR. phosphorylation on Chk1, Chk2, and p53 was found to be ATM-dependent, whereas ATR also contributed to Chk1 phosphorylation ... from full text, A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1186-92",
                "id": "15533933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0697"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATR))",
              "summary_text": " Treatment with estrogen can block DNA damage-induced senescence. Moreover, WRN is suppressed by ATR that is activated by DNA damage, whereas WRN can be induced by ATR elimination. ",
              "citation": {
                "type": "PubMed",
                "name": "Horm Res Paediatr 2010 74(1) 33-40",
                "id": "20395656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0696"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATR))",
              "summary_text": "We show that pure ATR is a protein kinase which is activated by circular single-stranded, double-stranded or linear DNA.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Nov 18 18(48) 6707-13",
                "id": "10597277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0695"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "relation": "increases",
        "target": "tscript(p(HGNC:TP73))",
        "directed": false,
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases tscript(p(HGNC:TP73))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a72",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases tscript(p(HGNC:TP73))",
              "summary_text": "p73 belongs to a family of transcription factors, including p53 and p63, that mediate response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2007 Jan 1095 315-24",
                "id": "17404044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe069b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases tscript(p(HGNC:TP73))",
              "summary_text": "p73-mediated induction of Bax expression following DNA damage requires YAP function and is attenuated by Akt phosphorylation of YAP.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Jan 11(1) 11-23",
                "id": "12535517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe069a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases tscript(p(HGNC:TP73))",
              "summary_text": "In p53-null Saos2 cells, cyclin G inhibited p73 induction in response to genotoxic stress",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Mar 20 22(11) 1678-87",
                "id": "12642871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe0699"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "relation": "increases",
        "target": "kin(p(HGNC:CHEK1))",
        "directed": false,
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:CHEK1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a73",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:CHEK1))",
              "summary_text": "We have shown recently that DNA damage effector kinase Chk1 is phosphorylated in vitro by protein kinase B/Akt (PKB/Akt) on serine 280. Activation of Chk1 by DNA damage in vivo is suppressed in presence of activated PKB. In this study we show that Chk1 is phosphorylated by PKB in vivo, and that increased phosphorylation by PKB on serine 280 correlates with impairment of Chk1 activation by DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe069f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "relation": "decreases",
        "target": "p(HGNC:CCND1)",
        "directed": false,
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\") decreases p(HGNC:CCND1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a74",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") decreases p(HGNC:CCND1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "relation": "increases",
        "target": "p(HGNC:GADD45G)",
        "directed": false,
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases p(HGNC:GADD45G)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a75",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases p(HGNC:GADD45G)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "relation": "increases",
        "target": "p(HGNC:CDKN2A)",
        "directed": false,
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases p(HGNC:CDKN2A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a76",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases p(HGNC:CDKN2A)",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway  for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-DCdk4 from phosphorylating Rb  unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 46,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases p(HGNC:CDKN2A)",
              "summary_text": "Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Mar 5 16(9) 1113-23",
                "id": "9528853"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "relation": "increases",
        "target": "cat(p(HGNC:EP300))",
        "directed": false,
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases cat(p(HGNC:EP300))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a77",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases cat(p(HGNC:EP300))",
              "summary_text": "Here, we show that DNA damage induces the acetylation of p73 by the acetyltransferase p300....As shown in Figure 1C, exogenously expressed HA-tagged p73? is acetylated by cotransfected p300 (Figure 2A, lane 3). Treatment of cells with the anticancer drug doxorubicin  strongly potentiates the acetylation of p73? by p300 (Figure 2A, lane 4).SDS-PAGE and immunoblotted using an antiacetylated lysines polyclonal antibody (Upstate Biotechnology, Inc.)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Jan 9(1) 175-86",
                "id": "11804596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHEK1,pmod(P,S,317))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:CHEK1))",
        "directed": false,
        "label": "p(HGNC:CHEK1,pmod(P,S,317)) directlyIncreases kin(p(HGNC:CHEK1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a78",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,317)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,317)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns. Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4129-39",
                "id": "11390642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:POLB)",
        "relation": "actsIn",
        "target": "cat(p(HGNC:POLB))",
        "directed": false,
        "label": "p(HGNC:POLB) actsIn cat(p(HGNC:POLB))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a79",
          "evidences": [
            {
              "bel_statement": "p(HGNC:POLB) actsIn cat(p(HGNC:POLB))",
              "summary_text": "We describe a novel regulatory mechanism for DNA polymerase beta (Polbeta), a protein involved in DNA base excision repair (BER).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Nov 10(5) 1213-22",
                "id": "12453427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:POLB) actsIn cat(p(HGNC:POLB))",
              "summary_text": "POL b releases the remnant 59-deoxyribosephosphate (dRp), inserts a C residue, and recruits the LIG3-XRCC1 complex. LIG3 seals the nick as POL b dissociates. ",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Dec 3 286(5446) 1897-905",
                "id": "10583946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:POLB) actsIn cat(p(HGNC:POLB))",
              "summary_text": "In this study, we present the isolation from the nuclei of human cycling cells of a multiprotein complex containing most of the essential components of base excision repair (BER)/SSBR, including APE1, UNG2, XRCC1 and POLbeta, DNA PK, replicative POLalpha, delta and epsilon, DNA ligase 1 and cell cycle regulatory protein cyclin A",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(5) 1569-77",
                "id": "17289756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CHEK1))",
        "relation": "increases",
        "target": "deg(p(HGNC:CDC25A))",
        "directed": false,
        "label": "kin(p(HGNC:CHEK1)) increases deg(p(HGNC:CDC25A))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a7a",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CHEK1)) increases deg(p(HGNC:CDC25A))",
              "summary_text": "Phosphorylation by Chk1 and Cds1/Chk2 down-regulates Cdc25A levels in response to genotoxic stresses",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 31838-42",
                "id": "12801928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:CHEK1)) increases deg(p(HGNC:CDC25A))",
              "summary_text": "phosphorylation of Cdc25A on Ser-75 by Chk1 and its subsequent degradation is required to delay cell cycle progression in response to UV-induced DNA lesions.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29824-9",
                "id": "12759351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:CHEK1)) increases deg(p(HGNC:CDC25A))",
              "summary_text": "Using a small interfering RNA that enables the specific elimination of Chk1 expression, we show that the observed proteolysis of Cdc25A is mediated through Chk1. Moreover, Cdc25A overexpression abrogates the Chk1-mediated degradation and overcomes the doxorubicin-induced G2 arrest through dephosphorylation and activation of Cdc2/Cdk1 in a dose-dependent manner ... from full text, H1299 cells and tyrosine 15 phosphorylation of CDC2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 13 278(24) 21767-73",
                "id": "12676925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CHEK1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP73,pmod(P,S,47))",
        "directed": false,
        "label": "kin(p(HGNC:CHEK1)) directlyIncreases p(HGNC:TP73,pmod(P,S,47))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a7b",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CHEK1)) directlyIncreases p(HGNC:TP73,pmod(P,S,47))",
              "summary_text": "Consistent with this, we discovered that endogenous p73alpha interacts with Chk1 and is phosphorylated by Chk1 at serine 47 in vitro and in vivo. In contrast, Chk2 does not phosphorylate p73alpha in vitro. Moreover, mutation of serine 47 abolishes both Chk1-dependent phosphorylation of p73alpha upon DNA damage in vivo and the ability of Chk1 to upregulate the transactivation capacity of p73alpha. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(22) 8161-71",
                "id": "14585975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CHEK1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TP53,pmod(P,S,20))",
        "directed": false,
        "label": "kin(p(HGNC:CHEK1)) directlyIncreases p(HGNC:TP53,pmod(P,S,20))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a7c",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CHEK1)) directlyIncreases p(HGNC:TP53,pmod(P,S,20))",
              "summary_text": "We confirmed that recombinant hCHK1, but not a kinase-defective version of hCHK1, can phosphorylate p53 in vitro at S20. Additional inducible amino- and carboxy-terminal sites in p53 are also phosphorylated by hCHK1, indicating that this is an unusually versatile protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 289-300",
                "id": "10673501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CHEK1))",
        "relation": "increases",
        "target": "tscript(p(HGNC:TP53))",
        "directed": false,
        "label": "kin(p(HGNC:CHEK1)) increases tscript(p(HGNC:TP53))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a7d",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CHEK1)) increases tscript(p(HGNC:TP53))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNAPK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:FANCD2)",
        "relation": "increases",
        "target": "bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "directed": false,
        "label": "p(HGNC:FANCD2) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a7e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:FANCD2) increases bp(GOBP:\"double-strand break repair via homologous recombination\")",
              "summary_text": "Similar evidence concerning the FA proteins is less well developed. Cells deficient in Fancg are defective in repairing chromosomal DSBs by recombination34. Indicatively, mice in which Fanca or Fancd2 has been disrupted by gene targeting show aberrant meioses with failure of homologous pairing between chromosomes35,36; however, it remains to be directly demonstrated whether all of the FA proteins are required for the efficient repair of DSBs by homologous recombination, and if their loss affects this process to a similar extent.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "phos(p(HGNC:CDC25A))",
        "relation": "increases",
        "target": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "directed": false,
        "label": "phos(p(HGNC:CDC25A)) increases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a7f",
          "evidences": [
            {
              "bel_statement": "phos(p(HGNC:CDC25A)) increases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:RPS6KB1))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:TP63)",
        "directed": false,
        "label": "kin(p(HGNC:RPS6KB1)) directlyDecreases p(HGNC:TP63)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a80",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:RPS6KB1)) directlyDecreases p(HGNC:TP63)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"nucleotide-excision repair\")",
        "relation": "isA",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "bp(GOBP:\"nucleotide-excision repair\") isA bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a81",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"nucleotide-excision repair\") isA bp(GOBP:\"DNA repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:ATF2,pmod(P,T,71))",
        "directed": false,
        "label": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,71))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a82",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,71))",
              "summary_text": "Analysis of ubiquitination and degradation of the constitutively dimerized ATF2 mutant (ATF2(Delta150-248)) showed that activation of JNK or p38 kinase renders ATF2 resistant to ubiquitination and degradation. This effect is mediated by JNK/p38-dependent phosphorylation of ATF2 at Thr-69 and Thr-71, because the phosphorylation-deficient mutant (ATF2(Delta150-248-T69A,T71A)) was not protected from ubiquitination and degradation by the activation of SAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 28 275(17) 12560-4",
                "id": "10777545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,71))",
              "summary_text": "Interestingly, recent in vitro kinetic studies using recombinant active p38a expressed in Escherichia coli showed that p38 phosphorylates GST-ATF2 (amino acids 1-115) via a two-step (double collision) mechanism, involving the dissociation of mono-phosphorylated ATF2 Thr71 or Thr69 from the enzyme after the first phosphorylation step (Waas et al., 2001). Moreover, these authors found that mono-phosphorylation of ATF2 Thr69 strongly reduces the phosphorylation rate of Thr71, whereas, in contrast, mono-phosphorylation of Thr71 does not reduce the rate of Thr69 phosphorylation. Thus, efficient phosphorylation of ATF2 by recombinant E.coli-expressed active p38 only occurs in the order Thr71-> Thr69 + 71 (Figure 7). ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3782-93",
                "id": "12110590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,71))",
              "summary_text": "The transcription factor ATF2 is phosphorylated in vitro by p38 MAP kinase on Thr-69 and Thr-71 (17, 44).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,71))",
              "summary_text": "Phosphorylation of ATF2 on threonines 69,71 is mediated by stress activated protein kinases JNK (Buschmann et al., 2000, Gupta et al., 1995, Livingstone et al., 1995) or p38/MAPK (Raingeaud et al., 1996).",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:ATF2,pmod(P,T,69))",
        "directed": false,
        "label": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,69))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a83",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,69))",
              "summary_text": "Interestingly, recent in vitro kinetic studies using recombinant active p38a expressed in Escherichia coli showed that p38 phosphorylates GST-ATF2 (amino acids 1-115) via a two-step (double collision) mechanism, involving the dissociation of mono-phosphorylated ATF2 Thr71 or Thr69 from the enzyme after the first phosphorylation step (Waas et al., 2001). Moreover, these authors found that mono-phosphorylation of ATF2 Thr69 strongly reduces the phosphorylation rate of Thr71, whereas, in contrast, mono-phosphorylation of Thr71 does not reduce the rate of Thr69 phosphorylation. Thus, efficient phosphorylation of ATF2 by recombinant E.coli-expressed active p38 only occurs in the order Thr71-> Thr69 + 71 (Figure 7). ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3782-93",
                "id": "12110590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,69))",
              "summary_text": "Analysis of ubiquitination and degradation of the constitutively dimerized ATF2 mutant (ATF2(Delta150-248)) showed that activation of JNK or p38 kinase renders ATF2 resistant to ubiquitination and degradation. This effect is mediated by JNK/p38-dependent phosphorylation of ATF2 at Thr-69 and Thr-71, because the phosphorylation-deficient mutant (ATF2(Delta150-248-T69A,T71A)) was not protected from ubiquitination and degradation by the activation of SAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 28 275(17) 12560-4",
                "id": "10777545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,69))",
              "summary_text": "The transcription factor ATF2 is phosphorylated in vitro by p38 MAP kinase on Thr-69 and Thr-71 (17, 44).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(SFAM:\"MAPK p38 Family\")) directlyIncreases p(HGNC:ATF2,pmod(P,T,69))",
              "summary_text": "Phosphorylation of ATF2 on threonines 69,71 is mediated by stress activated protein kinases JNK (Buschmann et al., 2000, Gupta et al., 1995, Livingstone et al., 1995) or p38/MAPK (Raingeaud et al., 1996).",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 5'-to lesion\")",
        "relation": "isA",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 5'-to lesion\") isA bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a84",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 5'-to lesion\") isA bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 3'-to lesion\")",
        "relation": "isA",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 3'-to lesion\") isA bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a85",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"nucleotide-excision repair, DNA incision, 3'-to lesion\") isA bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\")",
        "relation": "isA",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\") isA bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a86",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\") isA bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "Cdt2-mediated XPG degradation promotes gap-filling DNA synthesis in nucleotide excision repair.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "25483071"
              },
              "metadata": {
                "created_by": "mgvelez96",
                "id": "55775d252f9e24174cfe07f2"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"nucleotide-excision repair, DNA gap filling\") isA bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "relation": "isA",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\") isA bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a87",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\") isA bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\") isA bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "Orchestral maneuvers at the damaged sites in nucleotide excision repair.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "25681868"
              },
              "metadata": {
                "created_by": "mgvelez96",
                "id": "55775d252f9e24174cfe07f0"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\")",
        "relation": "isA",
        "target": "bp(GOBP:\"nucleotide-excision repair\")",
        "directed": false,
        "label": "bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\") isA bp(GOBP:\"nucleotide-excision repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a88",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"nucleotide-excision repair, DNA duplex unwinding\") isA bp(GOBP:\"nucleotide-excision repair\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe06b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PARP1)",
        "relation": "increases",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "p(HGNC:PARP1) increases bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "alvarrben",
          "edgeId": "55775d252f9e24174cfe0a89",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PARP1) increases bp(GOBP:\"DNA repair\")",
              "summary_text": "Poly(ADP-ribose) polymerase-1 (PARP1) is a key facilitator of DNA repair.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "25528020"
              },
              "metadata": {
                "created_by": "alvarrben",
                "id": "55775d252f9e24174cfe07ee"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PARP1)",
        "relation": "increases",
        "target": "bp(\"DNA Repair\")",
        "directed": false,
        "label": "p(HGNC:PARP1) increases bp(\"DNA Repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "ndiaz",
          "edgeId": "55775d252f9e24174cfe0a8a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PARP1) increases bp(\"DNA Repair\")",
              "summary_text": "Poly(ADP-ribose) polymerase-1 (PARP1) is a key facilitator of DNA repair",
              "citation": {
                "type": "Other",
                "name": "Green AR1, Caracappa D, Benhasouna AA, Alshareeda A, Nolan CC, Macmillan RD, Madhusudan S, Ellis IO, Rakha EA., 2015, \"Biological and clinical significance of PARP1 protein expression in breast cancer.\"",
                "id": "25528020"
              },
              "metadata": {
                "created_by": "ndiaz",
                "id": "55775d252f9e24174cfe07ef"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to osmotic stress\")",
        "relation": "association",
        "target": "bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "directed": false,
        "label": "bp(GOBP:\"response to osmotic stress\") association bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "55775d252f9e24174cfe0a8b",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to osmotic stress\") association bp(GOBP:\"nucleotide-excision repair, DNA damage recognition\")",
              "summary_text": "Acute elevation of NaCl causes DNA double-strand breaks in cell culture, and the DNA breaks persist even after the cells are adapted to high NaCl.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "14983007"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "55775d252f9e24174cfe080f"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "Embryonic fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PRKDC)",
        "relation": "hasModification",
        "target": "p(HGNC:PRKDC,pmod(P,T,2647))",
        "directed": false,
        "label": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,T,2647))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a8c",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRKDC) hasModification p(HGNC:PRKDC,pmod(P,T,2647))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PARP1)",
        "relation": "decreases",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "p(HGNC:PARP1) decreases kin(p(HGNC:ATM))",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "55775d252f9e24174cfe0a8d",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PARP1) decreases kin(p(HGNC:ATM))",
              "summary_text": "PARP-1 negatively regulates ATM kinase activity in response to DSB (double-strand break).",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "15178448"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "55775d252f9e24174cfe0813"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "Embryonic fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "relation": "increases",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATM))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "55775d252f9e24174cfe0a8e",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATM))",
              "summary_text": "DNA damage activates ATM through intermolecular a autophosphorylation and self-dissociation.",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "15178448"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "55775d252f9e24174cfe0812"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "embryonic fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATM))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway  for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-DCdk4 from phosphorylating Rb  unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 46,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATM))",
              "summary_text": "We show that, upon DNA damage, RASSF1A is phosphorylated by ATM on Ser131 and is involved in the activation of both MST2 and LATS1, leading to the stabilization of p73....As shown previously, expression of RASSF1A  enhances the stability of p73 [7], but this stabilization was further enhanced when combined with DNA damage (Figure 4C, left). In agreement with a role for the ATM phosphorylation site in pathway signaling, RASSF1A-S131A blocked the stabilization of p73 in response to cisplatin-mediated DNA damage (Figure 4C, right).",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2009 Dec 15 19(23) 2020-5",
                "id": "19962312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATM))",
              "summary_text": "Exposure of ES cells to genotoxins caused an ATM-dependent nuclear accumulation of Abl but not Abl muNLS. ES cells expressing Abl muNLS exhibited delayed Bax activation, reduced cytochrome c release and decreased caspase-9 activity in response to DNA damage. These results provide a genetic proof that Abl nuclear entry contributes to DNA damage-induced activation of the intrinsic apoptotic pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2007 Jun 14(6) 1139-48",
                "id": "17363963"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe07e1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATM))",
              "summary_text": "We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA molecules. Inactive ATM dimers were activated in vitro with DNA in the presence of MRN",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Apr 22 308(5721) 551-4",
                "id": "15790808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe069e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATM))",
              "summary_text": "activation of the G2 checkpoint begins with the detection of DNA damage by the sensory molecules ATM and ATR",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe069d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "bp(GOBP:\"cellular response to DNA damage stimulus\") increases kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation on Chk1(Ser-345), Chk2(Thr-68), and p53(Ser-15)following oxidative damage by IR involved both ATM and ATR. phosphorylation on Chk1, Chk2, and p53 was found to be ATM-dependent, whereas ATR also contributed to Chk1 phosphorylation ... from full text, A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1186-92",
                "id": "15533933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "55775d252f9e24174cfe069c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HDAC2)",
        "relation": "association",
        "target": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "directed": false,
        "label": "p(HGNC:HDAC2) association bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "55775d252f9e24174cfe0a8f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:HDAC2) association bp(GOBP:\"cellular response to DNA damage stimulus\")",
              "summary_text": "Our data suggest a model in which HDAC1/2 mediated protein deacetylations, including those on H3K56 and H4K16, promote DSB repair, particularly NHEJ (Fig. 8).",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "20802485"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "55775d252f9e24174cfe0816"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "relation": "decreases",
        "target": "bp(\"DNA Repair\")",
        "directed": false,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") decreases bp(\"DNA Repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "55775d252f9e24174cfe0a90",
          "evidences": [

          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "relation": "decreases",
        "target": "bp(GOBP:\"DNA repair\")",
        "directed": false,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") decreases bp(GOBP:\"DNA repair\")",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "55775d252f9e24174cfe0a91",
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") decreases bp(GOBP:\"DNA repair\")",
              "summary_text": "Accumulation of oxidative damage to nucleic acids by cigarette smoke may lead to an increased risk of cancers and lung aging;8,9 in fact, COPD lungs have increased expression of markers of cellular senescence, which may correlate with decreased lung repair, further increasing tissue damage that characterizes the progressive and irreversible nature of lung destruction in COPD.",
              "citation": {
                "type": "Other",
                "name": "Int J Chron Obstruct Pulmon Dis. 2011;6:209-17. doi: 10.2147/COPD.S15922. Epub 2011 Mar 13. Oxidative DNA damage in lung tissue from patients with COPD is clustered in functionally significant sequences. Pastukh VM1, Zhang L, Ruchko MV, Gorodnya O, Bardwell GC, Tuder RM, Gillespie MN.",
                "id": "21660298"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "55775d252f9e24174cfe081b"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "COPD",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "relation": "decreases",
        "target": "p(HGNC:HDAC2)",
        "directed": false,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") decreases p(HGNC:HDAC2)",
        "metadata": {
          "casual": false,
          "createdBy": "mzelikman",
          "edgeId": "55775d252f9e24174cfe0a92",
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") decreases p(HGNC:HDAC2)",
              "summary_text": "HDAC2 is reduced in lungs of patients with COPD. HDAC2 reduction is associated with inflammation, steroid resistance, and DNA damage as well as lung cellular senescence",
              "citation": {
                "type": "Other",
                "name": "Am J Physiol Lung Cell Mol Physiol. 2012 Oct 1;303(7):L557-66.",
                "id": "22842217"
              },
              "metadata": {
                "created_by": "mzelikman",
                "id": "55775d252f9e24174cfe081d"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "COPD",
                "cell": "",
                "tissue": "Lung"
              }
            }
          ]
        }
      }
    ]
  }
}
